final program pdf

Transcription

final program pdf

Programme
Final
Final
Program
We share your commitment to improving the
lives of cancer patients and are proud to be
a sponsor of the 2014 Canadian Association
of Nurses in Oncology.
Pr
lenalidomide capsules
Pr
pomalidomide capsules
Pr
thalidomide capsules
®
© 2014 Celgene Inc.
REVLIMID, POMALYST, THALOMID, VIDAZA, ISTODAX and ABRAXANE
are registered trademarks of Celgene Corporation
Lundbeck
in oncology
We believe in being open to new knowledge. But even
more, our sense of humanity defines how we reach out
to another human being and the world around us.
We have created an animated video aimed at helping
children better understand cancer in the family and
help them cope with the situation. If you think that
this video could be helpful for your patient, it is located
at http://www.lundbeck.com/ca/en/therapeutic-areas/
oncology.
Lundbeck
en oncologie
Nous croyons en l’ouverture d’esprit face aux nouvelles
connaissances. En outre, ce qui nous définit le plus est
notre sens de l’humanité et la façon dont nous tendons
la main à ceux qui nous entourent.
Nous avons créé une vidéo d’animation dont l’objectif
est d’aider les enfants à mieux comprendre le cancer
lorsqu’il survient dans leur famille et à faire face à
la situation. Si vous pensez que cette vidéo pourrait
être utile à votre patient, voici l’adresse URL où elle
peut être visualisée : http://www.lundbeck.com/ca/fr/
les-maladies/oncologie.
RECONNAISSANCE DES
ETOILES DE L’ACIO/CANO
Il nous fait plaisir d’annoncer que nous
transmettrons en direct sur le Web notre
cérémonie de remise des prix et ce, pour la
deuxième année consécutive!
La Cérémonie de remise des prix ACIO/CANO aura lieu
LE MARDI 28 OCTOBRE 2014
de 9 h 30 à 10 h (heure de l’Est) / de 6 h 30 à 7 h (heure du
Pacifique) don la salle plénière du Hilton Québec.
La cérémonie de remise des prix sera
retransmise en direct sur le Web à
cette adresse :
www.cano-acio.ca/
2014-live-webcast
La cérémonie nous permet de reconnaître les contributions hors pair de nos membres
envers leur profession, leurs patients et la collectivité.
NOUS Y PRESENTERONS LES PRIX SUIVANTS :
∞∞ Prix Boehringer Ingelheim de l’infirmière en oncologie de l’année
∞ Prix d’excellence Pfizer en Recherche infirmière
∞ Prix d’excellence Pfizer en Éducation infirmière
∞ Prix d’excellence Pfizer en Leadership infirmier
∞ Prix d’excellence Pfizer en Pratique clinique infirmière
∞ Prix Agmen pour l’innovation dans l'enseignement aux patients en oncologie et à la famille
∞ Prix d'excellence en soins infirmiers liés au cancer du rein de l’Association canadienne du cancer du rein
∞ Prix d'excellence de Lymphome Canada à la mémoire de Nicholas Benum
∞ Prix œuvre de toute une vie de l'ACIO/CANO
Nous présenterons également les bourses d’étude et les subventions de voyage.
NOS DEUX CONFERENCES DONNEES DANS LE CADRE DE DEUX PRIX SPECIAUX AURONT LIEU AUX
HEURES ET DATES SUIVANTES :
DIMANCHE LE 26 OCTOBRE 2014 DE 14 H À 15 H
Présentation du Prix de conférence à la mémoire
de Helene Hudson, commandité par Amgen
LUNDI LE 27 OCTOBRE 2014 DE 9 H À 10 H
Présentation du Prix de conférence clinique
de l’ACIO/CANO
LES PRIX DE PRESENTATION D'ABREGES SUIVANTS SERONT REMIS LORS DE LA CEREMONIE DE CLOTURE
∞ Prix pour abrégé de la Fondation canadienne des tumeurs cérébrales
∞ Prix de Cancer de l'ovaire Canada ∞ Prix de la meilleure affiche décerné par les sections de l’ACIO/CANO
LA CEREMONIE DE CLOTURE SE DEROULERA LE MERCREDI 29 OCTOBRE 2014 A PARTIR DE 16 H DON LA SALLE PLENIERE
Nous tenons à remercier les membres du leadership qu’ils ont manifesté en proposant la candidature d’un ou d’une de leurs
collègues à un prix. Nous souhaitons également remercier tous les commanditaires des prix!
4
Conférence annuelle CANO/ACIO 2014 | Ville de Québec, Québec
CANO/ACIO Annual Conference 2014 | Quebec City, Quebec
RECOGNIZING
CANO/ACIO STARS
We are pleased to announce the
second annual live webcast of
our awards ceremony!
The CANO/ACIO Awards Ceremony is scheduled for
TUESDAY, OCTOBER 28, 2014
9:30am-10am Eastern / 6:30am to 7am Pacific
in the Plenary Room of the Hilton Québec.
The awards ceremony will be
live webcast at:
www.cano-acio.ca/
2014-live-webcast
At the ceremony we will recognize the extraordinary contributions of our members to their
profession, their patients and their community.
THE FOLLOWING AWARDS WILL BE PRESENTED:
∞
∞ Boehringer Ingelheim Nurse of the Year Award
∞ Pfizer Award for Excellence in Nursing Research
∞ Pfizer Award for Excellence in Nursing Education
∞ Pfizer Award for Excellence in Nursing Leadership
∞ Pfizer Award for Excellence in Nursing Clinical Practice
∞ Amgen Award for Innovation in Oncology Patient and Family Education
∞ Kidney Cancer Canada Award of Excellence in Kidney Cancer Nursing
∞ Lymphoma Canada Award of Excellence in Memory of Nicholas Benum
∞ CANO/ACIO Lifetime Achievement Award
As well, we will present the education scholarships and travel grants.
OUR TWO AWARD LECTURES ARE SCHEDULED FOR:
SUNDAY, OCTOBER 26, 2014 FROM 2PM – 3PM
Helene Hudson Lecture and Award
Presentation, sponsored by Amgen
MONDAY, OCTOBER 27, 2014 FROM 9AM – 10AM
CANO/ACIO Clinical Lecture and
Award Presentation
THE FOLLOWING ABSTRACT AWARDS WILL BE PRESENTED AT THE CLOSING CEREMONY
∞ Brain Tumour Foundation of Canada Abstract Award
∞ Ovarian Cancer Canada Award ∞ CANO/ACIO Chapter Poster Award
THE CLOSING CEREMONY IS WEDNESDAY, OCTOBER 29, 2014 AT 4:00 PM IN THE PLENARY ROOM
We wish to thank members for the leadership shown in nominating one of their colleagues for an award. And,
we wish to thank the sponsors of the awards!
As a member of the Janssen Pharmaceutical
Companies of Johnson & Johnson, Janssen Inc.
is dedicated to addressing and solving the most
important unmet medical needs of our time. Driven
by our commitment to the passionate pursuit of
science for the benefit of patients, we work together
to bring innovative ideas, products and services to
patients across Canada and around the world.
À titre de membre du groupe des entreprises
pharmaceutiques Janssen de Johnson & Johnson,
Janssen Inc. s’emploie à répondre aux besoins
non satisfaits les plus importants de notre temps.
Poussés par notre passion de mettre la science au
service des patients, nous collaborons à de nouvelles
solutions, produits et services pour le bien des
patients dans le monde entier.
Janssen Inc.
19 Green Belt Drive
Toronto, Ontario
M3C 1L9
vx140174
© 2014 Janssen Inc.
www.janssen.ca
Our purpose:
Make a difference
Nous mettons la
science au service
des patients
Toutes nos félicitations aux candidat(e)s au prix
de l’infirmier(ère) de l’année pour 2014!
Congratulations to the Nominees of
the 2014 Nurse of the Year Award!
Denise Bryant-Lukosius,
Hamilton, ON
Irène Leboeuf,
Montreal, QC
Marie-France Vachon,
Montreal, QC
Donalda MacDonald,
Toronto, ON
Janet Giroux,
Kingston, ON
Nanette Cox Kennett,
Edmonton, AB
Donna Van Allen,
Millbank, ON
Jennifer Wiernikowski,
Hamilton, ON
Philiz Goh,
Toronto, ON
Harold Dunn,
Karey McCann,
Edmonton, AB
Tammie Murray,
London, ON
Lourdes-de-Blanc-Sablon, QC
Heidi Thomas,
Hamilton, ON
Tracey Moffatt,
Toronto, ON
La remise du prix de 2014 fera l’objet d’une webémission en direct
le 28 octobre, de 9 h 30 à 10 h (HAE) / de 6 h 30 à 7 h (HAP) à
The 2014 Nurse of the Year Award will be live webcast on
October 28, 9:30am – 10:00am EDT / 6:30am – 7:00am PDT at
WWWW.CANO-ACIO.CA/2014-LIVE-WEBCAST
Encore une fois, toutes nos félicitations et nos meilleurs voeux à l’ensemble des candidates et candidats.
Congratulations and best wishes to all nominees.
L’ACIO/CANO tient à remercier Boehringer Ingelheim (Canada) du généreux soutien qu’elle a fourni envers ce prix.
CANO/ACIO gratefully acknowledges the generous support of Boehringer Ingelheim (Canada) for this award.
Ondissolve ODF
Pr
TM
Ondansetron Orally Disintegrating Film
•Ondansétron
QuICk-DISSOLVING
designed for orale
filmFILM
à dissolution
1,*
Live Type
CheltenhamITCbyBT*
convenient administration without water
• DEMONSTRATED to be well tolerated1
– Most common side effects reported for
ondansentron in controlled clinical trials
were headache (11%) and constipation
(4%). Other adverse events include
sensations of flushing
or warmth (<1%)
Clinical experience of ONDISSOLVETM in
children is currently limited; ONDISSOLVETM
is not indicated for the treatment of
children 3 years of age or younger.
Indications and clinical use
• Adults: ONDISSOLVETM is indicated for the prevention of nausea and
vomiting associated with emetogenic chemotherapy, including high
dose cisplatin, and radiotherapy; and the prevention and treatment of
post-operative nausea and vomiting.
• Pediatrics (<18 years of age): Clinical experience of ondansetron
in children is currently limited; however, ondansetron was effective
and well tolerated when given to children 4-12 years of age postchemotherapy. ONDISSOLVETM is not indicated for use in pediatric
patients post-radiotherapy or for post-operative nausea or vomiting.
ONDISSOLVETM is not indicated for the treatment of children ≤3 years
of age.
• Geriatrics (>65 years of age): Post-chemotherapy and -radiotherapy,
efficacy and tolerance of ondansetron in patients in this population
were similar to those observed in younger adults. ONDISSOLVETM is
not indicated for the prevention or treatment of post-operative nausea
or vomiting in this population.
Contraindications
The concomitant use of apomorphine with ondansetron is contraindicated
based on reports of profound hypotension and loss of consciousness
when apomorphine was administered with ondansetron.
Relevant warnings and precautions
• Cross-reactive hypersensitivity has been reported between 5-HT3
antagonists. If a patient has experienced even a mild hypersensitivity
type reaction to a 5-HT3 antagonist, do not use another one.
• Rarely, transient ECG changes including QT interval prolongation and
post-marketing cases of Torsade de Pointes have been reported in
patients using ondansetron. Do not use ONDISSOLVETM in patients with
© 2014 Takeda Canada, Inc. All rights reserved.
TM
Trademark of Takeda GmbH, used under licence.
Takeda Canada, Inc. Oakville, Ontario L6M 4X8
38917-1-Eng-Journal ad-pass1.indd 1
congenital long QT syndrome or who may develop prolongation of QTc
unless nausea and vomiting cannot be controlled with other drugs.
• ONDISSOLVETM is not effective in preventing motion-induced nausea
and vomiting.
• In patients with moderately or severely impaired hepatic function, a
reduced dosage is recommended and a total daily dose of 8 mg
should not be exceeded.
• Monitor patients with signs of subacute intestinal obstruction.
• Ondansetron does not itself appear to induce or inhibit the
cytochrome P450 drug metabolizing enzyme system of the liver.
Because ondansetron is metabolised by hepatic cytochrome P450
drug-metabolizing enzymes, inducers or inhibitors of these enzymes
may change the clearance and, hence, the half-life of ondansetron. On
the basis of available data no dosage adjustment is recommended for
patients on these drugs.
• Not recommended for use during pregnancy or while nursing.
For more information
For important information on conditions of use, contraindications,
warnings, precautions, adverse reactions, interactions and dosing,
please consult the product monograph at http://www.takedacanada.
com/ca/ondissolvepm. The product monograph is also available by
contacting Takeda Canada at 1-866-295-4636.
* Clinical significance has not been established.
Reference: 1. ONDISSOLVETM ODF (ondansetron orally disintegrating film)
Product Monograph. Takeda Canada, Inc., July 2012.
OND-13-1-04-E
2014-04-23 3:38 PM
"!" " #" ! $#!!
!
!"""
%!
Liste des commanditaires et exposants/
sponsor and exhibitor listing
The 26th CANO/ACIO Annual Conference is made possible by the generous support of the following organizations:
La 26ème conférence annuelle de l’ACIO/CANO est rendue possible grâce au généreux soutien des organisations suivantes:
Platine / Platinum
Or / Gold
Argent / Silver
Bronze/Bronze
App Sponsor
Symposium / Symposia
Abbott Nutrition • Amgen • Astellas • Boehringer Ingelheim • Celgene • Janssen Inc. • Merck • Novartis • Roche
Panel de discussion / Focus Group
Boehringer Ingelheim
Sponsors des récompenses / Award Sponsors
Amgen • Brain Tumour Foundation • Boehringer Ingelheim • CANO/ACIO BC, Ottawa, PEI, and Toronto
Chapters • Ovarian Cancer Canada • Kidney Cancer Canada • Lymphoma Canada • Pfizer Canada Inc.
Exposants / Exhibitors
Abbott Nutrition • Advanced Innovations Inc. Bio Oil • Alberta Health Services • Amgen • Astellas • Bayer •
Becton Dickinson (BD) Canada • Bristol-Myers Squibb (BMS) • Boehringer Ingelheim • CANO/ACIO • Canadian Breast
Cancer • Canadian Nurses Association • Cancer and Careers • Carefusion • Celgene • Cold Comfort Canada Inc. • Eisai
Limited • Fondation Sur la pointe des pieds • Fresenius Kabi Canada • GlaxoSmithKline (GSK) • ICU Medical Inc. •
Innovation OncoSolutions Inc. • Janssen Inc. • Kidney Cancer Canada • Look Good Feel Better and
FacingCancer.ca • Lundbeck • Lymphoma Canada • Merck • Oncology Nursing Society • Pfizer Injectables • Pfizer
Oncology • Roche • Shoppers Drug Mart Specialty Health Network • Sphynx Médical Inc. • Takeda • The Leukemia &
Lymphoma Society of Canada • Trudell Medical Marketing Limited
10
Table DES MATIÈRES /
Table of contents
Liste des commanditaires et exposants / Sponsor and Exhibitor Listing . ................................................................................ 10
Mots de bienvenue / Welcome Notes . ................................................................................................................................................... 12
Lettre de la Présidente / Letter from the President .......................................................................................................................... 18
Bienvenue à Québec / Welcome to Quebec . ....................................................................................................................................... 20
Informations sur la conférence / General Conference Information . .......................................................................................... 22
Liste des membres des comités / Committee Listing ....................................................................................................................... 23
C’est ça Québec ! / This is Quebec City! . ............................................................................................................................................. 24
Plan du centre de conférences / Conference Floor Plan . ............................................................................................................... 28
Plan et liste des exposants / Exhibitor Floor Plan and Listing ..................................................................................................... 29
Programme de la conférence d’un coup d’ œil / Program–at–a–Glance .................................................................................. 30
Horaire des réunions / Meeting Schedule ........................................................................................................................................... 32
Jour Un / Day One . ...................................................................................................................................................................................... 33
Jour Deux / Day Two . ................................................................................................................................................................................. 40
Jour Trois / Day Three ................................................................................................................................................................................ 47
Jour Quatre / Day Four . ............................................................................................................................................................................. 54
Abrégés des présentations orales / Oral Abstract Presentations ................................................................................................. 61
Séance d’affichage / Poster Presentations ..........................................................................................................................................117
Liste des exposants / Exhibitor Listing............................................................................................................................................... 133
Carte de Québec / Quebec City Map ...................................................................................................................................................140
dimanche, 26 Octobre - mercredi, 29 Octobre, 2014 CANO/ACIO 2014 Conférence annuelle
Sunday, October 26 - Wednesday, October 29, 2014 CANO/ACIO Annual Conference 2014
11
Cʹest avec plaisir que je salue chaleureusement tous ceux et celles qui participent à la 26e Conférence annuelle de l’Association canadienne des infirmières en oncologie (ACIO), qui a lieu à Québec. Ce congrès constitue le cadre idéal pour les infirmières dʹapprofondir leurs connaissances et dʹêtre mieux informées au sujet des évolutions les plus récentes de leur métier. Je suis convaincu que les participantes profiteront grandement des débats pour échanger des idées et des expériences dans le but dʹaméliorer la pratique infirmière en oncologie. Depuis sa fondation, lʹACIO poursuit sans relâche la mission quʹelle sʹest fixée, à savoir, le perfectionnement des compétences du personnel infirmier et lʹoptimisation de la contribution de ses membres à la lutte contre le cancer. Je tiens à féliciter ces derniers de leur engagement et de leurs remarquables efforts pour dispenser, au quotidien, des soins de qualité aux patients. Au nom du gouvernement du Canada, je vous souhaite une conférence des plus fructueuses. OTTAWA 2014 I am pleased to extend warm greetings to everyone attending the 26th Annual Conference of the Canadian Association of Nurses in Oncology (CANO), in Quebec City. This conference provides an ideal forum for nurses to enhance their knowledge and become better informed about the latest developments in their profession. I am sure that participants will make the most of this opportunity to share ideas and experiences for applying best practices to oncology nursing. Since it was founded, CANO has never wavered in its mission to support the professional development of nursing staff and optimizing the contribution of its members to the fight against cancer. I congratulate them on their commitment and their remarkable efforts to deliver high‐quality care to patients every day. On behalf of the Government of Canada, I wish you a most productive conference. OTTAWA 2014 Au nom du gouvernement du Québec, c’est avec
plaisir que je transmets mes salutations à tous les
participants à la conférence annuelle de l’Association
canadienne des infirmières en oncologie.
Le Québec est fier d’accueillir dans sa capitale
nationale ce rendez-vous majeur dans le milieu
médical. C’est grâce à des événements comme celuici, qui constituent d’importants lieux d’échanges
d’informations, de connaissances et d’expériences,
que l’on peut actualiser la pratique et toujours
améliorer les soins infirmiers en oncologie. Autour
du thème Le patient partenaire, vous nourrissez les
savoirs et les espoirs, puisque vous participez autant
à relever les défis de la science que les défis humains,
si intimement liés dans la relation entre l’être qui reçoit
les soins et l’être qui les donne.
Je salue cette mission des plus méritoires que poursuit
l’Association canadienne des infirmières en oncologie
au service de la santé publique, et je lève mon
chapeau à vous tous ici qui l’accomplissez ensemble
de façon remarquable.
Je félicite les organisateurs et souhaite un excellent
séjour à tous dans la superbe ville de Québec!
Philippe Couillard
On behalf of the Québec government, I take pleasure
in extending greetings to all of the participants in the
annual conference of the Canadian Association of
Nurses in Oncology.
Québec is proud to host in its capital city this major
medical conference. It is through events such as
this one, which serve as a conduit for exchanging
information, knowledge and experience, that we can
update practices and constantly improve nursing care
in oncology. Under the theme “Patient Engagement,”
you are enriching knowledge and sustaining hope
since you are both meeting the challenges posed
by science as well as human challenges that are
inextricably linked in the relationship between patients
and caregivers.
I would like to pay tribute to this praiseworthy mission
that the Canadian Association of Nurses in Oncology
is pursuing in public health and congratulate all of
you here who are achieving this goal together in a
remarkable manner.
I congratulate the event’s organizers and hope that you
will all enjoy your stay in magnificent Québec City!
Philippe Couillard
Bienvenue à Québec!
C’est avec un grand plaisir que je vous souhaite la
bienvenue à Québec à l’occasion de la 26e conférence
annuelle de l’Association canadienne des infirmières en
oncologie.
Les personnes atteintes de cancer se trouvent sur un chemin
parsemé de souffrances physiques et morales, d’inquiétudes
et d’espoirs. Leurs proches voient aussi leur vie bousculée.
Les infirmières en oncologie agissent auprès d’eux, de façon
significative, en offrant soins, écoute, information et
conseils. Leur expertise et la passion qui les habite font
la différence au cours de cette épreuve.
Dans cet esprit, je suis convaincu que les idées novatrices
entendues à cette conférence ainsi que les échanges
stimulants
qui
suivront,
permettront
d’enrichir
les
connaissances et d’améliorer les pratiques pour le mieuxêtre des patients.
Plus belle que jamais en cette période automnale, Québec
vous offre un cadre idéal pour joindre l’utile à l’agréable.
Je vous invite à faire le plein d’énergie en partant à la
découverte des nombreux attraits d’une ville où l’art, la
culture, le plein air et la gastronomie occupent une place
de choix.
À tous et à toutes, je souhaite des échanges fructueux et un
excellent séjour parmi nous!
Le maire de Québec,
Régis Labeaume
Welcome to Quebec City!
It is with great pleasure that I welcome you to Quebec City
on the occasion of the 26th Annual Conference of the
Canadian Association of Nurses in Oncology.
Cancer patients find themselves on a path strewn with
physical and moral suffering, and worries, as well as hopes.
Their family and friends also find their lives upset.
Oncology nurses intervene with them in significant ways,
providing care, a listening ear, information, and advice.
Their expertise and the passion they bring to their work
make all the difference throughout this difficult time.
In this spirit, I am convinced that the innovative ideas
heard at this conference, and the stimulating exchanges that
follow, will contribute to enriching knowledge and improving
practices for the well-being of patients.
More beautiful than ever in this autumn time, Quebec City
offers an ideal setting for combining business with
pleasure. I invite you to replenish your energy by exploring
the many attractions of a city where art, culture, the
outdoors, and gastronomy occupy a prominent place.
To all of you, I hope that your meetings will be rewarding,
and that you will have an excellent stay with us!
The Mayor of Quebec City,
Régis Labeaume
Lettre de la Présidente
Chers collègues,
première importance à laquelle tous les membres devraient
assister. Lors de cette rencontre, le conseil présente aux
C’est au nom du conseil d’administration de l’ACIO/CANO
membres les grandes réalisations de l’association et ses divers
que je vous souhaite la bienvenue à la 26e conférence annuelle
rapports officiels. Cela comprend notamment le rapport de
de l’ACIO/CANO se tenant à Québec du 26 au 29 octobre 2014.
la présidente, le rapport de la trésorière, les grandes lignes de
notre plan stratégique et les progrès réalisés en la matière au
Le thème de la conférence « Le patient partenaire – Patient
cours de l’année écoulée, les défis qu’il faudra relever et les
Engagement » vient renforcer le concept selon lequel les choses
opportunités de participation offertes aux membres. L’AGA
se passent plus en douceur quand les patients, les familles et les
vous donne l’occasion d’entretenir un dialogue plus poussé
soignants sont tous impliqués, un concept que vient soutenir
avec votre conseil d’administration.
l’expérience des infirmières et diverses études. En explorant ce
qui revêt le plus d’importance, nous sommes plus susceptibles
J’adresse des remerciements particuliers aux coprésidentes
de dispenser des soins optimaux débouchant sur les meilleurs
de la conférence, Karyn Perry et Jeanne Robertson, aux
résultats possibles pour les patients et leurs proches. La
présidentes du comité de planification local, Lucie Tardif et
conférence rassemblera un groupe talentueux, engagé et
Geneviève Lepage, aux présidentes du comité de planification
exceptionnel d’infirmières provenant de tous les domaines de
scientifique, Virginia Lee et Karine Bilodeau, à la présidente
l’oncologie. Il s’agira d’une occasion d’apprendre, de célébrer et
du comité de reconnaissance de l’excellence, Lorraine
de réseauter avec nos collègues de partout au Canada et même
Martelli, et enfin à l’équipe du bureau national de l’ACIO/
d’autres parties du monde.
CANO, Ana Torres, Cornélie Lefèvre, et Carole Perez, ainsi
qu’à tous nos bénévoles et nos commanditaires !
Le comité directeur de la conférence, le comité de
planification local et le comité de planification scientifique
Pour terminer, j’espère que la conférence sera stimulante
ont travaillé d’arrache-pied afin de créer un programme
pour vous et qu’elle vous aidera à poursuivre vos objectifs
qui vous permettra d’appliquer ce que vous aurez appris en
de développement professionnel. Venez nous rejoindre dans
vue de transformer les soins dans votre milieu de travail. La
une des meilleures destinations au pays et faire de cette
conférence inclura notamment des présentations orales et par
conférence un événement inoubliable. Riche en attractions
affiches, des ateliers, des prix de conférence, la remise de prix
naturelles, culturelles et historiques – notamment le Vieux-
d’excellence les conférences plénières. Nous sommes ravies
Québec –, Québec saura vous charmer.
que ces derniers soient donnés par Andréanne Saucier, France
Legaré et Dawn Stacey ainsi que par notre invité spécial, Hugo
Je tiens à vous remercier à l’avance de votre soutien envers
Desrochers, qui parlera de son expérience à titre de patient
l’ACIO/CANO et de vos efforts pour faire de cette conférence
partenaire et de membre actif de la Société de leucémie et
une merveilleuse réussite!
lymphome du Canada.
Bien à vous,
Un des points saillants de notre conférence annuelle est
l’événement social qui aura lieu le mardi 28 octobre. Il se
déroulera au Musée de la civilisation situé à quelques pas
seulement du port de Québec et au cœur du Petit Champlain.
Un autre moment important est notre assemblée générale
annuelle qui se tiendra le mardi matin entre 8 et 9h30.
Barbara Fitzgerald, inf., M.Sc.inf.
Présidente
Association canadienne des infirmières en oncologie
Tous les membres de l’ACIO/CANO sont invités à assister à
l’assemblée générale annuelle. Il s’agit là d’une réunion de
18
Letter from the President
Dear Colleagues,
On behalf of the CANO/ACIO board, I welcome you
to the 26th annual CANO/ACIO conference in Quebec
City from October 26 to October 29, 2014.
The conference theme, ‘Le patient partenaire’,
‘Patient Engagement’, speaks to the fact that both the
experience of nurses and studies show that when
patients, families and caregivers are engaged, things
go more smoothly. Exploring what matters most
means we have a better chance to provide the best
care with the best possible outcomes for patients and
their families.
The conference will bring together a special,
talented, and committed group of nurses from all
fields of oncology. It is an opportunity to learn,
celebrate, and network with colleagues from across
Canada as well as from other parts of the world.
The conference planning steering, local planning
and scientific programming committees have worked
hard to create a program that will enable you to apply
what you have learned to transform care in your
work settings. The structure includes oral/poster
presentations, workshops, lectureship awards, awards
of excellence, and our keynote addresses. We are
pleased to have Andréanne Saucier, Dr. France Legaré
and Dr. Dawn Stacey as our keynote speakers along
with keynote Hugo Desrochers who will share his
experience as a patient partner and active member of
the Leukemia and Lymphoma Society of Canada.
Another highlight is our annual general meeting from
8 a.m. to 9:30 a.m. on Tuesday, October, 28, 2014. The
annual general meeting is an important meeting for all
members to attend. It is an occasion for the board to
present and report on the association’s achievements to
the members. This includes the president’s report, the
treasurer report, milestones and progress on our strategic
plan over the past year that will include challenges to be
met as well as opportunities for members to be involved.
It provides you an opportunity to engage with your
Board of Directors more deeply.
A special thank you to the conference co–chairs, Karyn
Perry and Jeanne Robertson, the local planning chairs,
Lucie Tardif and Geneviève Lepage, the scientific
programming chairs, Virginia Lee and Karine Bilodeau,
the recognition of excellence committee chair, Lorraine
Martelli, the CANO/ACIO head office team, Ana
Torres, Cornelie Lefevre, and Carole Perez, and all of our
volunteers and sponsors!
In closing, I hope the conference is restorative and
helps support your ongoing professional development
goals. Come and join us in one of the best destinations
in our country and make this a conference that you
will not forget. Quebec City will charm you with its
numerous natural, cultural and historical attractions
most notably in the Old Quebec sector.
I want to thank all of you in advance for supporting
CANO/ACIO and making this annual conference a
wonderful success!
Sincerely,
A highlight of our annual conference is the social
event on Tuesday, October, 28, 2014. It will be in the
heart of Petit Champlain just a few steps away from
the port of Quebec City at the Musée de la civilisation.
Barbara Fitzgerald, RN, MScN
President
Canadian Association of Nurses in Oncology
19
Bienvenue à Québec pour la
conférence annuelle
2014 DE L’ACIO/CANO
C’est avec beaucoup d’enthousiasme que le comité
de planification local de l’ACIO vous convie à la 26e
conférence annuelle de l’ACIO qui se tiendra à Québec
du 26 au 29 octobre 2014 sur le thème « Le patient
partenaire »
Les soins infirmiers en oncologie évoluent vers
une vision participative où patients, proches et
professionnels de la santé redéfinissent leur relation
afin de faire face aux défis de demain. Tout au long de
la trajectoire de la maladie, les personnes atteintes de
cancer, les proches et les professionnels doivent prendre
plusieurs décisions, alors que les options de traitement
deviennent plus nombreuses. La société d’aujourd’hui
valorise l’autonomie et le respect des choix personnels.
Les patients ont accès à une panoplie d’informations
spécialisées principalement via internet. Il est de notre
ressort d’accompagner nos patients et leurs proches dans
la trajectoire et dans leur prise de décision.
La reconnaissance de l’expérience et de l’expertise
des patients et des proches dans une prise de décision
partagée avec les professionnels devient une dimension
de plus en plus importante des soins en oncologie. Tant
au plan de la prestation des soins et de leur organisation
que de l’enseignement ou de la recherche, des initiatives
émergent pour que le patient et ses proches deviennent
des partenaires à part entière.
20
Nous espérons que les conférences, les ateliers, les
recherches et les séances de communication par
affichages qui seront présentés seront pour vous
une source d’inspiration afin d’optimiser la pratique
infirmière en oncologie et ainsi, d’offrir toujours les
meilleurs soins aux personnes atteintes de cancer et
à leurs proches. Les échanges avec vos collègues de
partout au Canada permettront, sans aucun doute, de
mettre à contribution votre expertise et vos compétences
pour vous aider à bâtir ensemble une pratique de soins
en oncologie toujours renouvelée, centrée sur les besoins
des patients et axée sur les résultats probants.
L’événement social et le 5 km de course/marche
seront, sans aucun doute, des moments privilégiés
pour échanger avec cette belle et grande communauté
d’infirmières en oncologie
C’est donc un plaisir pour nous de vous recevoir à
Québec, du 26 au 29 octobre, pour la conférence annuelle
de l’ACIO/CANO 2014.
Le comité local
Welcome to Quebec City for the 2014
CANO/ACIO Annual Conference
It is with a great deal of enthusiasm that CANO/ACIO’s
local planning committee invites you to the 26th Annual
CANO/ACIO Conference, which will take place in
Quebec City from October 26 to 29, 2014, on the theme:
“Patient Engagement.”
Oncology nursing is evolving toward a participatory
vision in which patients, loved ones and health
professionals redefine their relationship in order to
face tomorrow’s challenges. Throughout the disease
trajectory, cancer patients, loved ones and professionals
are faced with many decisions, and treatment options
are becoming more numerous. Today’s society values
autonomy, and respect for personal choices. Patients
have access to a wealth of specialized information
namely through the internet. It is our responsibility to
accompany our patients and their loved ones in this
trajectory and in their decision-making.
Recognizing the experience and expertise of patients
and loved ones through the sharing of decisionmaking with professionals is becoming more and more
important in oncology nursing. On the level of care
delivery and organizations as well as education or
research, new initiatives are implemented that allow
patients and loved ones to become complete partners.
We hope that the seminars, workshops, research, and
poster sessions that will be presented will be a source
of inspiration for you in optimizing oncology nursing
practice, and also continue providing the best care for
cancer patients and their loves ones. The exchange
with your colleagues from across Canada will doubtless
provide opportunities to contribute your expertise
and skills towards building together an oncology care
practice that is continually updated, centered on patient
needs, and based on evidence.
The social event and the 5 km run/walk will no doubt
be a special occasion for sharing among our beautiful
and widespread community of oncology nurses.
It is therefore a pleasure for us to welcome you in
Quebec City, from October 26 to 29, for the 2014 CANO/
ACIO Annual Conference.
The Local Committee
21
Informations sur la confÉrence /
General Conference Information
Inscription /Registration
Pour s’inscrire à la conférence, allez sur
le site internet de l’ACIO/CANO : www.
cano–acio.ca et complétez votre bulletin
d’inscription en ligne (payez par carte de
crédit et recevez $25 de remise) ou renvoyez
votre bulletin par télécopieur ou par la poste
(paiement par chèque uniquemement). Vous
recevrez un reçu par courriel lorsque votre
inscription aura été enregistrée.
L’inscription sur place est possible par chèque
ou carte crédit. Le bureau d’enregistrement se
situe dans le hall d’entrée.
Le centre de services aux conférenciers,
situé dans la salle Duchesnay, est équipé
d’ordinateurs pour que les conférenciers
puissent revoir leur présentations avant
leurs ateliers. Les heures du bureau
d’inscription et du bureau des services aux
conférenciers sont les suivantes:
Samedi 25 octobre | 4:00 pm - 8:00 pm
Dimanche 26 octobre | 6:30 am - 7:00 pm
Lundi 27 octobre | 6:30 am - 6:00 pm
Mardi 28 octobre | 6:30 am - 7:00 pm
Mercredi 29 octobre | 7:15 am - 4:00 pm
To register for the conference, go to the CANO/
ACIO website at www.cano–acio.ca and either
complete your registration online (pay by credit
card online & receive a $25 discount) or download
and submit by fax or mail a registration form
(cheque payment only). Once your registration has
been processed, a receipt will be emailed to you.
On-site registration will be available. Cheque
and credit card payment will be accepted. The
registration desk is located in the Lobby.
The speaker services center, located in
Duchesnay, is equipped with PC laptops for
speakers to review their presentations before
their session.
Speaker services and registration hours are
as follows:
Saturday, October 25 | 4:00 pm - 8:00 pm
Sunday, October 26 | 6:30 am - 7:00 pm
Monday, October 27 | 6:30 am - 6:00 pm
Tuesday, October 28 | 6:30 am - 7:00 pm
Wednesday, October 29 | 7:15 am - 4:00 pm
Logement/Accommodation
Pour le comfort des délégués, un nombre
limité de chambres ont été réservées à
l’hôtel Hilton à un tarif spécial.
22
Veuillez contacter l’hôtel directement au 1–418–
647–2411 pour faire une réservation en vous
présentant en tant que membre de l’Association
Canadienne des infirmières en oncologie afin
de bénéficier du tarif spécial. Vous pouvez aussi
réserver en ligne en suivant le lien sur la page de
la conférence www.cano-acio.ca.
For the convenience of conference attendees, a
limited number of rooms have been reserved at
the Hilton Quebec at a special rate.
Please call the hotel directly at 1–418–647–2411
to make reservations and identify yourself as
being with the “Canadian Association of Nurses
in Oncology” to obtain the conference rate.
You can also book online by following the link
on the annual conference page at
www.cano–acio.ca.
Soirée sociale/
Social Evening
Au cœur du Petit Champlain, à quelques pas du
Port de Québec, joignez–vous à nous pour un
souper–soirée au Musée de la civilisation de
Québec, le mardi 28 octobre 2014. Vos papilles,
vos yeux, vos oreilles et peut–être même vos
pieds en seront enchantés! Gastronomie et
animation sauront agrémenter cet événement
qui se tiendra dans un environnement
enchanteur et chargé d’histoire. La visite d’une
exposition s’ajoutera aux différentes activités de
la soirée. Inscrivez–vous en grand nombre!
Réservez votre billet dès maintenant!
In the heart of the Petit Champlain district, a
few steps from the Port of Quebec City, join us
for dinner and a social evening at the Musée
de la civilisation, on Tuesday October 28th,
2014. Your taste buds, eyes, ears, and perhaps
even your feet will be delighted! Gastronomical
pleasures and a program of entertainment will
highlight this event, which will take place in an
enchanting and very historic setting. An exhibit
tour will supplement the various activities of the
evening. We hope that many of you will register!
Get your social ticket now!
Activité spéciale : 5 km de
marche ou de course/Special
Activity: 5 km walk or run
Pour les personnes inscrites à l’évènement 5 km,
l’activité se tiendra dimanche 26 octobre et sera
supervisée par une équipe de kinésiologues du
Pavillon de prévention des maladies cardiaques
(PPMC) de l’Institut universitaire de cardiologie
et de pneumologie de Québec.
Le rassemblement des participants se fera dans
le hall de l’hôtel Hilton entre 5h30 et 6h00.
La course débutera à 6h00 du matin. Pour les
personnes ne résidant pas à l’hôtel Hilton, des
douches seront mises à votre disposition dans
la salle d’entraînement de l’hôtel.
For those who have registered for the 5 km
run/walk, the activity will take place Sunday
October 26 and will be supervised by a team of
kinesiologists from the Cardiovascular Disease
Prevention Department of the Quebec Heart
and Lung Institute.
Participants will meet in the Hilton hotel lobby
between 5:30 am & 6:00 am. The run/walk
will begin at 6:00 am. For registrants who are
not staying at the Hilton hotel, showers will
be available for you at the hotel workout room
following the event.
Traduction simultanée/
Simultaneous Translation
Les conférences plénières seront présentées
en français ou en anglais avec une traduction
simultanée. Les casques audios seront fournis
lors de l’enregistrement.
Plenary presentations will be both in English
and French. Simultaneous interpretation will be
provided. Please get your headset at registration.
Parfums/Scents
Veuillez noter que la conférence de l’ACIO/
CANO 2014 est un environnement sans parfum.
Par respect pour les autres participants, merci
de ne pas utiliser de fragrances ou autres
odeurs fortes lors de la conférence.
Please note that the CANO/ACIO 2014
conference is a scent free environment. Please
refrain from the use of perfumes or other strong
scents during the conference.
Information
Pour plus d’informations, veuillez contacter le
secrétariat de la conférence :
For further information contact the Conference
Secretariat:
CANO/ACIO Management Office
570 West 7th Avenue, Suite 400
Vancouver, BC V5Z 1B3
Tel: 604.874.4322 Fax: 604.874.4378
Email: cano@malachite–mgmt.com
Website: www.cano–acio.ca
Liste des Membres des ComitÉs
commitee listing
Comité de planification local /
Local Planning Committee
Comité du programme scientifique /
Scientific Program Committee
Geneviève Lepage, MSc.inf. CSIO(C), co–présidente
Karine Bilodeau, inf., PhD, CON(C)
SPC co–chair
Virginia Lee, RN, MScA, PhD
SPC co–chair
Lynn Kachuik, RN, BA, MSc, CON(C), CHPCN(C)
2012 SPC co–chair
Simonne Simon, RN, MN, BScN, CON(C)
2015 SPC co–chair
Jennifer Stephens, RN, BSN, MA, OCN
2013 SPC co–chair
Lucie Tardif, MSc.inf.
LPC co-chair
Tracy Truant, RN, MScN, PhD(c)
2013 SPC co–chair
Lucie Tardif, MSc.inf., co–présidente
Sandra Blanchette, BSc.inf., CSIO(C)
Stephanie Duguay, BSc.inf., CSIO(C)
Marie–Claude Fortin, BSc.inf., CSIO(C)
Brigitte Fournier, MSc.inf., CSIO(C)
Nathalie Gravel, BSc.inf., CSIO(C)
Marie de Serres, MSc.inf., CSIO(C)
Pierre Verret, MSc.inf., CSIO(C)
Pierre Verret, MSc.inf., CSIO(C)
SPC committee member
Comité d’organisation de la
conférence / Conference Planning
Steering Committee
Jeanne Robertson, RN, BSc, BA, MBA
CPSC co–chair
Karyn Perry, RN, BSN, MBA, CON(C)
CPSC co–chair
Lucie Tardif, MSc.inf.
LPC co–chair
Geneviève Lepage, MSc.inf., CSIO(C)
LPC co–chair
Virginia Lee, RN, MScA, PhD
SPC co–chair
Karine Bilodeau, inf., PhD, CON(C)
SPC co–chair
Charissa Cordon, RN, MN, CON(C)
2015 LPC co–chair
Diana Incekol, RN, BScN, MScN, CON(C)
2015 LPC co–chair
Conseil d’administration de l’ACIO /
CANO Board of Directors
Barbara Fitzgerald, RN, MScN
President
Tracy Truant, MScN, RN, PhD(c)
Vice–President
Jeanne Robertson, RN, BSc, BA, MBA
Treasurer
Lorna Roe, RN, MScN, BSc
Director–at–Large – Communications
Karyn Perry, RN, BSN, MBA, CON(C)
Director–at–Large – Education
Christine Zywine, RN(EC), MScN, CON(C)
Director–at–Large – External Relations
Corsita Garraway, RN(EC), MScN, CON(C)
Director–at–Large – Membership
Laura Rashleigh, RN, BScN, MScN, CON(C)
Director–at–Large – Professional Practice
Sally Thorne, RN, PhD, FCAHS
Director–at–Large – Research
Margaret Fitch, RN, PhD
Canadian Oncology Nursing Journal Editor–in–Chief
Cindy McLennan, RN, BScN, MBA, CON(C)
Incoming Director–at–Large – Membership
Shari Moura, RN, MN, CON(C), CHPCN(C)
Incoming Director–at–Large – External Relations
Dawn Stacey, RN, PhD, CON(C)
Incoming Director–at–Large – Research
23
C’est ça Québec !
Capitale de la province de Québec, berceau de la civilisation française en Amérique
du Nord, joyau du patrimoine mondial selon l’UNESCO. Québec a une identité qui
lui est propre et qui la distingue des autres villes du Canada. Classée meilleure
destination au pays en 2013 par le prestigieux magazine touristique « Travel and
Leisure », la ville de Québec saura vous charmer de par sa multitude d’attraits
naturels, culturels et historiques. Venez découvrir plus de 400 ans d’histoire à travers
ceux–ci, notamment dans le secteur du Vieux–Québec. Que ce soit pour assister à
des festivals, des événements de grande envergure, pour participer à des activités
récréatives, de détente ou pour une bonne dose d’adrénaline, vous pourrez vivre vos
passions à Québec dans un environnement à vous couper le souffle.
Profitez–en également pour admirer le Château Frontenac, « l’hôtel le plus
photographié dans le monde », situé tout en haut du Cap Diamant. Appelée à devenir
un véritable oasis au cœur de la ville, la Promenade Samuel–De Champlain vous fera
parcourir un circuit enchanteur le long des berges d’un des 25 plus longs fleuves
du monde, le Saint–Laurent. Et pourquoi ne pas partir à la découverte de ce qui fait
la renommée gastronomique de la ville de Québec en visitant l’un des nombreux
restaurants de classe internationale offrant une cuisine française et continentale
raffinée. Terminez votre soirée sur la Grande Allée et vous comprendrez pourquoi
Québec représente une destination à ne pas manquer!
this is quebec city!
Capital of the province of Quebec, cradle of French civilization in North America, jewel of world
heritage according to UNESCO. Quebec City’s unique identity sets it apart from other cities in Canada.
Ranked in 2013 as the best destination in the country by the prestigious tourism magazine Travel and
Leisure, Quebec City will charm you with its numerous natural, cultural and historical attractions.
Come and discover more than 400 years of history, notably in the Old Quebec sector. Whether it’s to
participate in festivals, large scale events, or recreational activities, whether it’s to relax or to get a boost
of adrenaline, you can live your passions in Quebec City’s breathtaking environment.
You’ll also want to visit Château Frontenac, “the most–photographed hotel in the world,” located at the
very top of Cap Diamant. Promenade Samuel–De Champlain, which has become a true oasis in the heart
of the city, will take you on an enchanting tour along the banks of one of the world’s 25 longest rivers,
the St. Lawrence. You may want to discover for yourself the reason why Quebec City has acquired such
an enviable reputation for gastronomy by visiting one of its numerous world–class restaurants offering
fine French and continental cuisine. Wrap up your evening on Grande Allée and you’ll understand why
Quebec City is a destination not to be missed!
24
25
25
Nous vous présentons l’App de la conférence ACIO/CANO !
Introducing the CANO/ACIO 2014 Conference App!
Saviez-vous qu’il y a une app de conférence que vous pouvez télécharger et
qui indique toutes les informations utiles : ateliers, présentateurs, abrégés,
lieux, cartes, et autres informations importantes ?
Event Directory
2014
CONFÉRENCE ANNUELLE
ANNUAL CONFERENCE
Did you know that there is a conference app that you can download that lists all
of the session information, speakers, speaker bios, abstracts, venue maps, and
other important conference information?
Téléchargez l’app sur votre iPhone, iPad, Android, ou Blackberry
en scannant le code QR ou en recherchant “ACIO” ou “CANO”
dans le magasin d'applications de votre téléphone.
Download the app onto your iPhone, iPad, Android, or Blackberry
by scanning the QR code or searching for “ACIO” or
“CANO” in your phone’s app store.
ACIO/CANO remercie la Société canadienne du cancer
pour son parrainage exclusif de l'app de la conférence 2014
CANO/ACIO would like to thank the Canadian Cancer Society
for their exclusive sponsorship of the 2014 conference app
LET’S THINK
IF ONE OF US CAN COME UP WITH AN IDEA TO HELP OUR PATIENTS,
WHAT COULD ALL OF US COME UP WITH?
26
27
Plan du VOS
centre
de conférences/
RÉUNIONS
- BANQUETS •
conference centreSUR
floor
plan
VIEUX-QUÉBEC
•
In Old Quebec
Rez-de-chaussée • Main Floor
1er étage • 1st
Cuisine
PORTNEUF
Kitchen
DUFFERIN
SAINT-LOUIS
KENT
DE TOURNY
Allegro Bar
& Restaurant
Old Quebec
Lobby
Stairs /
Escalator
LAUZON
PALAIS
Étage
Floor
École
School
Reception
Conf.
1er étage
• 1st
Style en U
Banquet
U-shape
Cuisine
Kitchen
MONTMORENCY
PORTE
KENT
In Old Quebec
DUCHESNAY
COURVILLE
PORTE
SAINT-LOUIS
SUR VIEUX-QUÉBEC •
Main
entrance
Rez-de-chaussée • Main Floor
Maitre d’hotel
PORTE
DU PALAIS
Théâtre
Theater
SAINTE
PORTNEUF
FOY
VILLERAY
SILLERY
Grande Place
SAINT-LOUIS
PORTE
DU PALAIS
Escalier / Ascenseur
vers vestibule
KENT
DE TOURNY
Stairs Bar
/ Escalator
Allegro
to main lobby
& Restaurant
vers vestibule
Stairs / Escalator
to main lobby
Dimensions
LAUZON
(lg) x (la)
x (h) : pi
DUCHESNAY
COURVILLE
SAINTE
FOY
ORLEANS
Escalier / Ascenseur vers 1e étage
PORTNEUF
PORTE
KENT
Grande Place
Business
Center
VOS RÉUNIONS - BANQUETS •
Kitchen
PORTE
SAINT-LOUIS
Centre d’
st
Cuisine
Maitre d’hotel
ORLEANS
étage • 1
SAINTE
FOY
VILLERAY
Maitre d’hotel
PORTE
SAINT-LOUIS
MONTMORENCY
PORTE
KENT
SILLERY
Grande Place
Exhibit
Hall
Lobby
Dimensions
PORTE
DU PALAIS
(lg) x (la) x (h) : pi
Escalier / Ascenseur vers 1e étage
Stairs /
Escalator
Main
entrance
Étage
Floor
PALAIS
2e étage • 2nd
École
School
Reception
vers vestibule
Stairs / Escalator
to main lobby
Conf.
Banquet
Style en U
U-shape
Théâtre
Theater
Dimensions
(lg) x (la) x (h) : pi
2e étage • 2
BEAUPORT
BEAUMONT
BERNIERES
BELAIR
BERNIERES
28
BEAUPORT
Plan et liste des exposants/
exhibitor floor plan AND LISTING
Exhibit Hours: Sunday, October 26, 7:30 am - 10:00 pm | Monday, October 27, 10:00 am - 6:00 pm
Tuesday, October 28, 10:00 am - 3:45 pm
38
39
40
41
42
43
Monte
charge
PORTE ST-LOUIS
37
35
36
34
33
32
31
30
14
ANTI-CHAMBRE
PORTE ST-LOUIS
13
s
le rs
rs eu
Ve ens
c
s
a
12
sortie
29
15
28
16
27
17
26
18
PORTE KENT
ANTI-CHAMBRE
PORTE KENT
11
10
9
25
19
Vestiaire
8
7
sortie
ANTI-CHAMBRE
PORTE DU PALAIS
24
PORTE DU PALAIS
23
20
Téléphones
Toilettes
21
5
sortie
2
3
6
4
murale en courte pointe
EXHIBITOR NAME
BOOTH
EXHIBITOR NAME
BOOTH
EXHIBITOR NAME
BOOTH
Celgene
21 & 23
Lymphoma Canada
35
30
Merck
2
Eisai Limited
18
Oncology Nursing Society
36
Fondation Sur la pointe des pieds
41
Pfizer Injectables
29
20
Fresenius Kabi Canada
28
Pfizer Oncology
26
GlaxoSmithKline (GSK)
15
Roche
11
ICU Medical Inc.
17
Bristol-Myers Squibb (BMS)
40
6
Innovation OncoSolutions Inc.
12
Shoppers Drug Mart Specialty
Health Network
9
Janssen Inc.
10
Sphynx Médical Inc.
34
Canadian Breast Cancer Network
39
Kidney Cancer Canada
33
Takeda
27
Canadian Nurses Association (CNA)
31
Look Good Feel Better and
FacingCancer.ca
4
The Leukemia & Lymphoma
Society of Canada 38
Trudell Medical Marketing Ltd.
37
Abbott Nutrition
5
Advanced Innovations Inc. Bio Oil
3
Cold Comfort Canada Inc.
Alberta Health Services
14
Amgen
24
Astellas
Bayer
Becton Dickinson (BD) Canada
CANO/ACIO
42 & 43
Cancer and Careers
32
Carefusion
13
Lundbeck Canada
19 & 25
16
7&8
29
29
Programme de la conférence d’un coup d’oEil
SAMEDI 25 OCTOBRE 2014 / SATURDAY, OCTOBER 25, 2014
4:00 pm – 8:00 pm
Inscription / Registration Lobby
Jour un : dimanche 26 octobre 2014 / Day One: Sunday, October 26, 2014
6:00 am – 7:00 am
Course/Marche de 5 km / 5 km Run/Walk
6:30 am – 7:00 pm
7:30 am – 8:45 am
Déjeuner éducatif Celgene / Celgene Breakfast Symposium Kent/Palais
9:00 am – 10:30 am
Cérémonie d’ouverture et conférence plénière I - Hugo Desrochers / Opening Ceremony & Keynote presentation I – Hugo Desrochers Kent/Palais
10:30 am – 11:00 am
Pause santé sponsorisée par Astellas / Health Break sponsored by Astellas Exhibit Hall
11:00 am – 12:30 pm
Atelier /
Workshop
I–01 Dufferin
Atelier /
Workshop
I–02 Villeray
Atelier simultané /
Concurrent Session
I–03 De Tourny
Concurrent Session
I–04 Courville/
Montmorency
Concurrent Session
I–05 Beaumont/
Belair
12:30 pm – 2:00 pm
Dîner éducatif Abbott Nutrition / Abbott Nutrition Lunch Symposium Kent/Palais
2:00 pm – 3:00 pm
Conférence Helene Hudson sponsorisée par Amgen / Helene Hudson Lectureship sponsored by Amgen Kent/Palais
3:00 pm – 3:30 pm
Pause santé sponsorisée par Takeda / Health Break sponsored by Takeda Exhibit Hall
3:30 pm – 5:30 pm
Concurrent Session
II–01 Dufferin
Concurrent Session
II–02 Villeray
Concurrent Session
II–03 De Tourny
Concurrent Session
II–04 Courville/
Montmorency
Concurrent Session
II–05 Beaumont/
Belair
Complementary
Medicine SIG
De Tourny
Radiation SIG
Courville/
Montmorency
Gynecological
Cancer SIG
Orleans
5:30 pm – 6:30 pm
Education Committee Hematology BMT
Dufferin
SIG Villeray
6:30 pm – 7:30 pm
Panel de discussion / Focus Group - Boehringer Ingelheim Beaumont/Belair
7:30 pm – 9:00 pm
Réception de bienvenue sponsorisée par Celgene / Welcome Reception sponsored by Celgene Exhibit Hall
Concurrent Session
I–06
Kent/Palais
Concurrent Session
II–06
Kent/Palais
Jour deux : lundi 27 octobre 2014 / Day Two: Monday, October 27, 2014
6:30 am – 6:00 pm
7:30 am – 8:45 am
Déjeuner éducatif Astellas / Astellas Breakfast Symposium Kent/Palais
9:00 am – 10:00 am
ACIO/CANO Conférence clinique et remise de prix / CANO/ACIO Clinical Lectureship and Award Kent/Palais
10:00 am – 10:30 am
Pause santé sponsorisée par Celgene/Health Break sponsored by Celgene Exhibit Hall Poster Groupe 1/Poster Group 1 Portneuf/Sainte Foy/Orleans
10:30 am – 12:00 pm
Session éducative ACIO/CANO, ONS, ISNCC / CANO/ACIO, ONS, ISNCC Symposium Kent/Palais
12:00 pm – 1:30 pm
Dîner éducatif Janssen / Janssen Lunch Symposium Kent/Palais
1:45 pm – 3:15 pm
Atelier bilingue /
Bilingual Workshop
III–01 Dufferin
3:15 pm – 3:45 pm
Pause santé sponsorisée par Amgen/Health Break sponsored by Amgen Exhibit Hall Poster Groupe 2/Poster Group 2 Portneuf/Sainte Foy/Orleans
3:45 pm – 5:15 pm
Atelier /
Workshop
IV–01 Dufferin
5:15 pm – 6:15 pm
Rencontre du Conseil des sections / Council of Chapters Meeting Courville/Montmorency
6:15 pm – 8:00 pm
Souper éducatif Boehringer Ingelheim / Boehringer Ingelheim Dinner Symposium Kent /Palais
30
Atelier /
Workshop
III–02 Villeray
Atelier bilingue /
Bilingual Workshop
IV–02 Villeray
Concurrent Session
III–03 De Tourny
Atelier
simultané /
Concurrent
Session
IV–03 De Tourny
Concurrent Session
III–04 Courville/
Montmorency
Atelier
simultané /
Concurrent
Session
IV–04 Courville/
Montmorency
Atelier
simultané /
Concurrent
Session
IV–05 Beaumont/Belair
Concurrent Session
III–05 Beaumont/
Belair
Atelier
simultané /
Concurrent
Session
IV–06
Kent/Palais
Concurrent Session
III–06
Kent/Palais
ACIO/CANO
groupe de réfléxion sur la thérapie
de radiation /
CANO/ACIO
Radiation Therapy
Think Tank Plaines
Conference Program-at-a-Glance
Simultaneous Interpretation into
French
Simultaneous Interpretation into
english
Jour trois : mardi 28 octobre 2014 / Day three: Tuesday, October 28, 2014
6:30 am – 7:00 pm
6:30 am – 7:45 am
Déjeuner éducatif Novartis / Novartis Breakfast Symposium Kent/Palais
8:00 am – 9:30 am
Assemblée Générale Annuelle de l’ACIO/CANO - CANO/ACIO AGM Kent/Palais
9:30 am – 10:00 am
Cérémonie des prix ACIO/CANO - CANO/ACIO Award of Excellence Ceremony Kent/Palais
10:00 am – 10:30 am
Pause santé sponsorisée par Roche / Health Break sponsored by Roche Exhibit hall
Poster Groupe 3 / Poster Group 3 Portneuf/Sainte Foy/Orleans
10:30 am – 12:00 pm
Concurrent Session
V–01 Dufferin
Concurrent Session
V–02 Villeray
Concurrent Session
V–03 De Tourny
Concurrent Session
V–04 Courville/
Montmorency
12:00 pm – 1:30 pm
Dîner éducatif Amgen / Amgen Lunch Symposium Kent/Palais
1:30 pm – 2:45 pm
Conférence plénière II sponsorisée par Lundbeck /
Keynote Address II sponsored by Lundbeck - Dawn Stacey and France Légaré Kent/Palais
2:45 pm – 3:30 pm
Pause santé sponsorisée par Lundbeck / Health Break Sponsored by Lundbeck Exhibit Hall
Poster Groupe 4 / Poster Group 4 Portneuf/Sainte Foy/Orleans
3:30 pm – 5:00 pm
Atelier /
Workshop
VI–01 Dufferin
Concurrent Session
VI–02 Villeray
Concurrent Session
VI–03 De Tourny
Concurrent Session
VI–04 Courville/
Montmorency
Surgical Oncology Nursing SIG
De Tourny
Concurrent Session
V–05 Beaumont/
Belair
Concurrent Session
V–06
Kent/Palais
Concurrent Session
VI–05 Beaumont/
Belair
Concurrent
Session VI–06
Kent/Palais
Advanced Practice Nursing SIG
Courville/Montmorency
5:15 pm – 6:15 pm
Leadership/Management SIG Dufferin
7:00 pm onward
Soirée sociale / Social Event Musée de la civilisation
Rassemblement dans le hall à 6:15 pm pour le départ du premier bus / Meet in the lobby at 6:15 pm for the first bus departure
Jour quatre : mercredi 29 octobre 2014 / Day four: Wednesday, October 29, 2014
7:15 am – 4:00 pm
7:15 am – 8:45 am
Déjeuner éducatif Merck / Merck Breakfast Symposium Kent/Palais
9:00 am – 10:00 am
Conférence plénière III sponsorisée par Astellas / Keynote Address III sponsored by Astellas - Andréanne Saucier Kent/Palais
10:00 am – 10:30 am
Pause santé sponsorisée par Janssen / Health Break sponsored by Janssen Exhibit Hall
10:30 am – 12:00 pm
Atelier /
Workshop
VII–01 Dufferin
12:15 pm – 1:45 pm
Dîner éducatif Roche / Roche Lunch Symposium Kent/Palais
2:00 pm – 3:30 pm
Concurrent Session
VIII–01 Dufferin
Atelier /
Workshop
VII–02 Villeray
Concurrent Session
VIII–02 Villeray
Concurrent Session
VII–03 De Tourny
Concurrent Session
VIII–03 De Tournyt
Concurrent Session
VII–04 Courville/
Montmorency
Concurrent Session
VII–05 Beaumont/
Belair
Concurrent Session
VII–06
Kent/Palais
Concurrent Session
VIII–04 Courville/
Montmorency
Concurrent Session
VIII–05 Beaumont/
Belair
Concurrent Session
VII–06
Kent/Palais
3:30 pm – 4:00 pm
ACIO/CANO Présentation spéciale - Bernard Roy: Quand le savant-soignant devient malade-aidant /
CANO/ACIO Special Presentation - Bernard Roy: Quand le savant-soignant devient malade-aidant Kent/Palais
4:00 pm – 4:30 pm
Cérémonie de clôture et remise de prix pour abrégés / Closing Ceremony and Abstract Award Presentation Kent/Palais
31
Horaires des réunions /
Meeting Schedule
Dimanche 26 octobre / Sunday, October 26, 2014 | 5:30pm – 6:30pm
Education Committee (Dufferin)
Hematology BMT Special Interest Group (Villeray)
Complementary Medicine Special Interest Group (De Tourny)
Radiation Special Interest Group (Courville/Montmorency)
Gynecological Cancer Special Interest Group (Orleans)
Dimanche 26 octobre / Sunday, October 26, 2014 | 5:30 pm – 7:30 pm
Editorial Meeting (Plaines)
Lundi 27 octobre / Monday, October 27, 2014 | 5:15 pm – 6:15 pm
Rencontre du Conseil des sections / Council of Chapters Meeting (Courville/Montmorency)
Mardi 28 octobre / Tuesday, October 28, 2014 | 8:00 am – 9:30 am
Assemblée Générale Annuelle ACIO/CANO / CANO/ACIO Annual General Meeting (Kent/Palais)
Mardi 28 octobre / Tuesday, October 28, 2014 | 9:30 am – 10:00 am
Cérémonie des prix ACIO/CANO / CANO/ACIO Award of Excellence Ceremony (Kent/Palais)
Mardi 28 octobre / Tuesday, October 28, 2014 | 5:15 pm – 6:15 pm
Leadership/Management Special Interest Group (Dufferin)
Surgical Oncology Nursing Special Interest Group (De Tourny)
Advanced Practice Nursing Special Interest Group (Courville/Montmorency)
Reviewer Meetings (Beaumont/Belair)
Mercredi 29 octobre / Wednesday, October 29, 2014 | 4:00 pm – 4:30 pm
Cérémonie de clôture et remise de prix pour abrégés /
Closing Ceremony and Abstract Award Presentation (Kent/Palais)
32
Dimanche 26 octobre 2014
Sunday, October 26, 2014
Course/Marche de 5 km / 5 km Run/Walk
6:00 AM – 7:00 AM | Lobby, Hilton Quebec
Déjeuner éducatif Celgene /
Celgene Breakfast Symposium
7:30 AM – 8:45 AM | Kent/Palais
New Therapeutic Options for the
Management of Metastatic Pancreatic Cancer
Speakers:
Rob El’Maraghi, MD, Chief of Oncology Simcoe-Muskoka
Regional Cancer Program, Royal Victoria Regional Health
Centre Chair, Community Oncologists of Metro-Toronto.
Daphnee Lamoussenery, B.Sc.inf, Infirmière Pivot en
Oncologie, Centre universitaire de sante McGill.
Learning Objectives:
At the conclusion of this session, participants will be able to:
1. Identify clinical challenges and opportunities for
improving the management of pancreatic cancer
2. Discuss the application of current research in the
treatment of metastatic pancreatic cancer
3. Counsel patients and manage predictable adverse
events encountered during treatment
Cérémonie d’ouverture et conférence
plénière I / Opening Ceremony &
Keynote Presentation I
Conférence plénière I
Keynote Presentation I:
Hugo Desrochers, Patient
Partenaire
Hugo, pilote d’avion à Air Canada, se souvient encore
de cette belle journée ensoleillée d’août 2010 qui allait
être le début d’une nouvelle ère pour lui et ses proches.
Comme pilote, il est formé pour faire face à des
situations d’urgence, mais jamais de l’envergure d’un
diagnostic de cancer. « C’est tout un choc d’apprendre
un diagnostic de leucémie ». Son implication active
dans les étapes de son traitement et le soutien de ses
proches furent des éléments clés tout au long de cette
épreuve. « Il est incroyable de voir toute la mobilisation
et l’entraide qui s’organisent autour de nous dans ce
type d’épreuve ». Malgré la fatigue extrême causée
par la maladie et les traitements, il a le vent dans les
voiles grâce à son entourage, rien ne peut l’arrêter. À
29 ans, il voit le tout comme une pause dans sa vie, le
temps de reprendre son souffle. Il y a environ vingtcinq ans, le type de leucémie (leucémie promyélocytaire
aigüe) dont il est atteint, était l’un des plus meurtriers.
Cependant, grâce à la recherche, il s’agit maintenant
d’une leucémie avec un excellent pronostic. Il a donc eu
le désir d’aider à faire avancer la recherche pour tous
les cancers hématologiques. Il découvre alors la Société
de leucémie et lymphome du Canada et participe depuis
deux ans à une marche annuelle pour amasser des
fonds. Il est membre actif de l’organisation et jusqu’à
présent il a amassé plus de 50 000$. Il reste beaucoup à
faire pour enrayer les cancers, mais Hugo a la conviction
que tous ensemble nous pouvons faire évoluer les
traitements et aider, de mille et une façons, les gens qui
sont aux prises avec le cancer.
Hugo, an Air Canada pilot, still recalls that gorgeous sunny
day in August 2010 that marked the start of a new era for
him and his loved ones. As a pilot, he was trained to face
emergency situations, but never of the magnitude of a
cancer diagnosis. “It’s quite a shock to learn that you have
leukemia,” he says. His active involvement in the various
phases of his treatment and the support of his loved ones
were key elements throughout this challenging time. “It’s
incredible to see the extent to which people mobilize and
organize around us in this sort of situation.” Despite the
extreme fatigue caused by the disease and the treatments,
he is upbeat. Thanks to the people that surround him, he
feels nothing can stop him. At 29 years of age, he sees this
experience as a pause in his life, so he can catch his breath.
About 25 years ago, his type of leukemia (acute
promyelocytic leukemia) was one of the most deadly.
However, thanks to research, it now has an excellent
prognosis. He has therefore felt the urge to advance research
for all forms of hematological cancer. He discovered the
Leukemia & Lymphoma Society of Canada and for the past
two years has taken part in an annual march to raise funds.
33
jour un / day one
jour un/day one
jour un / day one
He is an active member of the organization, and so far has
raised over $50,000. Much remains to be done to eradicate
cancer, but Hugo is convinced that together we can advance
treatments and help in countless ways those who are
struggling with cancer.
Atelier simultané / Concurrent Session
I–03 11:00 AM – 12:30 PM | De Tourny
Pause santé / Health Break
10:30 AM – 11:00 AM
| Exhibit Hall
What is the Patient Really Learning?
Standardizing Systemic Therapy Patient
Education across Nova Scotia
Atelier / Workshop I–01
11:00 AM – 12:30 PM | Dufferin
Moving Research into Action: Doing It
and Using It
Sally E. Thorne, RN, PhD1, Krista L. Wilkins, RN, PhD3,
Christine Maheu, RN, PhD 4, Catriona J. Buick, RN, MN,
CON(C)2, Jennifer M. Stephens, RN, BSN, MA, OCN1, Aronela
Benea, RN, MScN 2, Dawn Stacey, RN, PhD, CON(C)5, Lorelei
Newton, RN, PhD6. 1School of Nursing, University of British
Columbia, Vancouver, British Columbia, Canada, 2Princess
Margaret Cancer Centre, Toronto, Ontario, Canada, 3Faculty
of Nursing, University of New Brunswick, Fredericton, New
Brunswick, Canada, 4School of Nursing, McGill University ,
Montréal, Québec, Canada, 5School of Nursing, University of
Ottawa, Ottawa, Ontario, Canada, 6Vancouver Island Cancer
Centre, BC Cancer Agency, Victoria, British Columbia, Canada.
Atelier / Workshop I–02
11:00 AM – 12:30 PM | Villeray
Patient Involvement: Experiences from
a Large Interdisciplinary Competence
Development Program at a Danish
University Hospital
Berit Kjaerside Nielsen, PhD1, Lisbeth Kallestrup,
MD2, Kirsten Lomborg, PhD1. 1Clinical Medicine, Aarhus
University, Aarhus, Denmark, 2Abdominal Centre, Aarhus
University Hospital, Aarhus, Denmark.
I–03–A 11:00 AM – 11:45 AM
Kara Henman, MN, Michele Rogez, BScN. Cancer Care
Nova Scotia, Halifax, Nova Scotia, Canada.
I–03–B 11:45 AM – 12:30 PM
Engaging Patients in the Development and
Implementation of Patient Education Material; An Approach to Developing Materials
for an Innovative Therapy
Julie Diemert, BScN, CON(C)2, Jazmin Estibal, BScN2,
Debbie Miller, BScN, MN, CETN(C)2, Tamara Harth, BA(HON),
MLIS1, Yoo–Joung Ko, MD, MMSc, SM, FRCP(C)3, Paul J.
Karanicolas, MD, PhD, FRCS(C)4, Eirena N. Calabrese,
BScN, MN2. 1Program Manager and Regional Lead Patient
Education Toronto Central North LHIN, Sunnybrook Health
Sciences Centre, Toronto, Ontario, Canada, 2Nursing,
Odette Cancer Centre, Sunnybrook Health Sciences Centre,
Toronto, Ontario, Canada, 3Medical Oncology, Sunnybrook
Health Sciences Centre, Toronto, Ontario, Canada, 4Surgical
Oncology, Sunnybrook Health Sciences Centre, Toronto,
Ontario, Canada.
I–04 11:00 AM – 12:30 PM | Courville/
Montmorency
I–04–A 11:00 AM – 11:45 AM
Resilience in Health Crises
Doreen Westera, MScN, MEd, Doreen Dawe, Prof, Msc.
Nursing, Memorial University, St John’s, Newfoundland,
Canada.
34
I–06 11:00 AM– 12:30 PM | Kent/Palais
Mastering Life in Limbo: Exploring the
Family’s Heroic Journey through the World
of Chronic Cancer
I–06–A 11:00 AM – 11:45 AM
Linda C. Watson, RN, PhD, CON(C), Shelley Raffin
Bouchal, RN, PhD. Faculty of Nursing, University of Calgary,
Calgary, Alberta, Canada.
I–05 11:00 AM – 12:30 PM | Beaumont/
Belair
I–05–A 11:00 AM – 11:45 AM
L’intégration des patients comme
partenaires de soins au sein de l’équipe
interdisciplinaire du cancer de la thyroïde
du CHUM : une démarche d’amélioration
continue gagnante !
Catherine Derval, M.Sc., Joé T. Martineau, M.Sc.,
PhD(C), Centre hospitalier de l’Université de Montréal,
Montréal, Québec, Canada.
I–06–B 11:45 AM – 12:30 PM
The Lived Experience of Hospitalized Dying L’introduction du patient–partenaire: nos
Patients Waiting for a Transfer to Palliative bons coups et nos défis d’adaptation
Care
Vasiliki Bitzas, PhD(C)1, Catherine Thibeault, PhD2,
Franco Carnevale, PhD1, Helene Ezer, PhD1, Mary Ellen
Macdonald, PhD3, S. Robin Cohen, PhD1. 1Department of
Oncology, McGill University, Montréal, Québec, Canada,
2Trent / Fleming School of Nursing, Trent University, Toronto,
Ontario, Canada, 3Oral Health and Society, Faculty of
Dentistry, McGill University, Montréal, Québec, Canada.
I–05–B 11:45 AM – 12:30 PM
Louise Compagna, Baccalauréat2, Caroline Provencher,
Maîtrise1, Madeleine Desforges, Maîtrise1. 1Oncologie,
Hopital Maisonneuve–Rosemont, Montréal, Québec, Canada.
Dîner éducatif Abbott
Nutrition / Lunch
Symposium Abbott Nutrition
12:30 PM – 2:00 PM | Kent/Palais
Caring for Patients Who Desire Death; A
Study to Understand Oncology Nursing
Practice
Nurses Are Pivotal in the Care of
Malnourished Hospital Patients
Marina Chirchikova, B.Sc., M.Sc(A), N, RN1, Veronique
Daniel, M.Sc. Applied (N)1, Vasiliki Bitzas, PhD(C)2,
David Wright, N., PhD1, Marie–Laurence Fortin, N., M.Sc.
(N)2. 1Nursing, McGill, Montréal, Québec, Canada, 2Jewish
General Hospital, Montréal, Québec, Canada.
Bridget Davidson, MHSc, RD, Executive Director,
Canadian Malnutrition Task Force
Speaker:
In 2013 the Canadian Malnutrition Task Force completed
a study in 18 hospitals (academic and community) in 8
provinces to determine the prevalence of malnutrition. The
study demonstrated that 45% of patients are malnourished
upon admission, malnutrition increases the length of stay and
re-admission rates and malnourished patients are 6.5 times
more likely to die within 30 days of hospitalization compared
to nourished patients. There are many factors contributing to
malnutrition in the hospitalized patient.
35
jour un / day one
I–04–B 11:45 AM – 12:30 PM
jour un / day one
et leurs préoccupations par rapport à leur propre bienêtre. Leurs inquiétudes centrales portent sur leur capacité
réduite de s’occuper de leurs enfants et sur les années
qu’elles ne pourront possiblement pas passer avec eux.
Elles doivent composer, d’une part, avec les demandes
liées au diagnostic et à leur traitement et, d’autre part, avec
leur rôle de mères. Lorsqu’elles traversent l’expérience du
diagnostic, du traitement et du suivi, elles font un effort
mental prodigieux pour demeurer positives et profiter
au maximum de leur temps avec leurs enfants. Cette
présentation vise, d’une part, à faire état des résultats
d’une étude sur une théorie ancrée réalisée auprès de 18
jeunes mères et, d’autre part, à dialoguer avec nos collègues
Although nurses see nutrition care as important, they lack
infirmières au sujet de stratégies de soins susceptibles
the knowledge on how to detect and treat malnutrition. de rendre l’expérience du cancer moins pénible pour les
Malnutrition is a complex problem that requires an interjeunes mères et leur famille.
disciplinary approach to care, and nurses have a unique role
Les résultats de cette étude semblent indiquer que les
to play in addressing the problem. Nutrition risk screening
jeunes mères qui vivent avec le cancer souhaitent entre
and facilitating protected mealtimes are key activities that
autres protéger leurs enfants tout au long de l’expérience.
nurses can be involved with in their contribution to a system La protection affective est un résultat préliminaire. Les
jeunes mères semblent vouloir diminuer l’impact de
wide approach to caring for malnourished patients. leur cancer sur leurs enfants et leur famille. Cela est
particulièrement évident lors de l’apparition d’effets
secondaires comme la perte de cheveux, la fatigue, la
By the end of this session, the participants will:
nausée et les vomissements. De plus, l’étude indique que
• Learn about the problem of malnutrition in Canadian
les enfants et la famille des jeunes patientes protègent à
hospitals
leur tour ces dernières sur le plan affectif. La protection
• Be able to use screening tools for detecting malnutrition
affective est un processus psychosocial qui comprend
and understand the difference between screening and
les composantes suivantes : faire face à un diagnostic de
nutrition assessment
maladie mortelle et subir le traitement; conserver une vie
familiale aussi routinière que possible; trouver de nouvelles
• Be equipped with the necessary tools for the
complementary role of the nurse on the inter-disciplinary façons de vivre l’intimité; et créer une nouvelle façon de
définir la normalité.
team in providing optimal nutrition care A patient meal satisfaction survey identified some of the
barriers affecting patients’ ability to eat, which included
missed meals due to scheduled procedures, interruptions,
disturbances such as smell, noise and activity and poor
body positioning. A nurse survey focused on their attitudes,
perceptions and understanding of malnutrition prevalence
in hospitalized patients. The majority of respondents (52%)
felt that malnutrition was not a problem in hospitalized
patients, that is, it did not occur in <25% of patients, but
almost all believed that a nutrition assessment should occur
on admission (93.5%).
Conférence Helene Hudson /
Helene Hudson Lectureship
L’engagement des jeunes mères avec le
système de soins contre le cancer
Judith Strickland, RN, BN, MN, CON(C), Faculty of
Nursing, Western Regional School of Nursing , Corner Brook,
NL, Newfoundland, Canada.
Il existe très peu d’études sur les patientes atteintes de
cancer qui ont des enfants, même au sein de la recherche
auprès de jeunes femmes atteintes d’un cancer du sein.
Pour les jeunes mères, le cancer est source d’une détresse
toute particulière, pour des raisons qui dépassent leur âge
36
Young Mothers’ Engagement with the
Cancer Care System
Very few studies have focused on cancer patients who are
mothers, even within breast cancer research about younger
women. For young women who are mothers, the cancer
experience is distressing, not simply because of their age or
concern for themselves. They are worried about the potential
loss of years with their children and ability to mother them.
While nurses are engaged with young mothers who are
cancer patients, these mothers are engaged in taking care
of their children. They juggle the demands of diagnosis and
treatment with fulfilling their role as mothers. When they
go through diagnosis, treatment, and even follow–up, they
do tremendous mental work to stay positive in thought and
to make the most of their time with their children. The aim
of this presentation is to report findings from a grounded
theory study involving 18 young mothers, and to dialogue
3:00 PM – 3:30 PM
Exhibit Hall
II–01 3:30 PM – 5:30 PM | Dufferin
II–01–A 3:30 PM – 4:00 PM
Does Gender Matter in Patient
Engagement? A Qualitative Study of
Approaches to Rehabilitation in Male
Cancer Survivors
Charlotte Handberg, PhD student, MPH, RN, Sally E.
Thorne, Professor, PhD, RN, FAAN, FCAHS3, Julie Midtgaard,
PhD Associate Professor, Psychologist4, Claus V. Nielsen,
Professor, PhD, MD2, Kirsten Lomborg, Professor, PhD, MSN,
RN1. 1Department of Clinical Medicine and Department of Public
Health, Aarhus University and Aarhus University Hospital,
Aarhus, Central Denmark Region , Denmark, 2Department
of Public Health, Section for Clinical Social Medicine and
Rehabilitation, Public Health and Quality Improvement, Aarhus
University, Aarhus , Central Denmark Region , Denmark,
3School of Nursing, University of British Columbia, Vancouver,
British Columbia, Canada, 4The University Hospitals Centre for
Health Care Research (UCSF), Copenhagen University Hospital,
Copenhagen, The Capital Region of Denmark , Denmark.
II–01–B 4:00 PM – 4:30 PM
Navigating and Engaging Patients During
the Diagnostic Phase of the Colorectal
Cancer Journey
Julie Diemert, BScN, CON(C)1, Shady A shamalla, MD,
MSc, FRCSC2, Eirena N. Calabrese, BScN, MN1. 1Nursing,
Toronto, Ontario, Canada, 2Surgical Oncology, Sunnybrook
Health Sciences Centre, Toronto, Ontario, Canada .
II–01–C 4:30 PM – 5:00 PM
Engaging Survivors’ Perspectives to Promote
Equity in Cancer Survivorship Care
Tracy L. Truant, RN, MSN1, PhD(c), Sally Thorne,
Professor, PhD, RN, FA AN, FCAHS1, Lynda G. Balneaves,
RN, PhD1, Carolyn Gotay, PhD2. 1School of Nursing,
University of British Columbia, Vancouver, British
Columbia, Canada, 2School of Population and Public
Health, University of British Columbia, Vancouver, British
Columbia, Canada.
II–01–D 5:00 PM – 5:30 PM
Wellness Beyond Cancer Program:
Empowering Patients to Meet Their
Survivorship Needs
Carrie Liska, BScN2, Gail Larocque, BHScN2, Lise Paquet,
PhD1, A. Robin Morash, BScN, MHS2. 1Psychology, Carleton
University, Ottawa, Ontario, Canada, 2Oncology, The Ottawa
Hospital, Ottawa, Ontario, Canada.
II–02 3:30 PM – 5:30 PM | Villeray
II–02–A 3:30 PM – 4:00 PM
Patients as Partners: What Our Patients
Are Telling Us
Paula P. Calestagne, B.A.1, Vasiliki Bitzas, PhD(C)2.
1Quality, Jewish General Hospital, Montrea;, Québec, Canada,
2Nursing, Jewish General Hospital, Montréal, Québec, Canada.
37
jour un / day one
with nursing colleagues about strategies for care that may
make young mothers’ journies through cancer a little easier
for them and their families. The findings of this study suggest
that the experiences of young mothers involves emotionally
protecting their children throughout their cancer situation.
Emotional protecting is a preliminary finding; it represents
how young mothers lessen the affects of their cancer on their
children and family. This is particularly obvious when they
are dealing with side effects such as hair loss, fatigue, nausea
and vomiting. In turn, they find that their children and family
are emotionally protecting them. Emotional protecting is a
psychosocial process that consists of the following: facing a
life–threatening diagnosis and undergoing treatment; keeping
family life as routine as possible; finding new ways to be close;
and, creating a new normal.
jour un / day one
II–02–B 4:00 PM – 4:30 PM
II–03–B 4:00 PM – 4:30 PM
Transforming Care at the Bedside –
Engaging Staff and Patients in Quality
Improvement
Engaging with and Advocating for Patients
about Additional Cancer Treatment
Options...Subsequent Entry Biologics
Valerie Cass, MBA, Norine Heywood, MScN, Irene Gyimothi,
DEC, Alejandro Ramirez, DEC, Vanessa Lopez, DEC, Beverle
Henry, DEC. Transplant and Hepatobiliary Surgery, McGill
University Health Center, Montréal, Québec, Canada.
Karyn Perry, BSN, MBA, CON(C)1, Dauna Crooks, PhD2.
1Director of Education, independent nurse consultant,
Vancouver, British Columbia, Canada, 2Chair, Cancer Advocacy
Coalition of Canada , Toronto, Ontario, Canada.
II–02–C 4:30 PM – 5:00 PM
II–03–C 4:30 PM – 5:00 PM
I Have a Voice… Please Involve Me, Don’t Engaging Patients in Research – A
Ignore Me
Standardized Nurse Led Informed
Consent Education Program
Nancy–Anne Pringle, RN, Silvana Angotti, RN, Beverly
Brooks, RN. Malignant Hematology, Princess Margaret
Cancer Centre, Toronto, Ontario, Canada.
Jodi LeBlanc, RN, BN. Tumour Tissue Repository, BC
Cancer Agency, Victoria, British Columbia, Canada.
II–02–D 5:00 PM – 5:30 PM
II–03–D 5:00 PM – 5:30 PM
Engaging Chemotherapy Patients in
Self–Care through Nursing Support
Consent for Chemotherapy: More Than
Just the Paper It’s Written On
Shelley Dick, RN, Yvonne Miller, RN, Sarah Bouchard,
RN BScN. Chemotherapy Unit, BC Cancer Agency/Fraser
Valley Cancer Center, Surrey, British Columbia, Canada.
Maggie Ford, Nursing Supervisor. Ambulatory Nursing,
Sunnybrook – Odette Cancer Centre, Toronto, Ontario, Canada.
II–03 3:30 PM – 5:30 PM | De Tourny
II–04 3:30 PM – 5:30 PM | Courville/
Montmorency
II–03–A 3:30 PM – 4:00 PM
II–04–A 3:30 PM – 4:00 PM
Lifestyle Interventions Combined with Acupuncture-Like Transcutaneous Electrical Nerve Family Member Distress: A New
Stimulation (ALTENS) in Managing Hot Flash- Screening Tool for Nursing Assessment
es Induced by Breast Cancer Treatment: Results Anita Mehta, PhD, Marc Hamel, PhD. Psychosocial
Oncology Program, McGill University Health Centre,
of a Phase II Randomized Controlled Trial
Margaret Forbes, RN(EC), BScN, MN, CON(C)1,
Raimond Wong, MD, MBBS, FRCPC2, Stephen Sagar, MD,
BSc, MB, MS, MRCP2, Joseph Hayward, PhD, MCCPM2, Mark
N. Levine, MD, MSc, FRCPC, FASCO2, Jim Julian, M.Math,
1McMaster University, Hamilton, Ontario, Canada.
38
II–05 | Beaumont/Belair
Development of the MaTT Online
Transitions Toolkit for Male Caregivers
Of Partners with Breast Cancer
II–05–A 3:30 PM – 4:00 PM
Kelly S. Struthers Montford, MA3, Wendy D. Duggleby,
PhD, RN, AOCN3, Cheryl Nekolaichuk, PhD, RPysch6, Roanne
Thomas, PhD1, Ceinwen Cumming, PhD, RPysch5, Sunita
Ghosh, PhD, P. Stat2, Katia Tonkin, PhD, MD4. 1School of
Rehabilitation Sciences, University of Ottawa, Ottawa,
Ontario, Canada, 2Medical Oncology and Alberta Health
Services–Cancer Care, University of Alberta, Edmonton,
Alberta, Canada, 3Faculty of Nursing, University of Alberta,
Edmonton, Alberta, Canada, 4Medical Oncology, University
of Alberta, Edmonton, Alberta, Canada, 5Division of Palliative
Medicine, University of Alberta, Edmonton, Alberta, Canada,
6Palliative Care Medicine and Oncology, University of
Alberta, Edmonton, Alberta, Canada.
jour un / day one
II–04–B 4:00 PM – 4:30 PM
It’s Not Just Hair: A Sikh Perspective
Jagbir K. Kohli, RN, MN, BC Cancer Agency, Vancouver,
British Columbia, Canada.
II–05–B 4:00 PM – 4:30 PM
Haida Gwaii – Cancer Care
Sylvi Baillie, RN. Systemic Therapy, BC Cancer Agency–
Sindi Ahluwalia Hawkins Centre for Southern Interior,
Kelowna, British Columbia, Canada.
II–04–C 4:30 PM – 5:00 PM
II–05–C 4:30 PM – 5:00 PM
Patients’ and Family Member’s
Perspectives of Remote Cancer
Treatment–Related Symptom Support:
a Descriptive Study
Addressing the Challenges among Non–
English Speaking Patient Population
in the Pre–Chemotherapy Nursing
Assessment Process
Dawn Stacey, RN, PhD, CON(C)1, Meg Carley, BSc6,
Barb Ballantyne, RN, BNSc, MScN, CON(C)2, Kimberley
A. Barkhouse, RN, BScN3, Myriam A. Skrutkowski, RN,
MSc, CON(C)4, Angela Whynot, RN, BScN, CON(C)5, Pan–
Canadian Oncology Symptom Triage and Remote Support1.
1School of Nursing, University of Ottawa, Ottawa, Ontario,
Canada, 2Health Sciences North, Sudbury, Ontario, Canada,
3Victorian Order of Nurses, Halifax, Nova Scotia, Canada,
4McGill University Health Centre, Montréal, Québec, Canada,
5Capital Health, Halifax, Nova Scotia, Canada, 6Centre for
Practice Changing Research, Ottawa Hospital Research
Institute, Ottawa, Ontario, Canada.
Esther H. Chow, MScN, Jagbir K. Kohli, RN, MN, Karen
Janes, MN, Maxine Alford, PhD, Siby Elizabeth Thomas,
MSN. Professional Practice Nursing, BC Cancer Agency,
Victoria, British Columbia, Canada.
II–04–D 5:00 PM – 5:30 PM
Joanne Crawford, RN, BScN, CON(C), MScN, PhD
II–05–D 5:00 PM – 5:30 PM
South Asian Immigrants Perceptions
of Colorectal Cancer Screening: A
Qualitative Exploration
(Candidate). Nursing, Brock University, St. Catharines,
Ontario, Canada.
Patient Engagement – A Key Building
Block to Advancing Patient and Family
Centred Care
Cathy DeGrasse, BScN, MSN, Gwen Barton, BNSc, MHA.
Cancer Program, The Ottawa Hospital, Ottawa, Ontario, Canada.
39
II–06 3:30 PM – 5:30 PM | Kent/Palais
II–06–A 3:30 PM – 4:00 PM
Panel de discussion Boehringer Ingelheim /
Boehringer Ingelheim Focus Group
6:30 PM – 7:30 PM
| Beaumont/Belair
L’aventure thérapeutique de la fondation Réception de bienvenue/
sur la pointe des pieds
Welcome Reception
Catherine Provost, Fondation Sur la pointe des pieds,
7:30 PM – 9:00 PM | Exhibit Hall
Chicoutimi , Québec, Canada.
jour deux / day two
II–06–B 4:00 PM – 4:30 PM
Le yoga comme allié dans l’épreuve du
cancer pour transcender le soi blessé et
œuvrer à la renaissance
Valérie Desgroseilliers, Nicolas Vonarx, PhD. Faculté des
sciences infirmières, Université Laval, Québec, Québec, Canada.
II–06–C 4:30 PM – 5:00 PM
Développement d’un plan de soins de suivi
pour des femmes atteintes du cancer de
l’endomètre à la fin des traitements initiaux
Johanne Hébert, M.Sc., PhD3, Lise Fillion, PhD1, 2.
1Sciences infirmières, Université Laval, Québec, Québec,
Canada, 2Centre de recherche clinique et évaluative en oncologie
(CRCEO), CHU de Québec, Québec, Québec, Canada, 3Sciences
infirmières, Université Laval, Québec, Québec, Canada.
jour deux/
day two
Lundi 27 octobre 2014
Monday, October 27, 2014
Déjeuner éducatif Astellas /
Astellas Breakfast Symposium
Beyond Survival in mCRPC –
Helping Patients Achieve “Meaningful Time”
• Review treatment goals for CRPC
• Discuss how the newer oral hormonal agents for CRPC
address patient reported outcomes
• Discuss the role of the nurse within the multidisciplinary
team in supporting the care of CRPC patients Atelier simultané / Concurrent Session
II–06–D 5:00 PM – 5:30 PM
ACIO/CANO Conférence clinique et remise
de prix / CANO/ACIO Clinical Lectureship
and Award Presentation
La personne âgée et ses proches au cœur
de la pratique infirmière oncogériatrique
Non, pas encore : l’expérience vécue de
France Robert, Maîtrise en sciences infirmières,
Caroline Malenfant inf. B.Sc., Karine Labarre, Maîtrise en
diagnostics successifs de cancer
sciences infirmières. Centre d’excellence sur le vieillissement
de Québec, CHU de Québec, Québec, Québec, Canada.
Comité et rencontre des groupes d’intérêts/
Committee and SIG Meetings
5:30 PM – 6:30 PM
See page 32 for listings
40
Krista Wilkins, PhD, Megan Williams, BN, Facult y of Nursing,
University of New Brunswick , Fredericton , New Brunswick, Canada.
Environ un Canadien sur deux sera atteint d’une forme ou
une autre de cancer au cours de sa vie, et certains d’entre eux
vivront assez longtemps pour recevoir plus d’un diagnostic
de cancer primitif. La recherche semble indiquer que les
diagnostics multiples ont un impact négatif sur l’état mental
Unwanted Encore: The Lived Experience
of Having Multiple Cancer Diagnoses
Approximately one in two Canadians will develop some form
of cancer, and some will live long enough to be diagnosed
with multiple primary cancers. There is some indication that
multiple primary cancer diagnoses negatively impact survivors’
mental and physical status, and quality of life. Existing research
studies do not fully capture the complexity of the experience
of living with multiple primary cancer diagnoses. Accordingly,
a qualitative study was conducted to address the following
research question: What meanings do individuals assign to the
lived experience of having multiple primary cancer diagnoses?
This presentation will provide preliminary data on the shared
meanings and common features, or essences, of having multiple
primary cancers. Participants were individuals from Atlantic
Canada with a history of multiple primary cancer diagnoses. To
be eligible for the study, participants (1) had two or more cancer
diagnoses at least 6 months apart, (2) were at least one year
post their most recent diagnosis, (3) were able to speak and read
English and (4) were 19 years of age or older. Data were captured
through semi–structured interviews. Interviews were transcribed
and reviewed for common meanings. This study yields findings
that can provide empirically–based guidance to healthcare
providers to help support cancer survivors in a more holistic
way throughout the extended continuum of care and ultimately
improve the health of individuals who have had multiple
primary cancers. Knowledge gleaned from understanding the
lived experiences of cancer survivors is critical to influencing
a nationwide healthcare priority to develop quality cancer
survivorship programs.
Pause santé / Health Break | Exhibit Hall
Poster Groupe 1 /Poster Group 1
| Portneuf/Sainte Foy/Orleans
10:00 AM – 10:30 AM
Session éducative ACIO/CANO, ONS,
ISNCC / CANO/ACIO, ONS, ISNCC
Symposium
10:30 AM – 12:00 PM
| Kent/Palais
CANO/ACIO, ONS, ISNCC,
AQIO: Perspectives on Assisted
Dying Legislation
Barbara Fitzgerald, RN, MScN, President, Canadian
Association of Nurses in Oncology, Margaret Barton-Burke,
PhD, RN, FAAN, President, Oncology Nursing Society,
Janice Stewart, RN, ScN, MHS, Treasurer, International
Society for Nurses in Cancer Care, Vasiliki Bessy Bitzas, RN,
PhD, CHPCN(C), Representative, l’Association Québécoise
des Infirmières en Oncologie (CANO/ACIO Quebec Chapter),
Gary Rodin, MD, Palliative Care/Systems.
Background:
Recent legislation in the province of Quebec regarding physicianassisted death as a part of comprehensive end of life care will
now allow terminally ill patients to choose when they die. This
symposium will explore the issue of right to assisted dying
within cancer care from Canadian, American, and International
perspectives, exploring challenges, controversies and the
framework of end-of-life care in which assisted dying is situated.
Strategies for oncology nurses, individually and collectively, to
influence structures and contexts so that cancer patient and
family end-of-life care needs are met will be discussed.
Objectives:
• Using Quebec’s Bill 52 as an example, too appreciate the benefits,
challenges and limitations of right to assisted dying legislation.
• Describe similarities and differences among Canadian,
American, and international perspectives regarding end of
life care in cancer.
• Describe opportunities for oncology nurses (and organizations,
e.g. CANO/ACIO) to influence structures and contexts so that
cancer patient and family -life care needs are met.
41
jour deux / day two
et physique des survivants, ainsi que sur leur qualité de vie.
Les études existantes ne captent pas pleinement la complexité
d’une telle expérience. Nous avons donc effectué une étude
qualitative autour de la question de recherche suivante : quels
sens les patients donnent-ils à leurs diagnostics successifs
de cancer primitif ? Cette présentation abordera des résultats
préliminaires sur les sens partagés et les traits communs ou
l’essence du vécu de diagnostics successifs de cancer primitif.
Les participants vivaient dans les provinces atlantiques et
avaient reçu plus d’un diagnostic de cancer primitif. Pour
pouvoir prendre part à l’étude, les candidats devaient : (1) avoir
reçu au moins deux diagnostics de cancer à des intervalles
d’au moins six mois ; (2) avoir reçu leur dernier diagnostic au
moins un an auparavant ; (3) savoir parler et lire l’anglais ; et
(4) avoir au moins 19 ans. Nous avons recueilli les données au
moyen d’entrevues semi-structurées que nous avons ensuite
transcrites et analysées afin de recenser les sens communs. Les
résultats de cette étude présentent aux fournisseurs de soins
des pistes empiriques leur permettant d’offrir aux survivants
du cancer un soutien plus holistique dans le continuum de
soins élargi et, ultimement, d’améliorer la santé des personnes
atteintes de plusieurs cancers primitifs au fil du temps. Il est
essentiel de comprendre l’expérience vécue des survivants
du cancer et d’utiliser les connaissances ainsi réunies afin
d’accorder la priorité à l’élaboration, dans l’ensemble du pays, de
programmes de survivance au cancer de qualité.
Dîner éducatif Janssen /
Janssen Lunch Symposium
Today, there are several treatment options that are available
for patients in oncology.
Vancouver, British Columbia, Canada, 4UBC School of Nursing,
University of British Columbia, Vancouver, British Columbia,
Canada, 5Regional Program Director, Janeway Hospital,
Eastern Health, Children & Women’s Health Program, St.
John’s , Newfoundland, Canada, 6Associate Professor, School of
Nursing, Lakehead University, Thunder Bay, Ontario, Canada .
In the first part of this symposium, Lorne Aaron MD, FRCS(c),
will discuss how to put the patient at the center and improve
his quality of life while managing effectively his mCRPC.
Atelier / Workshop III–02
1:45 PM – 3:15 PM | Villeray
mCRPC Management and Quality of Life:
The Voice of the Patient
Acute Oncology Care: A Workshop to
Increase Knowledge and Understanding of
Acute Disorders and Treatment–Related
Complications in Oncology Patients and
the Subsequent Communication and
Management of Symptoms
jour deux / day two
1.Discuss the available treatment options for the management
of metastatic castrate resistant prostate cancer
2.Determine how to evaluate the improvement of quality of life
in patients with mCRPC
3.Understand the follow up requirements for patients with mCRPC
The second part of the symposium will be dedicated to
multiple myeloma; through a review of the most recent
evidence and sharing of patient experience Dominic
Duquette, B.Pharm, MSc will discuss how to optimize
the management of patients with multiple myeloma and the
important role of the nurse.
How to Optimize Patient Management with
Multiple Myeloma
Learning objectives:
Through a review of the most recent evidence and sharing of
patient experience, this educational program will endeavor to:
1. Discuss how newer approaches to therapy have improved
the management of treatment-related side effects
2. Explore the role of risk stratification and post-transplant
strategies to deepen response to treatment
3.Understand the important role of the nurse in the
management of multiple myeloma
Atelier bilingue / Bilingual Workshop
III–01 1:45 PM – 3:15 PM | Dufferin
A Focus on Writing for Publication:
Getting Started
Margaret I. Fitch, RN, PhD1, Jeanne D. Robertson, RN,
MBA5, Janice Chobanuk, RN, MN, CON(C), HPCN(C)2, Sharon
L. Thomson, RN, MSc3, Sally E. Thorne, RN, PhD4, Patricia A .
Sevean, RN, MA(N), EdD6. 1Head, Oncology Nursing; Director,
Patient & Family Support Program, Odette Cancer Centre,
Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada,
2Director, Ambulatory Care & Systemic Therapy, Community
Oncology, Alberta Health Services, Edmonton, Alberta, Canada,
3Clinical Advisor, College of Physicians & Surgeons of BC,
42
Sharon McGonigle, RN–EC, MScN, NP–Adult.
Radiation Medicine, Princess Margaret Cancer Center,
Toronto, Ontario, Canada.
III–03 1:45 PM – 3:15 PM | De Tourny
III–03–A 1:45 PM – 2:15 PM
The How–to’s of Developing a Program
for Adolescents and Young Adults with
Cancer
Laura Mitchell, BA, BScN, MN, Hayley Panet, MHSc
Health Admin, CHE, Norma D’Agostino, PhDC Psych., Terri
Stuart-McEwan, RN, BScN, MHS, CHE, Abha Gupta, MD, MSc,
FRCPC. Princess Margaret Cancer Centre, Toronto, Ontario.
III–03–B 2:15 PM – 2:45 PM
Understanding the Relationship
between Symptoms and Quality of Life
in Children Following Brain Tumour
Treatment: Development of a Clinical
Practice Framework
Gail Macartney, RN(EC), PhD, CON(C)1, Margaret B.
Harrison, RN, PhD2, Elizabeth VanDenKerkhof, RN, DrPH2,
Dawn Stacey, RN, PhD, CON(C)3. 1Children’s Hospital of
Eastern Ontario, Ottawa, Ontario, Canada, 2School of Nursing,
Queen’s University, Kingston, Ontario, Canada, 3School of
Nursing, University of Ottawa, Ottawa, Ontario, Canada.
III–03–C 2:45 PM – 3:15 PM
III–04–C 2:45 PM – 3:15 PM
Perceptions of the “Venturing Out Pack
Program” as Tangible Support for Young
Adults with Cancer
“Now what?”: Life After Breast Cancer –
Engaging Patients in Well Follow–up Care
III–04 1:45 PM – 3:15 PM | Courville/
Montmorency
III–05 1:45 PM – 3:15 PM | Beaumont/
Belair
III–05–A 1:45 PM – 2:15 PM
Getting Rid of the Ostrich Syndrome:
Engaging Patients in Advance Care Planning
Lynn E. Kachuik, RN, BA, MS, CON(C), CHPCN(C)
Palliative Care, The Ottawa Hospital, Ottawa, Ontario, Canada.
III–04–A 1:45 PM – 2:15 PM
Optimizing Registered Nurse Roles in
III–05–B 2:15 PM – 2:45 PM
the Delivery of Cancer Survivorship Care
Managing Cancer and Living
(CSC) within Primary Care Settings
Meaningfully (CALM): A Pilot Study of
Lindsay Yuille, BSc.N, MSc.N (student)1, Denise E.
a Nurse–Delivered Psychotherapeutic
Bryant–Lukosius, PhD1, Ruta Valaitis, PhD1, Lisa Dolovich,
Intervention for Cancer Patients
PhD2. 1School of Nursing, McMaster University, Hamilton,
Ontario, Canada, 2Department of Family Medicine, McMaster
University, Hamilton, Ontario, Canada.
III–04–B 2:15 PM – 2:45 PM
Addressing Unmet Needs of Cancer
Survivors: Engaging Patients in the
Design and Development of a Nurse
Practitioner–Led Model of
Survivorship Care
Devi Ahuja, RN, MN, NP–adult, CON(C), Maria Rugg,
MN, CHPCN(C). Oncology, Trillium Health Partners,
Mississauga, Ontario, Canada.
Carmine Malfitano, MSW, RSW, Judy Jung, BSc,
BScN, RN, Sarah Hales, MD, FRCPC, Anne Rydall, MSc,
Rinat Nissim, PhD, C. Psych., Gary Rodin, MD, FRCPC.
Psychosocial Oncology and Palliative Care, Princess
Margaret Cancer Centre, Toronto, Ontario, Canada.
III–05–C 2:45 PM – 3:15 PM
Empowering Nurses: An Inter–
professional Initiative to Expand Nursing
Skills in Providing Emotional Care
Cathy Kiteley, RN, MScN, CON(C), CHPCN (C), Maritza
Kontos, RN, MN, CON(C), Jarmila Grof, RN, CON(C), Kim
Thompson, MSW, RSW, Elisa Rink, MSW, RSW, Rita Tamas,
RN, CON(C), Karen Halden, RN, BScN, CON(C). Oncology,
Trillium Health Centre, Mississauga, Ontario, Canada.
43
jour deux / day two
Laila M. Wazneh, RN, BScN, MSc (A)3, Argerie Tsimicalis,
RN, PhD 2, Doreen Edward, BComm 4, Margaret Purden, N.,
PhD 2, Carmen G. Loiselle, N., PhD1. 1Department of Oncology
and Ingram School of Nursing, Jewish General Hospital, McGill
University, Montréal , Québec, Canada, 2Ingram School of
Nursing, Faculty of Medicine, McGill University, Montréal ,
Québec, Canada,3Ingram School of Nursing, McGill University,
Montréal , Québec, Canada, 4Venturing Out Beyond Our
Cancer (VOBOC), Montréal, Québec, Canada.
Angela K. Leahey, BScN, MN, Oncology Nursing,
Sunnybrook Odette Cancer Centre, Toronto, Ontario, Canada.
III–06 1:45 PM–3:15 PM | Kent/Palais
Atelier / Workshop IV–01
3:45 PM – 5:15 PM | Dufferin
III–06–A 1:45 PM – 2:15 PM
Are You Challenged when Asked to Manage
an Oncology Patient with a Wound?
Learn How to Become More Confident by
Improving Your Knowledge and Clinical
Skill Level in Wound Care Management
La formation continue comme outil
de développement des compétences
en soins palliatifs : vers un cadre
de référence pour les infirmières en
oncologie
Stephanie E. Chadwick, MClSc – WH CETN(C).
Medical Oncology Wound & Ostomy, Princess Margaret
jour deux / day two
Jean–François Desbiens, PhD sciences infirmières1,
Gabrielle Fortin, doctorante en service social2. 1Faculté
des sciences infirmières, Université Laval, Québec, Québec,
Canada, 2Équipe de Recherche Michel–Sarrazin en
Oncologie psychosociale et Soins palliatifs (ERMOS) Centre
de recherche du CHU – L’Hôtel–Dieu de Québec, Québec,
Québec, Canada.
IV–02 3:45 PM – 5:15 PM | Villeray
III–06–B 2:15 PM – 2:45 PM
Engaging with Nurses in Graduate Study
Programme de formation en ligne pour
les infirmières pivot en oncologie
Sonia Joannette, BAC1, Stéphane Dubuc, Maîtrise2.
1Direction québécoise de cancérologie, Québec, Québec,
Canada, 2Centre d’expertise en santé de Sherbrooke,
Sherbrooke, Québec, Canada.
III–06–C 2:45 PM – 3:15 PM
Lire, réfléchir, apprendre l’oncologie et
s’amuser : le club de lecture !
Nicole Tremblay, Maîtrise en sciences infirmières,
Hocine Tensaout, Baccalauréat en sciences infirmières.
Oncologie, Hôpital Maisonneuve–Rosemont, Montréal,
Québec, Canada.
Poster Groupe 2 / Poster Group 2
3:15 PM – 3:45 PM
Engagement avec les infirmières dans
les études supérieures
Jennifer M. Stephens, RN, BSN, MA, OCN2, Karine
Bilodeau, RN, MSN, PhD, CON (C)3, Catriona J. Buick, RN, MN,
CON(C), PhD(C)4, Jacqueline Galica, RN, BScN, MScN, CON(C),
PhD(student)4, Charlotte Handberg, RN, MPH, PhD Student 1,
Johanne Hebert, inf., M.Sc., Ph.D (C)5, Jagbir K. Kohli, RN, MN,
PhD Student2, Leah K. Lambert, RN, PhD(C)2, Tracy L. Truant,
RN, MSN, ,PhD(c)2. 1Aarhus University, Aarhus, Denmark,
2University of British Columbia School of Nursing, Vancouver,
British Columbia, Canada, 3University of Montréal, Montréal,
Québec, Canada, 4University of Toronto, Toronto, Ontario,
Canada, 5University of Laval, Québec, Québec, Canada.
IV–03 3:45 PM – 5:15 PM | De Tourny
IV–03–A 3:45 PM – 4:15 PM
Exploring Tobacco Use and Smoking
Cessation Best Practices from the
Perspectives of Individuals with Lung
Cancer and Health Professionals
Arlene Court, RN, BScN, CON(C)4, Bonnie Bristow,
MRT(T), BSc 2, Elaine Curle, RN4, Lisa Di Prospero, MRT(T),
MSc, BSc2, 5, Leslie Gibson, OT Reg (Ont.), BHSc (OT), BKin1,
Margaret I. Fitch, RN,PhD 4, Andrea Eisen, MD, FRCP3, 5, Kittie
44
IV–03–B 4:15 PM – 4:45 PM
IV–04–B 4:15 PM – 4:45 PM
Developing a Program of Care Focusing on
the Patient, not the Pathology: The McCain
Centre for Pancreas Cancer Experience
Allyson Nowell, BSc, MSc, Princess Margaret Cancer
Centre, Toronto, Ontario, Canada.
IV–04–C 4:45 PM – 5:15 PM
Development of an Oral Health Teaching
Module on a Hematology–Oncology Unit Creating a Platform for Patient
Engagement within the Role of Nursing
Sandra Fraser, MScN(cand)2, Karine Lepage,
MSc(Admin)1, Jessica Emed, MSc(A)1. 1Hematology–Oncology, in an Ambulatory Cancer Care Setting
Jewish General Hospital, Montréal, Québec, Canada, 2School
of Nursing, University of Ottawa, Ottawa, Ontario, Canada.
IV–03–C 4:45 PM – 5:15 PM
Patient Engagement through Research:
InterDry Ag and Radiation Skin
Reactions of the Breast
Crystele R. Montpetit, FVCC, RN, BScN, Radiation
Therapy, Fraser Valley Cancer Center, Surrey, British
Columbia, Canada.
Angela Blasutti–Boisvert, RN, BScN, Suzanne Madore,
RN, Fatima Kanji, RN, BScN, Debbie Bedard, RN.
Cancer Centre, The Ottawa Hospital, Ottawa, Ontario, Canada.
IV–05 3:45 PM – 5:15 PM | Beaumont/Belair
IV–05–A 3:45 PM – 4:15 PM
Strengthening the Foundation of Malignant
Hematology Nursing Education
IV–04 3:45 PM – 5:15 PM | Courville/
Montmorency
Karelin Martina, RN, MN, CON(C)1, Diana Incekol, RN,
BScN, MScN, CON(C)2, Rana Jin, RN, BScN, MScN,
CON(C), 1Princess Margaret Cancer Centre, University
Health Network, 2UHN, Princess Margaret Cancer Centre,
University Health Network.
IV–04–A 3:45 PM – 4:15 PM
IV–05–B 4:15 PM – 4:45 PM
Patients as Partners in Care: The Experience Reflecting the Oncology Nursing Practice
Standards in the Electronic Environment:
of Patients Attending an Interdisciplinary
Cancer Nutrition Rehabilitation Program for A Rebuild
the Treatment of Cachexia
Christine Gervais, RN, BScN, CON(C)2, Kristen Jensen,
Kimberley Gartshore, MSc(A), CON(C)1,2, Yu Hong
(Lilly) Luan, MSc(A) Student2, Monica P. Parmar, MSc(A),
PhD Student1,2. 1Segal Cancer Centre, Jewish General
Hospital, Montréal, Québec, Canada, 2Ingram School of
Nursing, McGill University, Montréal, Québec, Canada.
BscPT, MLIS3, Debra Hendel, RN CON(C)4, Justine
Ferguson, RN, CON(C) 5, Donna Van Allen, RN, BHScN, CON(C)1.
1Oncology, Grand River Hospital, Kitchener, Ontario, Canada,
3Information Technology, Grand River Hospital, Kitchener,
Ontario, Canada, 4Oncology, Grand River Hospital, Kitchener,
Ontario, Canada, 5Oncology, Grand River Hospital, Kitchener,
Ontario, Canada.
45
jour deux / day two
Pang, BSc, MMSt4. 1Patient and Family Support, Odette Cancer
Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario,
Canada, 2Department of Radiation Therapy, Odette Cancer
Canada, 3Department of Medical Oncology, Odette Cancer
Canada, 4Department of Nursing, Odette Cancer Centre,
Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada,
5University of Toronto, Toronto, ON, Toronto, Ontario, Canada.
IV–05–C 4:45 PM – 5:15 PM
Common Cancer Site Learning Guides:
Helping to Fill a Gap for Registered
Nurses New to Oncology
Ava L. Hatcher, RN, BN, CON(C)2, Gwenyth A. Hughes,
RN, BSN, MN, CON(C)1, Heather Watson, RN, BSN1.
1Professional Practice Nursing, BC Cancer Agency, Victoria,
British Columbia, Canada, 2Professional Practice Nursing,
BC Cancer Agency, Prince George, British Columbia, Canada.
jour deux / day two
IV–06 3:45 PM–5:15 PM | Kent/Palais
IV–06–A 3:45 PM – 4:15 PM
Programme de récupération rapide après
une chirurgie colorectale (rér–ccr):
un changement de paradigme pour
l’équipe de soins
Céline Bergeron, M.Sc1, Jacynthe Landry, BSc.inf3, Bolduc
Mario, MSc.inf.1, Suzanne Martel, BSc.inf3, Marie–Claude Gauvin,
MSc.inf.1, Bergeron Martin, BSc2, Marie–Josée Huot, MSc.inf1.
1Direction des soins infirmiers, CHU de Québec, Québec, Québec,
Canada, 2Direction des ressources humaines, CHU de Québec,
Québec, Québec, Canada, 3Direction famille enfance jeunesse
et santé de la femme, CHU de Québec, Québec, Canada.
ACIO/CANO groupe de réflexion sur la
thérapie de radiation / CANO/ACIO
Radiation Therapy Think Tank
3:45 PM - 5:15 PM | Plaines
Laura Rashleigh, RN, MScN, CON(C), CHPCN(C),
CANO/ACIO Director at Large – Professional Practice,
Tracy Truant, RN, MScN, PhD(c), CANO/ACIO
VP, Arlene Court, RN, BScN, CON(C), CANO/ACIO
Radiation Special Interest Group Co-Chair, Laurie Ann
Holmes, RN, BscN, CON(C), CANO/ACIO Radiation
Special Interest Group Co-Chair, Brenda C. Ross, RN,
BScN, CANO/ACIO Project Leader.
More than half of all cancer patients will receive radiation
therapy at some point during the cancer experience. CANO/
ACIO recognizes that the care for patients receiving radiation
is an integral part of our specialty practice and that nurses are
an integral part of the radiation oncology team. To support
Irène Leboeuf, M.Sc.inf., CSIO(C)1, Claire Beaudin, M.Sc.
this practice, a CANO/ACIO working group is developing
inf.2, Carole Auger, inf.2, Carole Richard, Md2. 1DSI, CHUM,
Montréal, Québec, Canada, 2CHUM, Montréal, Québec, Canada. national radiation oncology nursing practice standards and
competencies to guide care. The first step in this process is the
completion of an environmental scan and the identification of
practice issues faced by nurses across the country.
IV–06–B 4:15 PM – 4:45 PM
Transition après la résection d’un
méningiome : patient partenaire
Martine Dallaire, M.Sc.2, Clémence Dallaire, PhD3,
Catherine Balg, M.Sc2, Lucille Juneau, M.Sc1. 1Soins aux
ainés et vieillissement, CHU de Québec, Québec, Québec,
Canada, 2Neurosciences, CHU de Québec, Québec, Québec,
Canada, 3Faculté sciences infirmières, Université Laval,
Québec, Québec, Canada .
IV–06–C 4:45 PM – 5:15 PM
The CANO/ACIO board and radiation special interest
group invite you to participate in this think tank to review
preliminary environmental scan results, and share your
stories, experiences and challenges in meeting the needs
of patients and their families when receiving radiation
therapy. The workshop will include strategies to validate the
environmental scan results, and capture participants’ insights
which will be integrated into the Radiation Oncology Nursing
Practice Standards and Competencies’ development process.
This think tank will be interactive, with group discussion
and brainstorming throughout the session. All conference
attendees are welcome. Come share your expertise and
exercise your voice in shaping cancer care in Canada.
Évaluation de la charge de travail, du
climat d’équipe, de la qualité de la pratique
infirmière et de la nature du partenariat
avec les familles sur une unité d’oncologie
et de médecine pédiatrique
46
Souper éducatif Boehringer Ingelheim/
Dinner Symposium
6:15 PM – 8:00 PM
| Kent/Palais
jour trois/
day three
Mardi 28 octobre 2014
Tuesday, October 28, 2014
Déjeuner éducatif
Novartis / Novartis
Breakfast Symposium
Improving the Management of
Advanced Non-Small Cell Lung Cancer
(NSCLC)
Enhancing Nurse/Patient Partnerships:
A Treatment Decision Making Guide
Presentation 1:
Louise Binder, B.A., LL.B, LL.D(hon), O.Ont.
The Evolving Role of Nurses in Partnering
with Patients: Getting the Most from Treatment with the Best Possible Quality of Life
Mélanie Gosselin, B.Sc.inf. Clinique d’oncologie
ambulatoire, Institut Universitaire de Cardiologie et de
Pneumologie de Québec (IUCPQ)
Presentation 2:
Recent Advances in the Treatment of NSCLC
Nicole Bouchard, MD, Respirologist, Fellowship in Lung
Cancer, Associate Professor of Medicine, Université de
Sherbrooke.
By attending this session you will:
Speaker:
Facilitator:
Olga Guerra, BScN, CON(C)
Based on the expanded and increasing role oncology nurses
play in the management, treatment and support of patients
living with cancer, it is essential for nurses to know about and
communicate useful resources to better support the patients,
caregivers and/or the families in treatment decision making.
Ms. Louise Binder, well known for her involvement with
patients and patient associations, will present an overview
of the Patient’s Decision Guide about Treatments developed
between Health Canada, and two patient advocates, Ms.
Binder and Ms. Linda Wilhelm from the arthritis community.
The Guide provides a roadmap of important considerations
for patients, caregivers, family members and others who assist
them in treatment decision making along the continuum of
disease management.
•
Better understand the evolution of treatment options for
patients with advanced NSCLC
•
Review the pivotal role nurses play in working with
patients to help them manage the side effects of
treatment
•
Discuss the role of nurses in understanding patient
The desired outcome of this symposium is to reinforce the
expectations of treatment and uncovering what is
important to the patient in terms of lifestyle and activities role of the oncology nurse in the management and support of
patients living with cancer and to provide them with tools to
optimize this role.
This session will include a discussion period where
participants will be invited to share their own experience with
patients.
47
jour trois / day three
Rencontre des conseils de chapitre /
Council of Chapters Meeting
5:15 PM – 6:15 PM | Courville/
Montmorency
Objectives:
• Describe and leverage key messages of the new Guide :
Patient’s Decision Guide about Treatment
V–01–B 11:15 AM – 12:00 PM
•
Familiarize oncology nurses with the information and
tools contained in this new Guide
•
Gain insights and advice to better support patients with
their diseases/conditions, the available treatment options
and the healthcare system
Implementation of a Nursing Triage Role
in Ambulatory Cancer Care: Engaging
Patients and Families in Identifying the
Need for Oncology Nursing Care
This presentation will be based on evidence, achieve scientific Angela K. Leahey, RN, MN1, Margaret I. Fitch, RN,
integrity, be unbiased and balanced and there will be no negative PhD2, Angela D. Boudreau, RN, MN, CON(C)3, Arlene R.
Court, RN, BScN, CON(C)4, Larissa Day, RN, MSc CON(C)5,
reference to another company or their products/services.
Assemblée générale annuelle de l’ACIO/
CANO/CANO/ACIO Annual General
Meeting 8:00 AM – 9:30 AM
Kent/Palais
Cérémonie de remise de prix de l’ACIO /
CANO/ACIO Awards of Excellence
Ceremony 9:30 AM – 10:00 AM
Kent/Palais
10:00 AM – 10:30 AM
Holly Krol, RN, CON(C)7, Fiona McCullock, RN, BScN6,
Sherrol Palmer Wickham, RN, BScN, CON(C)8. 1Advanced
Practice Nurse, Oncology Nursing, Sunnybrook Odette M6
Breast Centre, Toronto, Ontario, Canada, 2Head, Oncology
Nursing; Director, Patient & Family Support Program,
Toronto, Ontario, Canada, 3Advanced Practice Nurse,
Chemotherapy Unit, Odette Cancer Centre, Sunnybrook
Health Sciences Centre, Toronto, Ontario, Canada,
4Clinical Educator, Oncology Nursing, Odette Cancer
Centre, Sunnybrook Health Sciences Centre, Toronto,
Ontario, Canada, 5Advanced Practice Nurse, Oncology
Nursing, Odette Cancer Centre, Sunnybrook Health
Sciences Centre, Toronto, Ontario, Canada, 6Supervisor,
Oncology Nursing, Odette Cancer Centre, Sunnybrook
7Manager, M6 Breast Centre, Odette Cancer Centre,
Sunnybrook Health Sciences Centre, Toronto, Ontario,
Canada,8Manager, Ambulatory Clinics & Chemotherapy ,
V–01 10:30 AM – 12:00 PM | Dufferin
V–02 10:30 AM – 12:00 PM | Villeray
V–01–A 10:30 AM – 11:15 PM
V–02–A 10:30 AM – 11:15 AM
Developing a Provincial Manpower Plan for
the Pivot Nurse in Oncology: Addressing
the Challenge of Meeting Patients’ Needs at
a Time of Scarce Resources
Model of Care Redesign at the Cancer
Centre of Southeastern Ontario:
Transforming the Patient Experience
through Patient and Family Engagement
Andréanne Saucier, MScN, CON(C), oncology nurse2,
Alain Biron, N., PhD1. 1Quality management department,
McGill University Health Centre, Montréal, Québec, Canada,
2Cancer care mission, McGill University Health Centre,
Kelly Bodie, BScN, MN, David Girard, BA, MBA. Kingston
General Hospital, Kingston, Ontario, Canada.
48
Making a Difference – Sharing Lessons
Learned in the Implementation of a
Patient Engagement Group in a Cancer
Network in Scotland
Lorna J. Roe, RN, BSc, MSc. Systemic Therapy, BC
Cancer Agency, Abbotsford, British Columbia, Canada.
V–03 10:30 AM – 12:00 PM | De Tourny
V–03–A 10:30 AM – 11:15 AM
Modeling Chronic Disease Self–
Management Support in Cancer Care
Aronela Benea, MScN, Aleksandra Chafranskaia, PT,
MHSc, Pamela Catton, MD, MHPEd, FRCPC, Stephanie
Phan, OTRg.(Ont.), HBSc(OT). Cancer Survivorship Program,
Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
Wayne Enders, RN, Dave J. Whiteside, BScN, Sarah
Champ, BScN. Nursing Education, Alberta Health Services
Community Oncology, Edmonton, Alberta, Canada.
V–04–B 11:15 AM – 12:00 PM
“911, What is Your Emergency?”
Oncologic Emergency Guideline
Development in Nova Scotia
Kara Henman, MN, Michele Rogez, BScN. Cancer Care
Nova Scotia, Halifax, Nova Scotia, Canada.
V–05 10:30 AM – 12:00 PM | Beaumont/
Belair
V–05–A 10:30 AM – 11:00 AM
V–03–B 11:15 AM – 12:00 PM
A Creative Response to a Unique Need: A
Multi–Partnered Collaboration to Create
Canada’s First Retreat for Young Adult
Cancer Survivors Living with Advanced
and Metastatic Disease
National Update Canadian Cancer
Control Strategy, Embedding Person–
Centred Perspective 2014
Emily Drake, MA1, Suzanne O’Brien, MA1, Jennifer
Finestone, MA2, Doreen Edward, BComm3. 1Hope & Cope,
Montréal , Québec, Canada, 2Cedars CanSupport, Montréal,
Québec, Canada, 3VOBOC, Montréal, Québec, Canada.
Scott Secord, RSW, MSW. Cancer Control, Canadian
Partnership against Cancer, Toronto, Ontario, Canada.
V–05–B 11:00 AM – 11:30 AM
V–04 10:30 AM – 12:00 PM | Courville/
Montmorency
V–04–A 10:30 AM – 11:15 AM
Maintenance of Competency for
Specialized Oncology Nurses in Rural
and Remote Centres
Beyond the Pink Ribbons: The
Development of an Education Module to
Engage, Examine, and Enhance Critical
Thinking
Brenda Sabo, RN, PhD2, Sharon Batt, PhD3, Karyn E.
Perry, MBA, BScN, RN1, Erna Snelgrove–Clarke, RN,
PhD2, Karyn Perry, RN, BSN, MBA, CON(C), Deborah
L. McLeod, RN, PhD4, Tina Ruel, BA2. 1Consultant,
Peterborough, Ontario, Canada, 2Nursing, Dalhousie
University, Halifax, Nova Scotia, Canada, 3Health Services,
Dalhousie University, Halifax, Nova Scotia, Canada,
4Psychosocial Oncology, Capital district Health Authority,
Halifax, Nova Scotia, Canada.
49
V–02–B 11:15 AM – 12:00 PM
V–05–C 11:30 AM – 12:00 PM
Dîner éducatif Amgen /
Amgen Lunch Symposium
12:00 PM – 1 :30 PM | Kent/Palais
A Pilot Study Evaluating Canadian
Cancer Patients’ Treatment Related Out– Is Your Patient at Risk for
of–Pocket Costs
Chemotherapy-Induced Neutropenia? A
Look at Formalizing Risk Assessment
Margaret I. Fitch, RN, PhD1, Christopher J. Longo,
PhD2. 1Head, Oncology Nursing; Director, Patient & Family
Support Program, Odette Cancer Centre, Sunnybrook
Chair: Inara H. Karrei, RN, BScN, MEd, CON(C), Nurse
Educator - The Ottawa Hospital Cancer Centre
Speaker: Atelier simultané / Concurrent Session
V–06 10:30 AM–12:00 PM | Kent/Palais
V–06–A 10:30 AM – 11:15 AM
Association Canadienne des Agences
Provinciales du Cancer : Lignes
directrices pour l’utilisation sécuritaire
des thérapies systémiques orales
Melany Leonard, BScN, MSc(A), CON(C)1, Heather
Logan, BScN, MHSc2. 1Oncologie/hematologie, McGill
University Health Center, Montréal, Québec, Canada,
2Canadian Association of Provincial Cancer Agencies,
V–06–B 11:15 AM – 12:00 PM
Le rôle de l’infirmière dans la gestion
des effets secondaires des thérapies
ciblées en cancer du poumon : pour une
meilleure qualité de vie
Susan F. Dent, BSc, MD, FRCP(C), Medical OncologistThe Ottawa Hospital Cancer Centre, Associate Professor,
Department of Medicine - University of Ottawa Objectives: • Understand the clinical impact of chemotherapy-induced
neutropenia (CIN) and its complications
• Discuss the efficacy and safety of Granulocyte colonystimulating factors (G-CSFs) in CIN
• Recognize patient-, disease-, and treatment-related risk
factors for febrile neutropenia, and the need to formally
assess patient risk
Chemotherapy-induced neutropenia (CIN) and its
complications can have significant clinical impact. Amgen
Canada’s luncheon symposium at this year’s CANO/ACIO
annual conference will help elucidate the severity of this
clinical impact and will discuss the efficacy and safety of
the agents used in managing CIN. Through an interactive,
case-based workshop, the session will also seek to illustrate
the importance of formally assessing a patients risk for
developing febrile neutropenia by looking at patient-,
disease-, and treatment-related risk factors. Symposium
participants will get hands-on experience with the recently
developed Febrile Neutropenia (FN) Risk Assessment Guide,
a web-based guide to support healthcare practitioners with
assessing their patients’ risk of developing FN.
Mélanie Gosselin, B.Sc, Oncologie ambulatoire, IUCPQ,
Québec, Québec, Canada.
50
Conférence plénière II /
Keynote Presentation II
1:30 PM – 2:45 PM
| Kent/Palais
decision–making: how to equip care teams so they can develop
a common vision of shared decision–making with patients as
partners. She directed the Cochrane Review of interventions
for improving the adoption of shared decision making.
Dawn Stacey and France Légaré
Dawn Stacey inf., CSIO(C), PhD,
Chaire de recherche en transfert des
connaissances aux patients
Dawn Stacey inf., PhD, CSIO(C), est professeure associée à
l’École des sciences infirmières de l’Université d’Ottawa. Elle
est chercheure à l’Institut de recherche de l’Hôpital d’Ottawa
Médecin de famille depuis 1990, France Légaré est professeure
où elle dirige le groupe de recherche sur les Aides à la décititulaire au Département de médecine familiale et de médecine
sion pour le patient. Elle est la chercheure principale pour
d’urgence de l’Université Laval. Après ses études en médecine et
une résidence en medicine familiale, elle a obtenu une maîtrise en la Cochrane Review of Patient Decision Aids, co–présidente
santé communautaire pendant laquelle elle a étudié les décisions du comité directeur du Patient Decision Aid Standards
des médecins et des femmes de recourir à l’hormonothérapie Collaboration (IPDAS), et co–chercheure pour la Cochrane
Review of Interventions to Improve the Adoption of Shared
substitutive. En 2005, elle a obtenu son doctorat avec une thèse
Decision Making. Ses recherches portent sur le transfert de
abordant un sujet relativement novateur à l’époque : comment
connaissances au patient, le développement et l’évaluation
inciter les professionnels de la santé à partager les décisions
avec leurs patients. Depuis 2006, elle est titulaire d’une Chaire d’aides à la decision pour le patient; le coaching décisionnel, l’implantation d’aides à la décision dans la pratique, la
de recherche du Canada en implantation de la prise de décision
partagée dans les soins primaires. Elle dirige le site de l’université pratique téléphonique et les approches interprofessionnelles
Laval du Réseau canadien Cochrane depuis 1999. Son programme en décision partagée. Elle collabore avec le Ministère de la
santé de la Saskatchewan pour l’implantation de la décision
de recherche vise à fournir aux professionnels de la santé et
partagée et des aides à la decision dans cette province. Mme
aux patients les outils nécessaires afin d’optimiser les decisions en santé. Elle s’intéresse particulièrement à une approche Stacey a reçu en 2012 le prix d’excellence en recherche en
soins infirmiers en oncologie de l’ACIO/CANO. Le site Web
interprofessionnelle en matière de prise de décision partagée:
de son programme de recherche est accessible à http://decicomment outiller les équipes de soins pour qu’elles puissent
développer une vision commune de la décision partagée, avec un sionaid.ohri.ca.
patient–partenaire. Elle dirige le revue Cochrane “Interventions
Dawn Stacey, RN, PhD, CON(C), Canada Research Chair in
to Improve the Adoption of Shared Decision Making”.
knowledge transfer to patients
France Légaré, B.Sc. Arch, MD, PhD, CCFP, FCFP, Canada
Research Chair in implementation of shared decision–making
in primary care
A family doctor since 1990, Dr. France Légaré is a full professor
in the Department of Family Medicine and Emergency Medicine at Laval University. After her medical studies and her residency in family medicine, Dr. Légaré obtained her Masters in
community health in which she studied doctors’ and women’s
decisions to turn to hormone replacement therapy. In 2005,
she was awarded her PhD with a dissertation on a relatively
novel topic at the time: how to make health professionals share
decision–making processes with their patients. Since 2006, she
has held a Canada Research Chair in implementation of shared
decision–making in primary care. She has directed the Canadian Cochrane Centre’s site at Laval University since 1999. Her
research program aims to give health professionals and patients
the necessary tools to optimize health–related decisions. She is
particularly interested in an interpersonal approach to shared
Dawn Stacey, RN, PhD, CON(C), is an associate professor at the
University of Ottawa’s School of Nursing. She is a researcher at
the Ottawa Hospital Research Institute, where she directs the
patient decision aids research group. She is a senior researcher
for the Cochrane Review of patient decision aids, co–president
of the Patient Decision Aids Standards Collaboration’s Executive Committee (IPDAS), and co–researcher for the Cochrane
Review of interventions to improve the adoption of shared
decision making. Her research focuses on knowledge transfer
to the patient, development and evaluation of decision aids for
patients, decisional coaching, implementation of decision aids
in practice, telephone practice and interprofessional approaches
in shared decision–making. She works with the Saskatchewan
Department of Health to implement shared decision–making
processes and decision aids in the province. In 2012, Dr. Stacey
received CANO/ACIO’s Award of Excellence in Oncology Nursing Research. Her research program’s website can be found at
http://decisionaid.ohri.ca.
51
France Légaré, B.Sc.Arch., MD, PhD,
CCFP, FCFP, Chaire de recherche du
Canada en implantation de la prise
de décision partagée dans les soins
primaires
| Portneuf/Sainte Foy/
Orleans
2:45 PM – 3:30 PM
Atelier / Workshop VI–01
3:30 PM – 5:00 PM Dufferin
Unpacking Complex CAM and Cancer
Situations: Decision Coaching in Real Time
Brenda C. Ross, RN, BScN3, Tracy L. Truant, RN, MSN,
PhD(c), Lynda G. Balneaves, RN, PhD2, Kathleen Yue, RN,
MN4, Brenda La Prairie, RN, BScN5, Senz Hamilton, RN,
BSN6. 1School of Nursing, UBC, Vancouver, British Columbia,
Canada, 2School of Nursing, UBC , Vancouver, British
Columbia, Canada, 3CAMEO Program, BC Cancer Agency,
Vancouver, British Columbia, Canada, 4Radiation Program,
BC Cancer Agency, Victoria, British Columbia, Canada,
5Systemic Therapy Program, BC Cancer Agenncy, Victoria,
British Columbia, Canada, 6Clinical Trials, BC Cancer
Agency, Victoria, British Columbia, Canada.
VI–02 3:30 PM – 5:00 PM | Villeray
VI–02–A 3:30 PM – 4:00 PM
Primary Care and Oncology:
Implementation and Early Evaluation of
a Survivorship Nurse Practitioner Role
Kristina Morrison, MSN, NP (F), BC Cancer Agency,
Vancover, British Columbia, Canada.
VI–02–B 4:00 PM – 4:30 PM
Developing and Maintaining Competency
for Cancer Chemotherapy Care: Evaluating
an Innovative Model
Laura Rashleigh, RN, BScN, MScN, CON(C), CHPCN(C),
Donalda MacDonald, RN, CON(C), Komal Patel, RN,
BScN, MN, CON(C), CHPCN(C), Tracy Soong, BSc(cand),
Jiahui Wong, PhD, Mary Jane Esplen, RN, PhD
52
VI–02–C 4:30 PM – 5:00 PM
The Impact of Matching Patient Needs
to Nursing Resources: Lessons Learned
from Applying the Synergy Model in a
Hematology/Hsct Unit
Yayra Amenudzie, RN, BScN1, Elizabeth O’Sullivan,
RN, BScN, MScN1, Georgia Georgiou, BA, BEd, MEd1,
Jennifer Wiernikowski, RN(EC), MN, NP-Adult, CON(C)1,
Elizabeth Heelam, RN, BScN, BHSc, CON (C)1, Enoch Ho,
MPh, RPT, R Acu2, 1Hamilton Health Sciences , Hamilton ,
Ontario, Canada, 2Hamilton Health Sciences , Hamilton ,
Ontario, Canada.
VI–03 3:30 PM – 5:00 PM | De Tourny
VI–03–A 3:30 PM – 4:00 PM
Use of a Dvd to Improve Head & Neck
Cancer Patients Information Retention
Renata Benc, BA, MSc(N), CON(C)2, Christina
MacDonald, BScN, MSc(N), CON(C)1. 1Head and Neck, ENT
clinic, Segal cancer Centre, Jewish General Hospital, Montréal,
Québec, Canada, 2Radiation Oncology, Segal Cancer Centre,
Jewish General Hospital, Montréal, Québec, Canada.
VI–03–B 4:00 PM – 4:30 PM
Educating the Leukemia Population: The
Development and Implementation of an
Educational Toolkit to Support the New
Leukemia Patient Population throughout
the Trajectory of Care
Christine Bent, RN, BScN, Sandra Bolyki, RN, BA, Oma
Boodhoo, RN, BScN, MN, Katherine Lee, RN, BScN, Laura
Olmi, RN, BScN, Kaminiben Patel, RN, BScN,
Erin Saretz, RN, BScN, Susan Robinson, RN, BScN, MN,
Maggie Dilling, RN, BScN. Malignant Hematology, University
Health Network, Princess Margaret Cancer Centre, Toronto,
Ontario, Canada.
An Introduction to Chemotherapy: A
Presentation for Patients and Families
Gwenyth A. Hughes, RN, BSN, MN, CON(C)2,
Brenda La Prairie, RN, BSN, CON(C)1. 1Systemic
Therapy Program, British Columbia Cancer Agency,
Victoria, British Columbia, Canada, 2Professional Practice
Nursing, British Columbia Cancer Agency, Victoria, British
Columbia, Canada.
VI–04 3:30 PM – 5:00 PM | Courville/
Montmorency
VI–04–A 3:30 PM – 4:00 PM
Bridging the Research–Practice Gap
in Oncology Nursing Practice: A New
Brunswick Perspective on Academic–
Practice Partnerships
Krista Wilkins, PhD2, Kimberly Chapman, MSN1. 1Horizon
Health Network, Fredericton and Upper River Valley Area ,
New Brunswick, Canada, 2Faculty of Nursing, University of
New Brunswick, Fredericton, New Brunswick, Canada.
VI–04–B 4:00 PM – 4:30 PM
Nurse Practitioners in Cancer Care:
Enhancing Patient Engagement in Care
Krista Rawson, MN1, Sarah Wall, PhD2. 1Alberta Health
Services, Red Deer, Alberta , Canada, 2Faculity of Nursing,
University of Alberta, Edmonton, Alberta, Canada.
VI–05 3:30 PM – 5:00 PM | Beaumont/
Belair
VI–05–A 3:30 PM – 4:00 PM
Supporting Nursing Practice: Perceptions
of Professional Practice Effectiveness
Lorelei Newton, RN, PhD, Maxine Alford, PhD, Gwenyth
A . Hughes, RN, BSN, MN, CON(C), Karen Janes, RN, MN,
Kira K. Cooksley, RN, MN, CPHON. Provincial Professional
Practice Leader – Nursing, BC Cancer Agency, Vancouver,
VI–05–B 4:00 PM – 4:30 PM
The Interprofessional Improvement
Team: A Key Approach to Ensure
Excellence in Cancer Care
Andréanne Saucier, MScN, CON(C), oncology nurse,
Carolyn Freeman , MBBS, FRCPC, FA STRO. Cancer Care
mission , McGill University Health Centre, Montréal ,
Québec, Canada .
VI–05–C 4:30 PM – 5:00 PM
Establishing an Oncology Nursing
Leadership Advisory Group within a
Regional Cancer Centre
Charmaine Lynden, RN, MN(EC), Meghan MacMillan, RN,
MScN, Cathy Kiteley, RN, MN, Devi Ahuja, MN, RN(EC),
Susan Daley, RN, BScN, Catherine Sodoski , RN, BN, Laurie
Van Dorn, RN, Maritza Carvalho, RN, BN, Lynda Larmour,
BA, RN, Maria Rugg, MN, Jarmila Grof, RN, BN. Oncology,
Trillium Health Partners, Mississauga, Ontario, Canada .
VI–04–C 4:30 PM – 5:00 PM
Advanced Practice Nursing in Action:
Shaping Nursing Practice for People
Dealing with Breast Cancer
Kim Chapman, MSc(N), Oncology, Horizon Health
Network, Fredericton and Upper River Valley Area,
Fredericton, New Brunswick, Canada.
53
VI–03–C 4:30 PM – 5:00 PM
VI–06 3:30 PM–5:00 PM | Kent/Palais
VI–06–A 3:30 PM – 4:00 PM
Les problèmes qui contribuent au
niveau de détresse chez des patients
nouvellement référés en clinique
ambulatoire de soins palliatifs
Nathalie Aubin, M. Sc.2, Andréa Laizner, PhD3, Anita
Mehta, PhD1, Marc Hamel, PhD1. 1programme d’oncologie
psychosocial, Centre universitaire de santé McGill , Montréal,
Québec, Québec, Canada, 2Programme de soutien en
oncologie et soins palliatifs, Centre universitaire de santé
McGill, Montréal, Québec, Québec, Canada, 3Département de
recherche en soins infirmiers, Centre universitaire de santé
McGill, Montréal, Québec, Québec, Canada.
VI–06–B 4:00 PM – 4:30 PM
Développement d’un outil de soutien
à l’exercice optimal de l’autonomie
relationnelle (OSER) en soins palliatifs
Mireille Lavoie, PhD2, Véronique Turcot te, M.Sc.1, S. Robin
Cohen, PhD3, Jean–François Desbiens, PhD2, Lise Fillion,
PhD2, Camille Gagné, PhD2, Kathleen Lechasseur, PhD2.
1Cent re de recherche du CHU de Québec, Québec, Québec,
Canada , 2Faculté des sciences inf ir mières, Université Laval,
Québec, Québec, Canada , 3Depart ment of Oncology, McGill
University, Mont réal , Québec, Canada
VI–06–C 4:30 PM – 5:00 PM
Rencontre des comités et groupes
d’intérêts spéciaux / Committee + SIG
meetings 5:15 PM – 6:15 PM
Details page 32
Soirée sociale / Social Event
7:00 PM – Onwards
| Musée de la civilisation
Details page 22
jour quatre /
day four
Mercredi 29 octobre 2014
Wednesday, October 29, 2014
Déjeuner éducatif Merck /
Merck Breakfast Symposium
Implications of Immuno-Oncology for
Oncology Nursing
Speaker:
Teresa Petrella, BSc, MD, MSc, FRCPC, Medical
Oncologist Chair, NCIC Melanoma Clinical Trials Group
Chair, Melanoma Site Group Odette Cancer Centre Assistant
Professor, University of Toronto
jour quatre / day four
Démarche d’amélioration continue :
vers un parcours qualifiant pour le
développement des compétences en
oncologie
At the conclusion of this program, participants will be able to:
Catherine Derval, M.Sc., Louise Handfield, M.Sc.,
CSISP(C), Irène Leboeuf, M.Sc., CSIO(C), Catherine Genest,
M.Sc., CSIO(C), Joannie Van Houtte, B.Sc., DESS (étudiante),
Dominique Lachapelle, M.Sc., Marielle Roy, M.Sc., Audrey
Chouinard, M.Sc., CSIO(C). Centre hospitalier de l’Université
de Montréal, Montréal, Québec, Canada.
• Review the use of immune checkpoint inhibitors in the
treatment of cancer, particularly metastatic melanoma
54
• Relate the mechanism of action of immune checkpoint
inhibitors to the role of the immune system in the
pathophysiology of cancer
• Assess immune-related adverse events in the management
of oncology patients treated with immunotherapy
Conférence plénière III /
Keynote Presentation III
9:00 AM – 10:00 AM
| Kent/Palais
années à venir nous interpellent à réussir la mise en oeuvre
du concept de patient partenaire et par le fait même, celui
d’infirmière partenaire.
Andréanne Saucier, MScN, CON(C), oncology nurse
Andréanne Saucier is the Director of Nursing of the McGill
University Health Center. She is also the Co–Director of
the Office of Continuous Improvement of Quality and
Performance. She is an Assistant Professor at McGill
Andréanne Saucier est directrice
University’s Ingram School of Nursing and EXTRA Fellow of
des soins infirmiers au centre
the Canadian Foundation for Healthcare Improvement. Ms.
universitaire de santé McGill
Saucier has been passionate about oncology nursing for the
(CUSM). Elle assure aussi la co-direction du bureau
past 20 years. As a clinician, she is interested in integrating
d’amélioration continue de la qualité et la performance.
families in cancer care and she helps nurses become skilled
Elle est assistante professeur à l’école des sciences
in family intervention. She works on improving continuity
infirmières de l’Université McGill et boursière du
of care, which so often seems to be lacking in cancer care. As
programme FORCES de la Fondation canadienne pour
a manager, she endeavours to develop novel approaches for
l’amélioration des services de santé. Depuis vingt ans,
nursing practices and the organization of care and services in
Andréanne Saucier se passionne pour les soins infirmiers
a way that ensures the health system serves cancer patients
en cancérologie. D’abord en tant que clinicienne, elle se
and not the other way around. For several years, she has
préoccupe de l’intégration des familles dans les soins aux
personnes atteintes de cancer et appuie les infirmières dans been contributing to different projects with the Canadian
l’acquisition de compétences en intervention familiale. Elle Association of Nurses in Oncology (CANO/ACIO), the
Canadian Association of Provincial Care Agencies (CAPCA),
se soucie d’améliorer la continuité des soins qui semble
the Canadian Partnership Against Cancer (CPAC), and the
si souvent déficiente aux personnes atteintes de cancer.
Secrétariat international des infirmières et infirmiers de
Par la suite, en tant que gestionnaire, elle consacre ses
l’espace francophone (SIDIIEF). She is convinced that
énergies à développer des approches novatrices pour la
research and continued quality improvement projects are
pratique infirmière et l’organisation des soins et services
levers to transform the delivery of care. She participates
afin que le système de santé soit au service des personnes
atteintes de cancer et non pas le contraire. Depuis plusieurs as a member or lead on various research projects as well
années, elle se joint aux différents travaux de l’Association as several cancer–care committees at both the provincial
and national levels. Known for her creativity, her ability to
canadienne des infirmières en oncologie (ACIO/CANO),
encourage collaboration among her peers, her humanity,
à l’Association canadienne des agences provinciales de
her determination to improving the quality and delivery
cancer (ACAPC), au Partenariat canadien contre le cancer,
au Secrétariat international des infirmières et infirmiers de of cancer care, and her ability to act as a role model for
l’espace francophone (SIDIIEF). Persuadée que la recherche nurses and other health professionals, Andréanne Saucier
received in 2011 the Canadian Association of Nurses in
et les projets d’amélioration continue de la qualité sont
Oncology’s Leadership Award. Throughout her varied and
des leviers pour transformer la prestation des soins, elle
participe comme membre ou comme responsable à diverses all–encompassing trajectory as a passionate oncology nurse,
Ms. Saucier has learned to work as a partner with other
recherches ainsi qu’à plusieurs comités provinciaux
health professionals, but especially with patients and their
et nationaux en cancérologie. Reconnue comme une
loved ones. According to her, the years to come will see
infirmière créative, habile à susciter la collaboration de
the successful implementation of the concept of patient as
ses pairs, humaine et soucieuse d’améliorer la qualité et
partner and therefore of nurse as partner.
la performance des soins en cancérologie, modèle de rôle
pour les infirmières et les autres professionnels de la santé,
Andréanne Saucier a reçu en 2011 le prix Leadership de
l’Association canadienne des infirmières en oncologie.
Ce parcours dense et fécond d’une infirmière passionnée
10:00 AM – 10:30 AM
en oncologie témoigne de l’apprentissage du travail en
partenariat avec les intervenants de la santé mais surtout
| Exhibit Hall
avec les patients et leurs proches. Selon Mme Saucier, les
55
Andréanne Saucier, M.Sc.
inf., CSIO(C), infirmière en
oncologie
Atelier / Workshop VII–01
10:30 AM – 12:00 PM | Dufferin
VII–03–B 11:15 AM – 12:00 PM
Submitting to the Canadian Oncology
Nursing Journal (CONJ): Achieving Success
Nova Scotia: Opening Pandora’s Box of
Oral Systemic Therapy
L. Thomson, RN, MSc3, Sally E. Thorne, RN, PhD4, Patricia
A. Sevean, RN, MA(N), EdD5. 1Head, Oncology Nursing;
Director, Patient & Family Support Program, Odette Cancer
Canada, 2Regional Program Director, Janeway Hospital Site
2J141, Eastern Health, Children & Women’s Health Program,
St. John’s, Newfoundland, Canada, 3Clinical Advisor, College
of Physicians and Surgeons British Columbia, Vancouver,
British Columbia, Canada, 4UBC School of Nursing,
Canada, 5Associate Professor, School of Nursing, Lakehead
University, Thunder Bay, Ontario, Canada, 6Director,
Ambulatory Care & Systemic Therapy, Alberta Health
Services, CancerControl Alberta, Community Oncology,
Thunder Bay, Ontario, Canada.
Michele Rogez, BScN, Kara Henman, MN. Cancer Care
Nova Scotia, Sydney, Nova Scotia, Canada.
Atelier / Workshop VII–02
10:30 AM – 12:00 PM | Villeray
VII–04 10:30 AM – 12:00 PM | Courville/
Montmorency
VII–04–A 10:30 AM – 11:15 AM
The MUHC Cancer Pain Program: An
Interdisciplinary Approach to Cancer
Pain Management
Sara Olivier, BSN, MN(C)1, Jordi Perez, MD2, Rosemary
O’Grady, MN1, Manuel Borod, MD1, Yoram Shir, MD3. 1Supportive
& Palliative Care, MUHC, Montréal, Québec, Canada, 2AEPMU
and Supportive & Palliative Care, MUHC, Montréal, Québec,
Canada, 3AEPMU, MUHC, Montréal, Québec, Canada.
Oncology Leadership Workshop: Moving
from Being Good to Being Great Change Atelier simultané / Concurrent Session
VII–04–B 11:15 AM – 12:00 PM
Leaders
Engaging Patients and Families through
Janice Chobanuk, RN, MN, CON(C), HPCN(C).
CancerControl Alberta Community Oncology, Alberta
a Provincial Cancer Patient Navigation
Health Services, Edmonton, Alberta, Canada.
Program: Evaluating the Impact
VII–03 10:30 AM – 12:00 PM | De Tourny
VII–03–A 10:30 AM – 11:15 AM
Canadian Association of Provincial
Cancer Agencies: Oral Cancer Drug
Therapy Safe Use and Safe Handling
Guidelines
Melany Leonard, BSc(N), MSC(A)1, Heather Logan, BSc(N),
MHSc2. 1Oncology/Hematology, McGill University Health
Center, Montréal, Québec, Canada, 2Canadian Association of
Provincial Cancer Agencies, Toronto, Ontario, Canada.
56
Linda C. Watson, RN, PhD, CON(C), Jennifer Anderson, RN,
MN, CON(C), Kristina Vimy, RN, BN, Andrea William, BA. Alberta
Health Services, CancerControl Alberta, Calgary, Alberta, Canada.
VII–05 10:30AM – 12:00 PM |
Beaumont/Belair
VII–05–A 10:30 AM – 11:15 AM
The Nurses’ Role in Understanding
Health Literacy
Sarah Champ, BScN1, Dave J. Whiteside, BScN1, Wayne
Enders, RN1, Keira MacKinnon, BEd, BA2. 1Nursing Education,
Alberta Health Services Community Oncology, Edmonton,
Alberta, Canada, 2Patient Education Specialist, Cross Cancer
Institute, Edmonton, Alberta, Canada.
VII–05–B 11:15 AM – 12:00 PM
Health Literacy and the Effects on
Oncology Patients
Gurjeevan Dosanjh, BScN, Provincial Professional
Practice, BC Cancer Agency, Vancouver, British Columbia,
Canada.
Dîner éducatif Roche /
Roche Lunch Symposium
12:15 PM – 1:45 PM
| Kent/Palais
An Update on Safety and Side Effect
Management of New Therapies in HER2
Positive Metastatic Breast Cancer
Speaker 1
Inara H. Karrei, RN, BScN, MEd, CON(C), Nurse
Educator, The Ottawa Hospital Cancer Centre.
Speaker 2
VII–06–A 10:30 AM – 11:15 AM
La pratique interprofessionnelle centrée
sur le patient : étude de cas multiples
d’équipes en oncologie
Karine Bilodeau, RN, MSN, PhD2, Sylvie Dubois, RN, M.
Éd., MBA, PhD1, Jacinthe Pepin, RN, MSN, PhD2. 1Direction
des soins infirmiers, Centre hospitalier de l’Université de
Montréal, Montréal, Québec, Canada, 2Faculté des sciences
infirmières, Université de Montréal, Montréal, Québec,
Canada.
VII–06–B 11:15 AM – 12:00 PM
Le dépistage systématique de la détresse
auprès des patients atteints d’un
cancer pulmonaire : bonifier le travail
interdisciplinaire
Sébastien Simard, PhD, Brigitte Fournier, MSc, Lynda
Fradette, BSc, Mélanie Gosselin, BSc, Nadine Blanchin,
BSc, Michelle Martineau, BSc, Isabelle Perreault, , MSc, Lise
Tremblay, MD. Institut universitaire de cardiologie et de
pneumologie de Québec (IUCPQ), Québec, Québec, Canada.
Sean Hopkins, BSc (Hon), BSP, Pharmacy Manager,
Simcoe Muskoka Regional Cancer Program, Royal Victoria
Regional Health Centre.
This lunch symposium will cover the safety and dosing of the
latest treatments for HER2+ve metastatic breast cancer, from
a nurse and a pharmacist’s perspective.
Learning objectives:
Following this symposium, the participants will be able to:
1. Describe nursing considerations in the administration of
new targeted therapies in metastatic breast cancer (mBC)
2. Effectively manage common side effects related to the
treatment of HER2 positive mBC
3. Recognize the potential for medication error between
Herceptin (trastuzumab) and Kadcyla (trastuzumab
emtansine) and explore best-practice protocols for medical
distinction of these agents
VIII–01 2:00 PM – 3:30 PM | Dufferin
VIII–01–A 2:00 PM – 2:30 PM
Patient Engagement Requires Team
Engagement
Janice Dirksen, BScN, BC Cancer Agency, Vancouver,
57
VII–06 10:30 AM–12:00 PM
| Kent/Palais
VIII–01–B 2:30 PM – 3:00 PM
Enabling Self–Management for Patients
and Families in the Acute Phase of
Treatment for Head and Neck Cancer
Sharon McGonigle, MScN, NP, Radiation Medicine,
Princess Margaret Cancer Center, Toronto, Ontario, Canada.
VIII–01–C 3:00 PM – 3:30 PM
Engaging Patients across the Trajectory
of Cancer Treatments: Creating a Patient
Information Pathway
Jennifer Smylie, RN, MScN, Lynn E. Kachuik, RN, BA,
MS, CON(C), CHPCN(C). The Ottawa Hospital, Ottawa,
Ontario, Canada.
VIII–02 2:00 PM – 3:30 PM | Villeray
VIII–02–A 2:00 PM – 2:30 PM
Patient Engagement in Transforming the
Practice of Safer Delivery of Drugs
Anne Schmidt, RN, CON(C)1, Debra Hendel, RN, CON(C)2,
Donna Van Allen, RN BHScN, CON(C)1. 1Oncology, Grand
River Hospital, Kitchener, Ontario, Canada, 2Oncology,
Grand River Hospital, Kitchener, Ontario, Canada.
VIII–02–B 2:30 PM – 3:00 PM
Chemotherapy Administration on NonOncology Units: Nurses’ Experience,
Improving the Process and Supporting
Clinical Practice Standards
Luisa Luciani Castiglia, N, MScA, CON(C)2, Virginia
Lee, RN, PhD1, Louise Fullerton, N, MScA4, Sonia Castiglione,
N, MScA3, Myriam A. Skrutkowski, N, MSc, CON(C)1, Andréane
Chevrette, N, BScN, MGP(C), CON(C)5. 1Research Institute, McGill
University Health Centre, Montréal, Québec, Canada, 2Cancer
Care Mission, McGill University Health Centre, Montréal, Québec,
58
Canada, 3Centre for Nursing Research, McGill University Health
Centre, Montréal, Québec, Canada, 4Surgical Services, McGill
University Health Centre, Montréal, Québec, Canada, 5Quality
and Performance Improvement Office, Cancer Care Mission,
McGill University Health Centre, Montréal, Québec, Canada.
VIII–02–C 3:00 PM – 3:30 PM
From Intravenous to Oral Anticancer
Drugs: Setting Up an Interdisciplinary
Project to Ensure Safe and Efficient
Treatments
Audrey Chouinard, Masters1, Joannie Van Houtte
St–Gelais, Bachelor2. 1Oncology, Centre hospitalier de
l’Université de Montréal, Montréal, Québec, Canada,
2Oncology, Centre hospitalier de l’Université de Montréal,
Montréal, Québec, Canada
VIII–03 2:00 PM – 3:30 PM | De Tourny
VIII–03–A 2:00 PM – 2:30 PM
How to Operationalize the Resource
Intensity Weightings in an Ambulatory
Chemotherapy Suite
Donna Van Allen, RN, BHScN, CON(C)1, Anne Schmidt,
RN, CON(C)1, Junghee Ahn, RN, CON(C)1, Tracy Solonika, RN,
BSN, MN Oncology, CON(C)2, Michelle Wald, RN, BSN, CON(C)2.
2Oncology, Lakeridge Health, Oshawa, Ontario, Canada.
VIII–03–B 2:30 PM – 3:00 PM
Transforming Ambulatory Oncology Care:
Optimizing the Oncology Patient Experience
Allyson Nowell, BSc, MSc, Terri Stuart–McEwan, BScN,
MHS, Kathy Davison, RN, BAS, MHS. Princess Margaret
Transforming Nursing Practice: Implementing Bedside Shift Report to Enhance Patient
Experience, Promote Safety and Nurse Accountability in Oncology – Palliative Unit
Jennifer Eccles, MSN, Maria Cherry Sunga, Diploma,
Shehnaz Bandali, Diploma. Cancer Care, North York
General Hospital, Toronto, Ontario, Canada.
VIII–04 2:00 PM–3:30 PM | Courville/
Montmorency
VIII–04–A 2:00 PM–2:30 PM
Increasing Health Literacy by
Engaging Patients and Families in the
Development of Educational Resources
Shawne P. Gray, BScN, CON(C), Sonali Kirschenbaum,
BScN, Harvey H. Wong, MD, FRCP(C), Rose Rivera, BScN,
MN, Larissa Day, BScN, MSc, CON(C).Sunnybrook Odette
VIII–04–B 2:30 PM – 3:00 PM
Understanding the Perspectives of Older
Adults about Cancer Information
Margaret I. Fitch, RN, PhD2, Tamara Harth, BA(HON),
MLIS1. 1Program Manager, Cancer Patient Education Program,
Toronto, Ontario, Canada, 2Head, Oncology Nursing; Director,
Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
VIII–04–C 3:00 PM – 3:30 PM
Is What I Need to Know, What My Patients
Actually Want to Know? – An Analysis of
Oncology Nurses’ Resource Needs Compared
to Oncology Patients’ Priority Concerns and
Support Needs at End of Treatment
Lisa Lun, RN, BScN, MA(Ed), CHPCN(C)1, Soma
Persaud, RN, BScN, MN(Ed), CON(C)3, Jana Ailenberg,
RN, BScN, CON(C)2, Jill Whittaker, RN, BScN, CON(C)4,
Pauline Brillinger, RN, BScN5. 1Integrated Cancer Care,
Humber River Hospital, Toronto, Ontario, Canada,
2Chemotherapy Clinic, North York General Hospital, Toronto,
Ontario, Canada, 3Medicine Program, Mackenzie Health,
Toronto, Ontario, Canada,4Chemotherapy, Stronach Cancer
Center, Newmarket, Ontario, Canada, 5Oncology, Markham
Stouffville Hospital, Markham, Ontario, Canada.
VIII–05 2:00 PM – 3:30 PM |
Beaumont/Belair
VIII–05–A 2:00 PM – 2:30 PM
Implementation of an Electronic
Documentation System in Radiation
Oncology: A Nursing Perspective
Angela Whynot, RN, BScN, CON(C). Capital Health,
Halifax, Nova Scotia, Canada.
VIII–05–B 2:30 PM – 3:00 PM
Improving Documentation of Oral
Chemotherapy at a Community Teaching
Hospital
Meghan MacMillan, RN, MScN, Maritza Carvalho, RN,
BN, Simerjit K. Gollee, RN, BScN, Katherine Enright, MD,
Bernadette Almeida, RPh, BScPhm, ACPR, Laurie Van Dorn,
RN, Carole Goulet, RN, Lorminia Realeza, RN, Linda G. Nixon,
RN, Catherine Sodoski, Bachelor’s of Nursing. Oncology,
Trillium Health Partners, Mississauga, Ontario, Canada.
VIII–05–C 3:00 PM – 3:30 PM
Improving Interprofessional
Communication and Patient Experience:
Our Experience of the Evolution
of Electronic Documentation in
Ambulatory Chemotherapy
Judy Chung, RN, BScN, Marci Sweeney, RN, CON(C).
Chemotherapy Nursing, Odette Cancer Centre, Sunnybrook
Health Sciences Centre, Toronto, Ontario, Canada.
59
VIII–03–C 3:00 PM – 3:30 PM
VIII–06 2:00 PM – 3:30 PM
| Kent/Palais
VIII–06–A 2:00 PM – 2:30 PM
La contribution des infirmières en
oncologie pour relever les défis reliés à la
chimiothérapie par voie orale : le cas de
la clinique de neuro–oncologie du chu
de Québec
Maria Gabriela Ruiz, M.Sc. Inf., CSN, Vicky Gélinas,
Pharmacienne, Johane Pelletier, B.Sc. inf, Nicole Plante,
B.Sc. inf. CHU de Québec, Québec, Québec, Canada.
VIII–06–B 2:30 PM – 3:00 PM
De la recherche à la pratique :
harmonisation du développement
professionnel des infirmières pivot en
oncologie
Irène Leboeuf, M.Sc.inf., CSIO(C), Catherine Genest,
M.Sc.inf., CSIO(C), Catherine Derval, M.Sc.inf., Louise
Handfield, M.Sc., Dominique Lachapelle, M.Sc., Joannie
Van Houtte, B.Sc., DESS (étudiante), Marielle Roy, M.Sc.,
Audrey Chouinard, M.Sc., CSIO(C). DSI, CHUM, Montréal,
Québec, Canada.
VIII–06–C 3:00 PM – 3:30 PM
Un cadre de référence pour soutenir la
fonction évaluation de l’infirmière pivot en
oncologie (ipo) au Québec
Brigitte Fournier, MSc2, Sébastien Simard, PhD2, Lise
Fillion, PhD1. 1CRCEO, Québec, Québec, Canada, 2IUCPQ,
Québec, Québec, Canada.
60
Présentation spéciale /
Special Presentation – Bernard Roy
Quand le savant–soignant devient
malade–aidant
Bernard Roy, PhD, Faculté des sciences infirmières,
Université Laval, Québec, Quebec, Canada
Mon nom est Bernard Roy. Je suis infirmier, anthropologue
et professeur en sciences infirmières. En 2010, à 54 ans,
je me présente en urologie à l’hôpital. Je suis en pays de
connaissance. J’ai travaillé en ces lieux une quinzaine
d’années. Je connais l’infirmière qui m’accueille. Nous
avons, jadis, travaillé ensemble. À l’urgence, l’urographie a
révélé que des calculs rénaux sont à l’origine de l’hématurie
qui se produit après mes périodes de jogging. Les pierres ne
voulant pas quitter mon tractus urinaire mon médecin de
famille me réfère en urologie. Dans la salle de cystoscopie,
l’atmosphère est détendue. J’espère que ce ne sera pas
trop long. Je dois me présenter à une importante réunion
dans une heure. L’urologue, l’infirmière et moi, pendant
l’examen, badinons. Nous nous remémorons des souvenirs.
Le cystoscope avance dans mon urètre, traverse ma prostate,
entre dans ma vessie. Mes yeux rivés sur le moniteur,
j’espère apercevoir ce satané caillou qui occasionne mes
saignements. La caméra s’arrête sur une petite masse
sanguinolente. L’urologue demande à l’infirmière de
prendre un cliché. Il me dit : «Il est là ton problème ! Tu as
un cancer de la vessie». Le sol se dérobe. Ma vie bascule. Je
suis un malade. Je suis un cancéreux. On m’opère. Le cancer
revient quelques mois après. La même année, ma compagne
apprend qu’elle souffre d’un cancer du sein. Nous sommes
parents d’une fille de 9 ans. Le savant–soignant est devenu
malade. Le soigné–malade devient soignant–aidant. Mon
exposé reposera sur des données parlantes issues de ce
parcours de malades, de soignants, d’aidant–aimant au
cœur d’un système de santé en manque de soins.
Mon regard ne sera pas celui de l’analyste de faits
observables, quantifiables. Ce sera celui d’un homme, d’un
époux, d’un amant, d’un père… d’un malade, d’un infirmier,
enseignant–chercheur et anthropologue. Le regard porté
sera critique et utopique. Les propos seront sincères, sans
détour peut–être même déstabilisants.
My name is Bernard Roy. I am a nurse, anthropologist, and
professor of nursing. In 2010, at 54 years of age, I arrived as a
patient at the hospital’s Urology Department. I was in familiar
territory, having worked there for about fifteen years. I knew
the nurse who greeted me, as we had previously been coworkers. In the Emergency Department, the urography had
revealed that kidney stones were the source of the hematuria
that occurred after my jogging sessions. Since the stones
would not leave my urinary tract, my family doctor referred
me to a urologist. In the cystoscopy room, there was a relaxed
atmosphere. I hoped that it wouldn’t take too long. I had to be
at an important meeting in one hour. During the examination,
the urologist, the nurse, and I were bantering and recalling
memories. The cystoscope advanced into my urethra, went
through my prostate, and entered my bladder. My eyes riveted
on the monitor, I hoped to see the cursed stone that was
causing my bleeding. The camera focused on a small bleeding
mass. The urologist asked the nurse to take an image of it. He
said, “There’s your problem! You have bladder cancer.” The
ground gave way beneath my feet. My life changed. I was a
patient. I was a cancer patient. I underwent an operation, and
the cancer returned a few months later. The same year, my
partner learned that she had breast cancer. We were the parents
of a 9-year-old daughter. The scholar/health professional
became a patient. The care recipient/patient became a health
professional/informal caregiver. My presentation will be based
on telling information from the journey of patients, health
professionals, informal caregivers and loved ones within a
healthcare system in need of care. My viewpoint will not be
that of an analyst of observable and quantifiable facts. It will
be that of a man, a husband, a lover, a father, a patient, a nurse,
an educator/researcher, and an anthropologist. I will present
a fresh perspective that will be critical and utopian. The words
will be heartfelt and straightforward, perhaps even unsettling.
Cérémonie de clôture et remise de prix
pour abrégés / Closing Ceremony and
Abstract Award Presentation
4:00 PM – 4:30 PM
| Kent/Palais
ABRÉGÉS DES
PRÉSENTATIONS
ORALES / ORAL
ABSTRACT
PRESENTATIONS
Dimanche 26 octobre 2014
Sunday, October 26, 2014
Atelier / Workshop
I-01-A 11:00 AM - 12:30 PM
Moving Research into Action: Doing It
And Using It
Sally E. Thorne, RN, PhD1, Krista L. Wilkins, RN, PhD3,
Christine Maheu, RN, PhD4, Catriona J. Buick, RN, MN,
CON(C)2, Jennifer M. Stephens, RN, BSN, MA, OCN1, Aronela
Benea, RN, MScN2, Dawn Stacey, RN, PhD, CON(C)5, Lorelei
Newton, RN, PhD6. 1School of Nursing, University of British
Columbia, Vancouver, British Columbia, Canada, 2Princess
Margaret Cancer Centre, Toronto, Ontario, Canada, 3Faculty
of Nursing, University of New Brunswick, Fredericton, New
Brunswick, Canada, 4School of Nursing, McGill University ,
Montréal, Québec, Canada, 5School of Nursing, University of
Ottawa, Ottawa, Ontario, Canada, 6Vancouver Island Cancer.
Centre, BC Cancer Agency, Victoria, British Columbia, Canada.
The CANO/ACIO Research Committee is sponsoring an
interactive skill-building workshop using a “World Café”
approach to bring aspiring researchers together with more
seasoned oncology nurse researchers in a series of lively and
informative conversations. This format will allow you to get
to know some of Canada’s most well known oncology nurse
researchers who will be facilitating a series of table group
discussions. You will have about 20 minutes at each table. As
you move from one discussion group to the next, you will have
opportunities for on-site mentoring, project conceptualization
support, and general encouragement appropriate to wherever
you are at this stage of your own research career. Workshop
participants will benefit from the opportunity to listen to what
excites the experts about their own work and to gain advice on
the fascinating theoretical, technical and practical challenges
that oncology nurses encounter and overcome in the world of
research. The planning group will ensure that opportunities are
available for your participation in either or both of the official
languages. You will come away from this workshop energized
with ideas and full of renewed confidence about your capacity
to join in the excitement of oncology nursing research!
61
ABRÉGÉS DES PRÉSENTATIONS ORALES / ORAL ABSTRACT PRESENTATIONS
When the Scholar/Health Professional
Becomes a Patient/Informal Caregiver
Atelier / Workshop
I-02 11:00 AM - 12:30 PM | Villeray
I-03 11:00 AM - 12:30 PM | De Tourny
Atelier / Workshop
I-02-A 11:00 AM - 12:30 PM
I-03-A 11:00 AM - 11:45 AM
Patient Involvement: Experiences from
a Large Interdisciplinary Competence
Development Program at a Danish
University Hospital
What is the Patient Really Learning?
Standardizing Systemic Therapy Patient
Education across Nova Scotia
Berit Kjaerside Nielsen, PhD1, Lisbeth Kallestrup,
MD2, Kirsten Lomborg, PhD1. 1Clinical Medicine, Aarhus
University, Aarhus, Denmark, 2Abdominal Cent re, Aarhus
Universit y Hospital , Aarhus, Denmark .
Background: People want to take care of themselves,
even if they are living with one or more diseases or
functional impairment and we, as health professionals, must
support them in achieving this. Studies show that health
professionals are highly motivated to engage in patient
involvement. However, a framework making it possible
to work systematically with the involvement of patients
and families in practice is needed. At Aarhus University
Hospital, Denmark, we have piloted a large interdisciplinary
competence development program, providing clinical
staff with the knowledge of and insight into the tools and
methods for patient involvement, including shared decisionmaking and patient-initiated treatment. Furthermore, we
have tested and developed different methods for patient
involvement in 9 clinical departments, with the aim of
gaining experience locally and subsequently extract learning
across departments.
Objective: In the workshop, we invite participants
to consider the wide ranging ways that patients could
be involved in health care. We would like to share our
experiences from working with patient involvement in
an interdisciplinary competence development program.
Furthermore, we will present two models for involving
patients: 1) Shared decision-making and 2) Patient-initiated
treatment, including patient-reported outcomes. During the
workshop we will encourage the participants to be involved
in small group discussions and consider the ways health
professionals can help give voice to patients and encourage
them to come forward with their ideas and considerations of a
more involving, relevant and better health care.
Kara Henman, MN, Michele Rogez , BScN. Cancer Care
Nova Scotia , Halifax, Nova Scotia , Canada .
Introduction: In Nova Scotia, patients being treated for
cancer will be managed by an oncologist in a tertiary centre
but may receive systemic therapy at their local hospital. As
more patients are treated closer to home, more systemic
therapy (ST) teaching is requested to be completed at local
hospitals. A need was recognized for a standardized approach
to ST patient education, support for health care providers who
teach patients about their cancer treatments and assurance
that patients understood what was being taught. Cancer Care
NS formed a working group with representatives from the
tertiary centres and the health districts to develop a process
for standardizing patient education.
Approach: This working group developed a systemic
therapy teaching checklist for the educator to ensure
consistent information is discussed during teaching. This
checklist follows the patient during treatment, so that
subsequent providers know the information covered. CCNS
also amalgamated existing power point presentations
used in group teaching sessions at the two cancer centres,
to be one standardized slide deck and made available to
the remote clinics as well. A patient education video was
developed to enhance the teaching and learning process
and is available online to support teaching sessions and
also a resource for patients and families to view at home.
To measure patients understanding of information, CCNS
developed a learning module on the teach back method
of education including documentation tools with prompt
questions and an instructional video.
Outcomes: By standardizing the approach, providers will
feel confident patients are receiving the same information
no matter their location, patients can receive teaching closer
to home and the patient measure of understanding of what
is taught will be ensured by using the teach back approach.
These tools will ensure comprehensive and effective
Perspectives: Our hope is that participants will leave the
workshop with new inspiration into the work of creating more teaching and learning for healthcare providers and cancer
patient involving solutions and increased patient involvement patients in Nova Scotia.
in the hospital setting.
62
I-04 11:00 AM - 12:30 PM | Montmorency
Engaging Patients in the Development
and Implementation of Patient Education I-04-A 11:00 AM - 11:45 AM
Material; An Approach to Developing
Resilience in Health Crises
Materials for an Innovative Therapy
Julie Diemert, BScN, CON(C)2, Jazmin Estibal, BScN2,
Debbie Miller, BScN, MN, CETN(C)2, Tamara Harth , BA(HON),
MLIS1, Yoo–Joung Ko, MD, MMSc, SM, FRCP(C)3, Paul J.
Karanicolas, MD, PhD, FRCS(C)4, Eirena N. Calabrese, BScN,
MN2. 1Program Manager and Regional Lead Patient Education
Toronto Central North LHIN, Sunnybrook Health Sciences
Centre, Toronto, Ontario, Canada , 2Nursing, Odette Cancer
Canada , 3Medical Oncology, Sunnybrook Health Sciences
Centre, Toronto, Ontario, Canada, 4Surgical Oncology,
Doreen Westera, MScN, MEd, Doreen Dawe, Prof, Msc.
Nursing, Memorial Universit y, St John’s, Newfoundland ,
Canada .
It is sometimes easy for clinicians to focus on deficits,
problems, or pathology in their work with clients. Yet,
a strengths-based approach with the client as an active
partner is gaining momemtum in health care. In this
framework, clinicians assist clients to identify and use
their strengths and assets when dealing with a health crisis.
In effect, they are helping clients to develop resilience.
In the literature, resilience is portrayed variably as a
In Canada, colorectal cancer is the third most commonly
process, a psychological construct, a state-trait, a strategy,
diagnosed cancer. Fifteen percent of colorectal cancer
and a blend of nature and nurture, which suggests that
patients have liver metastases at diagnosis and sixty percent
it may be modifiable. Themes common in defintions of
of patients who go on to develop metastases will have liver
resilience are the notion of the ability to bounce back from
metastases. In a tertiary cancer centre in Toronto, a pilot
a stressful situation, to adapt to this situation, to remain
program was implemented as the first Canadian Hepatic
healthy in spite of the situation, and to actually thrive in
Arterial Pump Program for patients with unresectable
metastatic colorectal cancer liver metastases. In order to meet the midst of the situation. This presentation will focus on
the needs of this unique patient population, there was a need the concept of resilience and how clinicians can work with
clients as partners to increase resilience. The concept of
identified to develop specific education material. Patients
resilience will be explored, as well as the protective factors
making the decision to undergo the insertion of a hepatic
contributing to the resilience, such as: personal and family
arterial infusion pump (HAIP), which delivers chemotherapy
hardiness; spirituality; social support; positive coping; and
directly to the liver, is not an easy one. Patients are required
contextual framing. To illustrate these factors, excerpts
to adhere to strict guidelines in the scheduling of their
will be shown from a video which explores resilience in a
treatments, modify their lifestyle, and be engaged and active
woman with a physical disability who underwent surgery
partners in the management of the pump. An appointed
and chemotherapy for breast cancer. This woman is the
oncology nurse was provided the opportunity to travel to
co-presenter and will therefore be able to further illumiate
a well-known tertiary cancer centre in New York to observe
aspects of resilience during the discussion. Implications for
the patient journey for both new and current patients. By
clinicians will also be discussed in the presentation.
participating in this observership, care delivery and the
provision of patient education was witnessed. There was
a need to develop original education prior to the treatment
and care delivery to this unique patient population. Within
I-04-B 11:45 AM - 12:30 PM
the interprofessional team, patient education and evaluation
materials were developed. Patients were engaged during their
Mastering Life in Limbo: Exploring the
follow up visits and encouraged to provide feedback to drive
Family’s Heroic Journey through the
changes in the developed education material, enabling patients
World of Chronic Cancer
to influence care delivery. This population has unique needs
and requires tailored information, and it is essential to engage
Linda C. Watson, RN, PhD, CON(C), Shelley Raffin
these patients early on to effectively deliver safe, high quality
Bouchal , R N PhD. Faculty of Nursing, University of
care. The development and implementation of the education
Calgary, Calgary, Alberta , Canada .
materials for HAIP, as well as strategies for engaging patients in
the process will be discussed.
63
I-03-B 11:45 AM - 12:30 PM
Over the past 15 years numerous novel targeted therapies have
emerged which are changing the face of how we understand
and treat advanced cancer. These therapies target nuances
within the cancer cellular enviroment to limit growth and
spread. Clinical research has demonstrated positive impacts
on both progression free and overall survival, but to maintain
control patients must stay on these treatments indefinitely.
This has created a new chronic cancer trajectory, where
patients can live for extended periods of time with incurable
but treatable cancer. This ability to live longer with cancer,
without being ‘cured’, is changing how individuals and their
families experience their cancer journey. In an effort to
understand the needs of this emerging population, a qualitative
study informed by Gadamerian philosophical hermeneutics
was designed and conducted. Unstructured interviews were
conducted, recorded, transcribed verbatim and analyzed with
the goal of understanding the experience of these families.
This presentation will highlight how this research study was
conducted, and will share the research findings, which revolved
around how the family’s journey with chronic cancer differs
from the experience of living with cancer that is curable,
or living with cancer that is clearly palliative. Concluding
statements will identify how these research findings apply to
oncology nursing practice, and what innovations in education,
professional development supports, and practice roles would
contribute to the system’s ability to better support families who
are living with chronic cancer.
I-05 11:00 AM - 12:30 PM | Beaumont
I-05-A 11:00 AM - 11:45 AM
patients participated. All were interviewed while on acute care
wards and five were interviewed a second time after being
transferred to the palliative care unit. Data were collected
through semi-structured interviews, observations captured
in field notes and a reflexive journal. Data analysis was an
iterative process in which interpretations occurred within the
context of the hermeneutic circle and which emerged through
frequent writing and immersion with the data. During the
writing process and review of the transcripts, development
of summaries and phenomenological accounts, three parallel
strategies were employed to guide the interpretive process:
exemplars, paradigm cases and thematic analysis (Benner,
Tanner & Chesla, 1996). Key findings of this study include:
1) the awareness of one’s own finitude can be an experience
imbued with a profound sense of aloneness; 2) patients may
understand that they are dying prior to being told that they
are by their health care team; 3) the potential move to the
palliative care unit was considered an opportunity for hope
while at the same time the actual transfer caused distress
and amplified the existential aloneness of the participants;
4) religious and spiritual beliefs offered hope and comfort
but also have the potential to engender feelings of aloneness,
and those participants who described themselves as not
religious found comfort in rationality and secular spirituality.
Clinical implications for nurses working with dying patients
in acute care oncology settings will be explored, along with
implications for nursing leaders and policy makers.
I-05-B 11:45 AM - 12:30 PM
Caring for Patients Who Desire Death;
A Study to Understand Oncology
Nursing Practice
The Lived Experience of Hospitalized
Dying Patients Waiting for a Transfer to
Palliative Care
Marina Chirchikova, B.Sc., M.Sc (A) N, RN1, Veronique
Daniel , M.Sc. Applied (N)1, Vasiliki Bitzas, PhD(C)2,
David Wright, N., PhD1, Marie–Laurence Fortin, N., M.Sc.
(N)2. 1Nursing, McGill, Montréal , Québec, Canada, 2Jewish
General Hospital, Montréal, Québec, Canada .
Vasiliki Bitzas, PhD(C)1, Catherine Thibeault, PhD2,
Franco Carnevale, PhD1, Helene Ezer, PhD1, Mary Ellen
Macdonald, PhD3, S. Robin Cohen, PhD1. 1Department of
Oncology, McGill University, Montréal, Québec, Canada,
2Trent / Fleming School of Nursing, Trent University, Toronto,
Ontario, Canada, 3Oral Health and Society, Faculty of
Dentistry, McGill University, Montréal, Québec, Canada.
Background: Patients with advanced cancer experience
a large symptom burden which may lead them to desire
death. As Canadian society grapples with issues surrounding
end of life care and patient desire to die, nurses remain
remarkably absent from these discourses, despite being
intimately familiar with the dying process.
This interpretive phenomenological study influenced by
the philosophy of Heidegger (1962) and the methodology of
Benner (1984; 1994) aimed to understand the lived experience
of dying for hospitalized patients waiting to be transferred to
a palliative care unit for end of life care. Eleven terminally ill
Objective: The study seeks to answer the following research
question: “How do oncology nurses engage with patients with
advanced cancer for whom the desire for death may be a concern?”
The purpose of the study is to explore how oncology nurses
understand and respond to patients who may desire to die.
64
Results: Findings reveal that for these nurses, desire for
death is a multidimensional concept without a unifying
definition or meaning. Nurses described a variety of
approaches in responding to a patient’s individual desire for
death which entail deep therapeutic connectedness. On the
other hand, nurses also described important challenges they
experienced that may lead to relational disengagement.
Conclusions: Nurses unique perspectives on patient
desire for death adds nuance to this discourse. Despite
difficulties, nurses perceive patient desire for death as an
opportunity to put the patient back at the center of care.
Implications for Practice: Nurses are well situated
to contribute to ongoing discussions around end of life
care and assisted death. A strength-based professional
development approach is warranted to further cultivate
nurses’ self confidence in meaningful engagement with
patients who may desire death.
Atelier simultané en français /
French Concurrent Session
I-06 11:00 AM - 12:30 PM | Kent/Palais
I-06-A 11:00 AM - 11:45 AM
L’intégration des patients comme
partenaires de soins au sein de l’équipe
interdisciplinaire du cancer de la
thyroïde du CHUM : une démarche
d’amélioration continue gagnante !
Catherine Derval, M.Sc., Joé T. Martineau, M.Sc.,
PhD(C). Centre hospitalier de l’Université de Montréal,
Depuis plus d’un an, l’équipe interdisciplinaire du cancer
de la thyroïde du Centre hospitalier de l’Université de
Montréal (CHUM) a joint le Programme Partenaires de
soins qui a pour but de développer et consolider des
pratiques collaboratives entre professionnels de la santé
et patients. Au-delà de la collaboration professionnelle,
il s’agit d’accompagner l’évolution des pratiques de soins
vers une plus grande intégration des patients dans leur
propre processus de soins (CPASS, 2012). Chapeauté par
un groupe d’experts de l’Université de Montréal et prenant
appui sur les normes canadiennes et québécoises d’agrément
des établissements de santé, l’équipe interdisciplinaire du
CHUM s’est engagée dans une démarche d’amélioration
continue. Afin d’assurer cette mission, cinq étapes
résiduelles permettent d’assurer la pérennité de la démarche:
la création d’un comité d’amélioration continue composé
à la fois de professionnels de la santé et de patients
ressources, la réalisation d’un bilan d’équipe, la définition
d’un objectif de changement, l’identification de ressources
de transformation et l’évaluation de l’atteinte des objectifs.
Inspirée du modèle de la roue de Deming et du cycle PlanDo-Check-Act (Gey, 2007), cette démarche d’amélioration
continue a, jusqu’à présent, permis au comité de mettre sur
pied des projets réalistes qui améliorent le fonctionnement
de l’équipe interdisciplinaire et la qualité des soins offerts.
Cette communication présentera les différentes étapes de
la démarche, l’implication des patients partenaires et les
retombées cliniques de ce projet.
I-06-B 11:45 AM - 12:30 PM
L’introduction du patient–partenaire :
nos bons coups et nos défis d’adaptation
Louise Compagna, Baccalauréat2, Caroline Provencher,
Maît rise1, Madeleine Desforges, Maîtrise1. 1Oncologie,
Hopital Maisonneuve–Rosemont , Montréal , Québec,
Canada , 2Oncologie, Hopital Maisonneuve–Rosemont ,
Montréal , Québec, Canada .
Il peut sembler utopique de croire que la présence d’un
patient-partenaire dans les équipes d’amélioration continue
de la qualité apporte une perspective différente. Pourtant,
l’expérience que nous avons vécue s’est avérée fort
positive ! L’équipe suprarégionale en cancer du sein de
l’hôpital Maisonneuve-Rosemont a décidé d’aller de l’avant
en participant à la démarche d’amélioration continue du
partenariat de soins et de services du Centre de pédagogie
appliquée aux sciences de la santé de l’Université de
Montréal (CPASS). Nous avons intégré à notre équipe
interdisciplinaire une patiente-partenaire en vue d’avoir une
rėflexion plus riche et plus approfondie sur les réels besoins
des femmes qui traversent cette maladie. Accompagnée
par notre leader de collaboration en établissement dans le
cadre d’un projet de recherche, nous avons tenu plusieurs
rencontres menant à un diagnostic d’équipe. La présence
de notre patiente-partenaire nous a permis de cibler des
objectifs qui sont plus près de la réalité vécue des femmes
65
Interventions/Methods: This qualitative study
involved one-time semi-structured interviews with eleven
oncology nurses in various different roles.
et qui nous permettent de répondre plus adéquatement
à leurs besoins. Le partenariat développé avec celle-ci
nous a également permis d’avoir une vision basée sur
les expériences des patientes et sur les réels besoins qui
subsistaient suite à la phase aiguë des traitements. C’est
dans cette perspective que nous avons fait le choix de
développer des ateliers sous la thématique de la vie après
le cancer. Cette expérience nous a d’avantage sensibilisé
au vécu de notre clientèle et a favorisé la révision de notre
offre de services. De plus, la mise sur pied d’un groupe
de patientes-partenaires assure la pérennité de cette
initiative. Cette présentation se veut l’occasion de partager
avec vous l’expérience vécue par les gestionnaires et la
patiente-ressource, notre démarche, notre plan d’actions,
nos différentes réalisations, nos bons coups et les défis
d’adaptation liés à l’introduction du patient-partenaire dans
les équipes d’amélioration continue.
Les résultats de cette étude semblent indiquer que les
jeunes mères qui vivent avec le cancer souhaitent entre
autres protéger leurs enfants tout au long de l’expérience. La
protection affective est un résultat préliminaire. Les jeunes
mères semblent vouloir diminuer l’impact de leur cancer
sur leurs enfants et leur famille. Cela est particulièrement
évident lors de l’apparition d’effets secondaires comme la
perte de cheveux, la fatigue, la nausée et les vomissements.
De plus, l’étude indique que les enfants et la famille des
jeunes patientes protègent à leur tour ces dernières sur
le plan affectif. La protection affective est un processus
psychosocial qui comprend les composantes suivantes :
faire face à un diagnostic de maladie mortelle et subir le
traitement; conserver une vie familiale aussi routinière que
possible; trouver de nouvelles façons de vivre l’intimité; et
créer une nouvelle façon de définir la normalité.
Conférence Helene Hudson /
Helene Hudson Lectureship
2:00 PM - 3:00 PM
Very few studies have focused on cancer patients who are
mothers, even within breast cancer research about younger
women. For young women who are mothers, the cancer
experience is distressing, not simply because of their age or
concern for themselves. They are worried about the potential
loss of years with their children and ability to mother them.
While nurses are engaged with young mothers who are
cancer patients, these mothers are engaged in taking care
of their children. They juggle the demands of diagnosis and
treatment with fulfilling their role as mothers. When they
go through diagnosis, treatment, and even follow-up, they
do tremendous mental work to stay positive in thought and
to make the most of their time with their children. The aim
of this presentation is to report findings from a grounded
theory study involving 18 young mothers, and to dialogue
with nursing colleagues about strategies for care that may
make young mothers’ journies through cancer a little easier
for them and their families. The findings of this study suggest
that the experiences of young mothers involves emotionally
protecting their children throughout their cancer situation.
Emotional protecting is a preliminary finding; it represents
how young mothers lessen the affects of their cancer on their
children and family. This is particularly obvious when they
are dealing with side effects such as hair loss, fatigue, nausea
and vomiting. In turn, they find that their children and family
are emotionally protecting them. Emotional protecting is a
psychosocial process that consists of the following: Facing a
life-threatening diagnosis and undergoing treatment; keeping
family life as routine as possible; finding new ways to be close;
and, creating a new normal.
L’engagement des jeunes mères avec le
système de soins contre le cancer
Judith Strickland, RN, BN, MN, CON(C), Faculty of
Nursing, Western Regional School of Nursing , Corner
Brook , NL , Newfoundland , Canada .
Il existe très peu d’études sur les patientes atteintes de
cancer qui ont des enfants, même au sein de la recherche
auprès de jeunes femmes atteintes d’un cancer du sein. Pour
les jeunes mères, le cancer est source d’une détresse toute
particulière, pour des raisons qui dépassent leur âge et leurs
préoccupations par rapport à leur propre bien-être.
Leurs inquiétudes centrales portent sur leur capacité réduite
de s’occuper de leurs enfants et sur les années qu’elles ne
pourront possiblement pas passer avec eux. Elles doivent
composer, d’une part, avec les demandes liées au diagnostic
et à leur traitement et, d’autre part, avec leur rôle de mères.
Lorsqu’elles traversent l’expérience du diagnostic, du
traitement et du suivi, elles font un effort mental prodigieux
pour demeurer positives et profiter au maximum de leur
temps avec leurs enfants. Cette présentation vise, d’une
part, à faire état des résultats d’une étude sur une théorie
ancrée réalisée auprès de 18 jeunes mères et, d’autre part,
à dialoguer avec nos collègues infirmières au sujet de
stratégies de soins susceptibles de rendre l’expérience du
cancer moins pénible pour les jeunes mères et leur famille.
66
Young Mothers’ Engagement with the
Cancer Care System
II-01-A 3:30 PM - 4:00 PM
Results: Preliminary results suggest the presence of both
gender specific and organizational structural barriers for
male cancer survivor’s engagement in cancer rehabilitation.
These barriers provide a fascinating perspective on what
might impede or facilitate men’s participation in cancer
rehabilitation programming. The results will be considered
in the context of development of more gender-sensitive
rehabilitation services.
Does Gender Matter in Patient Engagement?
A Qualitative Study of Approaches to
Rehabilitation in Male Cancer Survivors
II-01-B 4:00 PM - 4:30 PM
Charlotte Handberg, PhD student, MPH, RN, Sally E .
Thorne, Professor, PhD, RN, FAAN, FCAHS3, Julie Midtgaard,
PhD Associate Professor, Psychologist4, Claus V. Nielsen,
Professor, PhD, MD2, Kirsten Lomborg, Professor, PhD, MSN,
RN1. 1Department of Clinical Medicine and Department of
Public Health, Aarhus University and Aarhus University
Hospital, Aarhus, Central Denmark Region , Denmark,
2Department of Public Health, Section for Clinical Social
Medicine and Rehabilitation, Public Health and Quality
Improvement, Aarhus University, Aarhus , Central Denmark
Region , Denmark, 3School of Nursing, University of British
Columbia, Vancouver, British Columbia, Canada, 4The
University Hospitals Centre for Health Care Research (UCSF),
Copenhagen University Hospital, Copenhagen, The Capital
Region of Denmark , Denmark.
Navigating and Engaging Patients During
the Diagnostic Phase of the Colorectal
Cancer Journey
Julie Diemert, BScN, CON(C)1, Shady A shamalla , MD,
MSc, FRCSC2, Eirena N. Calabrese, BScN, MN1. 1Nursing,
Toronto, Ontario, Canada, 2Surgical Oncology, Sunnybrook
Health Sciences Centre, Toronto, Ontario, Canada .
A potential diagnosis of cancer can be an overwhelming and
stressful event that can evoke fear, uncertainty and anxiety. At a
large tertiary cancer centre in Toronto, patients referred after
colonoscopy for suspicion of a colorectal cancer are referred
Objective: To describe the health professionals’ perspectives, to the Colorectal Cancer Diagnostic Assessment Program (DAP)
attitudes and conduct toward male cancer survivors and cancer and navigated by a nurse navigator through the diagnostic phase
rehabilitation, and to suggest a specific research-based strategy of their journey. Previously, patients had multiple visits before a
for male cancer survivors in rehabilitation.
diagnosis and treatment decision was made, were overwhelmed
and inundated with tests, ambivalence with little guidance or
background: The growing proportion of patients who
support, and were left with unmet informational needs and
survive their cancer has resulted in a rising number of
distress as they navigated this path alone. Strategies to provide
people suffering from ongoing side effects and residual
information and engagement with nursing are enabled through
consequences of their disease. An increasing body of
the process of the DAP, which aims to reduce uncertainty
evidence endorses rehabilitation as being necessary and
and stress of the patient, and provide support throughout
beneficial. Although male cancer survivors have unmet
the diagnostic phase. Patients referred to the DAP receive an
rehabilitation needs, they are nevertheless significantly
in depth telephone interview, history and assessment, and
underrepresented in current programs due to various
barriers. The majority of the health professionals responsible assessment of information needs by the nurse navigator. This
allows patients and their family members the opportunity to
for their care, treatment and rehabilitation are women. The
interaction of masculinities and femininities in this context become partners in their care while receiving expert knowledge,
assistance in the coordination of care, tests, and appointments,
can affect health behaviours and outcomes.
and psychosocial support. Patients come to their first clinic
visit better prepared and knowledgeable about their disease and
Methodology: Using interpretive description
treatment possibilities. This allows patients and their families
methodology with symbolic interaction as a theoretical
framework, we collected data through a 7 month field study to become active participants in treatment decisions. On-going
evaluation of patients and their experiences continues to provide
in three oncology wards and three municipality services
positive feedback on the role and importance of the nurse
in Denmark. The informants were 68 health professionals;
navigator during the diagnostic phase. This presentation will
nurses, radiologists, physiotherapists and social and health
highlight the process and role of the nurse navigator within the
care assistants, all women except one. Data consisted of
DAP program and discuss strategies used to facilitate patient
12 semi-structured focus group interviews, participant
engagement to ensure patients and their family members become
observation, ad hoc conversations and documents.
partners in their care early on in the cancer journey.
67
II-01 3:30 PM - 5:30 PM | Dufferin
II-01-C 4:30 PM - 5:00 PM
II-01-D 5:00 PM - 5:30 PM
Engaging Survivors’ Perspectives to Pro- Wellness beyond Cancer Program:
mote Equity in Cancer Survivorship Care Empowering Patients to Meet Their
Survivorship Needs
Tracy L . Truant, RN, MSN, PhD(c)1, Sally Thorne,
Professor, PhD, R N, FAAN, FCAHS1, Lynda G. Balneaves,
RN, PhD1, Carolyn Gotay, PhD2. 1School of Nursing,
University of British Columbia , Vancouver, British Columbia,
Canada,2School of Population and Public Health, University
of British Columbia , Vancouver, British Columbia , Canada.
Background: New models of care (MoC) are emerging
to address cancer survivors’ unmet needs, but few consider
health and social disparities in their development,
limiting access to high quality survivorship care for many.
Understanding how disparities influence the development
of and access to survivorship MoC is essential to ensure
individuals’ needs, rather than social privileges, guide the
distribution of opportunities for high quality survivorship
care and optimal health.
Aim: This study explores and explains how the layering
and intersection of social, political, economic and personal
factors, and health experiences and health management
strategies shape the development of and access to quality
survivorship care for Canadians with cancer. Moving
beyond simply describing, this study considers possibilities
for action to create equitable survivorship MoC that
recognize the complexities inherent in survivorship care.
Methods: This study employs a qualitative interpretive
description approach, scaffolded by nursing’s disciplinary
epistemology and pragmatism, sensitized by an intersectional
lens and critical perspectives. Three interconnected
phases are included: 1) secondary analysis of a Canadian
Communication in Cancer Care database; 2) critical textual
analysis (e.g., survivorship guidelines, policies, resources); and
3) survivor and key stakeholder interviews.
Results: Phase 1 and 2 results are presented, offering
survivors’ transition experiences from cancer treatment
to survivorship care. Findings are contextualized to
explore how various structural factors shape these
experiences, highlighting problematic areas and making
recommendations for improvement in how we communicate
about, shape and enact equitable survivorship MoCs.
Carrie Liska, BScN2, Gail Larocque, BHScN2, Lise
Paquet, PhD1, A . Robin Morash , BNSc, MHS2. 1Psychology,
Carleton University, Ottawa , Ontario, Canada , 2Oncology,
The Ottawa Hospital , Ottawa , Ontario, Canada .
Expected improvements in colorectal cancer (CRC) survival,
combined with the high numbers of new cases annually
(23,900 in Canada, 2013), will lead to an increasing number
of survivors. Implementation of standardized follow-up
protocols has been shown to be associated with improved
patient outcomes in part due to early detection and
treatment of cancer recurrence. The Wellness Beyond
Cancer Program (WBCP) was introduced in March 2012 to
raise health care providers’ awareness of the needs of CRC
patients who are completing their primary cancer treatment
and to ensure the delivery of appropriate survivorship care.
A key element of the program is the provision to patients
and their primary care providers (PCP) of a cancer care
summary and follow-up surveillance plan. This is in the
form of a “wellness care plan” and facilitates the transition
and coordination of follow up care between cancer
specialists and PCPs. In addition, because the concept of
empowerment is a central construct for the management
of cancer survivors, our program also aimed to empower
patients to participate in the management of their care.
Upon referral to WBCP, all patients are asked to complete
a needs assessment and an empowerment questionnaire.
A summary of their individual needs is included on their
wellness care plan. Patients are also asked to attend a CRC
survivorship class to reinforce and promote self-care and
empowerment. One year after referral to the WBCP, patients
are asked to fill the needs assessment and empowerment
questionnaire once again. This presentation will provide an
overview of the WBCP; program successes and challenges.
In particular, our presentation will address two questions:
1) Has the WBCP impacted patients’ identified needs and
their perceived levels of empowerment and 2) Is a change in
empowerment linked to a change in identified needs?
Conclusions: This study offers insights into
how current survivorship MoC may unwittingly
reduce opportunities for survivor health and makes
recommendations to promote strategic thinking regarding
MoC for equitable cancer survivorship.
68
II-02-B 4:00 PM - 4:30 PM
Concurrent Session II-02-A
3:30 PM - 4:00 PM
Transforming Care at the Bedside –
Engaging Staff and Patients in Quality
Improvement
Patients as Partners: What Our Patients
are Telling Us
Paula P. Calestagne, BA1, Vasiliki Bitzas, PhD(C)2.
1Quality, Jewish General Hospital, Montreal, Québec,
Canada, 2Nursing, Jewish General Hospital, Montréal,
Québec, Canada.
Valerie Cass, MBA , Norine Heywood , MScN, Irene
Gyimothi , DEC, Alejandro Ramirez , DEC, Vanessa Lopez,
DEC, Beverle Henry, DEC. Transplant and Hepatobiliary
Surgery, McGill University Health Center, Montréal ,
Québec, Canada .
Transforming Care at the Bedside (TCAB) is a quality
improvement program launched by the Robert Wood
Patient satisfaction surveys are useful tools used by many
Johnson Foundation and IHI in 2003. The hepatobiliary
health care institutions to design, develop and monitor
surgery unit of the McGill University Health Centre was one
patient and family centred services and programs. Within
of the units who developed a TCAB quality improvement
our institution, emphasis is placed on the patient-centered
initiative. The goals of the project included: 1) reduction of
approach. Our institution ensures that there are patient
nosocomial infections; 2) Building of organizational capacity
representatives on key hospital committees, including
in quality improvement processes; 3) Improvement of inter
the hospital’s Quality and Risk Management Committee.
departmental teamwork; and 4) Engagement of patients /
Recently, one of these patient representatives led the
development and implementation of the hospital’s SpeakUp! families in unit-based quality improvement activities. Inter
departmental teams comprised predominantly of front line
Campaign. The hospital’s oncology division was among the
staff and a patient/family representative were created. A
first divisions to routinely seek feedback from their patient
PDSA rapid improvement process was utilized as a structure
population. Our palliative care unit, part of this division,
for quality improvement projects, focused on infection
has been conducting surveys since 2003. Incorporating the
survey process into ongoing quality improvement initiatives, control and 5S LEAN principles (sort, set, shine, standardize,
sustain). Project outcomes included improvements in
has allowed palliative care patients and their families to
infection rates, infection control processes, efficiency of
influence their environment, address their main concerns,
work processes, inter disciplinary teamwork, and staff and
and become partners with their health care team. A series
patient engagement.
of surveys were structured to allow patients to rank both
their satisfaction and importance rating; allowing the unit
to prioritize areas for improvement. A section for patient
comments was also included. Once analyzed, the results
II-02-C 4:30 PM - 5:00 PM
have assisted the unit leaders in addressing areas of lower
satisfactions, as well as planning a major renovation of the
I Have a Voice… Please Involve Me,
unit. The cycle of surveys, improvements and follow-up
Don’t Ignore Me
surveys has allowed the unit to monitor the progression
of satisfaction levels and assess the effectiveness of
Nancy–Anne Pringle, RN, Silvana Angotti, RN, Beverly
improvement initiatives. Survey results have been shared
Brooks, RN. Malignant Hematology, Princess Margaret
Cancer Centre, Toronto, Ontario, Canada .
with the hospital’s Board, senior leadership, within the
oncology division and with the unit’s staff.
Fear and uncertainty are initial emotions expressed when
patients hear the word “Leukemia”. They are thrown
into a world of fear, confusion, and language they don’t
understand. Patients need to be involved in their care.
Advances in treatment delivery and side effect management
have allowed for the majority of chronic myeloid leukemia
(CML) therapies to be delivered on an outpatient basis.
Nurses at a large urban hospital developed and continue to
develop tools to educate patients. Informed and educated
patients and their families can take an active role in health
69
II-02 3:30 PM - 5:30 PM | Villeray
care decision making. Our patient support group is very
active and now has an official standing as a non-profit
organization called “The Canadian CML Network”. Members
range in age from eighteen to eighty four. They relate and
learn from each other by sharing their stories, insights and
advice. It is an amazing thing to see tears at the beginning of
a meeting that turn into a confident smile by the end. This
presentation will review how patient engagement has been
intertwined in the diagnosis, treatment and management of
this challenging disease. Using case studies, presenters will
discuss the views of both patient and nurses. In addition,
the cases will demonstrate how to promote patient’s rights
and choices.
II-02-D 5:00 PM - 5:30 PM
Engaging Chemotherapy Patients in
Self–Care through Nursing Support
II-03 3:30 PM - 5:30 PM | De Tourny
II-03-A 3:30 PM - 4:00 PM
Lifestyle Interventions Combined with
Acupuncture-Like Transcutaneous
Electrical Nerve Stimulation (ALTENS) in
Managing Hot Flashes Induced by Breast
Cancer Treatment: Results of a Phase II
Randomized Controlled Trial
Margaret Forbes, RN(EC), BScN, MN, CON(C) 1,
Raimond Wong, MD, MBBS, FRCPC2, Stephen Sagar, MD,
BSc, MB, MS, MRCP2, Joseph Hayward, PhD, MCCPM2,
Mark N Levine, MD, MSc, FRCPC, FASCO2, Jim Julian,
M.Math2. 1McMaster University, Hamilton, Ontario, Canada,
Shelley Dick, RN, Yvonne Miller, RN, Sarah Bouchard ,
RN BScN. Chemotherapy Unit , BC Cancer Agency/Fraser
Valley Cancer Center, Surrey, British Columbia, Canada.
Women with breast cancer can experience significant
treatment induced vasomotor symptoms (TIVS). Nonhormonal strategies for TIVS (e.g. acupuncture, Venlafaxine)
may provide relief but may be intolerable due to the invasive
The Canadian Association of Nurses in Oncology
nature of the treatment or potential side effects. As such,
National Standards for Chemotherapy clearly outline the
women may prefer lifestyle strategies (LS) that can be
professional and organizational responsibilities for providing
self-administered. ALTENS is a non-invasive needleless
timely, comprehensive, and patient-centered care for
technique that uses specific electrical parameters to stimulate
individuals receiving cancer chemotherapy. Meeting these
selected acupoints to achieve clinical response with minimal
responsibilities continues to be a challenge in our current
health care environment. Increasing numbers of patients are toxicity. ALTENS can be administered with minimal training,
is amenable to quality assurance, and can allow for self
receiving more complex treatments over longer periods of
treatment by women. This study aimed to evaluate the
time throughout the cancer experience. Staffing, space, and
other resource pressures make it necessary to look for creative efficacy of ALTENS in addition to LS in relieving TIVS in
women with breast cancer.
strategies to address patient care needs, prepare for safe
chemotherapy treatment, and ensure effective and efficient
Eligible subjects were postmenopausal women with stages 0-3
use of professional expertise. Patient engagement is essential
breast cancer who had completed cancer treatment and were
to achieve these goals. Clinical nurses in our comprehensive
experiencing hot flashes for ≥ one month with a Hot Flash
cancer centre recognized the need to build on and advance
Score (HFS) ≥15 in one week prior to consent. Anti-estrogen
improvements in pre-chemotherapy assessment and care.
therapy was permitted. Non-hormonal drug therapies were
They proposed a more explicit and intentional partnership
prohibited. Subjects were randomized to either LS (control)
between patients, nurses, and physicians that would recognize
or LS with concurrent ALTENS (combined). LS consisted of
each partner’s expertise, contributions, and priorities when
standardized counseling delivered by a specially trained nurse
addressing needs for patient safety and supportive care.
practitioner at week 0 with reinforced counseling at weeks
This presentation will outline the initial challenges and
12 and 24. ALTENS was given twice weekly for 12 treatments
goals, the strategies and resources used to promote patient
over an 8-week period. The HFS, Hot Flash Related Daily
engagement, and the processes and supporting resources for
Interference Scale and the Short Form version 2 health survey
collaborative patient assessment and care. Evaluation data
were administered at weeks 0, 12 and 24. Heart rate variability
from the patient, healthcare professional, and organizational
was measured at weeks 0 and 12. The primary study endpoint
perspectives will be shared.
was the number of responders, defined as women who had >
50% reduction in their HFS between weeks 0 and 12.
70
II-03-C 4:30 PM - 5:00 PM
Engaging Patients in Research – A
Standardized Nurse Led Informed
Consent Education Program
Jodi LeBlanc, RN, BN. Tumour Tissue Repository, BC
Cancer Agency, Victoria , British Columbia, Canada.
ALTENS in combination with lifestyle strategies is a
promising non-pharmacologic approach that showed
Patient engagement in cancer research is critical to discover
improvement in managing TIVS in women with breast cancer.
better approaches to diagnosis, treatment and care. The
Results support its evaluation in phase 3 studies.
project nurse for a biobank at a cancer research center in
western Canada, identified that standardized education
regarding informed consent may assist staff in engaging
patients in research. With limited literature available on
II-03-B 4:00 PM - 4:30 PM
developing an informed consent education program, the
Engaging with and Advocating for Patients Project Nurse looked to the Tri-Council Policy Statement
for the Ethical Conduct for Research Involving Humans
about Additional Cancer Treatment
(TCPS 2, 2010) to inform the development of the program.
Options...Subsequent Entry Biologics
The objectives of the program are to increase knowledge,
quality of communication and to teach personnel to conduct
Karyn Perry, BSN, MBA, CON(C)1, Dauna Crooks, PhD2.
Independent Nurse Consultant, Vancouver, British Columbia,
consent interviews in a timely and understandable manner.
Canada, 2Chair, Cancer Advocacy Coalition of Canada ,
Tools are provided for interacting with patients through a
program that is flexible, requires minimal resources and
has measurable outcomes. The initial education is designed
The oncology treatment landscape is constantly evolving.
to be completed within a 3 month timeframe and includes
A new admission to the field is Subsequent Entry Biologics
discussion of techniques for consenting, observation,
(SEBs), also referred to as biosimilars. SEB’s are a class
feedback, and review of pertinent procedures. Ongoing
of drug derived through living organisms that are similar
support is provided through an ‘open-door’ policy for
to an approved innovator biologic. The high cost of
questions and routine check-in. The implementation of
biologics has created a demand for SEBs as a cost-saving
the consent education program provides tools to assist in
alternative. Biologics are expected to represent 20% of
consenting patients for research purposes. This presentation
the pharmaceutical market over the next decade. The
will describe the development of the informed consent
availability of SEBs in Canada offers the potential to provide
education program, provide details of program components
patients with access to additional treatment options;
and link the material to the importance of patient
however, SEB’s are not identical to their innovator products engagement in research.
because their chemical characteristics cannot be precisely
duplicated during the manufacturing process. Therefore,
SEBs may have unique efficacy, immunogenicity, and safety Atelier simultané / Concurrent Session
II-03-D 5:00 PM - 5:30 PM
profiles that are distinct from their innovator products.
The role for oncology nurses in treatment with SEBs will
Consent for Chemotherapy: More Than
be complex and multifaceted given the physical, economic
and safety issues as examples. Ethical issues inherent in
Just the Paper It’s Written On
SEB use will challenge oncology nurses to act on behalf of
Maggie Ford, Nursing Supervisor, Ambulatory Nursing,
patients and to be very knowledgeable about the scope and
Sunnybrook – Odette Cancer Centre, Toronto, Ontario, Canada.
resolution of SEB issues.
Patient-centered care and patient engagement are widely
recognized as core to providing quality cancer care.
Patients and their families are key partners in provision
of cancer care and their ability to adequately understand
the diagnosis and treatment plan is essential to this
71
71 eligible subjects with a median age of 52 were randomized
to combined (n=36) and control (n=35) arms. At 12 weeks there
were 11 (30.6%) responders in the combined arm versus 2
(5.7%) in the control (p=0.012). The results at 24 weeks were 14
versus 4, respectively (p=0.013). Arms were balanced for antiestrogen use. Two subjects chose to discontinue ALTENS after
experiencing symptoms improvement. There were no serious
adverse events.
partnership. There is also growing body of evidence that
patients who engage in their health care have better
outcomes. The potential risk and harm associated with
antineoplastic agents has led to development of standard
practices such as written chemotherapy consent. CANO/
ACIO, ONS, ASCO and Accreditation Canada outline
written informed consent as part of good clinical practice
which establishes clear support for the rights of patients
to receive and understand all elements of consent. The
most important part of the consent process is informing the
client to enable autonomous decision making. Informed
decision making is a dialogue between patient and health
care provider about risks, benefits, alternative treatments,
side effects and treatment intent, while considering the
patient’s rights, culture and values. Although chemotherapy
consent is inherent in practice, written consent can have
its challenges. Our centre’s first attempt at compliance
with written chemotherapy consent was met with many
challenges. We have since re-implemented our written
chemotherapy consent process and created structures with
which to sustain the change. This presentation will highlight
our process, its evaluation and feedback mechanisms and
future recommendations to enhance the sustainability of
the process. Provision of written chemotherapy consent
provides the final step in this process of engagement where
the health care team has supported a patient coming to an
informed decision about the course of treatment offered.
Written consent clarifies treatment plans and is used as
communication for the interprofessional team.
II-04 3:30 PM - 5:30 PM | Montmorency
II-04-A 3:30 PM - 4:00 PM
Family Member Distress: A New
Screening Tool for Nursing Assessment
Anita Mehta, RN, PhD, Marc Hamel , PhD. Psychosocial
Oncology Program , McGill University Health Centre,
Montréal , Québec, Canada .
Oncology nurses are in a prime position to support patients in
distress. They are also a valuable resource to family members
that accompany patients along the cancer journey. While
some studies report that family members of cancer patients
experience high levels of distress, little is known about
the source of distress. To date, there are no measures that
screen for sources of distress in family members of cancer
patients. In order to address this concern, a research study
72
was conducted to create a family problem checklist (FPC):
a screening tool to assess sources of distress. A three step
process was used to generate items for the FPC. First, the
researchers conducted a comprehensive literature review on
possible sources contributing to emotional distress in family
members of oncology patients. Second, two separate focus
groups, one of health care professionals in oncology and the
other of family members of cancer patients, were done. Goals
of these focus groups were to: 1) review the preliminary items
generated from the literature review; 2) solicit suggestions
of additional items; and 3) provide overall impression of the
FPC. Phase 2 of the study will validate the new checklist by
conducting several psychometric tests for the FPC. Results
suggest that similar to cancer patients, family members report
sources of distress related to practical, emotional, social/
family, and spiritual domains. Family members also report
additional domains that appear unique to their experience;
including those pertaining to relational, self-care, patientcare and communication. Results from phase 2 describing
family member feedback on the tool will also be presented.
This study resulted in the creation of a new screening tool
for distress in family members of cancer patients. Oncology
nurses will likely find this measure an important initial
screening tool to engage the family members in a dialogue
about their distress and intervene accordingly.
II-04-B 4:00 PM - 4:30 PM
Development of the MaTT Online
Transitions Toolkit for Male Caregivers
Of Partners with Breast Cancer.
Kelly S. Struthers Montford, MA3, Wendy D. Duggleby,
PhD, RN, AOCN3, Cheryl Nekolaichuk, PhD, R Pysch6, Roanne
Thomas, PhD1, Ceinwen Cumming, PhD, R Pysch5, Sunita
Ghosh , PhD, P. Stat 2, Katia Tonkin , PhD, MD4. 1School
of Rehabilitation Sciences, University of Ottawa, Ottawa,
Ontario, Canada, 2Medical Oncology and Alberta Health
Services–Cancer Care, University of Alberta , Edmonton,
Alberta, Canada, 3Faculty of Nursing, University of Alberta,
Edmonton, Alberta, Canada, 4Medical Oncology, University of
Alberta, Edmonton, Alberta, Canada, 5Division of Palliative
Medicine, University of Alberta , Edmonton, Alberta, Canada,
6Palliative Care Medicine and Oncology, University of
Alberta, Edmonton, Alberta, Canada .
Background: The research team has developed an online
male spouse transitions toolkit (MaTT). The toolkit is designed
to help male spouses of women with breast cancer increase
their awareness of the possible transitions and experiences
they may have as a husband and caregiver, as well as to stay
organized and seek help and resources as needed.
methods: The transition toolkit was developed based
on the findings of a mixed-methods study of the transition
experiences of 104 male spouse caregivers, and by using a
four-round Delphi study. The Delphi process involved an 11
member national expert panel: two male spouses of women
with breast cancer, one oncologist, two psychologists, one
sociologist, one physiotherapist, two nurse practitioners, one
social worker, and one medical statistician. Phases 1 to 3 of
the Delphi process were conducted via email and lasted six
months. The expert panel then met in person (phase 4) to
finalize MaTT.
Results: The resulting toolkit has six sections: about me;
common changes to expect; frequently asked questions;
resources; calendar; and important health information.
These sections contain activities and exercises, as well as
electronic templates (i.e., resources, calendar) that users can
conveniently download from their home computer, tablet, or
smart phone.
Conclusion: The purpose of the intervention is to
support male spouses of women with breast cancer deal
with the multiple transitions they experience. By using the
Delphi process with an expert panel, and by basing MaTT on
research findings, the team has developed an intervention
that is potentially feasible and acceptable. The next step
is to conduct a pilot study to determine if it is acceptable,
feasible, and has the potential to support male spouses.
II-04-C 4:30 PM - 5:00 PM
Patients’ and Family Member’s
Perspectives of Remote Cancer
Treatment–Related Symptom Support:
A Descriptive Study
Dawn Stacey, RN, PhD, CON(C)1, Meg Carley, BSc6,
Barb Ballantyne, RN, BNSc, MScN, CON(C)2, Kimberley
A . Barkhouse, RN, BScN3, Myriam A . Skrutkowski , RN,
MSc, CON(C)4, Angela Whynot , RN, BScN, CON(C)5, Pan–
Canadian Oncology Symptom Triage and Remote Support1.
1School of Nursing, University of Ottawa , Ottawa, Ontario,
Canada, 2Health Sciences North , Sudbury, Ontario, Canada,
3Victorian Order of Nurses, Halifax, Nova Scotia , Canada,
4McGill University Health Centre, Montréal, Québec, Canada,
5Capital Health , Halifax, Nova Scotia , Canada, 6Centre
for Practice Changing Research , Ottawa Hospital Research
Institute, Ottawa, Ontario, Canada .
Purpose: To assess patients’ and family member’s
satisfaction with remote cancer treatment-related symptom
support.
Methods: A descriptive study was guided by the
Knowledge-to-Action Framework. Eligible patients (and/
or family member) received support by telephone or email
for a cancer-treatment symptom within the last month at
one of three ambulatory cancer programs (Ontario, Quebec,
Nova Scotia). The short questionnaire for out-of-hours care
instrument used to measure satisfaction was analyzed with
univariate statistics.
Results: Of 105 patients and/or family members who
completed the survey, 83% called about themselves and
17% on behalf of a family member. Most (79%) called during
regular working hours Monday to Friday. Participants
received advice over the phone (90%) and/or were advised to
go to the clinic (9%) and/or to emergency (13%). Participants
reported speaking with a nurse (84%) or a doctor, other
health service professional (e.g. pharmacist), or triage clerk.
Two people (2%) left a message and were not called back.
For those who spoke to a nurse, most were satisfied/very
satisfied with: the way the call was handled (94%), manner
of nurse (89%), explanation about problem (89%), treatment/
advice given (85%), getting through (85%), and wait time to
speak to a nurse (75%). Suggestions were shorter call back
time, weekend access to support, more knowledgeable
advice on self-care strategies, more education at discharge,
and documenting calls (to avoid repeating, improve
continuity).
Conclusions: Although most were satisfied with remote
support services, suggested changes to improve remote
support were providing time for call back, nurses with access
to previous calls, and more patient education including selfcare strategies.
II-04-D 5:00 PM - 5:30 PM
Patient Engagement – A Key Building
Block to Advancing Patient and Family
Centred Care
Cathy DeGrasse, BScN, MSN, Gwen Barton, BNSc, MHA.
Cancer Program, The Ottawa Hospital, Ottawa, Ontario, Canada.
Over the past few years, our comprehensive cancer program
has made a significant commitment to advancing patient
and family centred care. A major part of this work has
involved engaging patients as partners with the goal of
improving the patient experience with cancer care.
73
Objective: The purpose of this presentation is to describe
the Delphi process employed in the development of MaTT.
This work was launched in 2011 when we conducted a
stakeholder engagement session with patients and family
members from across the catchment area. We received
many recommendations including the need to continue
involving patient and family in planning and decisionmaking in all aspects of the program. Since then, many
strategies have been implemented to advance patient
engagement including revamping the Patient and Family
Advisory Council (PFAC), creating a patient experience
position to support the clinical team, and the ongoing
involvement of patients and family members as advisors on
working groups and committees across the program. Nurses
are taking part in a large scale transformation project within
the clinic environment focusing on building capacity within
their team to allow them to more fully engage patients as
partners in their care and the decision-making process.
As we know, the spectrum of patient engagement ranges
from simply sharing of information, to full collaboration
and empowerment. For patients to become partners in the
healthcare environment, there is a need for a cultural shift
within the traditional model. This change requires strong,
supportive leadership to ensure everyone understands
why and how the voice of patients and family matters.
Our presentation will share our successes with respect to
patient engagement, and our lessons learned. Examples
will demonstrate the important role of nurse leaders, nurse
educators and nurse clinicians with respect to facilitating
patient engagement. We will also report on our efforts to
evaluate the impact of a patient and family centred care
approach from a programmatic perspective.
II-05 3:30 PM - 5:30 PM | Beaumont
II-05-A 3:30 PM - 4:00 PM
It’s Not Just Hair: A Sikh Perspective
Jagbir K. Kohli, RN, MN, BC Cancer Agency, Vancouver,
Brit ish Columbia , Canada .
South Asians are the largest visible minority group in
Canada, of which the largest sub-group originates from
the north Indian region of Punjab, where the predominant
religion is Sikhism. The core values of the Sikh faith are
intended to be intertwined in all aspects of one’s life,
including their physical identity. A Sikhs’ uncut hair
signifies an acceptance of the natural order and a gift from
the Creator, an external commitment to Sikh principles
and beliefs, and an integral component of the Sikh psyche
74
and identity. Recognizing the potential importance of
hair for Sikh oncology patients can help practitioners be
more sensitive to the unique meaning of alopecia for Sikh
patients. Awareness of common beliefs and practices – a
component of cultural competency - can help clinicians be
more sensitive to the possible needs and concerns of the
individual patient. Recognizing the potential importance of
hair for Sikh oncology patients by conducting a thorough
nursing assessment of the patients’ understanding and
concerns about alopecia may better align your nursing
care with the needs of the patient. This presentation will
build on the positive feedback and curiosity that was
sparked from the CONJ publication about the same topic.
It will focus on background of Sikhism including common
beliefs and practices, and unique considerations and
strategies for nurses when providing care to Sikh patients.
This presentation aims to increase nurses’ sensitivity and
awareness of the frequently misunderstood Sikh patient
population, which is key to move towards participatory
health care models. With increased knowledge about diverse
patient populations, by encouraging patient autonomy and
personal choice, by validating the patients’ unique identity,
practices and beliefs, we create an environment to allow for
patient engagement to flourish.
II-05-B 4:00 PM - 4:30 PM
Haida Gwaii – Cancer Care
Sylvi Baillie, RN, Systemic Therapy, BC Cancer Agency–
Sindi Ahluwalia Hawkins Centre for Southern Interior,
Kelowna , British Columbia , Canada.
Haida Gwaii translated means “Islands of the Haida
People”. In fact it is a remote archipelago comprised of 150
islands off the north coast of British Columbia. Moresby
and Graham, the two main islands, are inhabited by a total
population of 4,500-5,000 people, of which 45% are Haida
First Nations. The Village of Queen Charlotte, population
950, has a 16 bed hospital. I was privileged to complete
a ten week cancer care locum in this historic community
in 2012, followed by two, three week locums in 2013. The
locums provided insight into sharp contrasts between urban,
tertiary care and small indigenous healthcare settings.
Since its inception five years ago, Haida Gwaii Cancer Care
program has evolved considerably. Prior to this, patients
and families were required to travel off island for timely
diagnostics, interventional procedures and treatment.
The remote community and transient weather conditions
created many obstacles for those needing these services. In
addition, First Nations cultural beliefs and practices required
consideration.
II-05-C 4:30 PM - 5:00 PM
Addressing the Challenges among Non–
English Speaking Patient Population
in the Pre–Chemotherapy Nursing
Assessment Process
Esther H. Chow, MScN, Jagbir K. Kohli , RN, MN, Karen
Janes, MN, Maxine Alford , PhD, Siby Elizabeth Thomas,
MSN. Professional Practice Nursing, BC Cancer Agency,
Victoria , British Columbia, Canada .
Pre-chemotherapy patient assessment is pivotal in
ensuring quality patient care and safe drug administration.
Aligning with the CANO/ACIO National Chemotherapy
Administration Standards and our organizations mission
and vision, a new standardized pre-chemotherapy
nursing assessment record has been implemented in
our organization. Preliminary data demonstrates the
effectiveness of this comprehensive assessment process
as the final check-point in ensuring safe administration
immediately prior to chemotherapy administration.
Comprehensive pre-chemotherapy assessment of patients
who do not speak English presents a major clinical
challenge. Even with the assistance of interpreters, the
symptom grading system is very complex to translate in
the reality of time-pressured clinical settings. An ideal
assessment approach that will address this challenge is
a process that will simultaneously respect the nature of
different cultures and languages, increase patient autonomy
and empowerment, and accommodate illiteracy, without
compromising the quality of assessment and lengthening
the time required. Based on these criteria and the significant
proportion of Chinese and Punjabi-speaking patients, a
new pre-chemotherapy related symptom self-assessment
form was developed in these two languages to complement
the use of interpreter and the existing nursing assessment
process. In the development process, patient engagement
was essential in knowledge transfer by their participation in
communicating frequently used colloquial healthcare terms
and their associated assumptions, thereby, supporting their
healthcare decision-making. The aim of this presentation
is to share the successes and lessons learned in this
collaborative development process.
II-05-D 5:00 PM - 5:30 PM
South Asian Immigrants Perceptions
of Colorectal Cancer Screening: A
Qualititive Exploration
Joanne Crawford, RN, BScN, CON(C), MScN, PhD
(Candidate), Nursing, Brock University, St. Catharines,
Ontario, Canada .
In Canada, colorectal cancer (CRC) is the third most
common cancer diagnosed in men and women and accounts
for the second highest cancer deaths. Screening has the
potential to prevent and detect CRC early, yet, uptake rates
continue to be low, especially for immigrant sub-groups.
South Asian (SA) immigrants, a rapidly growing population
in Canada begin to assume similar risk of CRC as their
non-Asian born Canadian counterparts with time spent in
the host country. With historically low cancer screening
rates, it is imperative to gain a deeper understanding of
CRC screening behaviours among SA immigrants with a
future aim to improve screening uptake, and in turn, reduce
morbidity and mortality. A qualitative study utilizing focus
group methods was undertaken to explore CRC screening
from the perspectives of SA immigrants living in a midsized urban city in Ontario, Canada. Findings revealed three
dominant themes. The first theme was beliefs and attitudes
toward Cancer centered on SA immigrants’ perceptions of
cancer and screening with subthemes: “early detection is
good”, “test only needed if symptomatic”, “cancer is scary”,
and “SA bowel practices”. The second theme of knowledge
and awareness focused on narratives of what was known
or not known about CRC and screening, awareness, and
outreach strategies. Sub-themes were comprised of: “sources
of information”, “knowledge status”, “awareness gained from
focus group”, and “raising awareness of CRC screening”.
The third theme was support and accessibility centered
on factors that enabled CRC screening, encompassing
sub-themes of: “family physician support”, “ethnicity
and gender of health care provider”, and “system level
issues”. These findings are of importance to cancer care,
oncology and community health nurses who promote CRC
screening among SA immigrants in their communities.
As well, findings will serve as a foundation in the future
development of a survey instrument to sample a larger SA
immigrant population.
75
Community advocacy and engagement secured the
delivery of accessible, comprehensive oncology care in a
safe and culturally respectful environment, close to home.
The presentation describes the victories and challenges
experienced by the Haida Gwaii Cancer Care program
stakeholders in achieving their goals.
Atelier simultané en français/
II-06 3:30 PM - 5:30 PM | Kent/Palais
II-06-B 4:00 PM - 4:30 PM
II-06-A 3:30 PM - 4:00 PM
Le yoga comme allié dans l’épreuve du
cancer pour transcender le soi blessé et
œuvrer à la renaissance
L’aventure thérapeutique de la fondation
sur la pointe des pieds
Valérie Desgroseilliers, Nicolas Vonarx, PhD. Faculté
Canada.
Catherine Provost, Fondation Sur la pointe des pieds,
Chicoutimi , Québec, Canada.
Le cancer évoque souvent un mal destructeur (Moulin,
2005). Les transformations et les pertes suivant sa survenue
s’insinuent sur un mode ramifié et affectent plusieurs
aspects de la vie. Aussi, le cancer se conçoit-il comme une
rupture existentielle qui se vit sous le signe de l’épreuve
(Fisher, 2008). Une perspective socio-phénoménologique
(Schütz) de l’existence nous autorise de penser que
chaque personne édifie son existence à partir d’un univers
de significations qui ordonnent une manière d’être au
monde. Des considérations psychosociales indiquent que
cette singularité repose sur l’intégration personnelle de
référents identitaires (Mucchielli, 2013). En reflétant une
contextualisation de soi, ces référents permettent aux
personnes de se situer dans la vie sociale et d’y trouver là
un confort de soi eu égard à des sentiments de cohérence
et d’unicité (Lipiansky, 2005). Lorsque de nouvelles
données d’existence s’imposent, les personnes peuvent être
plongées dans une crise existentielle. Toutefois, le caractère
paradoxal de l’épreuve suppose que tout désordre s’ouvre
sur un chemin de métamorphoses qui devient l’occasion de
transcender le soi blessé et de transformer ce qui concourt
à entretenir le mal (Marin, 2003). Ce chemin implique la
part réflexive du sujet. À partir de résultats de recherche
qui permettent de mieux comprendre le sens du yoga dans
l’expérience vécue du cancer, nous exposerons que l’épreuve
du cancer se vit aussi sous le signe de la renaissance et que
le yoga se présente comme un univers de sens à la source
de la reconstruction de soi. Le récit de vie de 14 personnes
ayant été atteintes du cancer révèle que cette épreuve
mène vers une quête de soi. Nous montrerons qu’à des fins
de transcendance, les personnes ont remis en question
leur manière de s’inscrire et de se relier au monde de la
vie. Dans cette mise à l’épreuve de soi le yoga est entendu
comme une philosophie de vie. Il se présente comme un allié
fondamental dans la reconquête de soi.
Depuis 1996, la Fondation Sur la pointe des pieds a
organisé des expéditions d’aventure thérapeutique pour
les adolescents atteints de cancer. C’est en 2013 que la
Fondation a choisi d’élargir sa mission afin d’accueillir
dans ses expéditions, les jeunes adultes allant jusqu’à 29
ans. Bien plus que des sorties de plein air, ces aventures
offrent une occasion de côtoyer des jeunes qui partagent les
mêmes réalités, d’échanger et de se comprendre sans avoir
besoin d’expliquer les choses. C’est aussi une opportunité
de tisser des liens d’amitié en relevant ensemble des défis,
comme bien des jeunes souhaitent le faire à cette période
de la vie. Notre organisme a émergé du désir de rendre
la nature accessible à des jeunes atteints de cancer pour
leur permettre de découvrir qu’ils peuvent vivre une
aventure exceptionnelle et accomplir de grands exploits.
En participant à des expéditions hors du commun et dans
la mesure de leurs forces, ils découvrent de nouveaux
horizons, d’autres cultures; ils renforcent leur confiance en
la vie et en eux-mêmes et comprennent qu’ils peuvent être
plus forts que la maladie, peu importe les défis qu’elle leur
réserve. La Fondation Sur la pointe des pieds a pour but
d’aider les adolescents atteints par le cancer, à retrouver leur
bien-être en relevant le défi d’une expédition d’aventure
thérapeutique exceptionnelle. Encadrées par des experts
du milieu médical et du plein air, les expéditions ont
aussi pour vocation de changer l’image de la maladie tant
auprès des participants que du public. Chaque année, la
Fondation Sur la pointe des pieds organise trois expéditions
qui se déroulent autant l’hiver que l’été. Chacune de ses
expéditions peut accueillir jusqu’à douze participants qui
sont sélectionnés grâce à l’aide précieuse de différents
contacts dans les centres hospitaliers du Canada. Vous
pourriez nous aider à recruter dans votre institution!
76
II-06-D 5:00 PM - 5:30 PM
Développement d’un plan de soins
de suivi pour des femmes atteintes
du cancer de l’endomètre à la fin des
traitements initiaux
La personne âgée et ses proches au cœur
de la pratique infirmière oncogériatrique
Johanne Hébert, M.Sc., PhD3, Lise Fillion, PhD1, 2.
Canada, 2Centre de recherche clinique et évaluative en
oncologie (CRCEO), CHU de Québec, Québec, Québec, Canada,
Canada.
Introduction. La survie, définie comme une période
pouvant débuter à la fin des traitements initiaux d’un
cancer, constitue une phase distincte de la trajectoire de
soins. Les soins en période de survie devraient comprendre
la prévention et la surveillance de la récidive ou de
nouveaux cancers, l’intervention sur les conséquences de
la maladie et des traitements et la coordination des soins
entre les spécialistes et la première ligne. Cependant, la
phase de l’après traitement demeure une phase négligée du
continuum de soins.
Objectif. Cette étude propose le développement et la mise
en place d’un plan de suivi pour les femmes atteintes
d’un cancer de l’endomètre selon lesrecommandations de
l’IOM (2006) et la perception des acteurs clés (personnes
atteintes, cliniciens et gestionnaires). Elle vise également
à documenter le rôle de l’infirmière en oncologie dans le
développement et la mise en place d’un tel plan de suivi.
Méthode/résultat. L’étude comporte deux phases et un
devis mixte. La phase I visait le développement d’un plan
de suivi et est terminée. Cette première phase a permis
l’élaboration d’un plan de suivi qui prend en compte à la
fois les recommandations de l’IOM et la perception des
acteurs clés. La phase II permet de le pré-tester sur un petit
échantillon et est présentement en cours.
Discussion. Selon notre connaissance, le PS n’est pas
intégré dans le contexte québécois alors qu’il correspond
aux orientations du programme québécois de lutte contre le
cancer (PQLC, 1998).
France Robert, Maîtrise en sciences infirmières,
Caroline Malenfant inf. B.Sc., Karine Labarre, Maîtrise en
sciences infirmières. Centre d’excellence sur le vieillissement de
Québec, CHU de Québec, Québec, Québec, Canada .
Au cours des 30 dernières années, l’augmentation
du nombre de personnes atteintes d’un cancer est
principalement liée au vieillissement démographique
et à l’augmentation de l’espérance de vie. Au Canada,
près de la moitié des nouveaux cas cancers sont
diagnostiqués chez les personnes de 70 ans et plus. Les
besoins spécifiques des personnes âgées atteintes de
cancer justifient le développement d’une approche qui
associe les compétences gériatriques et oncologiques
soit l’oncogériatrie. Cette approche multidimensionnelle
permet d’identifier les risques actuels et potentiels liés à
la condition gériatriques en considérant entre autres, la
diminution des réserves physiologiques, la comorbidité,
la polypharmacothérapie, les états fonctionnels, cognitif
et nutritionnel, la situation sociale et environnementale.
C’est dans ce contexte que la clinique d’oncogériatrie du
CHU de Québec s’est développée en 2012. L’approche
préconise la participation de la personne âgée et ses
proches à chaque étape du processus soit de l’évaluation
au choix de traitement, jusqu’au suivi. La pratique
infirmière oncogériatrique est basée sur la connaissance
de l’approche systémique familiale et les compétences
d’évaluation gériatrique et oncologique. Il a été démontré
que la prise de décision des personnes âgées à l’égard
d’un traitement peut changer lorsqu’elles reçoivent de
l’information relative aux différents choix de traitements.
Les bénéfices d’un traitement, l’impact sur la qualité de
vie, le souhait des proches et le fardeau potentiel sur la
famille influencent aussi la prise de décision. L’approche
oncogériatrique place les préoccupations et les attentes
de la personne au cœur de l’évaluation et de la décision. À
partir des concepts qui sous-tendent la pratique infirmière
oncogériatrique, cette présentation vise à démontrer
l’intégration de principes de l’approche systémique
familiale et leur impact pour la personne âgée et sa famille
dans le choix de traitement et le suivi.
77
II-06-C 4:30 PM - 5:00 PM
Unwanted Encore: The Lived Experience
of Having Multiple Cancer Diagnoses
Approximately one in two Canadians will develop some
form of cancer, and some will live long enough to be
diagnosed with multiple primary cancers. There is some
indication that multiple primary cancer diagnoses negatively
ACIO/CANO Conférence clinique et
impact survivors’ mental and physical status, and quality
remise de prix / CANO/ACIO Clinical
of life. Existing research studies do not fully capture the
Lectureship and Award Presentation
complexity of the experience of living with multiple primary
9:00 AM - 10:00 AM
cancer diagnoses. Accordingly, a qualitative study was
conducted to address the following research question: What
Non, pas encore : l’expérience vécue de
meanings do individuals assign to the lived experience
of having multiple primary cancer diagnoses? This
diagnostics successifs de cancer
presentation will provide preliminary data on the shared
Krista Wilkins, PhD, Megan Williams, BN, Faculty of
meanings and common features, or essences, of having
Nursing, University of New Brunswick , Fredericton , New
multiple primary cancers. Participants were individuals
Brunswick , Canada .
from Atlantic Canada with a history of multiple primary
cancer diagnoses. To be eligible for the study, participants (1)
Environ un Canadien sur deux sera atteint d’une forme
had two or more cancer diagnoses at least 6 months apart,
ou une autre de cancer au cours de sa vie, et certains
(2) were at least one year post their most recent diagnosis,
d’entre eux vivront assez longtemps pour recevoir plus
(3) were able to speak and read English and (4) were 19 years
d’un diagnostic de cancer primitif. La recherche semble
of age or older. Data were captured through semi-structured
indiquer que les diagnostics multiples ont un impact
interviews. Interviews were transcribed and reviewed for
négatif sur l’état mental et physique des survivants,
common meanings. This study yields findings that can
ainsi que sur leur qualité de vie. Les études existantes
provide empirically-based guidance to healthcare providers
ne captent pas pleinement la complexité d’une telle
expérience. Nous avons donc effectué une étude qualitative to help support cancer survivors in a more holistic way
throughout the extended continuum of care and ultimately
autour de la question de recherche suivante : quels sens
improve the health of individuals who have had multiple
les patients donnent-ils à leurs diagnostics successifs de
primary cancers. Knowledge gleaned from understanding
cancer primitif? Cette présentation abordera des résultats
the lived experiences of cancer survivors is critical to
préliminaires sur les sens partagés et les traits communs
influencing a nationwide healthcare priority to develop
ou l’essence du vécu de diagnostics successifs de cancer
quality cancer survivorship programs.
primitif. Les participants vivaient dans les provinces
atlantiques et avaient reçu plus d’un diagnostic de cancer
primitif. Pour pouvoir prendre part à l’étude, les candidats
devaient : (1) avoir reçu au moins deux diagnostics de
cancer à des intervalles d’au moins six mois; (2) avoir reçu
leur dernier diagnostic au moins un an auparavant; (3)
savoir parler et lire l’anglais; et (4) avoir au moins 19 ans.
Nous avons recueilli les données au moyen d’entrevues
semi-structurées que nous avons ensuite transcrites et
analysées afin de recenser les sens communs. Les résultats
de cette étude présentent aux fournisseurs de soins des
pistes empiriques leur permettant d’offrir aux survivants
du cancer un soutien plus holistique dans le continuum
de soins élargi et, ultimement, d’améliorer la santé des
personnes atteintes de plusieurs cancers primitifs au fil du
temps. Il est essentiel de comprendre l’expérience vécue
des survivants du cancer et d’utiliser les connaissances
ainsi réunies afin d’accorder la priorité à l’élaboration, dans
l’ensemble du pays, de programmes de survivance au cancer
de qualité.
78
A Focus on Writing for Publication:
Getting Started
A . Sevean, RN, MA(N), EdD6. 1Head, Oncology Nursing;
Canada, 2Director, Ambulatory Care & Systemic Therapy,
Community Oncology, Alberta Health Services, Edmonton,
Alberta, Canada, 3Clinical Advisor, College of Physicians &
Surgeons of BC, Vancouver, British Columbia, Canada, 4UBC
School of Nursing, University of British Columbia, Vancouver,
British Columbia, Canada, 5Regional Program Director,
Janeway Hospital, Eastern Health, Children & Women’s Health
Program, St. John’s , Newfoundland, Canada, 6Associate
Professor, School of Nursing, Lakehead University, Thunder
Bay, Ontario, Canada .
The purpose of this instructional session is to assist
nurses who want to write manuscripts for publication in
professional journals. The members of the Editorial Board
of the CONJ will provide guidance for participants in the
process of writing and tips for achieving success. Both
first time and more seasoned writers are welcome. The
session will be organized to provide didactic instruction at
the beginning followed by a question and answer interval.
Participants are welcome to bring examples of their own
writing and/or feedback about manuscripts that have been
peer reviewed. Additionally, participants may bring ideas
about articles they wish to write and have a discussion
about how to proceed.
Atelier/ Workshop
III-02-A 1:45 PM - 3:15 PM
Acute Oncology Care: A Workshop to
Increase Knowledge and Understanding of
Acute Disorders and Treatment–Related
Complications in Oncology Patients and
the Subsequent Communication and
Management of Symptoms
Sharon McGonigle, RN–EC, MScN, NP–Adult.
Radiation Medicine, Princess Margaret Cancer Center,
Clinical problem solving is an important skill for the
specialized oncology nurse. Oncology nurses are often
the first point of care for patients and their families and,
as such, play a key role in identifying acute problems and
severe complications. These can arise either from the
treatment of, or as a consequence of a cancer diagnosis
in the inpatient or ambulatory setting. They can cause
confusion and suffering for both the patient and family.
Once the problem has been indentified, it should to be
communicated to other members of the inter-professional
team who need to determine its severity based on the
information given. Using a framework such as SBAR
(situation-background-assessment-recommendation),
the oncology nurse can organize his/her findings and
enable the team to clarify what issues require a clinician’s
immediate attention and action. Timely intervention
can improve patient outcomes and the wellbeing of
patients. This interactive workshop will focus on: a) Early
recognition of the clinical presentation and risk factors
for metabolic and structural acute oncology conditions
including electrolyte imbalances, sepsis, tumor lysis
syndrome, spinal cord compression and superior vena cava
obstruction, b) Case studies which incorporate nursing
interventions in response to these emergent conditions, and
c) Using the SBAR communication framework to enhance
communication between team members.
Atelier simultané/ Concurrent Session
III-03-A 1:45 PM - 2:15 PM
The How–To’s of Developing a Program for
Adolescents and Young Adults with Cancer
Laura Mitchell, BA, BScN, MN, Hayley Panet , MHSc
Health A dmin , CHE , Norma D’Agostino, PhDC Psych., Terri
Stuart-McEwan , R N, BScN, MHS, CHE , Abha Gupta, MD, MSc,
FRCPC. Princess Margaret Cancer Centre, Toronto, Ontario.
Adolescents and young adults (AYA) with cancer, who
are under 39 years of age, have unique psychosocial and
medical needs that are not optimally met in the current
healthcare structure. Some of their unique needs include
the desire for comprehensive information on fertility,
sexuality, nutrition, exercise and peer support. When these
needs are not addressed, young people are susceptible to
increasing levels of distress. In order to address these needs,
we have launched a program at a large tertiary cancer
centre which sees approximately 800 newly diagnosed
AYA patients annually. We will discuss the processes that
were explored for program development: (1) performing an
environmental scan of other AYA programs; (2) meeting
with health care providers in site groups to understand their
79
Atelier bilingue/ Bilingual Workshop
III-01-A 1:45 PM - 3:15 PM
specific challenges in caring for AYAs; and (3) attending
and observing in all clinics populated by AYAs to better
comprehend patient and health care provider concerns.
Through these methods, we have understood that health
care providers generally require specific education and
training on AYA issues. They welcome the opportunity
to learn and for additional support to help this patient
population. The patients would benefit from counseling
with an expert in AYA issues, such as the clinical nurse
specialist and dedicated psychologist. We will begin piloting
this new program through the leukemia and lymphoma sites
at this centre. Concurrently, we are working on methods
of evaluating the impact of the program and identifying
metrics to ensure its success. In summary, a model of care
designed to meet the unique needs of AYA patients should
be prioritized in cancer care programs. Outcomes from our
pilot study and next steps for the AYA program will conclude
this presentation.
III-03-B 2:15 PM - 2:45 PM
Understanding the Relationship
between Symptoms and Quality of Life
in Children Following Brain Tumour
Treatment: Development of a Clinical
Practice Framework
Gail Macartney, RN(EC), PhD, CON(C)1, Margaret B.
Harrison, RN, PhD2, Elizabeth VanDenKerkhof, RN, DrPH2,
Dawn Stacey, RN, PhD, CON(C)3. 1Children’s Hospital of Eastern
Ontario, Ottawa , Ontario, Canada , 2School of Nursing, Queen’s
Universit y, Kingston , Ontario, Canada, 3School of Nursing,
University of Ottawa , Ottawa , Ontario, Canada.
Background: Research reveals that children surviving
brain tumours have poorer quality of life (QOL) outcomes
post-treatment compared to other cancer survivors or
healthy peers. The key to patient and family engagement
includes understanding how we can prevent, manage and
optimize QOL outcomes related to symptom experience.
The purpose of this study was to develop a clinical practice
framework illustrating the relationship between symptom
experience and QOL in children who have completed
treatment for a brain tumour.
Methods: We describe the experience of 50 children
under the age of 18. First, an observational, cross-sectional
study design was used to survey the group. Symptom
experience was measured using the multidimensional
Memorial Symptom Assessment Scale (MSAS). QOL was
measured using the Pediatric Quality of Life Inventory.
Next, a qualitative study using interpretive description in a
80
subset of 12 survivors was completed to better understand
the perceived relationship between symptom experience,
coping and QOL outcomes. Finally, a clinical practice
framework was developed to summarize the study findings.
Results: Children experienced many symptoms
following completion of treatment. Pain, headaches, fatigue
and sleep problems caused the most distress. Although
children described multiple symptoms, overall, they
described their quality of life as good. They used a variety
of coping strategies to help mitigate the negative effects
of these symptoms including physical reconditioning and
volunteering. The clinical practice framework highlights
the physical, emotional, social and cognitive challenges
identified in the studies that need to be prevented, managed
or optimized in this population.
Conclusion: This framework can assist nurses in their
pivotal role involving the systematic assessment and
management of the multidimensional symptom experience
of children who have completed treatment for a brain
tumour. Next steps include validation of the framework.
III-03-C 2:45 PM - 3:15 PM
Perceptions of the “Venturing Out Pack
Program” as Tangible Support for Young
Adults with Cancer
Laila M. Wazneh, RN, BScN, MSc (A)3, Argerie Tsimicalis,
RN, PhD2, Doreen Edward, BComm 4, Margaret Purden, N.,
PhD 2, Carmen G. Loiselle, N., PhD1. 1Department of Oncology
and Ingram School of Nursing, Jewish General Hospital, McGill
University, Montréal , Québec, Canada, 2Ingram School of
Nursing, Faculty of Medicine, McGill University, Montréal
Québec, Canada,3Ingram School of Nursing, McGill University,
Montréal , Québec, Canada, 4Venturing Out Beyond Our Cancer
(VOBOC), Montréal, Québec, Canada.
Within the cancer community, young adults (YAs) with
cancer have been increasingly recognized as a distinct
group reporting many unmet supportive care needs.
“Venturing Out Beyond Our Cancer” (VOBOC) is a nonprofit community agency committed to providing YAs
with tangible supportive services. One of these services,
called the “Venturing Out Pack (Vo-Pak) Program” provides
backpacks containing three resource kits to assist them
throughout their cancer journey. However, little has
been documented on YAs’ perceptions of these kits. This
qualitative study’s aims were to: (a) explore YAs’ practical,
psychosocial, and information needs; (b) discuss the extent
to which Vo-Pak meets some of these needs; and (c) explore
how Vo-Pak could be further enhanced.
III-04-A 1:45 PM - 2:15 PM
Optimizing Registered Nurse Roles in
the Delivery of Cancer Survivorship Care
(CSC) within Primary Care Settings
Lindsay Yuille, BScN, MScN (student), Denise E.
Bryant–Lukosius, PhD 1, Ruta Valaitis, PhD1, Lisa Dolovich,
PhD2. 1School of Nursing, McMaster University, Hamilton,
Ontario, Canada, 2Department of Family Medicine, McMaster
University, Hamilton, Ontario, Canada.
The current approach to cancer survivorship care (CSC)
in Canada is unsustainable due to the rapidly increasing
number of cancer survivors at a time when there is
a shortage of human and financial resources. With
improvements in early detection, diagnosis, and treatment,
patients diagnosed with cancer are living longer. There is
also growing recognition of the chronic nature of cancer
survivorship. To address increasing pressures for cancer
services, provincial cancer agencies have introduced new
models of post-treatment follow-up that involve earlier
transition of cancer survivors from specialist care back
to their primary care providers. Currently, there is a gap
in research evidence regarding the role nurses working
in primary care settings play in the delivery of CSC. This
presentation will describe the results of a qualitative
descriptive study that identified and examined, the
strengths, gaps, barriers, and opportunities for optimizing
nursing roles in the delivery of CSC within primary care
settings from the perspective of registered nurses practicing
in primary care. 18 registered nurses from across Ontario
participated in this study. Each participant completed an
oral questionnaire and an in-depth telephone interview.
Descriptive statistics were used to describe demographics
characteristics of the sample. Qualitative content analysis
was used to identify and examine key themes related to
CSC. This presentation will: 1) build on current research
evidence about effective chronic disease management
and explore the transferability of this evidence to address
knowledge gaps and opportunities to improve CSC; and 2)
explore the facilitators and next steps necessary to augment
RN roles and stretch RN involvement in CSC within
primary care. Understanding, expanding and strengthening
nurses’ involvement with CSC is a practical approach that
may support uptake of critical evidence known about post
treatment survivorship care.
III-04-B 2:15 PM - 2:45 PM
Addressing Unmet Needs of Cancer
Survivors: Engaging Patients in the Design
and Development of a Nurse Practitioner–
Led Model of Survivorship Care
Devi Ahuja, RN, MN, NP–adult, CON(C), Maria
Rugg, MN, CHPCN(C). Oncology, Trillium Health Partners,
Mississauga, Ontario, Canada.
Breast cancer is the most prevalent malignancy in women
due to high incidence and improved survival. At a large
cancer centre within a regional cancer program, 1,224 newly
diagnosed breast cancer patients were seen in 2013. Over
80% of these patients will be long-term survivors living with
risk of recurrence, metastasis and late effects of treatment
(Grunfeld et al, 2006). The standard of care for surveillance
at this centre is routine clinic visits with specialists following
active treatment, focusing on screening and recurrence.
In cancer focus group meetings, patients identified a gap
in care while transitioning from active treatment to an
inactive phase of survivorship. Furthermore, the scores
on ambulatory oncology patient experience survey reflect
inadequate emotional support to cancer patients. The unmet
needs of cancer survivors underscore the importance of
an appropriate model of care for cancer surveillance. To
address this gap, a survivorship program with a NP-led
model of care is being developed. The program’s goal is
to improve patients’ experiences transitioning between
specialists and family physicians. With input from cancer
81
Twelve YAs with cancer were recruited at a universityaffiliated tertiary hospital in Montreal, Quebec. Semistructured interviews were conducted, transcribed, coded
and thematically analyzed. Overall, YAs perceived the
Vo-Pak as a welcoming, ready-to-use, timely package that
met several cancer-related needs. The Hospital Comfort
Kit was seen as a “hands-on” resource that comforted
them when hospitalized. The Venturing Out Kit was
construed as a catalyst for connecting with others and
offering them “guilt-free” complimentary outings. The
Friends of Lara Information Kit was commended for its
relevance as a “dispatcher” to important support resources.
Participants recommended delivery of the Vo-Pak soon
after diagnosis (within 2 months) and a broader awareness
and dissemination of the program. Enhancing the VoPak program by increasing awareness and promoting
networking among YAs with cancer is critical in meeting
their multidimensional needs. As a connecting resource,
the program has the potential to further assist in fostering
a culture of engagement among patients, healthcare
professionals and additional community programs.
survivors in every phase of planning, a collaborative and
interdisciplinary approach to care has been designed. The
survivorship program includes sub-programs for different
cancers, such as Breast Well Follow Up (BWFU), launched
in October 2013. This program consists of a NP-led BWFU
clinic providing supportive care and coordinating transition
of patients between care providers. Furthermore, the
program includes classes addressing educational needs
of cancer survivors. The BWFU program will serve as
a standard model to be implemented in other cancer
disease sites, commencing with the Colorectal Well Follow
Up sub program, slated to begin in 2014. Following the
implementation of the survivorship program at this cancer
centre, the program will be extended to all treatment centres
within the regional catchment area.
want more information about what to expect following their
treatment for breast cancer and/or their transition from the
care of the cancer centre back to the care of their primary care
practitioner is also available to patients and their families.
Both elements of the program will be discussed in detail
throughout the presentation.
III-04-C 2:45 PM - 3:15 PM
Lynn E. Kachuik, RN, BA, MS, CON(C), CHPCN(C).
Palliative Care, The Ottawa Hospital , Ottawa , Ontario, Canada.
III-05-A 1:45 PM - 2:15 PM
Getting Rid Of the Ostrich Syndrome:
Engaging Patients in Advance Care
Planning
Oncology patients are asked to make multiple decisions
regarding treatments throughout the course of their illness.
Engaging patients and families in their care empowers them
to become active rather than passive participants. However,
Angela K. Leahey, BScN, MN. Oncology Nursing,
the task of advance care planning (ACP) is often overlooked
Sunnybrook Odette Cancer Centre, Toronto, Ontario, Canada .
since the focus is on anti-cancer treatments. Cancer Care
Life after breast cancer is the period of time when the primary Ontario indicates that 40% of cancer patients visited the
ER in the last two weeks of life, 8% were admitted to ICU
treatment for breast cancer is complete and specialized
and 50% died in hospital. Our team’s research of oncology
follow up by the oncologist is no longer required. It is a
patients’ visits to ER within the last two weeks of life (n =
time when many individuals are told they have “graduated”
227) found that only 9% of patients had an advanced care
from cancer care and will now be followed by their primary
plan although 76% had metastatic cancer. Therefore, 38%
care practitioner. For some, this provides a sense of relief
of them were admitted to critical care settings or received
because they are now cancer-free and no longer require
invasive treatments. Discussions regarding goals of care
the expertise of a cancer specialist. For others, the thought
did not occur for 3.5 days after admission resulting in 99%
of leaving the cancer centre and the oncologist is cause for
of these patients dying in an acute care setting. Oncology
anxiety. Breast cancer patients from a large ambulatory
nurses are well positioned to introduce the topic of patients’
cancer centre reported that life after cancer was a time of
wishes since they develop a therapeutic relationship with
uncertainty with mixed emotions. Many talked about the
patients and their families as they provide care across
uncertainty around how to return to the life they had once
the trajectory of illness. These discussions are within the
known and indicated there was a sense of having a “new
normal”, recognizing that they would never go back to exactly scope of nursing practice but many oncology nurses and
oncologists fail to address this issue because they are
the way they were before being diagnosed with cancer and
uncomfortable and lack the skills to discuss ACP. The
that the cancer experience had definitely “changed” them.
Canadian Hospice Palliative Care Association has partnered
For one individual, the question was “Now what?”. There had
with industry to develop a web portal with materials to
been a clear plan while being treated and followed by the
support engagement of patients, families and health care
oncologist, but no clear plan for what to do after cancer care
professionals in advance care planning conversations. This
ended. A program for breast well follow-up care has been
presentation will focus on the strategies and tools employed
developed and is primarily focused on patient education and
in our cancer program to facilitate these discussions and
empowerment. The program highlights include a 1:1 consult
promote patient engagement in ACP. Tactics include
with an advanced practice nurse at the time of the patients’
posters, patient and staff education materials, targeted
discharge for a personalized discussion about treatment
training and mentoring as well as involvement of the Patient
history, long term effects, follow-up guidelines, and links to
Family Advisory Committee. It’s time to start having the
community-based services and healthy living resources. A
group-based education session for breast cancer patients that conversations, integrating ACP into routine oncology care.
“Now what?” Life After Breast Cancer –
Engaging Patients in Well Follow–up Care
82
III-05-C 2:45 PM - 3:15 PM
Managing Cancer and Living Meaningfully Empowering Nurses: An Inter–
(CALM): A Pilot Study of a Nurse–Delivered Professional Initiative to Expand Nursing
Psychotherapeutic Intervention for Cancer Skills in Providing Emotional Care
Patients
Cathy Kiteley, RN, MScN, CON(C), CHPCN(C), Maritza
Carmine Malfitano, MSW, RSW, Judy Jung, BSc,
BScN, RN, Sarah Hales, MD, FRCPC, Anne Rydall , MSc,
Rinat Nissim, PhD, C. Psych ., Gary Rodin , MD, FRCPC.
Psychosocial Oncology and Palliative Care, Princess
Margaret Cancer Centre, Toronto, Ontario, Canada .
Background: In Canada, there has not been standardized
training and supervision of nurses in the delivery of a
brief, individualized, supportive-expressive psychotherapy
that is sensitive to the emotional needs of patients facing
advanced illness and end of life. Data to date suggest that
such an intervention, called Managing Cancer and Living
Meaningfully (CALM), provides support and reflective space
for processing thoughts and emotions evoked by living with
advanced disease, and facilitates resolution of practical and
existential questions faced by such patients.
Objectives: This pilot study will: test the feasibility of
training advanced practice nurses (APNs) in oncology to
deliver CALM to advanced cancer patients; determine the
transferability of skills acquired through CALM for nursing
practice; and allow revisions to the CALM manual for APNs.
Methods: Three APNs at Toronto’s Princess Margaret
Cancer Centre will be trained and supervised in CALM by
the clinician investigators who developed the intervention.
Qualitative pre- and post-case load interviews will be
conducted with participants to assess their current roles and
changes in attitudes toward the training and provision of
psychotherapy. This data will be triangulated with qualitative
data from patient interviews.
Findings: The APNs have reported that the learning
process is engaging and relevant to their practices. Qualitative
data will be presented regarding their experience in CALM
training and supervision. This will include the personal
impact of being engaged in CALM training and their views
about its relevance and applicability as a nurse-delivered
intervention. This data will also be compared to that obtained
from patients.
Kontos, RN, MN, CONc, Jarmila Grof, RN, CON(C), Kim
Thompson, MSW, RSW, Elisa Rink, MSW, RSW, Rita Tamas,
RN, CON(C), Karen Halden, RN, BScN, CON(C). Oncology,
Trillium Health Centre, Mississauga, Ontario, Canada.
The importance for oncology nurses to address emotional
distress with their patients cannot be understated.
Approximately 35% of people diagnosed with cancer
experience clinically significant distress and all patients
experience some degree of distress (Bultz, 2006).
Psychosocial interventions increase well-being, improve
adjustment and coping and reduces distress. However,
nurses sometimes find themselves ill equipped and with
little time to adequately address the psychosocial needs
of their patients. The provision of emotional care is a core
nursing standard of practice and as such, nurses along with
their organizations need to ensure opportunities exist to
strengthen and foster excellence in emotional care. In 2013
a team of 6 oncology inter-professional staff attended a de
Souza expert facilitator workshop in psychosocial care. The
goal was to enhance knowledge and confidence in oncology
nurses working in the cancer centre and the in-patient
oncology and palliative care unit. A proposal was submitted
and endorsed by senior administration which outlined a
multifaceted educational approach including 3 educational
modules focusing on identified learning needs, a series of
self reflections based on the modules, and the introduction
of a mentorship program for nurses to debrief clinical
situations with an expert facilitator. A pre-survey monkey
questionnaire to determine topic areas perceived as most
important to be covered in the education revealed, how to
start conversations to address emotional distress, how to
engage in difficult conversations especially about end of life,
and how to provide emotional care within a fixed time frame.
Almost 60 nurses have attended the program, completed self
reflection exercises and implemented a practical tool to guide
assessment in providing emotional care. This presentation will
outline our program from proposal to evaluation including
results from our initial survey, pre and post knowledge and
confidence questionnaire.
Conclusions: This study will determine the extent to
which APNs can be taught to deliver a supportive-expressive
intervention to advanced cancer patients, the way that it
affects them personally, and the extent to which it can be
incorporated into their practice.
83
III-05-B 2:15 PM - 2:45 PM
III-06-A 1:45 PM - 2:15 PM
La formation continue comme outil de
développement des compétences en soins
palliatifs : vers un cadre de référence pour
les infirmières en oncologie
Jean–François Desbiens, PhD, sciences infirmières1,
Gabrielle Fortin, doctorante en service social2. 1Faculté
Canada , 2Équipe de Recherche Michel–Sarrazin en Oncologie
psychosociale et Soins palliat ifs (ER MOS) Centre de recherche
du CHU–L’Hôtel–Dieu de Québec, Québec, Québec, Canada.
en milieu pourront être proposées pour améliorer l’intégration
d’une approche palliative auprès des infirmières en oncologie.
III-06-B 2:15 PM - 2:45 PM
Programme de formation en ligne pour
les infirmières pivot en oncologie
Sonia Joannette, BAC1, Stéphane Dubuc, Maîtrise2. 1Direction
québécoise de cancérologie, Québec, Québec, Canada, 2Centre
d’expertise en santé de Sherbrooke, Sherbrooke, Québec, Canada.
Tout au long de la trajectoire en cancérologie, auprès de
la clientèle atteinte de cancer et leurs proches, l’infirmière
pivot en oncologie (IPO) a pour rôle d’évaluer, de soutenir,
Introduction : Les soins palliatifs constituent une
d’enseigner et de coordonner, avec habiletés et compétences.
approche de soins qui vise à améliorer la qualité de vie des
Pourtant, aucun programme académique n’enseigne cette
personnes atteintes d’une maladie grave tel que le cancer.
surspécialisation. La Direction québécoise de cancérologie,
C’est pourquoi l’OMS recommande que l’approche palliative
en collaboration avec le Centre de santé et des services
soit intégrée aux soins oncologiques usuels dès l’annonce
sociaux Champlain--Charles-Le Moyne et le Centre
d’un diagnostic de cancer avancé. Malheureusement, peu
d’infirmières ont eu l’occasion de développer des compétences d’expertise en santé de Sherbrooke ont créé le Programme
de formation en ligne afin d’offrir accessibilité et flexibilité
à prodiguer des soins palliatifs lors de leur formation initiale
à l’ensemble des 245 IPO de la province. L’établissement
ou en cours d’emploi, ce qui ne leur permet pas toujours de
des savoirs découle de la révision et de l’adaptation du
répondre adéquatement aux besoins de ces personnes.
Programme de formation de base de l’infirmière pivot en
Objectifs : Cette recherche vise à explorer comment la
oncologie élaboré en 2007 et, aussi, grâce aux partages de
formation continue chez des infirmières en oncologie peut
nombreux experts cliniques, technologiques, pédagogiques
assurer le développement de leurs compétences à appliquer
et de gestion des connaissances. Cet exposé a pour objectif
une approche de soins palliatifs chez des personnes atteintes de sensibiliser les participants au développement du
de cancer avancé.
Programme de formation en ligne à travers la combinaison
de ces trois activités (autoapprentissage, webinaires et
Méthode : Un total de 36 entrevues a été réalisé auprès
forum). Une discussion, sous forme de questions et réponses,
d’infirmières en oncologie dans deux centres hospitaliers
suivra autour des 10 thèmes de ce programme. Les résultats
universitaires du Québec. Une analyse conceptuelle des
du premier volet Urgences oncologiques seront partagés.
verbatim a été effectuée afin de mettre en lumière, à partir de
Une réflexion en groupe sur le transfert et l’intégration des
situations cliniques, les savoirs expérientiels et les stratégies
connaissances complètera ce moment d’échanges.
d’apprentissages particulières au développement des
compétences de soins palliatifs.
Résultats : Les analyses révèlent que le niveau de
compétence des infirmières à offrir des soins palliatifs
influence leurs perceptions à l’égard de la formation et
aux moyens qu’elles mettent en place pour faire face à
des situations complexes de soins palliatifs. Ainsi, plus le
niveau de compétence est élevé, plus on constate l’aisance
des infirmières à intégrer la formation reçue à leur pratique,
donnant lieu à une approche plus personnalisée centrée sur le
patient qui devient un partenaire de soins.
Discussion : En comparant les résultats de ces analyses avec
la littérature, des approches innovantes de formation continue
84
III-06-C 2:45 PM - 3:15 PM
Lire, réfléchir, apprendre l’oncologie et
s’amuser : le club de lecture !
Nicole Tremblay, Maîtrise en sciences infirmières, Hocine
Tensaout , Baccalauréat en sciences infirmières. Oncologie,
Hôpital Maisonneuve–Rosemont , Montréal, Québec, Canada .
Les défis en formation initiale et continue des infirmières
en oncologie se comptent par dizaines. De fait, l’oncologie
comme spécialité infirmière n’est pas reconnue par tous les
La tenue régulière d’un club de lectures est l’une des
stratégies de transfert des connaissances utilisée, depuis
4 ans, dans notre établissement. Nous verrons comment,
à partir d’une question clinique que se pose l’infirmière au
chevet, nous parvenons à des gains importants pour sa
pratique. Mais cette stratégie ne se fait pas sans remise en
question. Nous aborderons au cours de cette présentation
les joies et les limites de cette approche.
Atelier/ Workshop
IV-01-A 3:45 PM - 5:15 PM
Are You Challenged when Asked to
Manage an Oncology Patient with a
Wound? Learn How to Become More
Confident by Improving Your Knowledge
and Clinical Skill Level in Wound Care
Management
Stephanie E. Chadwick, MClSc – WH CETN(C).
Medical Oncology Wound & Ostomy, Princess Margaret
Cancer Cent re, Toronto, Ontario, Canada .
In this workshop clinicians will develop an increased
understanding of wound care principles for the oncology
patient. The principle of wound care management is
continually advancing in the perspective of prevention and
treatment. In order to understand the complexities of the
oncology patient and then add the complication of wound
care management one must understand the unique nature
of the oncology patient. This work shop will enhance the
basic principles of wound care and provide the twist of the
oncology patient. The key principle of knowing your patient
before you determine appropriate care of your patient’s
wounds is an essential component to enhance quality of
care. To enable interactive patient engagement through the
process of wound care decision making this workshop will
empower the clinician by providing the key tools required.
This interactive workshop will focus on: development of
basic wound care principles utilizing the concept of multiple
algorithms; concepts to optimize skin health; providing an
overview of dressing selections; discussing multiple types of
wound etiologies utilizing case studies to develop knowledge
transference of local wound care management.
IV-02-A 3:45 PM - 5:15 PM
Engagement avec les infirmières dans les
études supérieures
Engaging with Nurses in Graduate Study
Jennifer M. Stephens, RN, BSN, MA, OCN2, Karine
Bilodeau, RN, MSN, PhD, CON(C)3, Catriona J. Buick, RN,
MN, CON(C), PhD(C)4, Jacqueline Galica , RN, BScN, MScN,
CON(C), PhD(student)4, Charlotte Handberg, RN,MPH, PhD
Student1, Johanne Hebert , inf., M.Sc., Ph.D (C)5, Jagbir K.
Kohli, RN, MN, MSN, PhD(c), Leah K. Lambert, RN, PhD(C)2,
Tracy L . Truant, RN, MSN, PhD Student2. 1Aarhus University,
Aarhus, Denmark, 2University of British Columbia School of
Nursing, Vancouver, British Columbia, Canada, 3University of
Montréal, Montréal, Québec, Canada.
Purpose: In this bilingual workshop, participants will
explore the pros and cons of graduate study with an
emphasis on oncology nursing. A discussion of Canadian
programs is the major focus, although an international
oncology nursing doctoral program is also discussed. As
graduate students themselves, the presenters offer a realistic
vision of what graduate study is like at both the masters and
doctoral level. The first half of this session provides a brief
overview of major Canadian nursing graduate programs,
funding, and other pertinent information. Other topics of
discussion include choosing a supervisor, forming a thesis
committee, balancing life, work and education opportunities,
and engaging in scholarly activities as a graduate student.
The second half of this workshop includes a panel
presentation and discussion of real-life stories and examples
from current graduate students and guest speakers. An
interactive question and answer forum follows, in which
the audience can ask frank questions of the presenters.
Attendees considering a masters or doctoral program will
leave the session with a clearer perspective upon which to
base their decision to pursue graduate study.
Objective: Participants will gain an understanding
of options for engaging in graduate studies in oncology
nursing, including possible pathways to achieve their
education and career goals.
85
milieux académiques. La preuve en est l’absence de stage
obligatoire dans ce domaine pour l’obtention du diplôme et
du permis d’exercice. De plus, en même temps que le travail
exige plus que jamais des compétences spécialisées de la part
des infirmières exerçant en oncologie, les ressources pour leur
formation continue s’amenuisent.
IV-03-A 3:45 PM - 4:15 PM
IV-03-B 4:15 PM - 4:45 PM
Exploring Tobacco Use and Smoking
Cessation Best Practices from the
Perspectives of Individuals with Lung
Cancer and Health Professionals
Development of an Oral Health Teaching
Module on a Hematology–Oncology Unit
Arlene Court, RN, BScN, CON(C)4, Bonnie Bristow,
MRT(T), BSc 2, Elaine Curle, RN4, Lisa Di Prospero, MRT(T),
MSc, BSc2,5, Leslie Gibson , OT Reg (Ont.), BHSc (OT), BKin1,
Margaret I. Fitch, RN,PhD4, Andrea Eisen, MD, FRCP3,5,
Kittie Pang, BSc, MMSt4. 1Patient and Family Support, Odette
Cancer Centre, Sunnybrook Health Sciences Centre, Toronto,
Ontario, Canada, 2Department of Radiat ion Therapy, Odette
Ontario, Canada, 3Department of Medical Oncology, Odette
Ontario, Canada , 4Department of Nursing, Odette Cancer
Centre, Sunnybrook Health Sciences Cent re, Toronto, Ontario,
Canada, 5University of Toronto, Toronto, ON, Toronto,
Ontario, Canada .
Implementation of smoking cessation programs for patients
at cancer centres has been challenging. Health professionals
express concerns that asking patients with lung cancer about
tobacco use and intentions to quit smoking may potentially
increase stigma, shame, and blame. This study explores
the perspectives of patients with lung cancer and health
professionals regarding the practices of asking about tobacco
use, advising on quitting smoking, and offering a smoking
cessation intervention. A qualitative descriptive method was
utilized composed of two phases. Phase I involved three health
professional focus groups (n=16). Phase II involved semistructured patient interviews (n=19). All patient interviews and
focus groups were audio recorded and transcribed verbatim.
All patients had a diagnosis of lung cancer and a smoking
history. Multiple readings of each focus group transcript were
performed using narrative thematic analysis to identify major
themes. To ensure trustworthiness, researcher triangulation
was utilized by discussion analysis and coding throughout the
study. Findings from the health professional focus groups will
be shared highlighting the emerging themes: rationale for not
approaching (palliative, advanced disease, health professional
comfort level), challenges of offering smoking cessation (gaps
and barriers), identification of smokers (triggers to start a
conversation), and perception of patient’s receptivity. Analysis
of patient interviews revealed both similar and contrasting
themes highlighting significant implications for nursing
practice. Findings from this study will support and guide a
patient centred approach to smoking cessation best practices
ensuring the best possible care for patients and their families.
86
Sandra Fraser, MScN(cand)2, Karine Lepage,
MSc(Admin)1, Jessica Emed, MSc(A)1. 1Hematology–
Oncology, Jewish General Hospital, Montréal, Québec,
Canada, 2School of Nursing, University of Ottawa, Ottawa,
Ontario, Canada.
Background: While the link between oral health and
systemic diseases, infection and overall quality of life is
well documented in the literature, there is strong evidence
indicating that oral health needs of hospitalized patients
are not met at the same standard as other healthcare needs.
Oral health is key to hematology-oncology patients, as many
chemotherapy regimens put patients at high risk for painful
oral complications that can lead to increased morbidity,
and neutropenic patients in particular are at risk of lifethreatening infections.
purpose: To develop a teaching module promoting
evidence-based practice around oral health on our
hematology-oncology unit, with the overall goal of to
improve oral health and prevent associated complications
while supporting patient autonomy.
Methods: Knowledge translation is a process for
healthcare providers to bridge the gap between evidencebased knowledge and practice, and Graham’s Knowledge
to Action Framework guided the development of a needs
assessment survey as well as the content of the teaching
module. The needs assessment survey was conducted with
staff nurses to identify current practices, beliefs, knowledge
gaps, and preferred formats for receiving evidencebased information. The module content was then tailored
according to the survey, consultation with our speech
pathology and dentistry departments, based on the best
available evidence. Topics included: oral health assessment,
oral hygiene interventions, prevention and management of
oral complications, challenging situations including patients
resistant to care and those at risk for aspiration pneumonia.
The module was presented to the staff and evaluated after
the presentation.
IV-04-A 3:45 PM - 4:15 PM
Patient Engagement through Research:
InterDry Ag and Radiation Skin
Reactions of the Breast
Patients as Partners in Care: The Experience
of Patients Attending an Interdisciplinary
Cancer Nutrition Rehabilitation Program for
the Treatment of Cachexia
Crystele R. Montpetit, FVCC, RN, BScN. Radiation
Therapy, Fraser Valley Cancer Center, Surrey, British
Columbia, Canada.
Patients receiving radiation to the breast can suffer
from painful moist desquamation of the axilla and
the inframammary fold, making it difficult to wear
undergarments and perform daily activities. InterDry AG
is a textile dressing with an antimicrobial complex. This
dressing wicks away excess moisture and reduces friction,
itching and burning. Despite having properties that could
prove highly beneficial, a review of recent literature has
been unable to provide evidence in relation to the use of
InterDry Ag for radiation skin reactions. A preliminary study
was conducted to evaluate the potential ability of InterDry
Ag to relieve discomfort from radiation skin reactions of the
breast. Twenty eligible participants consented to wear the
InterDry AG as advised. The effectiveness of InterDry Ag
was evaluated every five days through a skin assessment
as well as a participant questionnaire. A personalized skin
care regime was developed during these appointments with
feedback from the patient. Patient engagement provided a
sense of empowerment as the patient became a partner in
their care. An unexpected, yet positive outcome of this study
has been the emotional support these patients received
during their skin assessments. A therapeutic relationship
developed between the nurse and the patient through the
research process. Patients shared their personal experiences
in terms of their diagnosis and its unique impact on their
lives. A significant decrease in the level of distress with these
patients was noted. Patient engagement through research
has revealed a need for future studies to examine the
benefits of increased nursing support while maintaining skin
integrity with the use of InterDry Ag.
Kimberley Gartshore, MSc(A), CON(C)1,2, Yu Hong
(Lilly) Luan, MSc(A) Student2, Monica P. Parmar, MSc(A),
PhD Student1,2. 1Segal Cancer Centre, Jewish General
Hospital, Montréal, Québec, Canada, 2Ingram School of
Nursing, McGill University, Montréal, Québec, Canada.
Introduction: Cancer cachexia is a debilitating
metabolic syndrome causing considerable physical,
emotional, and psychosocial effects on patients. Ambulatory
cancer nutrition rehabilitation (CNR) programs have been
established for the management of cancer cachexia through
a comprehensive interdisciplinary approach, though limited
evidence on the experience of patients attending such
services exists. Improved understanding of the experience
of patients attending such programs is needed to further
tailor interventions for this population, and to promote
the integration of supportive interventions throughout the
trajectory of cancer care.
Objectives: To explore the experience of patients with
advanced cancer and cachexia attending a CNR program.
Methods: This study was guided by a qualitative
descriptive design. Purposive sampling was used to recruit
ten cancer patients with at least one clinic visit to a CNR
program in an urban university-affiliated cancer centre. Semistructured interviews were audio-recorded, transcribed, and
coded. Thematic analysis was conducted concurrently with
the data collection.
Results: Three themes were described by participants: (1)
“Approach to Care”, highlighting the CNR team’s accessibility,
communication style, and culture of collaboration; (2)
“Being Known to Health Care Professionals”, including
individualized care and the element of human connection; (3)
“Patient Empowerment”, describing the process resulting from
a strong partnership between the CNR team members and
individual patients to foster self-management and enhance
self-efficacy in care.
Conclusion: Overall, participants described a positive
experience with tailored interdisciplinary interventions, and
a high level of engagement with the CNR program. Findings
point to the importance of patient empowerment in fostering an
effective patient-health care team partnership in oncology care.
87
IV-03-C 4:45 PM - 5:15 PM
IV-04-B 4:15 PM - 4:45 PM
to navigate. For many individuals, nurses become the face
of healthcare. They are the ones patients spend the most
time with and rely on to be their advocates. As a result,
Developing a Program of Care Focusing on nurses have a critical role with respect to the successful
implementation of patient engagement strategies. At our
the Patient, not the Pathology: The McCain cancer centre, we recognized the need to revisit the role of
Centre for Pancreas Cancer Experience
nurses in the clinics. It was believed that the nurses did
not have the capacity to fully engage patients as they were
Allyson Nowell, BSc, MSc. Princess Margaret Cancer
taking on many tasks that could be performed by other
Centre, Toronto, Ontario, Canada
staff members. Contributing factors include the high clinic
volumes and increasingly complex needs, as well as the lack
Pancreatic cancer is an aggressive disease where most
of consistently applied practice standards. There was a need
individuals will present with advanced disease. It is
to refocus efforts to ensure nurses are working to the full
extremely difficult to detect as the presenting symptoms
scope of practice, and within a patient and family centered
are often vague and can continue for months before
model where patients are seen as partners in their care.
investigations are pursued. Although pancreas cancer
Initially all clinic nurses completed a self-assessment survey
makes up only 2% of all new cancer cases diagnosed in
based on the CANO standards of care. Results revealed
Canada, it is the 4th leading cause of cancer death and
four key priority areas for consideration; including the telehas a 5 year survival of only 5%. A diagnosis of pancreatic
practice model, nursing documentation, daily assignment of
cancer is devastating to patients and families and is
heightened by the time it takes for a diagnosis. It is common work and the overall role of the specialized oncology nurse
in the clinic setting. Much of this work involved a detailed
to have more than 6 months of investigations before their
review of the CANO standards for the Specialized Oncology
diagnosis is confirmed. As the prognosis for people being
diagnosed with pancreatic cancer can be very short it creates Nurse. Clinic nurses reviewed each of the competencies in
the CANO domains and found that there were discrepancies
additional urgency in ensuring a rapid and streamlined
with what was expected of the Specialized Oncology Nurse,
diagnosis. In addition these paitents often present with
and what was actually occurring in the clinic setting. We
complex symptoms. At Princess Margaret Cancer Centre,
will share how we incorporated the voice of the patient
the Gastrointestinal group provides care for patients with
through this process, and ultimately, our plans to increase
pancreatic cancer and has long identified the complexity of
capacity within the clinic environment to allow nurses to
these patients. In 2011, this team began to explore ways to
address some of the gaps and complexities of caring for this more fully engage patients.
high needs population. This presentation will describe how
the McCain Centre for Pancreatic Cancer was developed. It
will include an overview of the complex issues in diagnosing
and caring for patients with pancreatic cancer, provide
IV-05-A 3:45 PM - 4:15 PM
details of the steps taken to create a robust program of
care for these patients, and describe the development of a
Strengthening the Foundation of Malignant
Pancreas cancer clinic.
Hematology Nursing Education
IV-04-C 4:45 PM - 5:15 PM
Creating a Platform for Patient
Engagement within the Role of Nursing
in an Ambulatory Cancer Care Setting
Angela Blasutti–Boisvert, RN, BScN, Suzanne Madore,
RN, Fatima Kanji, RN, BScN, Debbie Bedard, RN. Cancer
Centre, The Ottawa Hospital , Ottawa , Ontario, Canada.
Evidence continues to indicate that involving patients as
partners in care results in better health outcomes and lower
costs to the health care system. The environment in cancer
is complex and often difficult for patients and their families
88
Karelin Martina, RN, MN, CON(C)1, Diana Incekol, RN,
BScN, MScN, CON(C)2, Rana Jin, RN, BScN, MScN,
CON(C), 1Princess Margaret Cancer Centre, University Health
Network, 2UHN, Princess Margaret Cancer Centre, University
Health Network.
Patients with hematological malignancies often present with
aggressive disease requiring intense nursing care. Nurses
caring for these individuals depend on strong foundational
oncology knowledge. As part of a comprehensive two year
pathway, nurses are required to attend malignant hematology
and hematopoietic stem cell transplant courses to consolidate
practical and theoretical knowledge. Feedback from previous
course participants state that the course is quite advanced for
novice nurses.
and flow of our charting for nurses working within the
outpatient clinics and systemic therapy areas of the program.
It captures the key assessment criteria, interventions and
outcomes in a quick, easy-to-use electronic format. The work
that has been done will improve the patient experience, as
nurses and the interdisciplinary team will have the ability to
see the entire patient record in an easily accessible electronic
format. This enhanced documentation will ensure concise
communication regarding assessments, interventions and
patient outcomes across the program.
IV-05-B 4:15 PM - 4:45 PM
Common Cancer Site Learning Guides:
Helping to Fill a Gap for Registered Nurses
New to Oncology
Reflecting the Oncology Nursing Practice
Standards in the Electronic Environment:
A Rebuild
Christine Gervais, RN, BScN, CON(C)2, Kristen Jensen,
BscPT, MLIS3, Debra Hendel, RN, CON(C), Justine
Ferguson, RN, CON(C)5, Donna Van Allen , RN, BHScN,
CON(C)1. 1Oncology, Grand River Hospital , Kitchener, Ontario,
Canada, 2Oncology, Grand River Hospital , Kitchener, Ontario,
Canada , 3Information Technology, Grand River Hospital ,
Kitchener, Ontario, Canada , 4Oncology, Grand River Hospital ,
Kitchener, Ontario, Canada, 5Oncology, Grand River Hospital ,
Kitchener, Ontario, Canada.
IV-05-C 4:45 PM - 5:15 PM
Ava L. Hatcher, RN, BN, CON(C)2, Gwenyth A . Hughes,
RN, BSN, MN, CON(C)1, Heather Watson, RN, BSN1.
1Professional Practice Nursing, BC Cancer Agency, Victoria,
British Columbia, Canada, 2Professional Practice Nursing, BC
Cancer Agency, Prince George, British Columbia, Canada.
Approximately 85% of newly employed Registered Nurses
(RN) at a provincial cancer care organization in Western
Canada are new to oncology nursing. Some of these RNs
practice within ambulatory care settings providing pretreatment assessments and supportive care. While there
are many resources available to support the professional
development of the RNs, it is often difficult to determine
Given the complexity of care for oncology patients, it is
which resources are most relevant to their practice.
essential that a comprehensive and consistent patient
Professional Practice Nursing, in cooperation with
assessment and communication of patient issues are managed operational leaders and direct patient care RNs, identified
and evaluated across the interdisciplinary oncology team.
the need for a learning resource which would offer the new
Many patient interventions are based on the patient’s ESAS
RN employee an opportunity to learn about the experiences
scores, the utilization of Cancer Care Ontario’s Symptom
and treatment of people with specific types of cancer. The
Management Guidelines and follow the standards of practice “Common Cancer Sites: Basics and Nursing Management”
for oncology nurses set forth by the Canadian Association of
resource is a series of Learning Guides which focus on the
Nurses in Oncology. In 2008, Grand River Regional Cancer
most common forms of cancer. The Learning Guides have
Centre (GRRCC) was at the forefront of this work developing
been developed in a case study format to simulate what
“Oncology Nursing Practice Standards” for nurses working
a patient and RN may experience throughout the course
within the integrated cancer program. This innovative
of care – diagnosis, treatment, survivorship, progression
project has been updated this year to incorporate the
and palliation – while taking into consideration a “whole
symptom management guidelines developed by Cancer Care
person” approach that considers psychosocial and caregiver
Ontario. The scope of GRRCC nursing standards was then
needs. The Learning Guides contain links to a wide array
synthesized and reflected in the redesign of our computerized
of resources that the RN can review to further develop an
charting system. This ground breaking work incorporates the understanding of the disease process and patient experience.
documentation standards that have been set out by CANO
This presentation will describe the developmental process,
and Cancer Care Ontario. It combines these documentation
introduce the Learning Guides and share feedback from RNs
standards with the GRRCC practice standards and a holistic
who have utilized this learning resource.
assessment of cancer [patients into an electronic format. This
rebuild has allowed us to standardize the questions, content
89
To address the immediate needs, a unique workshop
was developed. This workshop closes the knowledge gap
and provides nurses better insight and understanding
of the hematological diseases, treatment and nursing
considerations. The workshop offers the uniqueness of
experiencing knowledge, critical thinking and vision into
the patient journey. The interwoven experience of theory,
practice and patient voice has brought forth an interesting
method of learning for the independent practitioners. Pre
and post evaluations demonstrate a significant increase in
knowledge uptake. This presentation will outline workshop
activities and discuss the approaches taken to facilitate
different learning needs.
IV-06-A 3:45 PM - 4:15 PM
IV-06-B 4:15 PM - 4:45 PM
Programme de récupération rapide après
une chirurgie colorectale (RÉR–CCR) :
un changement de paradigme pour
l’équipe de soins
Transition après la résection d’un
méningiome : patient partenaire
Irène Leboeuf, M.Sc.inf., CSIO(C)1, Claire Beaudin ,
M.Sc. inf.2, Carole Auger, inf.2, Carole Richard , Md2. 1DSI,
CHUM, Montréal , Québec, Canada , 2CHUM, Montréal ,
Québec, Canada .
Le programme de récupération rapide en chirurgie
colorectale poursuit deux objectifs. Premièrement, il
vise à réduire la réponse métabolique et physiologique
de l’organisme induite par la chirurgie colorectale en
utilisant un ensemble de stratégies coordonnées et
appuyées sur les données probantes et deuxièmement, à
promouvoir la reprise rapide de l’autonomie du patient
à ces activités quotidiennes de la vie (Fearon, 2012). Ce
programme demande une approche interdisciplinaire pré,
per et postopératoire avec une participation essentielle
du patient et de ses proches. Ce nouveau paradigme
appliqué en chirurgie a été initié au début des années
2000 par une équipe danoise et est utilisée depuis lors à
travers le monde, avec succès (Kelliher, Jones & Day, 2011).
Depuis 2011, une équipe interprofessionnelle de chirurgie
digestive d’un centre hospitalier universitaire de la région
de Montréal s’est intéressée à cette approche et a entrepris
une démarche pour l’implanter. Cette communication
permettra de faire un survol des différentes stratégies
utilisées dans la phase préopératoire, per opératoire,
postopératoire et lors du congé du patient. De plus, nous
expliquerons la démarche utilisée en période de préimplantation et d’implantation plus particulièrement,
celle liée à l’équipe des soins infirmiers. Finalement, nous
partagerons les leçons apprises de cette implantation.
90
Martine Dallaire, M.Sc.2, Clémence Dallaire, PhD3,
Catherine Balg, M.Sc2, Lucille Juneau , M.Sc1. 1Soins aux
ainés et vieillissement , CHU de Québec, Québec, Québec,
Canada , 2Neurosciences, CHU de Québec, Québec, Québec,
Canada , 3Faculté sciences inf irmières, Université Laval ,
Corps du Résumé : Des patients sont opérés pour
un méningiome. L’expérience des patients est parfois
assombrie par la survenue de déficits cognitifs, sensitifs
ou moteurs (Akagami, 2002; Schielstel et Ryan, 2009) et
par un manque de préparation pour leur retour à domicile,
situation confirmée par les infirmières pivots en oncologie
(IPO). Selon Meleis (2000), le retour au domicile constitue
une transition que l’on peut influencer positivement à l’aide
d’approches répondant aux besoins des personnes.
Objectif : Évaluer les effets d’interventions visant à
faciliter la transition entre l’hôpital et le domicile chez
les personnes ayant subi une résection d’un méningiome.
Méthode. Devis prospectif pré-post avec deux groupes :
suivi habituel des infirmières pour le groupe 1 et pour le
groupe 2, un enseignement sur les façons de composer avec
les symptômes résiduels. La collecte de données s’effectue
avec des questionnaires mesurant : Le sentiment d’être
prêt pour le retour à domicile, la qualité de vie, la qualité de
l’enseignement et la difficulté d’adaptation.
Résultats : Les comparaisons intra et interindividuelles
soulignent des éléments-clés de la transition à la lumière des
processus utilisés et permettent de bonifier les interventions
établies en considérant les patients partenaires.
Recommandations : Optimiser la contribution des
infirmières avec des interventions appuyées sur des résultats
de recherche.
Évaluation de la charge de travail, du
climat d’équipe, de la qualité de la pratique
infirmière et de la nature du partenariat
avec les familles sur une unité d’oncologie
et de médecine pédiatrique
V-01-A 10:30 AM - 11:15 AM
Céline Bergeron, M.Sc3, Jacynthe Landry, BSc.inf5, Bolduc
Mario, M.Sc.inf.2, Suzanne Martel, BSc.inf 6, Marie–Claude
Gauvin, M.Sc.inf.1, Bergeron Martin, B.Sc.4, Marie–Josée Huot,
M.Sc.inf 7. 1Direction des soins infirmiers, CHU de Québec,
Québec, Québec, Canada, 2Direction des soins infirmiers, CHU
de Québec, Québec, Québec, Canada, 3Direction des soins
infirmiers, CHU de Québec, Québec, Québec, Canada,4Direction
des ressources humaines, CHU de Québec, Québec, Québec,
Canada, 5Direction famille enfance jeunesse et santé de la
femme, CHU de Québec, Québec, Canada.
L’unité pédiatrique A-1500 du CHU de Québec compte 14
lits de médecine, 9 lits d’oncologie et 10 civières d’hématooncologie ambulatoire. Le personnel comprend des infirmières,
des infirmières auxiliaires et des préposés. L’équipe de soins
doit composer avec une clientèle mixte, différentes équipes
multidisciplinaires, des situations de soins variées et des
relations exigeantes avec les familles. Une perception de
surcharge de travail, un climat d’équipe tendu et un taux
croissant d’erreurs de médicaments ont incité la mise en place
d’une démarche d’évaluation de cette problématique. Une
phase importante de la démarche consistait à choisir les outils
adéquats pour documenter la situation de façon objective de
façon à pouvoir identifier les bonnes pistes d’intervention.
Les éléments à documenter étaient les suivants: 1) nature et
causes de la surcharge et de la souffrance d’équipe malgré
un ratio infirmière-patients semblable à d’autres centres
comparables; 2) qualité des soins; 3) nature et qualité du
partenariat avec les familles. Une collaboration entre les
soins infirmiers (gestionnaires et cliniciens) et les ressources
humaines a permis d’identifier et d’adapter les outils suivants,
qui ont servi à l’évaluation: 1) logiciel PRN (pour l’intensité
des activités de soins); 2) entrevues (pour les perceptions du
personnel); 3) observation (pour l’organisation du travail, la
nature de la pratique infirmière, les déplacements sur l’unité,
les interactions entre le personnel et les familles) 4) logiciel
Qualiticiel (pour la qualité des soins). Les normes de l’ACIO et
d’APHON ont servi à déterminer les standards de soins visés
en oncologie et ainsi, à identifier les soins qui auraient été
délaissés à cause de la situation. Le personnel de l’unité a fait
partie intégrante de cette démarche d’évaluation et de l’analyse
des résultats. Une évaluation structurée et bien ciblée permet
de mieux planifier l’intervention.
Developing a Provincial Manpower Plan for
the Pivot Nurse in Oncology: Addressing
the Challenge of Meeting Patients’ Needs at
a Time of Scarce Resources
Andréanne Saucier, MScN, CON(C), Alain Biron, N.,
PhD1. 1Quality management department, McGill University
Health Centre, Montréal , Québec, Canada, 2Cancer care
mission , McGill University Health Centre, Montréal , Québec,
Canada.
The Infirmière Pivot en Oncologie (IPO) was implemented in
2005 in Québec. The question about the adequate caseload for
IPO to appropriately intervene with cancer patients has been a
recurrent question from the nurses themselves and the Quebec
ministry of health. Following a provincial study conducted in
2012, IPO’s interventions and the associated time required for
each intervention in each phase of a typical patient trajectory
were identified. This time requirements identification was done
first through an expert panel. Then, a Delphi method was used
to obtain a consensus among all IPOs working in the province.
This professional consensus was compared to how IPOs
currently spend their time in a day using a time and motion
technique. The observation grid developed to perform this time
and motion study included the different nursing interventions
performed by IPOs as well as other organizational factors such
as waiting and searching for equipment. The two sets of study
data, professional consensus on time requirements and time
and motion provided the basis to estimate the number of IPO
required at the local, regional, and provincial level. A tool was
also developed to support this estimation at various levels. The
inevitable question of the right size accessibility following this
estimation exercise became central, as the resources human
and financial, are limited. Do all patients need the intervention
of an IPO? Which patients should be prioritized to receive
their interventions? As result, the Direction québecoise de
cancérologie mandated a subgroup in 2013 to develop and
pilot a triage system that could appropriately identify the
patients who would benefit the most from the interventions of
the IPO. This workgroup is presently reviewing the evidence
and consulting the different partners. This presentation will
review the different milestones toward a provincial manpower
planning exercise to provide cancer patients with IPO services.
91
IV-06-C 4:45 PM - 5:15 PM
V-01-B 11:15 AM - 12:00 PM
Implementation of a Nursing Triage Role in
Ambulatory Cancer Care: Engaging Patients
and Families in Identifying the Need for
Oncology Nursing Care
Angela K. Leahey, RN, MN1, Margaret I. Fitch , RN, PhD2,
Angela D. Boudreau , RN, MN, CON(C)3, Arlene R . Court, RN,
BScN, CON(C)4, Larissa Day, RN, MSc CON(C)5, Holly Krol ,
RN, CON(C)7, Fiona McCullock, RN, BScN6, Sherrol Palmer
Wickham, RN, BScN, CON(C)8. 1Advanced Practice Nurse,
Oncology Nursing, Sunnybrook Odette, Breast Centre, Toronto,
Ontario, Canada, 2Head , Oncology Nursing; Director, Patient
& Family Support Program , Odette Cancer Centre, Sunnybrook
Health Sciences Centre, Toronto, Ontario, Canada, 3Advanced
Practice Nurse, Chemotherapy Unit, Odette Cancer Cent
re, Sunnybrook Health Sciences Centre, Toronto, Ontario,
Canada,4Clinical Educator, Oncology Nursing, Odette Cancer
Canada, 5Advanced Practice Nurse, Oncology Nursing, Odette
Ontario, Canada, 6Supervisor, Oncology Nursing, Odette
Ontario, Canada , 7Manager, Breast Centre, Odette Cancer
Canada,8Manager, Ambulatory Clinics & Chemotherapy ,
Toronto, Ontario, Canada .
Canadian cancer facilities are facing the challenge of caring
for an increasing number of patients while experiencing
constrained or decreasing resources. New approaches to
person-centered care and care delivery are required. In
particular, new approaches are needed to ensure the patients
who require oncology nursing receive this service. Our
cancer centre has undergone redesign of our ambulatory
care delivery approach. Within this effort, oncology nursing
has implemented various strategies to facilitate specialized
oncology nurses working to full scope of practice and providing
access to nursing care for patients based on patient need. One
strategy, a triage nursing role, was designed to help nurses
rapidly identify which patients require nursing care and to
streamline the process of assessment and intervention. The
Triage Nursing Role has been implemented in out-patient
clinics with three patient populations: breast, heamatology, and
head & neck. The Triage Nurse conducts a brief, standardized
assessment that allows the patient and family to identify their
greatest concern and need during that clinic visit. This initial
triage assessment allows us to link the patient to a clinic-based
oncology nurse for a further, more indepth nursing assessment
and intervention. This in turn allows for patient engagement
and collaborative decision making about how to best support
92
the patient during their visit and throughout their cancer
journey. Our experience supports the value of the triage
nursing role to ensure the provision of person-centered care
and identification of those patients most in need of nursing
care while maintaining clinic flow within the ambulatory
setting. Through our implementation we have discovered future
opportunities for continued impact on the patient experience
through the use of the triage role.
V-02-A 10:30 AM - 11:15 AM
Model of Care Redesign at the Cancer
Centre of Southeastern Ontario:
Transforming the Patient Experience
through Patient and Family Engagement
Kelly Bodie, BScN, MN, David Girard, BA, MBA. Kingston
General Hospital , Kingston, Ontario, Canada .
To the Cancer Centre of Southeastern Ontario, Model of Care
refers to how care teams are organized and how cancer services
are delivered to patients. To ensure the new Model of Care would
best meet the needs of patients and families, it had to be designed
and implemented with these very people. A multi-disciplinary
team of 34 people including patients and families came together
as the catalyst to imagine the new future and build a plan to get
there. The team underwent a three session design process to reexamine and re-think how care is delivered and by whom. At the
onset of the design sessions, action was inspired by testimonials
from patients who shared stories about their journey through the
Cancer Centre. The stories amplified that the status quo was no
longer acceptable and that change was certain. Over 125 ideas for
improvement were shared which clearly underscored the need
to focus on two prominent objectives: improve communication
with patients and families; and decrease avoidable delays. After
the design sessions, all improvement ideas were consolidated and
prioritized with patients and families to produce a portfolio of
projects that would implement the new Model of Care by March
2015. Some key projects included: advance disease site teams;
improve transitions with primary care; empower staff by working
to full scope of practice; and improve integration of palliative care.
Projects were implemented using a shared leadership model
with patients, families and providers working together. When
issues arose, patients and families also had a seat at table of the
project governing body, the Model of Care Steering Committee.
Patients and families advocated that ongoing results should
be made public in order to hold everyone accountable for their
performance. In response, communication boards were created
and mounted in high traffic areas of the Cancer Centre to publicly
recognize accomplishments and share performance data.
Making a Difference – Sharing Lessons
Learned in the Implementation of a Patient
Engagement Group in a Cancer Network in
Scotland.
Lorna J. Roe, RN, BSc, MSc. Systemic Therapy, BC Cancer
Agency, Abbotsford, British Columbia, Canada.
This presentation will discuss the development of a patient
engagement group and strategy in a cancer network in
Scotland in 2005; the training offered to patients and
families to prepare them for their involvement and the
challenges faced during the successful implementation
of the group. Patient engagement is a much used term
describing an essential healthcare concept. It can take many
forms; the term often refers to health care professionals
simply seeking patients’ views on aspects of care and service
provision. There is also patient engagement in the form of
partnership working, where patients, families and health care
professionals work together to shape and develop cancer
services at all levels of care. However, without training and
support, patients and families can feel unsupported and often
disadvantaged when involved in a variety of initiatives. It
is recognized that people who have been affected by cancer
have a wealth of experience to offer, providing valuable and
unique perspectives on service delivery. This presentation
will describe training offered to patients and families in the
UK that prepares them to have a voice that determines future
cancer care.
V-03-A 10:30 AM - 11:15 AM
Modeling Chronic Disease Self–
Management Support in Cancer Care
Aronela Benea, MScN, Aleksandra Chafranskaia, PT,
MHSc, Pamela Catton, MD, MHPEd, FRCPC, Stephanie
Phan, OTRg.(Ont.), HBSc(OT). Cancer Survivorship Program,
Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
Background: Cancer is one of the most prevalent
chronic diseases in Canada. Many cancer survivors living
with late and persisting effects from treatment could
benefit from self-management support. To empower
patients/families to be active participants in their care
and assume the responsibility of managing the long term
effects of cancer, oncology nurses need to understand the
underlying principles of chronic disease self-management
and to be familiar with current frameworks that guide selfmanagement support.
Objective: This presentation will provide an overview
of chronic disease self-management key principles,
frameworks, and strategies in the context of cancer care. The
evidence on self-management support for cancer survivors
will be reviewed. The discussion will focus on the roles and
responsibilities of patients/families and nurses in cancer
related self-management, the differences between traditional
patient education and self-management education, and
the common self-management support models. An online
learning module on self-management support created at
Princess Margaret Cancer Centre will be presented.
Impact: Chronic disease self-management is based on patient
engagement in collaborative care. Oncology nurses attending
this presentation will enhance their knowledge of selfmanagement support strategies that promote the involvement
of patients/families in their care, which is crucial to improved
outcomes for people with long term conditions.
Conclusion: There is an increasing interest in the
adoption of chronic disease self-management models in
cancer care. While questions still remain about the most
effective self-management interventions for various cancer
populations, the key principles of self-management support
contribute to the enhancement of oncology nursing practice.
V-03-B 11:15 AM - 12:00 PM
National Update Canadian Cancer
Control Strategy, Embedding PersonCentred Perspective 2014
Scott Secord, MSW, RSW. Cancer Control , Canadian
Partnership against Cancer, Toronto, Ontario, Canada .
Created in 2007, CPAC is funded by the federal government
to accelerate cancer control. ‘Sustaining Action Toward a
Shared Vision 2012-2017,’ reflects the evolution of Canada’s
National Cancer Strategy builds on emerging needs
and priorities in the cancer system. In this interactive
presentation you will learn more about the role that National
Cancer Control Strategy. Focus will be placed on the
Person-Centred Perspective (PCP) Portfolio, including the
importance of embedding this perspective. The Portfolio has
four main foci of work targeting improvements to the patient
experience: Patient Reported Outcomes, Survivorship,
Transitions to Primary Care and Palliative and End-of-Life
Care. Participants will participate in KE and share cancer
workforce experience, evidenced-based guidelines, distress
93
V-02-B 11:15 AM - 12:00 PM
screening, survivorship care, psychosocial support, care
transitions, patient navigation and palliative end-of-life
care. Participants will achieve greater clarity of Canada’s
Strategy and how the Partnership, provinces and territories
collaborate on shared goals of improving the cancer
experience. PCP Portfolio investments of more than $12.5
million will support implementation of innovative projects
in: survivorship, patient reported outcome measurement,
primary care transitions and palliative end-of-life care
across Canada. This will lead to measurement of system
improvements that are both nationally and jurisdictionally
relevant to improving the patient experience. Strong
National Networks and meaningful engagement of patients
and families are key to accomplishing the work. The PCP
Advisory Group will serve as an example of one of the
ways patients and family representatives are engaged
as vital contributors to reaching program and corporate
goals. Discussion will focus on how this integrated
approach contributes to greater understanding of PCP and
identification of methods, models and measurement of
improvements to the patient experience.
We addressed not only those with infrequent practice
opportunities (part time and casual), but also those who have
been on an extended leave of absence. A monitoring system
was designed as a partnership between the nurse, their
immediate manager, and educator to follow their practice
frequency. Concurrent to this, an educational support program
will be instituted for those unable meet the set standards. Our
presentation will describe and discuss our journey from a front
line identified need to the implementation of a pilot program
around competency practice standards, which includes staff
monitoring and structured nursing educational support, followup, and evaluation.
V-04-A 10:30 AM - 11:15 AM
Introduction: In 2011 CCNS identified the lack
of consistent guidelines to support the care of patients
experiencing oncologic emergencies. Rather than develop new
guidelines, CCNS received permission from Alberta Health
Services (AHS) adapt their guidelines ‘Oncologic Emergencies:
A Guide for Family Physicians’, to meet our needs.
Maintenance of Competency for Specialized
Oncology Nurses in Rural and Remote
Centres
Wayne Enders, RN, Dave J. Whiteside, BScN, Sarah
Champ, BScN. Nursing Education, Alberta Health Services
Community Oncology, Edmonton, Alberta, Canada .
Chemotherapy administration encompasses high-risk drugs,
with complex administration processes requiring specialized
knowledge and skills. Specialty organizations have
developed standards for certification and skill maintenance
in chemotherapy administration. However, often these
standards are insufficient in relation to specialized oncology
nurses practicing in rural and remote areas with low patient
volumes. In order to address this gap, we first conducted a
literature search to establish existing guidelines for minimum
practice standards in chemotherapy administration, and then
compared this with our current standard. Furthermore, a
survey of community oncology stakeholders including front
line nurses, educators, and managers suggested minimum
competency maintenance standards. From the survey,
we found that frequency of chemotherapy administration
was the main factor in preserving comfort and competency
in chemotherapy administration. From the information
obtained, we developed a guideline outlining a minimum
practice standard for competency maintenance.
94
V-04-B 11:15 AM - 12:00 PM
“911, What is Your Emergency?” Oncologic
Emergency Guideline Development in
Nova Scotia
Kara Henman, MN, Michele Rogez , BScN. Cancer Care
Nova Scotia , Halifax, Nova Scotia, Canada.
Approach: The AHS guide was sent to stakeholders
across NS with a survey to give feedback on the relevance,
applicability and any adaptations that should be made fit
the needs of NS. Another survey was sent to patients in the
Cancer Patient Family Network (CPFN) to understand the
education provided about oncologic emergencies (OE’s) and
their experiences with an OE. A working group was formed to
tailor the guidelines to the NS practice context, including both
the pre-hospital (Emergency Health Services) and Emergency
Department setting. A second subgroup was formed to adapt
the febrile neutropenia guideline to include the management
of low risk patients, an area not addressed in the AHS guide.
Method: The working groups adapted the guidelines
and developed algorithms to be used as a quick reference
tools. They also standardized a “fever card” for use across
the province; this card was previously only being utilized
in one district health authority and had both a medical
oncology and hematology version. Now all patients receiving
systemic therapy at risk for developing FN will receive this
card. It includes instruction to patients and directions for
staff on what to do when the patient presents in the ED. The
Neutropenia patient education booklet was also updated.
V-05-A 10:30 AM - 11:00 AM
A Creative Response to a Unique Need: A
Multi–Partnered Collaboration to Create
Canada’s First Retreat for Young Adult
Cancer Survivors Living with Advanced and
Metastatic Disease
Emily Drake, MA1, Suzanne O’Brien, MA1, Jennifer
Finestone, MA2, Doreen Edward, BComm3. 1Hope & Cope,
Montréal , Québec, Canada, 2Cedars CanSupport, Montréal,
Québec, Canada, 3VOBOC, Montréal, Québec, Canada.
The adolescent and young adult (AYA) cancer movement
has been a consistently strong advocate for the needs of
this health population and while this movement has gained
considerable momentum over the past decade, the needs of
young adults living with advanced and metastatic disease
have not been as equally recognized or identified. This
presentation will describe the steps and procedures used
to create an innovative, multi-partnered, collaborative
response to a request from a group of young adults living
with advanced disease that we design and implement a
specialized retreat that would meet their unique needs and
concerns as they struggle to live with increasing uncertainty
and health fragility. With these young adults as consultants
and advisors, Canada’s first retreat for young adults
living with advanced and metastatic disease was created.
Lessons learned from the retreat and planning process will
be presented, as well as the challenges for sustainability
and cost-effectiveness of such programs. The authors will
incorporate video testimonials to highlight the patient
experience and the need for unique bilingual programming
for this patient population.
V-05-B 11:00 AM - 11:30 AM
Beyond the Pink Ribbons: The Development
of an Education Module to Engage,
Examine, and Enhance Critical Thinking
Brenda Sabo, RN, PhD2, Sharon Batt, PhD3, Karyn Perry,
RN, BSN, MBA, CON(C), Erna Snelgrove–Clarke, RN, PhD2,
Karyn Perry, RN, BSN, MBA, CON(C), Deborah L. McLeod,
RN, PhD4, Tina Ruel, BA2. 1Consultant Peterborough, Ontario,
Canada, 2Nursing, Dalhousie University, Halifax, Nova
Scotia, Canada, 3Health Services, Dalhousie University,
Halifax, Nova Scotia , Canada, 4Psychosocial Oncology,
Capital district Health Authority, Halifax, Nova Scotia,
Canada .
One of the most successful awareness campaigns targeting
cancer is related to breast cancer. The Pink Ribbon
Campaign has grown beyond a grassroots movement
founded by 68-year-old activist Charlotte Haley in an
effort to raise awareness about breast cancer and the
need for funding to support prevention research. But
has the campaign met its objectives? Barbara Brenner of
San Francisco, who for 15 years led the advocacy group
Breast Cancer Action, known for its Think Before You Pink
campaign, launched in 2002, says that “if people really
knew what was happening, they would be really pissed
off” (Pink Ribbons, Inc., 2011). The documentary, Pink
Ribbon Inc. challenges us to see the faces of breast cancer
rather than the pink ribbons. It encourages us to think
critically and call into question the meaning and purpose
of the campaign. It is provocative, discomforting and noncomplacent—a heady mix, guaranteed to stimulate debate
and encourage us to more closely examine social activism
and how easily it can become corporatized under the
umbrella of philanthropy. This presentation will highlight
the work undertaken by an interdisciplinary group of
researchers, educators and clinicians to engage students
across multiple disciplines in discussion about the influence
large philanthropic organizations have on attitudes, values,
beliefs; research funding; and the marginalization of other
cancers. It is our hope that the education modules, with
associated suggestions, will be used to open dialogue among
students, educators and oncology professionals alike. More
importantly, it may afford a starting point for action to
take place. It is not about ending the campaign, but about
changing the message.
95
Outcomes: The adaptation and development of these
resources will ensure patients experiencing an OE will
receive the same treatment whether they present in a
tertiary care facility or a rural site. The introduction of the
“fever card” across NS will also facilitate the standardization
of care for FN.
V-05-C 11:30 AM - 12:00 PM
V-06-A 10:30 AM - 11:15 AM
A Pilot Study Evaluating Canadian Cancer
Patients’ Treatment Related Out–of–Pocket Association Canadienne des Agences
Costs
Provinciales du Cancer : Lignes
directrices pour l’utilisation sécuritaire
Margaret I. Fitch, RN, PhD1, Christopher J. Longo, PhD2.
1Head , Oncology Nursing; Director, Patient & Family Support des thérapies systémiques orales
Program , Odette Cancer Centre, Sunnybrook Health Sciences
Centre, Toronto, Ontario, Canada , 2McMaster University,
Hamilton , Ontario, Canada
Objective: This project was undertaken to expand our
understanding of cancer patients out of pocket costs related
to their treatment and the implications on quality of life.
Existing quantitative work examines traditional cost items
(i.e., parking, medications, assistive devices, etc.) but fails
to garner insight regarding patients’ perspectives on other
types of items that require financial outlay during and
following a diagnosis of cancer.
Methods: In-depth interviews were conducted with
14 individuals either in person during a clinic visit or by
phone. Interviews were recorded and transcribed verbatim
for analysis. Using a collaborative research team approach,
the transcripts were subjected to a descriptive qualitative
analysis.
Results: Seven individuals with breast cancer, 3 with
colorectal cancer, 2 with lung cancer, and 2 with prostate
cancer completed the interviews. Consistent with existing
published work participants expressed concerns regarding
expenses related to: medications, complementary/
alternative medicines, devices, parking and travel. These
were exacerbated if they did not have insurance or lost
insurance coverage due to loss of work. Several noted these
financial challenges had a negative impact on their personal
and family’s quality of life. Although many acknowledged
in hindsight that additional insurance would have helped,
they also recognized that at the time of their diagnoses it
was not an option. Previously unidentified categorical costs
identified in this study included: modifications to housing
arrangements or renovations, impacts of an altered diet, and
special clothing.
Conclusion: We confirmed results of earlier quantitative
work conducted in a Canadian setting and identified
additional cost categories not previously explored in
quantitative work. Clearly financial burden can decrease
patient and family quality of life.
96
Melany Leonard, BSc(N), MSc(A), CON(C)1, Heather
Logan, BSc(N), MHSc2. 1Oncologie/hematologie, McGill
University Health Center, Montréal, Québec, Canada,
2Canadian Association of Provincial Cancer Agencies,
L’utilisation et la disponibilité de la chimiothérapie orale
est en croissance importante mondialement; de 25-50% des
400 nouveaux agents de chimiothérapie en développement
actuellement sont sous forme orale. Au Canada, la majorité
des soumissions au pan-Canadian Oncology Drug Review
sont pour des agents oraux ce qui augmente la probabilité
qu’ils soient disponible sur le marché canadien. Malgré que
ceci offre de nombreux avantages pour les patients et leurs
proches aidants, des inquiétudes au sujet de la manipulation
et de l’utilisation sécuritaire de ces médicaments dangereux
surgissent dans bien des juridictions. L’auto-administration
de la chimiothérapie orale transfère la responsabilité
pour l’administration et la surveillance d’une équipe de
professionnels de la santé vers le patient et peut réduire
les opportunités de dépistage et intervention précoce
lorsqu’apparait des effets secondaires ou toxicités.
L’association Canadienne des agences provinciales de
cancer (ACAPC) est un regroupement interprovincial des
programmes et des organismes provinciaux et territoriaux
de lutte contre le cancer au Canada. En Colombie
Britannique, Alberta, au Manitoba et à Terre Neuve ces
agences sont également responsables pour la prestation des
soins de cancer aux patients. Cette présentation décrira
les opinions des leaders de ces organismes en matière
d’utilisation et manipulation sécuritaire des agents oraux
de chimiothérapie et présentera certaines options afin
d’améliorer la prescription, la délivrance de médication,
la surveillance et l’éducation. De plus, cette présentation
servira à réviser des recommandations qui permettront
de réduire l’écart entre l’utilisation et la manipulation
sécuritaire de chimiothérapie intraveineuse et orale. Ces
recommandations sont complémentaires à celles déjà émises
par plusieurs organismes professionnels tel ACIO, ASCO
et l’ONS, the British Oncology Pharmacy Association, et
l’International Society of Oncology Pharmacy Practice
Standards.
Le rôle de l’infirmière dans la gestion des
effets secondaires des thérapies ciblées en
cancer du poumon : pour une meilleure
qualité de vie
Mélanie Gosselin, B.Sc. Oncologie ambulatoire, IUCPQ,
Mondialement, le cancer du poumon est le plus meurtrier
de tous les cancers, et la majorité des patients qui en sont
atteints reçoivent leur diagnostic alors que la maladie
est déjà à un stade avancé. Les pronostics sont donc
très sombres et ces patients ne reçoivent pour la plupart
qu’une seule ligne de traitement. Devant ces faits, il est
impératif de tout faire pour offrir le meilleur traitement à
notre clientèle dès le départ. La recherche de mutations
(ALK-EGFR) chez nos patients admissibles est devenue
un incontournable, car les thérapies ciblées représentent
une option de traitement efficace et mieux tolérée par nos
patients. Les effets secondaires des thérapies ciblées sont
différents des ceux occasionnés par la chimiothérapie,
avec lesquels les infirmières d’oncologie ont l’habitude de
travailler depuis de nombreuses années. Il est donc temps de
développer une expertise dans le domaine de la gestion de
ces effets indésirables Quel est notre rôle comme infirmière
auprès de cette clientèle? Comment pouvons-nous optimiser
la qualité de vie des patients recevant ce type de traitement?
Des outils ont été développés par le personnel spécialisé en
néoplasie pulmonaire de la clinique d’oncologie ambulatoire
de l’IUCPQ, pour évaluer et traiter les effets indésirables
associés à ce type de thérapie. Il a été démontré que le
résultat d’interventions infirmières efficientes permet aux
patients de prolonger leur vie dans de meilleures conditions.
Atelier/ Workshop
VI-01-A 3:30 PM - 5:00 PM
Unpacking Complex Cam and Cancer
Situations: Decision Coaching in Real Time
Brenda C. Ross, RN, BScN3, Tracy L . Truant , RN, MSN,
truan1, Lynda G. Balneaves, RN, PhD2, Kathleen Yue, RN,
MN4, Brenda La Prairie, RN, BScN5, Senz Hamilton, RN,
BSN6. 1School of Nursing, UBC, Vancouver, British Columbia,
Canada, 2School of Nursing, UBC , Vancouver, British
Columbia, Canada , 3CAMEO Program , BC Cancer Agency,
Vancouver, British Columbia , Canada, 4Radiation Program,
BC Cancer Agency, Victoria , British Columbia , Canada,
5Systemic Therapy Program, BC Cancer Agency, Victoria,
British Columbia, Canada, 6Clinical Trials, BC Cancer
Agency, Victoria, British Columbia , Canada .
Use of complementary and alternative (CAM) therapies
by cancer patients is increasing in Canada, yet most make
decisions about the integration of these therapies into
their care without the knowledge or support of health
care providers (HCPs). Patients have reported that they
would like HCPs to share in the decision-making process,
but many HCPs lack the needed CAM knowledge, skills,
and resources. Oncology nurses are in an ideal position to
engage people in meaningful discussions about the risks and
benefits of using CAM and to support evidence-informed
decisions. This facilitated and interactive workshop will
introduce a nurse-led, CAM decision support intervention
that has been evaluated at a one regional cancer centre and
combines credible CAM evidence with patients’ autonomy,
values, and beliefs. A variety of learning strategies,
including didactic presentations about decision support,
case studies, role playing exercises, and discussion, will be
used in the workshop. Participants will apply the approach
to a variety of complex clinical scenarios and will anticipate
the challenges and facilitators to moving CAM decision
support into the clinical setting. Participants will gain
practical, evidence-based knowledge and tools to support
cancer patients to make evidence-informed CAM decisions.
Through strengthening one’s own knowledge and skills in
providing CAM decision support and coaching, HCPs may
better engage patients and families in making evidenceinformed decisions about CAM that are right for them.
97
V-06-B
11:15 AM - 12:00 PM
VI-02-A 3:30 PM - 4:00 PM
VI-02-B 4:00 PM - 4:30 PM
Primary Care and Oncology:
Implementation and Early Evaluation of a
Survivorship Nurse Practitioner Role
Developing and Maintaining
Competency for Cancer Chemotherapy
Care: Evaluating an Innovative Model
Kristina Morrison, MSN, NP (F), BC Cancer Agency,
Vancouver, British Columbia, Canada.
Laura Rashleigh, RN, BScN, MScN, CON(C),
CHPCN(C), Donalda MacDonald, RN, CON(C), Komal Patel,
RN, BScN, MN, CON(C), CHPCN(C),Tracy Soong, BSc(cand),
Jiahui Wong, PhD, Mary Jane Esplen, RN, PhD
Background: In 2012, the Provincial Survivorship
Program at the BC Cancer Agency recognized the number
of “unattached” cancer survivors in the lower mainland.
Through the NP4BC campaign, funding was received to
support this population by implementing a family Nurse
Practitioner (NP) in primary care and oncology. In just ten
short months, over one hundred oncology patients have
been “attached” into the primary care practice of the NP.
The patients have been referred by their oncologist either at
initial diagnosis, during active treatment, at the surveillance
phase or at end of life.
Role: Development Relationship development between
the NP and oncologists played a vital role in the successful
development of this new position. The NP completed a
detailed orientation, education, GPO (general practitioner
in oncology) training and spent time in clinic with the
oncologists. In addition, the NP attended various oncology
meetings, conferences, rounds and met one-on-one with
various health care professionals within the cancer agency
to help promote the new role.
Introduction: Cancer chemotherapy administration
and care is complex and should be provided by Registered
Nurses with standardized, evidenced-based knowledge,
skill and judgment. CANO/ACIO recommends that
all nurses providing care for persons receiving cancer
chemotherapy engage in an initial competency program
and yearly competency maintenance process that meets
set national standards. An education institute developed
both a standardized competency development course
and competency maintenance program that address this
recommendation.
Objectives: To review all components of an innovative
education program utilized for cancer chemotherapy nursing
education across a large geographical area, including
development strategies, theoretical considerations and
evaluation results for a 5 year period.
Methods: Standardized curricula were developed for
initial and continuing competency integrating provincial
and national standards with guidance from an expert
advisory group and stakeholders. Multiple modalities were
utilized to implement the curricula, including eLearning,
videoconferences, workshops and an expert facilitator
training program, addressing various learning styles and
access issues.
Evaluation: Since the development of the role in
February 2013, evaluation has been ongoing consisting of
key stakeholder interviews and a patient satisfaction survey.
As a result of the interview findings, changes were made
to enhance the NP role, improve communication strategies
and overall increase the number of referrals. We are looking
forward to reviewing the results from the patient satisfaction
Results: Program evaluation results will be shared for
survey.
each component of the program. Evaluation results indicate
enhanced competency for participants completing the
Conclusion: The primary care and oncology family NP
courses. The pass rate for the initial competency course was
role is a brand new position within Canada. In the short
99.1% based on the 1880 learners who have finished to date.
time since its initiation, oncology patients have been able
Learnings for each component will be shared. Conclusion:
to obtain primary care with a focus on the surveillance and
A multimodal approach to competency development and
survivorship piece that coincides with a cancer diagnosis.
maintenance in cancer nursing care can address diverse
Plans are in place to replicate this role throughout the
learning needs across broad geographical areas, enhance
province with hopes that other provinces will recognize the
patient safety and quality, and promote standardized,
great advantages of this role and consider implementing it
evidence based care.
within their own organizations.
98
VI-03-A 3:30 PM - 4:00 PM
The Impact of Matching Patient Needs
to Nursing Resources: Lessons Learned
from Applying the Synergy Model in a
Hematology/Hsct Unit
Use of a Dvd to Improve Head & Neck
Cancer Patients Information Retention
Yayra Amenudzie, RN, BScN1, Elizabeth O’Sullivan, RN,
BScN, MScN1, Georgia Georgiou, BA, BEd, MEd1, Jennifer
Wiernikowski, RN(EC), MN, NP-Adult, CON(C)1, Elizabeth
Heelam, RN, BScN, BHSc, CON (C)1, Enoch Ho, MPh, RPT,
RAcu2, 1Hamilton Health Sciences , Hamilton , Ontario, Canada,
2Hamilton Health Sciences , Hamilton , Ontario, Canada.
Introduction: The Hematology/Hematopoietic Stem
Cell Transplant (HSCT) Program at the Juravinski Hospital
and Cancer Centre identified a unique opportunity to
enhance patient care and the work environment by piloting
the Synergy Model, a professional practice framework
which involves assessing patient acuity and making
assignments based on a “fit” between patient needs and
staff competency. Published research suggests the models’
patient-centered philosophy optimizes patient outcomes,
enhances collaboration and teamwork, helps teams make
objective decisions about staffing assignments, and helps
administrators establish staffing levels for effective patient
care and workload management. The model has been shown
to be beneficial in various health care settings, but has yet to
be applied with a hematology/HSCT patient population.
Thesis: A pilot project was undertaken to examine the
adaptability, applicability, and effectiveness of the Synergy
Model in a Canadian impatient hematology/HSCT setting.
Summary: A previously developed toolkit was used to
build a hematology/HSCT patient acuity tool which measures
patient complexity, stability, predictability, and participation
in care. There is high internal consistency of the tool (4
items, α > 0.7) and moderate agreement for the inter-rater
reliability analysis (Kappa= 0.68, p <.05). A nurse competency
assessment was developed using the Canadian Association
of Nurses in Oncology practice standards. Processes
were created for scoring patient acuity, making patient
assignments, and for making decisions about staffing levels.
The tool and processes were piloted starting in October 2013.
Conclusion: The Synergy model can be adapted and
applied to a hematology/HSCT population. We will share the
processes used to adapt and implement the model as well as
key enablers and barriers to implementation. By April 2014 we
will have a detailed analysis of the model’s impact on the unit.
These findings will be presented.
Renata Benc, BA, MSc(N), CON(C)2, Christina
MacDonald, BScN, MSc(N), CON(C)1. 1Head and Neck, ENT
clinic, Segal cancer Centre, Jewish General Hospital, Montréal,
Québec, Canada, 2Radiation Oncology, Segal Cancer Centre,
Jewish General Hospital, Montréal, Québec, Canada.
Despite receiving teaching pertaining to the radiation and /or
chemotherapy from several members of the interdisciplinary
team patients and family members felt they were not able to
retain a sufficient amount of the information being given to
prepare them for the treatment they receive. In an effort to
help increase retention our interdisciplinary team developed
a bilingual DVD for patients undergoing radiation and /
or chemotherapy for cancers of the head and neck region.
Treatments for cancer of the head and neck impacts speech,
nutrition, communication and patients’ overall quality of life.
This DVD was designed to complement the verbal and written
information already given. This DVD demonstrates the steps
required for preparation for the treatments, introduces the
treating team, and resources available. The DVD is designed
so patients’ and family members are able to view the DVD at
home at their own pace. The DVD can be viewed as a whole but
patients are encouraged to review at each section individually
as often as they feel is needed. This DVD was developed to
address the informational needs and engage patient’s to be
active participants in their treatment. This presentation will
discuss the development and implementation of the DVD, and
patients’ and families feedback.
VI-03-B 4:00 PM - 4:30 PM
Educating the Leukemia Population: The
Development and Implementation of an
Educational Toolkit to Support the New
Leukemia Patient Population throughout
the Trajectory of Care
Christine Bent, RN, BScN, Sandra Bolyki , RN, BA, Oma
Boodhoo, RN, BScN, MN, Katherine Lee, RN, BScN,
Laura Olmi , RN, BScN, Kaminiben Patel, RN, BScN, Erin
Saretz, RN, BScN, Susan Robinson, RN, BScN, MN, Maggie
Dilling, RN, BScN. Malignant Hematology, University Health
Network – Princess Margaret Cancer Centre, Toronto, Ontario,
Canada.
99
VI-02-C 4:30 PM - 5:00 PM
Background: Many patients in our experience who are
faced with a new diagnosis of acute leukemia have identified
feeling inundated and overwhelmed with the amount of
information provided. Patients have indicated the need
for more timely and meaningful provision of education in
general and specific information related to leukemia. The
reason for this initiative is related to the fact that discharges
were found to be disorganized, hurried and poorly planned.
Patients had acknowledged feeling ill-prepared to transition
into the community due to lack of consistency of message and
inadequate survival level knowledge. This resulted in increased
anxiety and the potential for poor health management
strategies for the patient and family. Educational material was
developed and constructed in a modular format to increase
retention, build understanding of information and provide a
forum for ongoing dialogue between the patient and nurse.
Material was compiled through collaboration with a multidisciplinary health care team who serve the patient and family
throughout the trajectory of care.. At present, no evaluative
tool exists to quantify the retention and understanding of
information provided to newly diagnosed patients with leukemia.
This package includes an evaluative tool to identify the retention,
gaps in the patient’s understanding of the information provided
and to promote patient empowerment through knowledge.
VI-03-C 4:30 PM - 5:00 PM
An Introduction to Chemotherapy: A
Presentation for Patients and Families
Gwenyth A. Hughes, RN, BSN, MN, CON(C)2, Brenda La
Prairie, RN, BSN, CON(C)1. 1Systemic Therapy Program,
British Columbia Cancer Agency, Victoria, British Columbia,
Canada, 2Professional Practice Nursing, British Columbia
Cancer Agency, Victoria, British Columbia, Canada.
The ability of patients to cope and care for themselves
are examples of the positive outcomes of quality cancer
education (CPAC, 2009). A multidisciplinary working group at
a provincial cancer agency developed a Tool Kit to be used to
facilitate and evaluate group chemotherapy patient education
sessions. Promoting consistency in information sharing,
focusing on what patients need to know prior to commencing
chemotherapy treatments and utilizing teaching strategies
which support health literacy needs have been central to this
initiative. As learning is an active and iterative process, the
education session is considered an important first step in
the learning process. It is recommended that all new patients
receiving oral or parenteral chemotherapy attend. This
introductory session provides the patient and family with
an overview of chemotherapy, the management of potential
side effects and self care strategies. The session is facilitated
100
by professionals from a variety of health care disciplines
who possess the requisite knowledge, experience and skills
necessary to support successful learning outcomes. The Tool
Kit contains a PowerPoint presentation and outline, facilitator
criteria and an assessment tool, links to resources to further
develop facilitation skills, a patient information package and
an evaluation tool. During this presentation we will share the
developmental process, including the literature and evidence
which informed the overall project, the Tool Kit, the provincial
dissemination plan and the uptake and impact of this quality
improvement initiative.
VI-04-A 3:30 PM - 4:00 PM
Bridging the Research–Practice Gap
in Oncology Nursing Practice: A New
Brunswick Perspective on Academic–
Practice Partnerships
Krista Wilkins, PhD2, Kimberly Chapman, MSN1. 1 Horizon
Health Network, Fredericton and Upper River Valley Area ,
New Brunswick, Canada, 2Faculty of Nursing, University of
New Brunswick, Fredericton, New Brunswick, Canada.
Oncology nursing practice environments are rich with questions
about the practices nurses engage in every day, many of these
questions go unanswered. In this presentation, we will tell you
about a new academic-practice partnership that we initiated
to ignite and support nurses’ curiosity about the best evidence
to guide clinical decision making. The partners were oncology
nurses from the Dr. Everett Chalmers Regional Hospital and
graduate students from the Faculty of Nursing, University of New
Brunswick. We asked the oncology nurses to identify practices
they engage in that are informed by evidence, practices that do not
have any evidence to support them and what changes they would
like to see in their practice. From this discussion, the oncology
nurses identified three problems in their current practice: fatigue
in patients with cancer, communicating about sexuality with
patients with cancer, and infection prevention techniques for
central venous access devices. The graduate students transformed
the oncology practice problems into focused questions, found
and evaluated relevant evidence, and developed a plan
for implementing changes in clinical practice (if warranted). A
one-page executive summary of the graduate students’ work was
shared with the oncology nurses. This new partnership afforded
an opportunity for nurses – including clinicians, educators and
researchers – to better understand the evidence that underlies
oncology nursing practice, challenge the status quo, and facilitate
evidence-informed decision-making and practice to improve the
quality of oncology care for patients and their families.
The HHN Breast Health Network raised concern that
care for people with breast cancer was not standardized
throughout Horizon. The HHN Breast Health Network
engaged the CNS, Oncology in Area 3 to collaborate with
Nurse Practitioners in Cancer Care:
them to identify ways to standardize breast health care
Enhancing Patient Engagement in Care
within Area 3 without the addition of human resources.
The ability of advanced practice nurses to critically
Krista Rawson, MN1, Sarah Wall , PhD2. 1Alberta Health
examine issues such gaps in care and then use the obtained
Services, Red Deer, Alberta , Canada , 2Faculity of Nursing,
information to influence care delivery became evident.
Universit y of Alberta , Edmonton , Alberta , Canada .
In-depth breast cancer knowledge, understanding of the
Oncology is evolving to become increasingly more participatory research process, and awareness of the broader issues that
and nursing roles are changing to engage patients and
the CNS, Oncology contributed fostered the development of
families more fully in care delivery. Nurse practitioners (NPs)
a model of care navigation. This presentation will describe
are well-placed among caregivers to influence the level of
how the CNS, Oncology facilitated standardization in care
patient engagement in cancer care. Research has shown that
through creatively using available resources.
the caring behaviours and patient-centred communication
styles that NPs use have an important impact on patient
engagement, outcomes, and satisfaction and on the quality of
care and patient adherence to treatment plans. Nevertheless,
VI-05-A 3:30 PM - 4:00 PM
there is considerably more to learn about the role of the nurse
practitioner in cancer care and the unique contribution it
Supporting Nursing Practice: Perceptions of
makes to the patient experience. This presentation will report
Professional Practice Effectiveness
on the results of a study that investigated the perspectives of
NPs, oncologists, and administrators in cancer care in Alberta
Lorelei Newton, RN, PhD, Maxine Alford, PhD, Gwenyth
about the unique and value added aspects of the NP role.
A . Hughes, RN, BSN, MN, CON(C), Karen Janes, RN, MN,
Participants identified the gaps that nurse practitioners can
Kira K. Cooksley, RN, MN, CPHON. Provincial Professional
fill and the distinctive contributions that they make. Nurse
Practice Leader – Nursing, BC Cancer Agency, Vancouver,
practitioners were noted to incorporate a holistic approach
to patient care that involved taking time with patients, fitting
their treatment plans into the realities and demands of patients’ Effective leadership is an essential element of positive
practice environments. Current research points to a strong
individual lives, offering them broad supportive care, and
correlation between organizational leaders’ and staff nurses’
caring for them into survivorship. In these ways, NPs were
perceptions of effectiveness of professional practice nursing
able to bring a strong patient focused perspective to care
teams (PPNT) and perceptions of positive, supportive work
that promoted patient autonomy, choice, and engagement as
environments. In light of this, and underscored by our
partners in their own care.
convictions to support nursing practice through multiple
avenues, our PPNT decided to take a risk: We employed
a survey to provide us with a snapshot of perceptions
VI-04-C 4:30 PM - 5:00 PM
of the PPNT effectiveness held by professionals in our
organization who are either in leadership positions or are
Advanced Practice Nursing in Action:
members of professional committees who collaborate with
Shaping Nursing Practice for People Dealing us. After careful consideration, we adapted Lankshear’s
with Breast Cancer
(2011) Professional Practice Leadership Questionnaire
(PPLQ) in order to examine the perceived effectiveness of
Kim Chapman, MSc(N), Oncology, Horizon Health
our PPNT (recognizing this may differ based on individual
Network , Fredericton and Upper River Valley Area ,
awareness of PPNT activities) as well as the perceived
Fredericton, New Brunswick , Canada .
areas of strengths and for improvement. The PPLQ survey
is designed to assess five factors of professional practice
Advanced practice nurses have the ability to influence the care
effectiveness (leadership, practice and care delivery,
of patients, engage them in their care, and impact positively
on outcomes in varied ways. A quality improvement initiative consultation, research and professional development). To
add depth to the survey, we overlaid five key processes of
undertaken in Horizon Health Network (HHN), Area 3
exemplifies the varied ways that a Clinical Nurse Specialist (CNS) team effectiveness (communication, cohesion, coordination,
participation in decision-making and problem-solving).
can enhance patient care and support colleagues in practice.
101
VI-04-B 4:00 PM - 4:30 PM
Through our commitment to thoughtful analysis of the
survey data regarding our perceived effectiveness, we
believe we can augment PPNT practices and profile within
the organization while continuing to contribute to positive
practice environments. During this presentation, we will
report on our findings of the key factors and processes of
team effectiveness and the implications of these findings to
the PPNT. We will also share lessons learned regarding the
intricacies of influencing practice environments in order to
support registered nurses to engage patients as one aspect of
providing optimal care.
VI-05-B 4:00 PM - 4:30 PM
VI-05-C 4:30 PM - 5:00 PM
Establishing an Oncology Nursing
Leadership Advisory Group within a
Regional Cancer Centre
Charmaine Lynden, RN, MN(EC), Meghan MacMillan, RN,
MScN, Cathy Kiteley, RN, MN, Devi Ahuja, MN, RN(EC),
Susan Daley, RN, BScN, Catherine Sodoski, RN, BN, Laurie Van
Dorn , RN, Maritza Carvalho, RN, BN, Lynda Larmour, BA,
RN, Maria Rugg, MN, Jar mila Grof, RN, BN, Oncology, Trillium
Health Partners, Mississauga, Ontario, Canada .
“Nursing leadership is a vital component in the delivery of
patient care. It shapes the profession, facilitates policies on
The Interprofessional Improvement Team:
mentoring and evidence-based practice and helps navigate
A Key Approach to Ensure Excellence in
change in challenging times” (2013, RNAO Leadership Best
Practice Guideline). Within Oncology, times are definitely
Cancer Care
challenging with cancer programs facing significantly
Andréanne Saucier, MScN, CON(C), Oncology nurse,
increasing volumes and complexity of treatments, coupled
Carolyn Freeman, MBBS, FRCPC, FASTRO. Cancer Care
with an aging patient population and nursing workforce.
Mission, McGill University Health Centre, Montréal , Québec,
Nursing leaders have been given an opportunity to become
Canada.
innovative and change the way high quality, evidence based
As co-directors of the quality and improvement program, our health care is being delivered. To address these realities,
strategy was to undertake multilevel interventions designed the Oncology Nursing leadership team at Trillium Health
Partners (THP) formed an advisory group to develop a
to engage clinicians, patients and decision makers in a
strategic plan to address these complex challenges that we
compelling vision of excellence in cancer care. We initiated
face within our oncology program. The purpose of the
changes that cross many structures (interprofessional,
Oncology Nursing Leadership Advisory Group (ONLAG)
interdepartmental, clinico-administrative) and all levels
is to provide a strategic nursing direction to the Integrated
of the organization (macro, meso and micro) that are
integrated with the vision of quality and performance of the Cancer Program (ICP) regarding nursing issues as they relate
to the oncology program at THP and to respond to requests
organization. We put in place a Quality and Performance
from the ICP regarding Oncology nursing practice within the
Improvement Office with clear accountability (clinical
organization. In keeping with a patient centred approach,
governance) and developed and tested a quality and
our aim is to maintain the patient as the pivot point around
performance dashboard. We tested a project management
all initiatives to ensure that they are receiving care that
approach to address areas for improvement. Front-line
meets their needs. A unique strategy that we employed by
clinicians and decision makers were empowered through
creation of interprofessional improvement teams that allow the ONLAG was to obtain feedback on our Strategic Plan
from the Patient Family Advisory Council in order to ensure
and support them to play a dual role as experts in both
that the direction we were taking was meeting their needs.
their discipline and continuous quality improvement. Our
This presentation will outline the process taken to establish
presentation will give examples of improvement projects
an Oncology Nursing Leadership Advisory Group, including
co-lead by oncology nurses and physicians to illustrate the
the development of a strategic plan and priorities. We will
skills required to conduct improvement projects. To sustain
also discuss current initiatives, obstacles encountered, and
change and further enhance both capacity and capability,
we are developing formal educational and training programs our successes.
in quality improvement for front-line clinicians and are
starting a patient advisory group. The need for protected
time for clinicians, particularly for physicians, must also
be addressed. The most important lesson was learning
to appreciate, value, and respect differences between
professional groups and indeed to capitalize on them.
102
VI-06-B 4:00 PM - 4:30 PM
Les problèmes qui contribuent au niveau
de détresse chez des patients nouvellement
référés en clinique ambulatoire de soins
palliatifs
Développement d’un outil de soutien
à l’exercice optimal de l’autonomie
relationnelle (OSER) en soins palliatifs
Nathalie Aubin, M. Sc.2, Andréa Laizner, PhD3, Anita
Mehta, PhD1, Marc Hamel, PhD1. 1programme d’oncologie
psychosocial, Centre universitaire de santé McGill , Montréal,
Québec, Québec, Canada, 2Programme de soutien en
oncologie et soins palliatifs , Centre universitaire de santé
McGill , Montréal, Québec, Québec, Canada, 3Département
de recherche en soins infirmiers, Centre universitaire de santé
McGill , Montréal, Québec, Québec, Canada
La prévalence de la détresse varie selon les individus, le type
et le stade du cancer ainsi que les symptômes. Identifier la
détresse tôt dans le continuum de soins palliatifs pourrait
permettre la prévention des problèmes psychologiques
co-morbides et améliorer la qualité de vie. Notre recherche
avait pour but 1) d’évaluer la prévalence de détresse chez les
patients palliatifs lors de leur première visite 2) de mieux
comprendre les raisons de la détresse 3) d’évaluer la relation
entre le niveau de détresse et la présence de symptômes.
Méthode:1)Thermomètre de Détresse (DT-Qc Centre
hospitalier universitaire de Québec) 2) Liste canadienne de
vérification de problème (CAPO) 3) Échelle d’évaluation des
symptômes d’Edmonton (ESAS) et 4) les informations sociaux
démographiques et diagnostic. Résultats: Des138 patients
recrutés, 63% d’entre eux ont un niveau de détresse égale ou
plus grand que 4/10. Les problèmes les plus fréquemment
identifiés dans la liste canadienne sont: le changement
d’apparence (58%), le poids (55.8%), le sommeil (56.5%), la
concentration/la mémoire (52.2%) et la constipation (50%).
Les symptômes égale ou plus grand que 4/10 indiqué dans le
ESAS sont: la fatigue (6/10), l’appétit (5/10), le sentiment de
bien-être (4/10) et la douleur (4/10). L’analyse statistique de
régression démontre que le sentiment de bien-être, l’anxiété
et la douleur explique 42% de la variance de la détresse
(p<.0001). La prévalence de la détresse est élevée chez les
patients avec un cancer avancé lors de leur première visite
en clinique ambulatoire en soins palliatifs. Ceci démontre
l’importance du dépistage systématique de la détresse. En
connaissant les facteurs possibles contribuant à la détresse,
l’équipe interdisciplinaire en partenariat avec le patient et ses
proches pourront décider du plan de soins individualisés. En
conclusion nous pouvons affirmer que ces résultats ont autant
d’implication au point vue clinique qu’au point de vue du
domaine de la recherche.
Mireille Lavoie, PhD2, Véronique Turcotte, M.Sc.1, S. Robin
Cohen , PhD3, Jean–François Desbiens, PhD2, Lise Fillion,
PhD2, Camille Gagné, PhD2, Kathleen Lechasseur, PhD2.
1Centre de recherche du CHU de Québec, Québec, Québec,
Canada, 2Faculté des sciences infirmières, Université Laval,
Québec, Québec, Canada , 3Department of Oncology, McGill
University, Montréal, Québec, Canada.
Énoncé du problème : Au fil de l’expérience du
cancer, les décisions à prendre deviennent plus nombreuses
et peuvent susciter des réflexions complexes chez les
patients. Les intervenants manquent souvent d’habiletés,
de confiance et d’outils pour discuter avec les patients et les
familles sur les décisions difficiles à prendre concernant les
soins de fin de vie.
Objectif: Le but de ce projet pilote consiste à développer
un outil à l’intention des patients, des proches-aidants et des
intervenants, pour soutenir la prise de décisions difficiles en
contexte de récidive de cancer ou de cancer métastatique.
Méthode: Le projet prend appui sur un procédé itératif
s’inspirant des principes de la recherche-action. Des
patients, des aidants et des cliniciens ont été rencontrés en
entretien de recherche individuel au cours des différentes
phases de développement de l’outil. Une première version
de l’outil a été élaborée à partir des données recueillies.
D’autres patients et proches-aidants seront ensuite appelés
à tester l’outil sur le terrain, en collaboration avec un
clinicien, dans le cadre d’une décision à prendre, afin
d’évaluer l’utilité de l’outil.
Répercussions et incidence sur le travail:
Nous souhaitons que l’usage de cet outil avec les patients
et leurs proches facilite la communication et le processus
entourant la prise de décisions difficiles, en suscitant
notamment des réflexions et des échanges, et en permettant
de clarifier les valeurs des patients et des proches.
103
VI-06-A 3:30 PM - 4:00 PM
VI-06-C 4:30 PM - 5:00 PM
Mercredi 29 octobre 2014
Wednesday, October 29, 2014
Démarche d’amélioration continue : vers un
parcours qualifiant pour le développement
Atelier / Workshop
des compétences en oncologie
VII-01-A 10:30 AM - 12:00 PM
Catherine Derval, M.Sc., Louise Handfield, M.Sc.,
CSISP(C), Irène Leboeuf, M.Sc., CSIO(C), Catherine Genest,
M.Sc., CSIO(C), Joannie Van Houtte, B.Sc., DESS (étudiante),
Dominique Lachapelle, M.Sc., Marielle Roy, M.Sc., Audrey
Chouinard, M.Sc., CSIO(C). Centre hospitalier de l’Université
de Montréal, Montréal, Québec, Canada.
Issues de programmes d’études différents et possédant
un niveau de connaissances et d’expériences très variées,
les nouvelles infirmières des secteurs d’oncologie et
de chirurgie oncologique au Centre hospitalier de
l’Université de Montréal (CHUM) présentent une disparité
de compétences acquises. Préoccupés par cette réalité,
les membres du comité de la pratique en oncologie ont
entrepris une démarche d’amélioration continue. Ainsi,
l’offre de formation continue a été révisée afin qu’elle soit
standardisée et qu’elle facilite l’intégration des compétences
nécessaires telles qu’énoncées par l’Association canadienne
des infirmières en oncologie (ACIO). L’approche novatrice
utilisée visait à analyser l’offre de formation continue
en vigueur à la lumière de l’expérience du patient et de
sa famille tout au long de la trajectoire de soins. Ainsi,
l’approche pédagogique a été bonifiée afin d’arrimer les
compétences requises de l’infirmière à l’expérience du
patient. Des parcours de formation continue ciblant les
deux premières années de pratique en oncologie ont été
développés pour les infirmières oeuvrant dans les différents
services de la trajectoire de soins : oncologie, radiooncologie, chirurgie oncologique et soins palliatifs. Les
périodes novice et débutante du stade de développement
professionnel selon Benner (2001) ont été privilégiées, car
cette période est charnière pour le développement des
compétences de l’infirmière ainsi que pour l’appropriation
de son rôle. L’offre de formation harmonisée vise ainsi
à assurer la qualité des soins prodigués à cette clientèle
tout en augmentant la satisfaction des infirmières et leur
rétention. Dans une optique de continuité des soins, tous les
parcours qualifiants permettent de mieux outiller l’infirmière
à accompagner le patient et sa famille selon une vision
globale. Cette communication présentera donc la démarche,
les parcours qualifiants et les étapes subséquentes pour
assurer l’opérationnalisation de ce projet.
104
Submitting to the Canadian Oncology
Nursing Journal (CONJ): Achieving Success
A . Sevean, RN, MA(N), EdD5. 1Head, Oncology Nursing;
Canada, 2Regional Program Director, Janeway Hospital Site,
2J141, Eastern Health, Children & Women’s Health Program,
St. John’s, Newfoundland, Canada, 3Clinical Advisor, College
of Physicians and Surgeons British Columbia, Vancouver,
British Columbia, Canada, 4UBC School of Nursing,
Canada, 5Associate Professor, School of Nursing, Lakehead
University, Thunder Bay, Ontario, Canada, 6Director,
Ambulatory Care & Systemic Therapy, Alberta Health
Services, Cancer Control Alberta, Community Oncology,
Thunder Bay, Ontario, Canada.
The purpose of this instructional session is to assist authors
who would like to submit an article to the Canadian
Oncology Nursing Journal achieve success in their
submission. Both first time and experienced authors are
welcome. Members of the Editorial Board will provide an
overview of the process for preparing a manuscript for
submission, submitting the manuscript to the Journal Editor,
and responding to the peer review feedback. The author
guidelines for the Journal will be reviewed and discussed
in detail (copies will be available at the session), including
those for full manuscripts as well as shorter feature or brief
communications. Topics suitable for the Journal will be
illustrated. The session will be organized to be interactive
and allow a substantial time for questions from the audience
and responses from the members of the Editorial Board.
than 400 new chemotherapy drugs in development are
for oral agents. In Canada, the majority of submissions
to the pan-Canadian Oncology Drug Review are for
oral agents, thereby increasing the likelihood of their
Oncology Leadership Workshop: Moving
availability in the Canadian market. Notwithstanding the
from Being Good to Being Great Change
numerous benefit that these drugs offer patients and their
Leaders
caregivers, concerns about safe use and handling of these
hazardous drugs are being raised in many jurisdictions. Self
Janice Chobanuk, RN, MN, CON(C), HPCN(C),
administration of oral chemotherapy transfers responsibility
Cancer Control Alberta Community Oncology, Alberta Health
for administration and monitoring from a team of healthcare
Services, Edmonton, Alberta, Canada .
professionals to the patient, and may diminish opportunities
to quickly identify and intervene when toxicity or side
Managers and leaders in oncology are constantly challenged
effects become apparent. The Canadian Association of
intellectually and emotionally by the rapidly changing
Provincial Cancer Agencies (CAPCA) is a pan-Canadian
healthcare industry. Patient centred care combined with
association of provincial cancer agencies and programs
quality leadership is integral to quality and safe patient care.
The purpose of this interactive oncology leadership workshop who are responsible for setting standards for the delivery
of cancer care in each province. In British Columbia,
is to give new and emerging leaders in cancer centres across
Alberta, Manitoba, and Newfoundland these agencies
Canada the opportunity to learn or enhance their skills to
are also responsible for providing direct patient care. This
deal with our dynamic health care environment and to liaise
presentation willt describe the shared opinions of the
with other managers dealing with similar challenges in their
leaders of these organizations with respect to the safe use
work environments. This instructional session will focus on
and handling of oral chemotherapy, and options to enhance
change theory/theories and change management, coaching
prescribing, dispensing, administration, monitoring, and
for success, dealing with stress, building high performance
education. Most importantly, this presentation will provide
teams and accountable leadership. The overarching goal of
a review of recommendations to close the gap that currently
the workshop is to provide attendees with best practices and
exists between the safe handling and use of intravenous and
tools to move from being good to great leaders in change
oral chemotherapy. These recommendations are intended
management and other key aspects of leadership such as
to complement those already issued by several professional
examining performance challenges, resistance to change,
organizations including CANO, ASCO and ONS, the British
emotional intelligence and program solutions. There will be
Oncology Pharmacy Association, and International Society
substantial time allotted for questions and discussions with
the participants and members from the Special Interest Group of Oncology Pharmacy Practice standards.
in Leadership. In addition, this interactive session will assist
the audience to gain awareness of processes and expectations Atelier simultané / Concurrent Session
essential for effective management and leadership that can be
VII-03-B 11:15 AM - 12:00 PM
applied in any organization.
Nova Scotia: Opening Pandora’s Box of Oral
Systemic Therapy
VII-03-A 10:30 AM - 11:15 AM
Canadian Association of Provincial Cancer
Agencies: Oral Cancer Drug Therapy Safe
Use and Safe Handling Guidelines
Melany Leonard, BSc(N), MSC(A)1, Heather Logan, BSc(N),
MHSc2. 1Oncology/Hematology, McGill University Health
Center, Montréal, Québec, Canada, 2Canadian Association of
Provincial Cancer Agencies, Toronto, Ontario, Canada.
Michele Rogez, BScN, Kara Henman, MN. Cancer Care
Nova Scotia, Sydney, Nova Scotia , Canada .
Introduction: Oral systemic therapy (ST) for cancer is
an emerging trend with 25% of treatment drugs expected to
be oral by 2015. While oral ST can appear safer and easier for
patients, this is not the case as the safety mechanisms in place
for IV ST are non-existent for oral. Moreover, studies also
show that many patients are non-adherent to oral treatments,
causing the drugs to be ineffective. While practitioners readily
relate to the challenges oral chemo poses, no policies exist to
support safe practice to patients or providers.
The use and availability of oral chemotherapy is a growth
phenomenon internationally. Globally, 25-50% of the more
105
Atelier / Workshop
VII-02-A 10:30 AM - 12:00 PM
Approach: Cancer Care Nova Scotia formed a working
group with oncology health professionals from across the
province to create an Oral Systemic Therapy for Cancer
Provincial Policy and Procedure. Our focus included:
ordering, preparation, dispensing, administration, patient
education and follow-up/adherence monitoring. All practice
settings, oncology unit, non-oncology units, long term care
and the patient’s home were considered.
Implications: A provincial policy was drafted and the
group recognized that the policy statements would have
impact on a variety of areas of the health care system.
Knowing this, we engaged various stakeholders (College of
Registered Nurses of Nova Scotia [NS], College of Licensed
Practical Nurses of NS, Pharmacy Association of NS, NS
Department of Continuing Care and Community Service,
Oncologists, Oncology nurses, managers), for feedback.
Outcome: Thus far there is strong agreement with the key
policy statements, although concern does exist in some of
the procedural statements with how facilities will be able to
comply. The need for education also became evident, which
led to the development of: an online Nursing and Pharmacy
“Toolkit”, a patient education pamphlet - Oral Systemic
Therapy for Cancer: A Guide for Patients and Families
and also led us to update the patient education pamphlet
Cytotoxic Precautions: A Guide for Home.
therapist as well as a Psychosocial Oncology Program offer
additional support upon referral. By means of providing
a comprehensive patient assessment and designing an
interdisciplinary therapeutic plan, the unique composition of
this core team constitutes a highly specialized service to meet
the needs of this complex patient population. This bilingual
presentation will describe the results of a retrospective
analysis of treatment modalities and the impact on pain
and other symptoms for patients seen within the CPP. First,
the assessment tools used for patient evaluation will be
presented, and an overview of the Program will be provided.
A descriptive analysis of treatment modalities offered to
patients including pharmacological treatments, interventional
therapies, radiotherapy, as well as referrals to allied health
services and to the Psychosocial Oncology Program will be
also presented.
VII-04-B 11:15 AM - 12:00 PM
Engaging Patients and Families through
a Provincial Cancer Patient Navigation
Program: Evaluating the Impact
Linda C. Watson, RN, PhD, CON(C), Jennifer Anderson,
RN, MN, CON(C), Kristina Vimy, RN, BN, Andrea William,
BA. Alberta Health Services, CancerControl Alberta, Calgary,
Alberta, Canada.
Across Canada, a concerted effort is underway to shift
from a historical “disease-centric” model of care towards
a more “person-centric” model. In a person-centric model,
patients and families are engaged as active participants in
The MUHC Cancer Pain Program: An
their own care, and receive services and supports designed
Interdisciplinary Approach to Cancer Pain to focus on their individual needs, values and preferences.
Research has demonstrated that person-centred care leads
Management
to higher levels of patient engagement and better health
Sara Olivier, BSN, MN(C)1, Jordi Perez, MD2, Rosemary
outcomes. Cancer Patient Navigation has been identified as
O’Grady, MN1, Manuel Borod, MD1, Yoram Shir, MD3.
a key driver to enhancing person-centred care and as such,
1Supportive & Palliative Care, MUHC, Montréal, Québec,
implementation of a provincial Cancer Patient Navigation
Canada, 2AEPMU and Supportive & Palliative Care, MUHC,
program in rural Alberta was initiated. This program
Montréal, Québec, Canada, 3AEPMU, MUHC, Montréal,
included the systematic introduction and integration of
Québec, Canada.
15 cancer patient navigators in rural and isolated urban
cancer care facilities across the province. Framed as a
The McGill University Health Centre (MUHC) Cancer
quality improvement endeavor a robust evaluation of
Pain Program (CPP) was launched in March 2011 in order
the program was conducted to evaluate the impact of the
to provide an interdisciplinary approach to cancer pain
program. The evaluation focused on a primary outcome
management. The CPP represents a unique collaboration
of improving the patient and family experience and
between different departments involved in the care of the
four secondary elements: program implementation, the
cancer pain patient. The core team is composed of palliative
care physicians, anaesthesiologists, a radiation oncologist, and navigator role, impact that navigation had on the team/
community collaboration and how improved navigation
a nurse clinician. Under the allied health service umbrella, a
supports impacted health system utilization.
designated social worker, physiotherapist, and occupational
VII-04-A 10:30 AM - 11:15 AM
106
VII-05-A 10:30 AM - 11:15 AM
The Nurses’ Role in Understanding Health
Literacy
Sarah Champ, BScN1, Dave J. Whiteside, BScN1, Wayne
Enders, RN1, Keira MacKinnon, BEd, BA2. 1Nursing
Education, Alberta Health Services Community Oncology,
Edmonton, Alberta, Canada, 2Patient Education Specialist,
Cross Cancer Institute, Edmonton, Alberta, Canada.
Patient education is a critical role of all nurses and is included
in the CANO practice standards for the specialized oncology
nurse. “The specialized oncology nurse prepares individuals
with cancer and their family for the many different aspects
of the cancer experience providing education, psychosocialspiritual support and counseling across the continuum” (CANO
2006). In order to provide effective patient education, the
nurse must first understand the basics of health literacy. The
Canadian Public Health Association defines health Literacy as
“Skills to enable access, understanding and use of information
for health”. A 2008 study showed that 60% of Canadians (88%
of seniors) have poor health literacy. The nurses ability to
assess patient motivators, identify barriers to learning, and
evaluating the patient’s health literacy are tools that will assist
in patient comprehension, and increase patient empowerment.
Many nurses may not readily recognize low health literacy
in their patients and its influence on their health outcomes.
Subsequently, with the assistance of a patient education
specialist, we have incorporated a health literacy presentation
into our nursing orientation program. This presentation offers
basic information on health literacy, assessing for health
literacy of patients, and some strategies to facilitate patient
understanding of important health information. This is an
interactive 30-minute presentation, with activities designed
to demonstrate low health literacy, and strategies to facilitate
patient understanding and empowerment.
VII-05-B 11:15 AM - 12:00 PM
Health Literacy and the Effects on Oncology
Patients
Gurjeevan Dosanjh, Bachelor of Science in Nursing
Degree. Provincial Professional Practice, BC Cancer Agency,
Vancouver, British Columbia , Canada .
Health literacy is a growing concern across Canada.
Research reports 60% of Canadians are not health literate
and patients with low health literacy levels tend to have
less medical knowledge. This serves as a barrier for
patients to access, understand and comprehend medical
information. Experiencing the cancer journey can be
difficult but the added stress of limited health literacy can
lead to further challenges. Patients with low health literacy
levels are at risk of being less engaged. An engaged patient
is one who is able to effectively communicate with his or
her health care team to optimize health. It is crucial to have
patient engagement as it can lead to informed decisions
and correct management and prevention of health.
Health literacy allows individuals to understand health
information which leads to better understanding of their
diagnosis and treatment, management and prevention and
screening. Health literacy can be influenced by education
level, socioeconomic and demographic factors and cultural
background. Low levels are present in those in poverty,
the elderly, immigrants, and members of the minority.
We need to recognize and address the concern of limited
health literacy. Gaps often exist as a result of assumptions
made about patients’ understanding and using complex
information. Effectively addressing health literacy can
improve patient engagement and lead to better health
outcomes. This presentation will focus on health literacy
and the challenges patients undergoing cancer treatment
can encounter. It will highlight the relationship between
patient engagement and health literacy. It will also state
implications for practice and strategies used to promote
both patient engagement and health literacy.
107
Numerous sources of data including focus groups, patient
and staff surveys, telephone interviews, workload measures,
documentation, and health system utilization data were
collected. Analysis of data collected suggests that the
introduction of the navigator role has had numerous positive
effects on the patient experience, on system efficiencies as
well as a decrease in some areas of health system utilization.
Key objectives of this presentation will be to highlight
navigation competencies, the approaches used to implement
this program and share the compelling program evaluation
data from all five domains evaluated. Key learning’s from
this program implementation will also be shared.
VII-06-A 10:30 AM - 11:15 AM
VII-06-B 11:15 AM - 12:00 PM
La pratique interprofessionnelle centrée
sur le patient : étude de cas multiples
d’équipes en oncologie
Le dépistage systématique de la détresse auprès des patients atteints d’un cancer pulmonaire : bonifier le travail interdisciplinaire
Karine Bilodeau, RN, MSN, PhD2, Sylvie Dubois, RN, M.
Éd ., MBA , PhD1, Jacinthe Pepin , RN, MSN, PhD2. 1Direction
des soins infirmiers, Centre hospitalier de l’Université de
Montréal , Montréal , Québec, Canada , 2Faculté des sciences
infirmières, Université de Montréal , Montréal , Québec,
Canada .
Sébastien Simard, PhD, Brigitte Fournier, MSc, Lynda
Fradette, BSc, Mélanie Gosselin, BSc, Nadine Blanchin,
BSc, Michelle Martineau, BSc, Isabelle Perreault, , MSc, Lise
Tremblay, MD. Institut universitaire de cardiologie et de
pneumologie de Québec (IUCPQ), Québec, Québec, Canada.
Les orientations ministérielles encouragent une pratique
interprofessionnelle centrée sur le patient (ICP) pour
soutenir les patients diagnostiqués d’un cancer au cours
de leur trajectoire de soins. Cette pratique assure une
meilleure communication et la sécurité des patients, et
améliore les soins et l’accès aux services (Santé Canada,
2010). Cependant, les études rapportent majoritairement
les perceptions des professionnels et nous informent sur
les facteurs organisationnels, procéduraux et relationnels
liés à cette pratique. Considérant l’importance de celle-ci, il
semble nécessaire de la documenter selon les perceptions
de patients, de proches et de professionnels dans un
contexte de soins réel. L’étude présentée a pour but de
décrire la pratique ICP au cours de la trajectoire de soins
en oncologie. Une étude qualitative de cas multiples a
été réalisée auprès de deux équipes interprofessionnelles
d’un centre hospitalier universitaire de la région de
Montréal. Des entrevues et de l’observation auprès de
patients, de proches et de professionnels ont été réalisées.
Les résultats suggèrent que la pratique ICP des équipes
est empreinte d’un dualisme de culture et est variable au
cours des différentes périodes de la trajectoire de soins.
De nombreux facteurs influencent la pratique tels que le
fonctionnement de l’équipe et l’environnement. De plus,
les patients rapportent faire l’expérience d’une pratique
ICP fluctuante, de bris dans la continuité des soins et
d’une transition difficile entre les différentes périodes de
la trajectoire. La description d’une pratique ICP souhaitée
propose un accompagnement respectant le rythme du
patient, sans prédominance des valeurs du professionnel et
une assiduité dans la collaboration des membres de l’équipe.
Enfin, des suggestions pour favoriser une pratique ICP et
l’accompagnement des patients au cours de la trajectoire de
soins en oncologie sont présentées.
108
Le dépistage de la détresse est l’une des initiatives majeures
dans l’organisation des soins centrés sur la personne. Au
Québec, il est considéré comme un standard d’accréditations
des équipes interdisciplinaires en oncologie. Toutefois, la
mise en place d’un Outil de dépistage de la détresse (ODD)
soulève des défis, particulièrement auprès d’une clientèle
rapidement confrontée à des soins palliatifs.
Objectif : Partager notre expérience d’implantation de
l’ODD auprès des patients atteints d’un cancer pulmonaire.
Méthode : À l’Institut universitaire de cardiologie et de
pneumologie de Québec, désigné équipe suprarégionale
en cancer du poumon, près de 1000 patients sont suivis
annuellement pour un cancer pulmonaire. Plus de la moitié
sont confrontés au diagnostic d’un cancer incurable et
doivent composer avec une maladie progressant rapidement.
Face à leurs besoins criant et à la complexité du suivi
interdisciplinaire, un comité d’implantation de l’ODD a
été mis en place. Notre stratégie repose sur une approche
par étapes : 1) concertation de l’équipe interdisciplinaire;
2) adaptation de l’ODD; 3) élaboration d’algorithmes de
référence; 4) formation; 5) utilisation par les infirmières
pivots; 6) évaluation de l’implantation; 7) consolidation.
Résultats : Des informations qualitatives sont présentées
sur les différentes étapes de l’adaptation de l’outil et sur
le processus d’implantation. Les principaux obstacles
et apprentissages sont discutés. Les initiatives visant la
poursuite du déploiement sont partagées. Des données
quantitatives sont présentées pour dresser un portrait de la
détresse et des besoins biopsychosociaux.
Conclusion : L’implantation de l’ODD se révèle un défi
de taille suscitant la révision de nos pratiques d’évaluation
et l’organisation de notre travail interdisciplinaire. En plus
d’être un outil de communication efficace entre le patient et
son équipe, il dresse un portrait rapide des besoins et facilite
l’articulation de nos interventions.
Patient Engagement Requires Team
Engagement
Janice Dirksen, BScN, BC Cancer Agency, Vancouver,
Only through strong interdisciplinary team engagement is
it possible to truly achieve patient engagement that benefits
the patient by meeting their needs and achieving the best
outcomes possible. While implementing the BC Patient
Safety and Quality Guidelines developed for seniors being
admitted into acute care, our team realized that all oncology
patients regardless of age, would benefit from assessment
and care planning in the key care areas identified - bowel
and bladder management; cognitive functioning; functional
mobility; medication management; nutrition nd hydration;
and pain management. These care areas are important
determinants of functional ability and when addressed
within the first 48 hours of admission, lead to a reduction in
functional decline and an improvement in patient outcomes.
We revised our nursing admission assessment form and
our daily care flow sheet to include the requirements of the
Hospital Care for Seniors initiative. During the trial phase of
these new tools we observed an increase in interdisciplinary
team engagement that has resulted in a more comprehensive
approach to patient care management. In our presentation
we will share our revised tools, our discoveries about
engaging the interdisciplionary team members during the
process, and the impact on patient engagement.
VIII-01-B 2:30 PM - 3:00 PM
Enabling Self–Management for Patients and
Families in the Acute Phase of Treatment
for Head and Neck Cancer
Sharon McGonigle, MScN, NP, Radiation Medicine,
Princess Margaret Cancer Center, Toronto, Ontario, Canada.
Background: Patients with head and neck cancers are
at risk for poor outcomes due to the multimodal nature of
treatment plans and high potential for treatment related
toxicity. When toxicities are not well managed, they can
severely impact quality of life, lead to treatment delays and
even hospitalization. Whilst there is a myriad of information
available and given to patients along their trajectory of care,
processing and embedding it in their daily routines can be a
challenge while on treatment. As toxicities develop, patients
often are unable to self-manage and start to spiral downwards.
Initiative: One academic health sciences cancer center has
developed an innovative approach to partnering with patients
for acute symptom management. In a collaborative Nurse led
and Nurse Practitioner managed acute care drop in clinic,
nurses provide care, including focused assessments related to
symptoms; teaching; and carry out nursing procedures. It is
based on a model of care that involves forming partnerships
with patients and families to enable and empower them to
engage in self-management.as they care for their treatment
toxicities. While the Nursing Clinic is accessible for all
patients while on radiation or combined chemotherapy/
radiation treatments, this presentation will focus on the unique
challenges of the head and neck population.
Impact: The collaborative role of the Nurse Practitioner
and Specialized Oncology Nurses supports patients in their
management of symptoms such as pain, fatigue, nausea,
vomiting, constipation, xerostomia, odynophagia, taste
changes, lack of appetite..
Conclusion: Nurses are well positioned to enable and
empower patients and families to care for themselves, as
expert coaches, knowledge workers, treatment providers and
coordinators of care. Case studies, processes and outcomes
of care will be shared
VIII-01-C 3:00 PM - 3:30 PM
Engaging Patients across the Trajectory
of Cancer Treatments: Creating a Patient
Information Pathway
Jennifer Smylie, RN, MScN, Lynn E . Kachuik , RN, BA,
MS, CON(C), CHPCN(C). The Ottawa Hospital , Ottawa,
Ontario, Canada .
Patients and their families encounter a multitude of issues
when faced with a diagnosis of lung cancer. They can
be overwhelmed with findings of an advanced stage of
disease as well as the need to make urgent decisons about
surgery, chemotherapy and radiation. Sometimes they are
significantly symtomatic on diagnosis. These patients are
stigmatized by a diagnosis of lung cancer due to public
perception of culpability as a result of their smoking.
In our cancer program we have over 600 new referrals
a year for patients with lung cancer. Our Lung Cancer
Transformation Project has attempted to make the referral,
intake, assessment, diagnosis and treatment phases of
the care trajectory as effective and efficient as possible to
streamline the process and reduce wait times. This has
been accomplished by applying the principles of a care
pathway. However, to fully engage this group of patients
109
VIII-01-A 2:00 PM - 2:30 PM
in their care we also focused on the complex needs of this
underserved and vulnerable group, working to engage them
in decision making and self care. This requires improved
patient and health care provider communication as well
as the use of multiple strategies and tools to address their
unique learning needs. Much as a clinical pathway guides
care, an information pathway can gude patient education,
navigation and engagement. This presentation will focus on
the development of our patient information pathway.
We will describe the various components including a patient
passport, a patient lung cancer guide and personal record,
a smoking cessation program, focused patient education
sessions, pre-operative post anaesthetic unit tours, and
symptom management tip booklets. Our patients are also
expected to complete the Edmonton Symptom Assessment
Scale on each visit to engage them as active participants
in their care. We will also share our successes, challenges
and patients’ evaluations of the various components of the
information pathway.
VIII-02-A 2:00 PM - 2:30 PM
with this new knowledge about best practice and their care.
An increased number of CVADs have been inserted. The
data collected during the development and implementation
phases included the measurement of mid cycle insertion
of CVADs, the number of extravasations and patient
satisfaction around the change in this practice. As Grand
River Hospital is a Best Practice Spotlight Organization this
CVAD assessment tool is an asset to the entire organization
and the patients we serve. An increased number of CVADs
have been inserted in the Oncology program. Grand River
Hospital is preparing to roll out this practice to the entire
organization. We are transforming the practice of safer
delivery of drugs and actively engaging and empowering our
patients in their health care decisions.
VIII-02-B 2:30 PM - 3:00 PM
Chemotherapy Administration on NonOncology Units: Nurses’ Experience,
Improving the Process and Supporting
Clinical Practice Standards
Luisa Luciani Castiglia, N, MScA, CON(C)2, Virginia
Lee, RN, PhD1, Louise Fullerton, N, MScA4, Sonia Castiglione,
Patient Engagement in Transforming the
N, MScA3, Myriam A . Skrutkowski, N, MSc, CON(C)1, Andréane
Practice of Safer Delivery of Drugs
Chevrette, N, BScN, MGP(C), CON(C)5. 1Research Institute,
Anne Schmidt, RN, CON(C)1, Debra Hendel, RN, CON(C)2,
2Cancer Care Mission, McGill University Health Centre,
Donna Van Allen, RN BHScN, CON(C)1. 1Oncology, Grand
Montréal, Québec, Canada, 3Centre for Nursing, Research,
River Hospital, Kitchener, Ontario, Canada, 2Oncology,
Grand River Hospital, Kitchener, Ontario, Canada.
4Surgical Services, McGill University Health Centre, Montréal,
Québec, Canada, 5Quality and Performance Improvement
Ambulatory medical oncology patients are receiving
Office, Cancer Care Mission, McGill University Health Centre,
numerous drugs within complex protocols. A greater number
of venous accesses are required for this patient group which
exposes the patient to an increased risk of extravasation.
A multidisciplinary, interdepartmental task force was struck
to develop program wide guidelines for utilizing central
venous access devices (CVAD) in the oncology population.
This inspired group reviewed research, current literature
and practices. The goal was to create an innovative tool
and process for assessing the need of a CVAD prior to
the initiation of treatment. The tools that were developed
aligned with the RNAO best practice guidelines. This
transformational practice was trialed utilizing small cycles
of change that align with the PDSA cycles in quality
improvement methodology. The tool and decision tree that
were ultimately developed are easy to use, and are critical in
the decision making process. The Vascular Assessment Tool
has provided an opportunity for increased staff and patient
education. Patients are actively engaged in the decision
tree and Best Practice Guidelines. Patients are empowered
110
At our university health centre, although the vast majority
of chemotherapy is administered in oncology settings,
about one third of in-patient chemotherapy is delivered
on non-oncology units. There are inherent challenges
associated with the administration of chemotherapy on
non-oncology units in accordance with the CANO Standards
and Competencies for Chemotherapy Nursing Practice. An
opportunity presented itself to refine oncology expertise on
surgical and medical units. Two main objectives emerged
from stakeholder exploration of existing practices: to
improve the process of interdisciplinary communication/
collaboration and to use a tailored and systematic approach
toward the implementation of practice guidelines. This
presentation will outline how we achieved these objectives:
1) Current practices were described using process mapping
on two surgical units.
This project was defined by collaboration across departments
of the organization and the use of a combined quality
improvement and knowledge translation methodology. A
collaborative interprofessional approach can provide assurance
to patients that they receive safe delivery of chemotherapy
treatment regardless of the setting they find themselves in.
VIII-02-C 3:00 PM - 3:30 PM
From Intravenous to Oral Anticancer Drugs:
Setting Up an Interdisciplinary Project to
Ensure Safe and Efficient Treatments
Audrey Chouinard, Masters1, Joannie Van Houtte
St–Gelais, Bachelor2. 1Oncology, Centre hospitalier de
l’Université de Montréal, Montréal, Québec, Canada,
2Oncology, Centre hospitalier de l’Université de Montréal,
Montréal, Québec, Canada
The use of oral anticancer drugs has exponentially increased
since the early 2000s’. Despite the many advantages of oral
therapies, a systematic approach is needed to ensure a safe
handling and disposal of these hazardous drugs as well
as an adequate management of their adverse events and
monitoring of compliance to treatment. To ensure a safe
and efficient treatment in ambulatory and home settings,
the collaboration between oncologists, pharmacists and
nurses is needed. This presentation will explain how a pilot
project planning to standardize nursing follow-up of patients
undergoing oral anticancer therapy is slowly changing into an
interdisciplinary project. Pharmacists, oncologists and nurses
are now joining forces to create and provide a structured
follow-up of these patients according to the latest standards
and recommendations. The actual context in which the
project took place, the planning, the timetable as well as the
different tools that were developed will be presented.
VIII-03-A 2:00 PM - 2:30 PM
How to Operationalize the Resource
Intensity Weightings in an Ambulatory
Chemotherapy Suite
Donna Van Allen, RN, BHScN, CON(C)1, Anne Schmidt,
RN, CON(C)1, Junghee Ahn, RN, CON(C)1, Tracy Solonika,
RN, BSN, MN Oncology, CON(C)2, Michelle Wald, RN, BSN,
CON(C)2. 1Oncology, Grand River Hospital, Kitchener,
Ontario, Canada, 2Oncology, Lakeridge Health, Oshawa,
Ontario, Canada.
The care of the oncology patient receiving chemotherapy
is increasingly complex. Resources are strained and
planning safe, high quality nursing care is an ongoing
challenge. Although the resource intensity weights (RIWs)
in ambulatory chemotherapy suites relating to nursing
workload were established several years ago by Cancer
Care Ontario, however using them effectively to measure
workload was not well understood. A provincial group
of managers and chemotherapy nurses came together to
identify strategies to effectively operationalize RIWs in each
center, recognizing the differences that existed from center
to center. Several members of the group had experimented
with ways to use the RIWs to quantify workload per nurse
and were unanimous on three fronts: 1) the RIWs worked
well to quantify workload from nurse to nurse. Each
nurse was satisfied workload was balanced, 2) more work
was required to identify the daily operational variables
that impacted nursing workload -an therefore the % of
worked hours the nurse could be scheduled- and, 3) that
to effectively use RIW metrics to quantify workload it was
imperative each site found a way to electronically build
them into scheduling. This presentation will show how the
sites identified the variables that dictated how much of the
day the nurse could be scheduled as well as the process of
utilizing the RIWs to balance workload
VIII-03-B 2:30 PM - 3:00 PM
Transforming Ambulatory Oncology
Care: Optimizing the Oncology Patient
Experience
Allyson Nowell, BSc, MSc, Terri Stuart–McEwan , BScN,
MHS, Kathy Davison , RN, BAS, MHS. Princess Margaret
111
An ideal process was developed and piloted, using a
checklist to evaluate feasibility and team meetings to seek
feedback. 2) A mixed method design was used to explore the
unique experience of nurses on non-oncology units who
administer chemotherapy to patients diagnosed with cancer.
Their perceptions and concerns were explored through the
use of a questionnaire and focus groups. We will describe
our final process for safe chemotherapy administration on
non-oncology units, as well as the strategies that nurses
identified would support them to deliver chemotherapy.
Princess Margaret Cancer Centre (PM) is a large research
and teaching oncology hospital located in Toronto, Canada.
It is part of the University Health Network and is Canada’s
leading cancer treatment and research facility. PM has 450
half-day Ambulatory clinics, with over 5,000 patient visits
per week. In 2012, there were 10,710 new cancer patients.
As patient acuity and ambulatory volumes increase (5% per
year), processes and roles need to be regularly evaluated
and improved upon. In 2013, the Ambulatory Care Strategic
Plan was launched and from this plan the Ambulatory
Patient Care Optimization Project was developed. The
aim of the project is to look at the challenges related to
increasing volumes, and implement innovative ways of
caring for this complex population to enable an exemplary
patient experience. The Ambulatory Optimization project
will ensure patients access the right clinician in a timely
manner; healthcare resources are aligned to ensure optimal
delivery of excellent patient care; and standard process are
established to ensure consistent, quality and seamless care.
This includes developing new models of care to maximize
the Oncology nurses role, developing innovative nurse led
and health professions led clinics and enhancing patient
navigation. This presentation will describe the Ambulatory
Patient Care Optimization Team’s project plan, including
work to date, anticipated outcomes, models of care, potential
risks and lessons learned along the way.
VIII-03-C 3:00 PM - 3:30 PM
Transforming Nursing Practice:
Implementing Bedside Shift Report to
Enhance Patient Experience, Promote
Safety and Nurse Accountability in
Oncology – Palliative Unit
Jennifer Eccles, MSN, Maria Cherry Sunga, Diploma,
Shehnaz Bandali, Diploma. Cancer Care, North York General
Hospital, Toronto, Ontario, Canada.
Background: The heart of our hospital is the patient and
family we cared for everyday. To ensure we are putting patient
first, North York General Hospital makes it a priority to grow
a culture of Patient and Family Centered Care. To in line with
this initiative, the Oncology –Palliative Unit was the first to
implement bedside shift report to enhance patient experience,
promote patient safety and nurse accountability.
Purpose: The goal of bedside shift report is to
engage patient and family and take part in this process.
Communication being an integral part in healthcare is the
key to a safe patient experience. The transfer of information
112
along with responsibility for care of patient from one nurse
to another happening at the bedside provides an opportunity
for the patient, family and their friends to ask questions,
clarify and confirm. It gives them an opportunity to hear
what has transpired during the shift and what will be the
next step for their care. Furthermore, the bedside shift report
prevents potential errors, breakdown in communication, and
promotes patient safety.
Method: The In-patient unit identified champions and
worked with hospital leaders, unit manager, clinical educator
along with patient and family advisors. The team attended
workshop, series of meetings, lectures and videos to develop
a strategy that is adaptable to the unit’s unique environment
and culture. A standardized hand-off tool was used to guide
the nurses of what information to include in the shift report.
Feedback helped refine the process. Information Brochure was
developed to inform patients and families.
Conclusion: This presentation will discuss the
transformation of patient care hand-off at the bedside by
focusing on Patient and Family Centered Care, its impact
on the patient’s journey. It will also highlight the challenges
barriers and strategies implemented to overcome these barriers.
VIII-04-A 2:00 PM - 2:30 PM
Increasing Health Literacy by Engaging
Patients and Families in the Development of
Educational Resources
Shawne P. Gray, BScN, CON(C), Sonali Kirschenbaum,
BScN, Har vey H. Wong, MD, FRCP(C), Rose Rivera , BScN,
MN, Larissa Day, BScN, MSc, CON(C).Sunnybrook Odette
Abstract: Recurrent malignant pleural effusion (MPE)
is a common complication of advanced malignancy
and can significantly impair respiratory function and
worsen quality of life. An innovative Effusion Procedure
Intervention Clinic (EPIC) was established to provide
symptom relief for outpatients where thoracenteses are
performed and tunneled catheters are inserted. Originally
we had outdated educational resources that contained a
high level of technical jargon which sometimes provoked
anxiety and fear in patients rather than engaging and
informing them.
VIII-04-B 2:30 PM - 3:00 PM
Understanding the Perspectives of Older
Adults about Cancer Information
Margaret I. Fitch, RN PhD2, Tamara Harth, BA(HON),
MLIS1. 1Program Manager, Cancer Patient Education Program,
Toronto, Ontario, Canada, 2Head, Oncology Nursing; Director,
Introduction: Cancer patients report that information
plays a significant role in their ability to cope with cancer
and manage the side effects of treatment. However, for
effective learning, it is important to tailor the provision of
information to the specific audience. There is a growing
number of older adults (65 years plus) who will be diagnosed
with cancer. They may experience unique barriers to
learning (poor eyesight, reduced hearing, etc).
Purpose: This work was undertaken to identify the
importance older adults assign to types of cancer-related
information, their satisfaction with the cancer-related
information they receive, and the barriers to effective
information provision in this age group.
Methods: Surveys (n=684) and in-depth interviews (n=39)
were used to gather perspectives from convenience samples
of older adults attending a comprehensive cancer centre.
Data were analyzed for 65-79 year and 80+ year groups.
Results: Information about the medical condition,
treatment options, and side effects were rated by patients
as the most important topics. Women assigned higher
importance ratings to information overall (t= 4.8, P< 0.01).
Although participants were generally satisfied with the
information they received, many reported they experienced
challenges communicating with health care professionals
because of the use of medical language and the fast pace
of speaking. Many expressed the desirability of speaking
directly with health care professionals, but also of the value
of having written documents to take home with them.
VIII-04-C 3:00 PM - 3:30 PM
Is What I Need to Know, What My Patients
Actually Want to Know? An Analysis of
Oncology Nurses’ Resource Needs Compared
to Oncology Patients Priority Concerns and
Support Needs at End of Treatment
Lisa Lun, RN, BScN, MA(Ed), CHPCN(C)1, Soma
Persaud , RN, BScN, MN(Ed), CON(C)3, Jana
Ailenberg, RN, BScN, CON(C)2, Jill Whit taker, R N, BScN,
CON(C)4, Pauline Brillinger, RN, BScN5. 1Integrated Cancer
Care, Humber River Hospital , Toronto, Ontario, Canada ,
2Chemotherapy Clinic, North York General Hospital , Toronto,
Ontario, Canada , 3Medicine Program , Mackenzie Health ,
Toronto, Ontario, Canada ,4Chemotherapy, Stronach Cancer
Center, Newmarket , Ontario, Canada , 5Oncology, Markham
Stouffville Hospital , Markham , Ontario, Canada .
The Central Local Health Integration Network (LHIN)
Regional Systemic Therapy (RSTP) Nursing committee
participated in a Patient Education (PE) project with the aim
to standardize and optimize the provision of information and
education resources for oncology patients. The findings from
the PE project identified a need to address how patients are
supported as they transition from systemic treatment to end
of treatment. There is much evidence in the literature that
exists to address informational needs of oncology patients,
including their informational priorities and acquistion, and
their learning styles and preferences. As a follow up to the
findings from the PE project, the RSTP Nursing committee
developed a nursing questionnaire asking oncology nurses
working in chemotherapy clinics and in the community setting
in the Central LHIN about what resources they actually use
and how they use them to provide support to their oncology
113
A priority of Sunnybrook’s Odette Cancer Centre is
improving the information and education provided to
patients and their families as a way of empowering them to
be more engaged in their care. According to the literature, it
is essential we consider the importance of health literacy in
developing patient education resources in order to maximize
health outcomes and improve patient safety. New resources
were developed by a collaborative interprofessional team
using Sunnybrook’s evidence based Patient Education
Toolkit and incorporating health literacy principles such as
plain language and clear design. Patient engagement was
enhanced by seeking feedback from patients and families
through surveys over the course of a month (n=20). Baseline
survey results guided the development of our initial tools
which were piloted in the clinic. A post survey was also
undertaken to ensure the new resources were clear, well
designed and informative. Revisions were made based on
these survey results to ensure patient needs were being
met. This presentation will share our results of using health
literacy principles and an evidenced based patient education
toolkit to create optimal patient education materials. We will
also highlight the benefits of engaging patients and families
throughout the process in order to ensure supportive and
usable resources are created.
patients who are completing their treatments. The nurses were
also asked about their learning priorities related to what they
perceived as priority needs/concerns of their patients as they
transition to end of treatment. A patient questionnaire was
also developed with similar question items as those of the
nurses. The questionnaire was distributed to oncology patients
in the hospital clinics and community. Based on the results
from both oncology nursing and patient questionnaires, an
analysis was completed to compare nursing perceptions and
educational needs/priorities with oncology patients’ priority
needs/concerns and expectations. This presentation will
outline the findings of the analysis and review common priority
areas for both oncology nurses and patients in the Central
LHIN. An outcome of this quality improvement initiative is
the development of the Central LHIN’s first Oncology Nursing
Clinical Day which will highlight those priority areas expressed
by nurses and patients at end of treatment.
VIII-05-B 2:30 PM - 3:00 PM
Improving Documentation of Oral Chemotherapy at a Community Teaching Hospital
Meghan MacMillan, RN, MScN, Maritza Carvalho, RN,
BN, Simerjit K. Gollee, RN, BScN, Katherine Enright, MD,
Bernadette Almeida, RPh, BScPhm, ACPR, Laurie Van Dorn,
RN, Carole Goulet, RN, Lorminia Realeza, RN, Linda G. Nixon,
RN, Catherine Sodoski, Bachelor’s of Nursing. Oncology,
Trillium Health Partners, Mississauga, Ontario, Canada.
As medication development for Oncology patients
continues to evolve, we are seeing increasing numbers
of oral chemotherapy agents. As institutional practices
have not changed as quickly at our organization, we
undertook a project to identify the issues associated with
oral chemotherapy practices at Trillium Health Partners
(THP) and to partake in a series of quality improvement
VIII-05-A 2:00 PM - 2:30 PM
initiatives to improve communication and decrease risk
to patients. In October 2013 audits were completed on 46
Implementation of an Electronic
patient charts. It was observed that only 62% of the ASCOONS oral chemotherapy documentation requirements were
Documentation System in Radiation
completed. A process map was created to identify problem
Oncology: A Nursing Perspective
areas and the main issues were labelled: Inconsistent
Angela Whynot, RN, BScN, CON(C), Capital Health ,
processes, time constraints, prescribing and inconsistent
Halifax, Nova Scot ia , Canada .
education, all leading to incomplete documentation of an
oral chemotherapy plan. The most consistently missed
The Department of Radiation Oncology in Nova Scotia
areas of documentation included education around
recently embarked on an initiative to move towards a
missed doses, food and drug interactions, safe-handling,
paperless workflow environment and implement an electronic
and that a chemotherapy care plan was provided to the
medical record. This presentation will describe the journey
patient. A working group was formed that included
from a nursing perspective as we transitioned to an electronic
stakeholders from the physician group, pharmacy, nursing,
documentation and communication system in radiation
drug reimbursement, clinical informatics and patient
oncology. The challenges faced, opportunities identified,
representatives to address some of the process issues around
and the resources developed to support the nursing staff will
oral chemotherapy. Solutions included implementing an
be highlighted. The collaboration and key contribution of
oral chemotherapy appointment type, creating a flowall team members will be highlighted. The implementation
sheet for oral chemotherapy documentation, creating a safe
of an electronic communication and documentation system
handling pamphlet, drug specific care plans and schedules,
required the team to re-evaluate and change processes. For
and working with the physician group to increase use of
oncology nursing this was an opportunity to highlight the
Computerized Physician Order Entry (CPOE) during oral
optimal role of the oncology nurse in the radiation oncology
chemotherapy ordering. Preliminary results are currently
review clinic. During the presentation we will share our
being analyzed. This presentation will include results from
experience as we worked to customize the tools available in
this quality improvement study including current status of the
the ARIA Patient Management system to meet the unique
project, obstacles encountered and successes.
needs of oncology patients receiving treatments to various
sites as well as to reflect best practices. As a nursing group
we strived to develop tools to facilitate nursing care planning
in a way that can be easily shared across the care team. The
site-specific nursing documentation tools will be shared.
The benefits, challenges, and lessons learned in the process
of transitioning to a paperless workflow and documentation
system will be highlighted.
114
Improving Interprofessional
Communication and Patient Experience:
Our Experience of the Evolution of
Electronic Documentation in Ambulatory
Chemotherapy
Judy Chung, RN, BScN, Marci Sweeney, RN, CON(C).
Chemotherapy Nursing, Odette Cancer Centre, Sunnybrook
Health Sciences Centre, Toronto, Ontario, Canada.
Electronic systems that support care have been integrated
to various degrees in healthcare facilities. Within our
ambulatory cancer centre, our chemotherapy unit employs
multiple systems to look up information, book patients
and communicate amongst and between professions. Our
ambulatory clinic areas implemented interprofessional
electronic clinical documentation though the use of
Mosaiq. Within the clinic setting, it became our official
electronic documentation record for clinic visits, screening,
telephone interventions and various patient assessments.
This has lead to improved communication between and
among professionals throughout the clinic. In 2014, the
Chemotherapy Unit implemented Mosaiq as one of the first
steps of moving towards full electronic documentation.
Mosaiq, separate from our chemo order entry and
medication administration system, is now the vehicle for
recording various assessments and interventions provided
by the nurses in Chemotherapy. The nurses have embraced
the system, seeing its value as clinical information is
readily accessible across treatment modalities, sites and
professions. We are now able to electronically record vein
assessments, pre-chemo assessments and chemotherapy
administration in a clear and concise format easily available
to the interprofessional team. For example, trends used in
treatment, such as weight, can be documented and seen
by clinic professionals, chemotherapy staff and pharmacy.
This presentation will provide an overview of our process of
integrating a system previously used only in radiation within
our centre, into our Chemotherapy Unit daily practice. We
will share the processes involved in the development and
its impact on development in other areas. We will discuss
how the current electronic systems used in our day to day
chemotherapy practice fit together and we will demonstrate
how this can enhance patient care and optimize our nursing
practice engagement across the continuum.
VIII-06-A 2:00 PM - 2:30 PM
La contribution des infirmières en
oncologie pour relever les défis reliés à la
chimiothérapie par voie orale : le cas de
la clinique de neuro–oncologie du CHU
de Québec
Maria Gabriela Ruiz, M.Sc. Inf., CSN, Vicky Gélinas,
Pharmacienne, Johane Pellet ier, B.Sc. inf, Nicole Plante, B.Sc.
inf. CHU de Québec, Québec, Québec, Canada .
La chimiothérapie par voie orale représente, en neurooncologie, le principal moyen d’administration de
traitement anticancéreux. Ce traitement comporte
plusieurs avantages pour le patient (sentiment de
contrôle, autonomie, qualité de vie). Par contre, il est
important de ne pas négliger les défis associés à la
chimiothérapie par voie orale. L’adhérence au traitement,
l’administration appropriée, le suivi des effets secondaires
et la manipulation sécuritaire du médicament sont des
enjeux préoccupants qu’il faut absolument considérer
avec patients et familles. Dans un souci d’offrir toujours
les meilleurs soins aux patients et famille, de valoriser
l’autonomie de ces derniers et de resserrer les liens
avec les soins de première ligne, la clinique de neurooncologie du CHU de Québec a mis en place des
mécanismes assurant la sécurité autour de l’utilisation
de la chimiothérapie par voie orale. En collaboration
étroite avec l’équipe de pharmacie, l’équipe médicale et
les patients, l’équipe d’infirmière a guidé ces démarches.
Les besoins et la réalité des patients neuro-oncologiques
ont orienté chacun des mécanismes qui ont découlé de ce
partenariat. Cet exposé vous présentera les divers outils
qui ont été mis en place ainsi que l’impact de ces derniers
sur la pratique infirmière et sur l’expérience patient.
115
VIII-05-C 3:00 PM - 3:30 PM
liste
ABRÉGÉS
desDES
abrégés
PRÉSENTATIONS
pour presentation
ORALES / ORAL
orale
ABSTRACT
/ abstract
PRESENTATIONS
listing
VIII-06-B 2:30 PM - 3:00 PM
VIII-06-C 3:00 PM - 3:30 PM
De la recherche à la pratique : harmonisation Un cadre de référence pour soutenir la
du développement professionnel des
fonction évaluation de l’infirmière pivot en
infirmières pivot en oncologie
oncologie (IPO) au Québec
Irène Leboeuf, M.Sc.inf., CSIO(C), Catherine Genest,
M.Sc.inf., CSIO(C), Catherine Der val , M.Sc.inf., Louise
Handfield , M.Sc., Dominique Lachapelle, M.Sc., Joannie
Van Houtte, B.Sc., DESS (ét udiante), Marielle Roy,
M.Sc., Audrey Chouinard , M.Sc., CSIO(C). DSI, CHUM,
Montréal, Québec, Canada .
Depuis l’introduction du rôle des infirmières pivot en
oncologie (IPO) en 2005, le Centre hospitalier de l’Université
de Montréal (CHUM) a développé des programmes
d’intégration spécifique selon les sites tumoraux. À ce jour,
cette approche a favorisé une disparité des programmes
d’orientation, d’accompagnement et d’évaluation des
compétences. De plus, une recherche menée par Leboeuf et
al. (2013) a mis en lumière certaines insatisfactions des IPO
(N=10) face à leur développement professionnel. En effet,
ces dernières ont manifesté le besoin d’avoir davantage
accès à des formations et d’être mieux soutenues dans
leurs apprentissages et dans l’appropriation de leur rôle
face aux autres professionnels. Ces constats ont amené les
membres du comité de la pratique en oncologie, composé
des conseillères en soins spécialisés et de la directrice
adjointe des soins infirmiers, à réfléchir sur l’encadrement
jusqu’alors offert par la Direction des soins infirmiers. Afin
d’assurer une qualité de soins optimale dans un contexte de
soins ultraspécialisés, une offre de service standardisée pour
le développement professionnel des IPO a été conçue et
proposée aux gestionnaires en oncologie. L’offre de service
élaborée fonde ses recommandations sur le programme
de formation de la Direction québécoise de cancérologie
(2007, 2013) et sur le profil des compétences de l’Association
canadienne des infirmières en oncologie [ACIO; 2006).
Cette démarche d’amélioration continue vise une meilleure
intégration des compétences des IPO ainsi qu’une
augmentation de leur assurance dans l’appropriation de leur
rôle. Cette communication présentera les différentes étapes
de la démarche, les recommandations émises, les impacts
envisagés ainsi que l’opérationnalisation du plan d’action.
116
Brigitte Fournier, MSc2, Sébastien Simard , PhD2, Lise
Fillion , PhD1. 1CRCEO, Québec, Québec, Canada , 2IUCPQ,
Introduction : Au Québec, l’infirmière pivot en
oncologie (IPO) joue un rôle central dans l’évaluation des
besoins des personnes atteintes de cancer. Disposant d’un
outil d’évaluation initial, elle doit maintenant intégrer un
outil de dépistage de la détresse.
Objectifs : Afin d’intégrer ces différents outils et d’améliorer
la démarche d’évaluation globale centrée sur la personne, un
cadre de référence favorisant l’établissement d’un partenariat
entre l’IPO et la clientèle oncologique a été élaboré pour clarifier
et guider la pratique évaluative de l’IPO.
Méthode : Le cadre a été élaboré à la suite d’une revue
systématique de recommandations issues d’organisations de
santé et de communautés scientifiques, de modèles théoriques
en soins infirmiers et de la pratique infirmière en oncologie.
Résultat : Le cadre propose une approche évaluative
centrée sur la personne et guide l’évaluation selon six
dimensions : les buts de l’évaluation, les personnes évaluées,
les moments d’évaluation, le contenu de l’évaluation, le
processus d’évaluation et l’utilisation des résultats de
l’évaluation. Ces dimensions sont précisées et l’emphase est
mise sur le processus d’évaluation.
Discussion : Pour mener à un partenariat réussi, le
processus d’évaluation doit être présent à tous les épisodes
de la maladie. Lors de ce processus, la personne évaluée est
invitée non seulement à exprimer les symptômes associés à
la maladie mais aussi à partager avec les professionnels de la
santé son expérience de vie et sa perception de la maladie,
à constater les ressources dont elle dispose et à découvrir
les ressources dont elle pourrait bénéficier pour faire face à
la maladie. Cette approche favorise une vision commune
des buts à poursuivre et l’élaboration partagée d’un plan
d’intervention par l’IPO, les autres professionnels faisant
partie de l’équipe interdisciplinaire en oncologie, la personne
atteinte et ses proches.
séance
d’affichage/
poster
presentations
P-11 | McLennan, Cynthia, RN, BScN, MBA , CON(C)
Groupe 1 / Group 1
Nursing Focused Assessment of New Patients in Ambulatory
Oncology Clinics
P-01 | Hyman, Jodi, RN, BScN, CON(C)
Patient Disconnection of Elastomeric Fluorouracil Pumps from
a Central Venous Access Device (CVAD): A Pilot Study
P-02 | Heyes, Susan, RN, BNg, (Hons), PhD (Cand)
How does Bladder Cancer Affect Couples and Families?
P-03 | Cass, Valerie, MBA
Patient and Family Experience with the Mayo Protocol
- Successful Navigation of a Novel Treatment for
Cholangiocarcinoma
P-04 | Thomas, Siby Elizabeth, RN, MSN
Wound Dressings during Cancer Radiotherapy: A Survey of
Canadian Practice
P-05 | Thompson, Corinne, RTT
Feasibility of Population Based Collection of Patient Reported
Outcome Measures in a Provincial Radiotherapy Program
P-06 | Carvalho, Maritza, RN, BN
Enhancing Patient Safety: Development of Home
Chemotherapy Spill Kits
P-07 | Waldie , Marian, RN, CON(C), BScN
Prostate Cancer and Informed Shared Decision-Making:
Implementation of a Patient Decision Aid for Men with
Localized Prostate Cancer
P-08 | Colquhoun, Freda, RN, BA, CON(C)
Implementation of Routine Symptom Screening with the
Edmonton Symptom Assessment System for Patients with
Head and Neck Cancer Undergoing Radiotherapy: A Quality
Improvement Project
P-09 | Compagna, Louise, Baccalauréat
Quand Le Patient-Partenaire Devient Expert!
Groupe 2 / Group 2
Lundi / Monday 3:15 PM - 3:45 PM
P-10 | Savage, Pam, RN, MAEd, CON(C) Patient Engagement in the Success of a Shared Care Model
P-12 | Grondin, Francine, Baccalauréat en sciences
Patients experts, professionnels apprenants, un partenariat
gagnant
P-13 | Abdelmalek, Fatima, RN, MN
P-14 | Stacey, Dawn, RN, PhD, CON(C)
Training for Nurses to Use Protocols when Providing Remote
Symptom Support to Oncology Patients: A Retrospective
Pre-/Post-Study
P-15 | Levina, Olga, BScN
Incidence and Management of Cardiac and/or Pulmonary
Adverse Events Following Single-Agent Carfilzomib
Treatment in Patients with Relapsed and/or Refractory
Multiple Myeloma
P-16 | Barton, Gwen, BScN, MHA
Improving the Patient Experience by Teaming Up with Cancer
Patients and Family Members
P-17 | MacDonald, Donalda, RN, CON(C)
What’s in a Blog? Sharing Oncology Nursing Excellence via
Social Media
P-18 | Taylor, Cathy, RN, CHPCN(C)
Patient Satisfaction Surveys Informing Change in Patient
Education and Expanding Patient Engagement
Groupe 3 / Group 3
Mardi / Tuesday 10:00 AM - 10:30 AM
P-19 | Burlein-Hall, Stephanie, RN, BScN, MEd,
CON(C)
End of Life Care and a Shared Vision of Nursing: Experiences
from an Education Workshop in Thailand
P-20 | Bélanger, Marie-Eve, B.Sc., CSIO(C)
Mobilisation de l’espoir chez la personne atteinte d’un
cancer du poumon de stade avancé : réflexion autour des
interventions infirmières recensées dans les écrits
P-21 | Williams-Brennan, Leslie, BSc, BScN, RN,
MN(student)
Social Determinants of Health Associated With Cervical Cancer
Screening Among Women Living in Developing Countries
P-22 | Gimmig, Karine, Baccalauréat
A Patient Centered Care Approach Through the
Implementation of a Comprehensive Distress Screening
Process of the Ambulatory and Hospitalized Patients;
Concrete Outcomes and Reflexions.
117
séance d’AFFICHAGE / poster presentations
Lundi / Monday 10:00 AM - 10:30 AM
The Hidden Impact of Healthcare Decision-Making on
Patient Engagement
P-23 | Tinker, Lisa, BScN, MHM
Working Together to Improve Outcomes: Strategies to
Improve Appointment Compliance with Colposcopy
P-24 | Bruyere, Sylvie, BScN, CON(C), CHPCN(C) 10:00 AM – 10:30 AM
The Long Road Home Engaging Patients in End of Life Care
Decisions: A Key Role for Oncology / Palliative Care Nurses
Facilitating Appropriate Place of Care
| Portneuf / Sainte Foy / Orleans
P-25 | McGuigan, Kelly, RN, BScN, MN, CON(C),
CHPCN(C)
P-01
The CALM Journey: Advanced Practice Nurses Engage in
Psychotherapy Training for Patients Living with Advanced
Cancer
P-26 | Diana, Ermel, RN, BScN, MV/TEd
Addressing the Needs of Canadians Living with Metastatic
Breast Cancer
Groupe 1 / Group 1
Patient Disconnection of Elastomeric
Fluorouracil Pumps from a Central Venous
Access Device (CVAD): A Pilot Study
Jodi Hyman, RN, BScN, CON(C), Theresa Whiteside, RN, BN,
CON(C). Cancer Care Manitoba, Winnipeg, Manitoba, Canada.
P-27 | Ramjohn, Linda, BScN, MSN, CON(C)
In 2012 Cancer Care Manitoba (CCMB) switched from battery
Improving Nursing Compliance with Documentation of Venous operated to elastomeric infusion pumps. This pump is proven
to be safer for patients. The elastomeric pumps are now used
Thromboembolism Education for Patients and Families
in all cancer centers throughout Manitoba. Currently patients
must attend a cancer program treatment room for connection
and disconnection of the fluorouracil (5FU) filled infusor pump.
Groupe 4 / Group 4
Mardi / Tuesday 2:45 PM - 3:30 PM
The current practice for disconnection may not be in the
patient’s best interest. Travel to a cancer center, additional
time away from work, parking and waiting can be costly.
P-28 | Wilson, Julie, RN, BScN, CON(C)
Applying Successful Innovative Strategies to Deal with Severe Many patients need to travel long distances for a 5 minute
disconection appointment.
Skin Reactions from Chlorhexadine/Alcohol Solutions
P-29 | Glavassevich, Mary, BA, MN
Utilizing Workload Measurement Data to Support Nursing
Time for Patient Teaching and Emotional Support
P-30 | Zimny, Nancy, BSN
A Standardized Approach to Ensuring Safety and Improving
Patient Experience in the Systemic Suite
P-31 | Holmes, Laurie Ann, RN, BScN, CON(C),
CHPCN(C)
Through Patient Engagement: Practice Changes are Made to
the Sarcoma Treatment Plan
P-32 | Richard, Rayelle, BScN
An Engaging Journey
P-33 | Lagace, Brenda, BN
Cervical Cancer and Canadian Aboriginal Women/Cancer
Cervical et les Femmes Canadiennes Autochtones
A literature search was undertaken and it is evident that
patients or caregivers could safely disconnect completed 5FU
elastomeric pumps and flush their CVAD’s. It was also clear
that this change in practice could have many benefits such as;
increased patient independence, and save nursing and chair
time in the busy treatment rooms.
It was agreed upon by the key stake holders that Infusional
chemotherapy treatments can be safely discontinued at
home by the patient or a caregiver provided the following key
elements are in place:
1. Thorough assessment to determine if patient/caregiver
met the inclusion criteria and is able to perform the
procedure at home.
2. Protocol to provide necessary supplies for the procedure.
P-34 | Holmes, Laurie Ann, RN, BscN, CON(C)
3. Scheduled sessions to teach patient / caregiver to
perform procedure.
P-35 | Long, Anita, BScN, MSN/ED, CON(C)
4. Backup system to support patient / caregiver experiencing
difficulties with the procedure or device at home.
A Patient’s Journey with Radiation Induced Brain Necrosis Taking a Lead in Oncology Nursing: The Elimination of NonNursing Duties to Facilitate Patient Teaching and Discharge
Planning
118
It was agreed that the home disconnection program would
be initially offered to patients that are receiving a 46 hour
continuous 5FU infusion.
P-02
How Does Bladder Cancer Affect Couples
and Families?
Susan M. Heyes, RN, BNg, (Hons), PhD (Cand)1, Ann
Harrington, RN, DNE , B.Ed , M.Ng, PhD, FACN MPCNA1,
Malcolm J. Bond , PhD2, Ingrid Belan , BSc, Grad Dip (AppSci),
PhD1. 1School of Nursing and Midwifery, Flinders University,
Bedford Park, South Australia , Australia, 2School of Medicine,
Flinders Universit y, Bedford Park , South Australia, Australia .
The aim of this study was to explore the topic of Bladder
cancer (BlCa) and to uncover what effects it has on couples
and families. More specifically, to understand the health care
needs of couples and families along the BlCa trajectory.
BlCa generally affects older people, has high recurrence rates,
with progression to muscle-invasive BlCa possible. Treatments
include cystoscopy, trans-urethral resection of bladder tumour
(TURBT), intravesical chemotherapy or Bacillus Calmette
Guerin (BCG), radiation therapy, and cystectomy.
P-03
Patient and Family Experience with
the Mayo Protocol – Successful
Navigation of a Novel Treatment for
Cholangiocarcinoma
Valerie Cass, MBA1, Aspen Gagne, BScN1, Norine
Heywood, MScN1, Nadia Zouari , BNI1,2, 1Transplantat ion
& Hepatobiliary Surgery, McGill University Health Center,
Montreal , Québec, Canada , 2Ingram School of Nursing,
McGill Universit y, Montreal , Québec, Canada .
In 2008 the Mayo Clinic developed a novel treatment
protocol for cholangiocarcinoma. The protocol
includes neoadjuvant chemoradiation followed by liver
transplantation. The McGill University Health Center
recently adopted this treatment protocol. The presentation
will explore the patient / family and team experience of
the trajectory through diagnosis to treatment with a novel
and aggressive protocol. Themes discussed will include
symptom management, uncertainty, resiliance, hope and
involvement of the patient and family as a partner in care.
P-04
Recruitment of BlCa participants and partners/family
(N=20) to the study was via a public hospital database. An
in-depth semi-structured interview was conducted with BlCa
participants and partners/family separately.
Wound Dressings During Cancer
Radiotherapy: A Survey of Canadian
Practice
Findings revealed that depending on the treatment
received BlCa participant’s lives were dominated by their
cancer, its treatment protocols, and constant surveillance.
BlCa participants suffered embarrassement, psychosocial
difficulties and urinary and sexual dysfunction. Partners/
family revealed a need for inclusion, information, and support
from health professionals and cancer-specific self-help
groups. They also indicated a need for open communication
with each other, particularly on sexual issues.
Siby Elizabeth Thomas, RN, MSN1, Sheryl ReimerKirkham, PhD, RN2, Rosemary Kohr, PhD, RN3. 1BC
CancerAgency, Fraser Valley, British Columbia, Canada,,
2Trinity Western University, Langley, British Columbia,
Canada, 3Kohr consulting, London, Ontario, Canada.
It is recommended that the observations reported from this
study be tested using a questionnaire specifically formulated
to test the salience of these findings with a greater number
of participants.
The implications of BlCa on the quality of life of couples
and families will then be able to be translated into nursing
care practices to support patients and their partners/
family/caregivers.
Patients undergoing radiotherapy typically experience
changes to the skin requiring dressings. Management
regarding radiating through wound dressings has been
variable and relates to the concern regarding surface dose
increase or bolus effect. The purpose of the paper is to identify
current evidence and practice through literature review and
a national environmental scan. Nurses from 34 Radiation
Oncology Centres in Canada were surveyed and current
practice survey data were collected from 18 centres.
In- depth telephone interviews were conducted with four
nurse participants to further understand the context of
this issue within the nursing practice environment. The
integrative results of the study were reviewed with five
clinical experts; recommendations for research, practice,
leadership and policy were made. Implications for clinical
119
This presentation will describe the key elements that are
required to set up this pilot project as well as implementation,
evaluation, lessons learned and future considerations.
practice include the involvement of Radiation Oncology
Nurses (RONs) in the treatment planning team, development
of clinical practice tools and the relevance of the Personcentred Nursing Framework for wound management during
radiotherapy. Keywords: Wound management, radiotherapy,
clinical decision-making, inter-professional practice, personcentred nursing.
P-05
Feasibility of Population Based
Collection of Patient Reported Outcome
Measures in a Provincial Radiotherapy
Program
Corinne Thompson, RTT1, Jackie Bergin, LPN, Julia
Suraci, RN1, Robert Olson , MD2. 1Radiation Therapy, British
Columbia Cancer Agency–Sindi Ahluwalia Hawkins Centre
for the Southern Interior, Kelowna , British Columbia,Canada,
2Radiat ion, Therapy, Brit ish Columbia Cancer Agency– Centre
for the North , Prince George, British Columbia , Canada.
significantly by treatment site (p = 0.50). Of those with a
concern, 88% reported at least a 1-point improvement in one
domain, while 55% reported improvement in all 3 domains.
Conclusions: Population-based collection of PROMs
was feasible during routine clinical care without incremental
staff resources. The burden on RTs & RNs to collect
information and offer support was low. The beneficial effects
of palliative RT for bone mets to improved pain, function,
and quality of life were confirmed in a real world population.
P-06
Enhancing Patient Safety: Development
of Home Chemotherapy Spill Kits
Meghan MacMillan, RN, MScN, Maritza Carvalho, RN, BN,
Catherine Sodoski , RN, BN, Bernadet te Almeida , RPh,
BScPhm , ACPR , Pat ricia Lymburner, MSW. Oncology,
Trillium Health Partners, Mississauga , Ontario, Canada .
Cancer care involves inherent risks to the patient, family
and treating staff members due to the toxicity of the
Background: Systematic collection of patient reported treatments. For patients on infusional 5-fluorouracil
outcome measures (PROMs) during clinical care and a
(5FU) who go home with an elastomeric bottle, they are
process to improve patient support following radiation
responsible for maintaining the integrity of the bottle.
therapy (RT) were identified as goals of the BC Cancer
Although the bottles are sturdy, occasionally an accident
Agency’s RT program.
will occur whereby the tubing is cut or the integrity of the
bottle is comprimised, leading to a chemotherapy spill in
Methods: Patients receiving RT for bone metastases
the home environment. Pets, children and other family
were chosen to pilot the process. Process design
members are at risk for exposure in such occurrences.
emphasized feasibility and practical use during clinical
care. Through a modified Delphi approach, 3 questions
In response to a spill in 2012 which resulted in the
from a validated questionnaire were selected to capture
involvement of a hazardous materials team at the patient’s
patient-reported health status, function, and quality
house, our regional cancer program began a project to
of life using a 5-point scale. Data was captured within
develop home chemotherapy spill kits. The contents of
the oncology information system. Patients were asked
the kit are quite simple, including a mask, absorbent pad,
the questions by a radiation therapist at CT simulation,
absorbent wipes, 2 pairs of gloves, a sealable plastic bag
& 3 weeks after RT by RN phone call. RNs also offered
and instructions.
support during the follow-up phone call.
Patients receive detailed teaching regarding how to
Results: All 6 cancer centres in BC participated. From
manage a home chemotherapy spill and a contact number
May to Dec 2013, 563 patients were approached at CT-sim that they can call day, night and weekends. In order to
and 408 were called by the RN 3 weeks after RT, with
service our linguistically diverse region, the instructions
response rates of 92% and 76%, respectively. 63% of the
evolved from mostly written instructions, to an image
RN calls took < 5 minutes. RN assistance to organize
based pamphlet to assist those who have difficulty
radiation oncologist or GP symptom-management
understanding written English.
appointments were required for 3% and 6% of patients,
respectively. 13% of patients received symptommanagement support from the RN. The most common
treatment site (47%) was the spine. There were highly
statistically significant improvements in pain, function, and
quality of life (p < 0.001for all 3 domains), which did not vary
120
Prostate Cancer and Informed Shared
Decision–Making: Implementation of
a Patient Decision Aid for Men with
Localized Prostate Cancer
Marian F. Waldie, RN, CON(C), BScN2, Jennifer Smylie,
R N, MScN 2, Dawn Stacey, R N, CON(C), PhD1, Salome Shin,
BA2, Robin Morash , R N, A PN, MScN2. 1Ottawa Hospital
Research Institute, Ottawa , Ontario, Canada , 2The Ottawa
Hospital , Ottawa , Ontario, Canada .
In 2013 an estimated 23,600 men were diagnosed with
prostate cancer in Canada. Treatments for prostate cancer
can affect the physical, social, psychological and spiritual
aspects of men’s and their partner’s lives. Patients must
weigh the benefits and risks of various treatments and
carefully consider the impact a treatment will have on their
quality of life.
In September 2010 the Ages Cancer Assessment Clinic
initiated the use of a decision aid for men diagnosed with
localized prostate cancer. The objective was to help prepare
men to talk with their doctor, to ask questions and discuss
how they feel about treatment options. Treatment choices
include watchful waiting, active surveillance, radiotherapies
and surgery. The patient decision aid serves as an adjunct
to practitioner counselling and is intended to help patients
become engaged in the decision-making process.
Nurses have played a critical role in ensuring that patients
receive a decision aid and in providing direction to
additional resources for patients and their partners. The
focus of this presentation will highlight the implementation
of the patient decision aid, the nursing experience and most
importantly the patient experience.
P-08
Implementation of Routine Symptom
Screening with the Edmonton Symptom
Assessment System for Patients with Head
and Neck Cancer Undergoing Radiotherapy:
A Quality Improvement Project
Freda Colquhoun, RN, BA, CON(C), Frances Faron,
RN, Kerry Jensen, RN, BScN, Josée Lamoureux, RN, BScN,
CON(C), Caroline Marchionni, RN, MScAdm, MScA, Irene
Valente, RN, BScN, 2Radiation Oncology Department, McGill
University Health Centre, Montreal, Québec.
The head and neck patient population represents a significant
group for radiation therapy nurses. These patients experience
a plethora of side effects including mucositis, stomatitis,
xerostomia, fatigue, anorexia and radiation dermatitis. This
significant treatment-related morbidity can be limited when
patients and families are empowered to be active partners
in the management of their symptoms. The interdisciplinary
team at a Canadian university-affiliated tertiary care centre
undertook a quality improvement pilot project to implement
routine screening of symptoms experienced by the head
and neck population. The project team involved multiple
physicians, nurses and administrators. Once the patient
trajectory through the department was mapped by a process
review expert, the Edmonton Symptom Assessment System
(ESAS) was selected as the tool to be used by all head and
neck patients. The patient trajectory begins with a thorough
assessment of symptoms before treatment begins using
this 10-item self-report, validated tool. Often completed by
the patient with input from the family, the tool was found
to promote dialogue between the patient, family and the
clinician as treatment progressed and side effects developed.
Preliminary results show high acceptance of this tool by
clinicians and patients with compliance rates above 80%.
Future goals are to begin using this instrument with other
cancer populations.
P-09
Quand le patient–partenaire devient expert !
Louise Compagna, Baccalauréat, Claudia Maltais,
Maîtrise, Nicole Deschenes, Baccalauréat , Caroline
Provencher, Maîtrise, Claudine Tremblay, infirmière, maîtrise
en sciences infirmières, conseillère clinicienne en soins
infirmiers oncologiques. Oncologie, Hopital Maisonneuve–
Rosemont, Montreal, Québec, Canada.
Depuis plusieurs années, l’équipe suprarégionale en cancer
du sein de l’HMR traite et accompagne des patientes tout
au long du continuum de soins. En 2009, l’équipe dédiée
en cancer du sein de l’HMR a innové en créant des classes
d’enseignement interdisciplinaire. Outre la satisfaction de
la clientèle et la responsabilisation du patient, l’observation
d’une multitude d’effets positifs ont été observés en regard
des préoccupations de l’équipe voulant éviter des ankyloses
articulaires au niveau de l’épaule du côté opéré, de diminuer
les douleurs engendrées, de prévenir le lymphoedème
et de réduire au minimum les adhérences cicatricielles.
Auparavant, il était fréquent de référer des patients en
physiothérapie à la suite de la chirurgie relative au cancer
de sein pour une limitation articulaire de l’épaule. Cette
diminution de mouvement entravait le processus de soins,
121
P-07
puisqu’il était alors impossible pour la patiente de placer
son bras en position suffisament élevée pour recevoir les
traitements de radiothérapie. Il s’agissait alors d’une urgence
thérapeutique et fonctionnelle. Cette immobilisation du
membre supérieur à la suite de la chirurgie était en grande
partie occasionnée par l’absence de lignes directrices et
claires. La participation du patient au processus de soins
en lui précisant la necessité de bouger, en lui expliquant la
rationnelle et en lui démontrant la façon de faire a permis
de diminuer de façon radicale les ankyloses articulaires
de l’épaule. Les références en physiothérapie pour cette
problématique sont maintenant évitées. Bien d’autres
répercussions positives du développement de la compétence
de soins du patient sont observés au quotidien. Le patientpartenaire, bien plus qu’une nouvelle philosophie, est une
occasion unique et privilégiée de communiquer ensemble
pour “l’aider à nous aider”. Cette présentation se veut
l’occasion de partager avec vous nos résultats ainsi que
quelques données statistiques.
3:15 PM – 3:45 PM
Groupe 2 / Group 2
P-10
Patient Engagement in the Success of a
Shared Care Model
Pam Savage, RN, MAEd, CON(C)2, Mary Doherty, BScN, MN,
NP–PHC1, Cindy Murray, BScN, MN, NP–Adult1, Kimberly Maki,
BScN1, 1Leukemia, Princess Margaret Cancer Centre, Toronto,
Ontario, Canada, 2Surgical Services TG & International.
Our institution is a major referral centre for patients
diagnosed with Acute Leukemia. We see an average of 250
patients each year. The treatment and management of these
patients has evolved over the years to include many advances
in therapies. This has resulted in higher patient volumes
which have placed significant demand on the current system.
The model of care has historically been centralized to our
center, a large tertiary hospital, leaving key stakeholders
in our catchment area out of the circle of care. This model
is not sustainable and does not take into consideration
the impact it has on the patient. This has presented an
opportunity to form partnerships with regional cancer
centres. Together, we are working to help transform the
delivery of care to a shared care model; we call outreach.
122
The goal of Leukemia Outreach is to work in collaboration
with oncology teams at other centers from our catchment
area to coordinate care as close to the patients home as
possible. The key components to outreach have been:
effective communication, involvement of key stakeholders
and patient engagement to evaluate its success.
This presentation will highlight successful partnerships
within our catchment area, the impact of receiving care
close to home on the patient experience, and how patient
engagement will drive the future of outreach success.
P-11
The Hidden Impact of Healthcare
Decision–Making on Patient Engagement
Cynthia A . McLennan, RN, BScN, MBA , CON(C),
Infusion & Oncology, Shoppers Drug Mart Specialty Health
Network, Mississauga, Ontario, Canada .
Canadian nurses practicing in the specialty of Oncology
have long been advocates for safe, high quality patient care.
By actively listening to our patients and their families we
tailor oncology care to the individual needs of the family
unit and we do this with great success. This ‘White Glove’
approach to patient engagement has resulted in higher
treatment compliance by the patients leading to improved
clinical outcomes. That said, what is currently happening
across Canada to negatively impact upon patient engagement
throughout their cancer journey is the reduction in Nursing
staff; the drop in education support for oncology nurses;
and, a resultant increase in wait times for access to care for
our patients. Using a Balanced Scorecard format measuring
the four quadrants of Satisfaction; Finance; Learning and
Innovation; and, Quality & Safety the subjective and objective
survey results and literature search clearly shows that while
our patients want to remain engaged in their cancer care, it
becomes increasingly difficult to do so when the oncology
nurse simply is not there. The actual costs associated with
patient engagement are numerous and quantifiable if we just
know what questions to ask and where to look for the data.
Since ‘data drives decisions’ it becomes obvious that our
patients are engaged; the oncology nurses are desperate to
remain engaged with our patients; but, the current Canadian
cancer care system is transpiring against this relationship
thereby negatively impacting upon patient engagement and
positive clinical outcomes.
P-13
Patients experts, professionnels
apprenants, un partenariat gagnant
Nursing Focused Assessment of New
Patients in Ambulatory Oncology Clinics
Francine Grondin, Baccalauréat en sciences, Nicole
Tremblay, Maîtrise en sciences infirmières. Hémato–oncologie,
Hôpital Maisonneuve–Rosemont, Montréal, Québec, Canada.
Fatima Abdelmalek, RN, MN, Angela K. Leahey, RN, MN,
Arlene R. Court , RN, BScN, Larissa Day, RN, MSc, CONC. The
Odette Cancer Centre, Toronto, Ontario, Canada .
Annuellement, en moyenne, l’Hôpital MaisonneuveRosemont procède à 160 greffes de cellules
hématopoïétiques. Le double de personnes y viendra
pour un bilan-pré-greffe. Dix fois plus, soit 3000, y ont
été greffées depuis les années 1980, et, de ce nombre pour
qui la greffe s’est avérée un succès, un suivi médical à
vie sera nécessaire pour la plupart. Les enjeux de soins
sont donc multiples dans le temps, tant pour la clientèle
que pour les professionnels. Diagnostic de maladie grave,
traitement complexe, voire mystérieux, anxiété fréquente,
symptômes physiques marqués parfois sur plusieurs années
et médication complexe représentent certains de ces défis
qui s’accompagnent, pour le professionnel, de temps et
de ressources limités. Les équipes d’amélioration continue
de la qualité réunissant patients et professionnels peuvent
permettre de surmonter des défis de soins.
Patients with a new cancer diagnosis face many challenges
that can negatively impact their overall health outcomes
and quality of life. With increased awareness, the nursing
team can provide various supports to aid these patients in
overcoming their unique issues. A large ambulatory care
oncology centre that sees over 10,000 new patients every
year is committed to creating a standardized new patient
visit. The process aimed at meeting the informational
needs of new patients as well as screening for patients who
may require early intervention and additional support.
[1] http://www.synapse.umontreal.ca/faculte/le-patientpartenaire-de-soins-nouvelle-image-de-marque-de-la-faculte/
The new nursing assessment was integrated into an
electronic documentation system and piloted in two disease
sties using iPads. The anticipated outcome from these
changes is that by encouraging patient involvement, the
needs of new patients will be more appropriately assessed
and met by nurses. The feedback and metrics from the pilot
are directing the roll-out and standardization of this process
throughout all disease sites.
Current practice and tools were evaluated by surveying
ambulatory oncology nursing staff (n=16) and engaging the
nursing practice council. Patient feedback was captured
through a survey that assessed their experience and the
resources they received (n=30). Results from the surveys
indicated a need for both a revised interprofessional
L’affiche proposée témoigne des travaux issus du
health history assessment form and a new nursing specific
Comité d’amélioration continue de greffe de cellules
assessment. Areas of care such as social supports, lifestyle,
hématopoïétiques. Ce comité réunissant patient et
and care planning were recognized as important to the
professionnel a développé des outils de soins permettant
nursing assessment. Additionally, three new nursing
la prise en compte des préoccupations et symptômes
assessments were identified as vital upon a patient’s
principaux de la clientèle ainsi que de son suivi
first visit: a falls risk assessment, a stress and coping
médicamenteux. Tel que retrouvé sur le site web de la
assessment, and a frailty assessment. These assessments
Faculté de médecine de l’Université de Montréal : «La
tools engage the patient in the creation of their care
réussite du partenariat de soins entre les patients/proches et plan by encouraging open communication, appropriate
les professionnels de la santé demeure certainement un des counseling, patient education and early referrals. Survey
leviers les plus efficaces pour l’amélioration significative de
results also lead to minor modifications to the new patient
leurs conditions respectives»[1].
information packages.
123
P-12
P-14
P-15
Training for Nurses to Use Protocols when Pro- Incidence and Management of Cardiac and/
viding Remote Symptom Support to Oncology or Pulmonary Adverse Events Following
Patients: A Retrospective Pre–/Post–Study Single–Agent Carfilzomib Treatment in
Patients with Relapsed and/or Refractory
Dawn Stacey, RN, PhD, CON(C)1, Meg Carley, BSc5, Barb
Ballantyne, RN, BNSc, MScN, CON(C)2, Myriam A . Skrutkowski, Multiple Myeloma
RN, MSc, CON(C)3, Erin Kolari, RN, BScN, CVA A2, Tara Shaw,
RN, CON(C)4, Pan–Canadian Oncology Symptom Triage and
Remote Support1. 1School of Nursing, University of Ottawa,
Ottawa, Ontario, Canada , 2Health Sciences North, Sudbury,
Ontario, Canada, 3McGill University Health Centre, Montreal,
Québec, Canada, 4Capital Health, Halifax, Nova Scotia,
Canada,5Centre for Practice Changing Research , Ottawa
Hospital Research Institute, Ottawa, Ontario, Canada .
Purpose: To evaluate training for nurses on use of the
pan-Canadian Oncology Symptom Triage and Remote
Support (COSTaRS) protocols for supporting patients
undergoing cancer treatment.
Methods: Retrospective pre-post study involved
workshops at 3 ambulatory oncology programs in Ontario,
Quebec, and Nova Scotia. Workshops included didactic
presentation, role-play with protocols, and group discussion.
Post-training a survey was used to self-rate confidence
in ability to provide symptom support and use protocols,
and satisfaction with training. Change in confidence was
measured using one-tailed paired t-tests.
Results: Twenty-two workshops from June 2013 to February
2014 included 107 participants (reaching 85%, 90%, and 97% of
eligible nurses at 3 sites). Of 107 participants, 90 completed the
survey (84% response rate). Compared to pre-training, nurses
post-training indicated improved confidence in their ability to
a) assess, triage, and guide patients in self-care for their cancer
treatment symptoms (p<0.01); and b) use COSTaRS protocols
to facilitate symptom assessment, triage, and care (p<0.01). The
workshop was rated as somewhat or very easy to understand
(98%), comprehensive (92%), and provided new information on
remote symptom management (87%). Participants agreed the
workshop met the learning objectives. Some (37%) specified not
enough time for role-play. Comments were generally positive.
Suggestions to improve the training were: longer workshops
with more time for role-play and using protocols during
documentation; booster sessions to reinforce learning; and
ongoing review and auditing of protocol use. Participants (94%)
would recommend the workshop to others.
Conclusions: The training workshop for using COSTaRS
protocols increased nurses’ confidence with providing
remote symptom support and was well received by nurses.
Subsequent workshops should consider being longer and/
or add booster sessions to further enhance nurses’ skills in
using protocols and documenting.
124
Olga Levina, BScN, Diana Arones, RN. Princess Margaret
Cancer Centre, Toronto, Ontario, Canada
Introduction: Patients with relapsed and/or refractory
multiple myeloma (RRMM) often present with comorbid
conditions that make them prone to an increased risk of
cardiac and/or pulmonary toxicities following the use of
anti-MM therapy. This population requires close monitoring,
and nurses play a critical role in supporting patient safety.
Methods: Safety data from 526 patients with RRMM in
4 phase 2 trials (PX-171-003-A0, PX-171-003-A1, PX-171004, and PX-171-005) of single-agent carfilzomib (CFZ), a
selective proteasome inhibitor approved in the US for the
treatment of relapsed and refractory MM, were used to
analyze the incidence of cardiac and pulmonary adverse
events (AEs). CFZ was administered intravenously over 2–10
minutes at a starting dose of 20 mg/m2 and a target dose of
27 mg/m2 in 28-day cycles for all studies except 005 (dosing
range, 15–27 mg/m2).
Findings: At baseline, 73.6% of patients had a cardiac
medical history. Cardiac AEs were reported in 22.1% of
patients; 14.3% developed hypertension and 7.2% developed
cardiac failure following exposure to CFZ. Pulmonary AEs
primarily consisted of dyspnea (42.2%), cough (26%), and
pneumonia (12.7%). Dyspnea events were primarily grade ≤2
and transient. Discontinuations and dose reductions related
to cardiac and/or pulmonary toxicities were uncommon.
Implication: In our experience at Princess Margaret
Cancer Center, cardiac and/or pulmonary toxicities may
be minimized by infusing CFZ over at least 10 minutes at
the recommended starting and target doses, maintaining
appropriate hydration, administering dexamethasone, and
modifying treatment as necessary. Nurses play an important
role in preventing and mitigating cardiac and/or pulmonary
AEs by educating patients before initiating CFZ to report all
AEs as early as possible to avoid unnecessary intensification
and possible treatment interruption. Oncology clinical
research nurses and patients are partners in care throughout
the duration of treatment with CFZ.
P-16
P-17
Improving the Patient Experience by
Teaming Up with Cancer Patients and
Family Members
What’s in a Blog? Sharing Oncology Nursing
Excellence via Social Media
Our comprehensive cancer program is currently involved
in a major transformation initiative focusing on improving
the patient experience with cancer care. A commitment
has been made to supporting a patient and family centred
care approach as the underlying framework. This involves
ensuring the voice of these key stakeholders is actively
consulted and incorporated into initiatives designed to
improve the patient experience.
In 2011, an in-depth consultation was held with patients and
family members. This resulted in many recommendations
on how the patient experience can be improved, thereby,
creating the initial platform for patient and family centred
care. Since that time, we have worked with our clinical
teams to respond to these issues and have more formally
involved patients and family members as ongoing advisors
to all aspects of the cancer program. Central to these efforts
has been the strengthening the role of the Patient and
Family Advisory Council (PFAC).
Knowledge is power – especially in the area of cancer care.
Every day there is new knowledge coming out on effective
approaches and or treatments in oncology care. Social
media provides an easy and efficient way of sharing the
latest advances in cancer care among oncology nurses.
A Canada-wide continuing education program has been
supporting communication and knowledge sharing using
its blog and other social media tools. Using a “multiauthor” blog, the organization has built a community of
blogger which includes staff from all areas of practice and
an invitation to nurses and the public to draft blog entries.
The organization also shares conversations via social
media and encourages discussion with each blog entry.
Blog topics range from patient safety and best clinical
practices, addressing psychosocial needs, conducting
effective communication and patient education, to
research and information technology advancement in
oncology nursing education.
Successes to date include involving advisors on hiring
committees for nurse management positions, a patient
and family centred care orientation session for all new
clinical and support staff and the establishment of a Patient
Experience Specialist position. Through these initial
efforts, we have found that successful implementation of
patient and family centred care approach requires strong
and consistent leadership at all levels. Ongoing advocacy
is essential to ensuring that barriers are overcome and the
ensuing cultural shift takes place.
The organization has reached nearly 6,000 nurses through
its innovative online platform.
Patients and family members are very interested in
contributing their time and energy to helping improve the
care system for future patients. We will continue to broaden
the base of opportunities for their involvement and focus on
evaluating the effectiveness of these efforts. Ultimately, our
efforts to support patient and family centred care will have a
positive impact on patient satisfaction and quality.
P-18
The blog was created in June 2013. To date there have been
over 60 blog entries, with over 2400 site visits. A content
analysis will be carried out of the entries and the emerging
themes and the usefulness of blog as an information
sharing tool will be discussed.
Patient Satisfaction Surveys Informing
Change in Patient Education and
Expanding Patient Engagement
Cathy Taylor, RN, CHPCN(C), Sara A shton , BA R LS, M A .
Durham Regional Cancer Cent re, Lakeridge Health, Oshawa ,
Ontario, Canada .
Our Breast Assessment Program (BAP) is designed to support
and educate patients through the diagnostic phase of breast
cancer. In collaboration with four general surgeons, the
nurse navigator supports patients through this journey and
125
Gwen Barton, BScN, MHA, Cathy DeGrasse, BScN, MSN.
Cancer Program, The Ottawa Hospital, Ottawa, Ontario,
Canada.
Donalda MacDonald, RN, CON(C), Shanna Brisebois,
BA , Laura Rashleigh, BScN, MScN, Komal Patel, BScN, MScN,
Mary Jane Esplen, PhD, de Souza Institute, Toronto, Ontario,
Canada
prepares many for surgery. Patient satisfaction surveys are
offered on a regular basis to gain a greater understanding
of the patient experience and to identify opportunities for
improvement. Results of initial patient satisfaction surveys
revealed a theme of uncertainty and being ill-prepared for
the surgical experience. In response to this feedback, the BAP
developed and implemented a pre-surgical education session
for patients and their families. Partnering with the community
cancer support center for a unique and innovative education
experience has led to a patient-centered, interactive, and
supportive program that prepares both patients and their
families for breast cancer surgery. The information covered
in the sessions was compiled by the nurse navigator based on
patient-identified needs.
Stephanie M. Burlein–Hall, RN, BScN, MEd, CON(C)1,
Catherine A . Kiteley, MScN2, Margaret I. Fitch , R N, PhD1,
Nilmanat Kittikor n , RN, PhD3. 1Nursing, Sunnybrook, Odette
Cancer Cent re, Toronto, Ontario, Canada , 2Trillium Health
Partners Cred Valley Hospital , Mississauga, Ontario, Canada,
3Nursing, Prince of Songkla University, Hat Yai , Thailand .
Engaging patients and families in planning for care is just as
important at the end of life as during the treatment phase of
any illness.
A Thai nursing professor was exposed to the role of Canadian
nurses in palliative care and believed there was potential
to adopt a similar role for nurses in Thailand. Through her
motivation, a workshop focusing on end of life care was
developed by Canadian and Thai faculty. Topics were drawn
Literature reviews and stakeholder engagement also provided from existing programs with an application to nursing care
significant contribution to the final content and presentation
at the end of life. Mode of delivery and learning was based
structure. Stakeholders included patients, cancer support
on principles of adult learning as most of participants were
centre staff, a BAP surgeon, program leadership, a patient
practicing clinicians. In preparation, the Canadian team
education lead, and oncology and surgical program colleagues. learned about Thai culture through various strategies to gain
The education sessions have been very well received, as
an understanding of the Thai health care system.
indicated by subsequent patient satisfaction surveys. Patients
and their families report decreased anxiety about surgery and The workshop focused on sharing knowledge/skills
and building capacity in care delivery. Skills related to
feeling prepared for the recovery process. Through ongoing
assessment of palliative care needs, delivery of evidencefeedback, the education sessions continue to evolve in order
based interventions; and communication with patients and
to meet the needs of the breast cancer patients and their
other team members were introduced. Personal reflection,
families. Our poster presentation will review the planning
group work, and role playing facilitated the practice of these
process; provide patient feedback, and share next-steps of
skills. Materials included resources translated into Thai for
the program. Our poster will demonstrate the success of an
innovative partnership to address patient needs and improve participants’ use in practice. Faculty interested in palliative
care are now able to offer their own Thai-language “end of
patient engagement and empowerment.
life care” workshops.
10:00 AM – 10:30 AM
Groupe 3 / Group 3
P-19
End of Life Care and a Shared Vision of
Nursing: Experiences from an Education
Workshop in Thailand
126
One interesting development was the building of a
relationship amongst the group and a beginning sense
of community as palliative care nurses. The sharing of
experiences and expertise allowed a sense of trust to build
and participants began to learn from one another, laying a
foundation for on-going networking and the beginnings of a
regional palliative care focus.
This presentation will describe: creating a proposal for
funding; development of content; facilitating learners’ needs;
outcomes and evaluation; ideas to facilitate education in
a different cultural setting; and personal reflections of a
shared vision of nursing between cultures.
P-20
P-21
Mobilisation de l’espoir chez la personne Social Determinants of Health Associated
atteinte d’un cancer du poumon de
with Cervical Cancer Screening among
stade avancé : réflexion autour des
Women Living in Developing Countries
interventions infirmières recensées dans Leslie Williams–Brennan, BSc, BScN, RN, MN(student)1,
les écrits
Denise Gastaldo, M A , BScN, PhD1, Donald C. Cole, MD, MSc,
INTRODUCTION : L’espoir peut se définir comme « une
force dynamique et multidimensionnelle caractérisée par
une attente encore confiante mais incertaine de parvenir
à un bel avenir, laquelle, pour la personne qui espère,
est réaliste et personnellement significative ». Plusieurs
bienfaits associés à l’espoir sont décrits dans la littérature,
notamment sur la qualité de vie des personnes atteintes
d’une maladie potentiellement mortelle. Compte tenu de
leur proximité avec le patient, les infirmières seraient des
actrices clé dans la mobilisation de l’espoir des patients
atteints de cancer.
OBJECTIF : Recenser les écrits afin de préciser les
interventions infirmières permettant de mobliser l’espoir des
personnes atteintes de cancer avancé.
MÉTHODE : Une recension des écrits a été menée sur les
bases de données PubMed, CINAHL et PsycINFO pour les
années 1987 à 2014. Les mots-clés hope, nurses, strategies et
cancer ont été utilisés. Les interventions recensées ont été
catégorisées selon les quatre attributs de l’espoir, tirés du
modèle conceptuel de Farran, Herth et Popovich (1995).
RÉSULTATS : Malgré la reconnaissance du rôle de
l’infirmière par rapport à la mobilisation de l’espoir des
patients atteints de cancer, peu d’évidences provenant de
la recherche clinique existent quant aux stratégies qu’elles
utilisent. En classifiant les interventions recensées selon les
quatre attributs de l’espoir provenant du modèle conceptuel
de Farran, Herth et Popovich (1995), les mécanismes
thérapeutiques impliqués dans les interventions se
précisent. DISCUSSION Plusieurs guides de pratique
clinique concernant l’approche aux personnes atteintes de
cancer avancé font référence à l’importance de maintenir
l’espoir sans nécessairement préciser comment. La présente
démarche suggère des pistes qui pourraient être davantage
documentées dans des recherches ultérieures et ainsi aider
les infirmières à choisir délibérément des interventions
visant à mobiliser l’espoir de patients atteints de cancer.
FRCP(C)2, Lawrence Paszat , MS, MD, FRCP(C)3. 1Nursing,
Universit y of Toronto, Toronto, Ontario, Canada , 2Dalla Lana
School of Public Health, University of Toronto, Toronto, Ontario,
Canada , 3Facult y of Medicine: Dept . Radiat ion Oncology,
University of Toronto, Toronto, Ontario, Canada .
Thousands of women living in many middle and low-income
(MLICs) countries are unnecessarily dying from cervical
cancer. We aimed to identify social determinants of health
(SDH) associated with cervical screening for women living in
MLICs, to inform responses to improve SDH associated with
screening.Through a scoping literature review, we located
original research articles on SDH associated with cervical
cancer screening through bibliographic databases and hand
searching. Included were those conducted in MLICs (n=37);
excluded were those focusing on screening-diagnostic
techniques or HPV vaccine. Narrative synthesis examined
the results in relation to a SDH framework. Our findings
revealed that the pathway to cervical cancer screening for
women living in MLICs was influenced by cultural and
societal values, socioeconomic status, ethnicity, geographic
location, health seeking behaviors, psychological stressors,
the health system and social cohesion. No single factor could
explain the observed screening patterns. Cervical cancer
screening among women living in MLICs are influenced
by the interaction of several SDH. From an intersectional
theoretical perspective, most researchers failed to explore
how screening may be influenced by women’s social
locations or how socially constructed identity categories
intersect to influence an individual’s health and illness
experience. By exploring the experiences of women situated
at the intersections of multiple dimensions of social
disparities, significant knowledge can be gained regarding
how SDH influence their health behaviors. This approach
may provide a richer understanding of the complexities that
influence women’s pathways to cervical cancer screening,
help healthcare practitioners engage more women to
participate in screening, as well as assist in the design of
international programs and policies.
127
Marie–Ève Bélanger, B.Sc., CSIO(C), Ét udiante à la
maîtrise en sciences infirmières avec mémoire2,1. 1CHU de
Québec, Québec, Québec, Canada , 2Faculté des sciences
infirmières, Université Laval , Québec, Québec, Canada .
P-22
A Patient Centered Care Approach through
the Implementation of a Comprehensive
Distress Screening Process of the
Ambulatory and Hospitalized Patients;
Concrete Outcomes and Reflexions.
Karine Gimmig, Baccalauréat, Manon Allard , BsN,
MBA . Cancérologie, Cent re Hospitalier St–Mary, Mont réal ,
Québec, Canada .
In 2008 the Cancer Care Day Center interdisciplinary team of
St. Mary ‘s Hospital implemented a distress screening process
for its ambulatory clientele. The process was the prerogative of
the pivots nurses who used it for the newly diagnosed patients.
Follow-up assessment of abnormal results is done by
visualization of the cervix using a colposcope (binocular
microscope) during a pelvic examination. The procedure,
called colposcopy, is used in conjunction with cytology,
pathology and HPV testing to effectively assess, diagnosis and
treat abnormalities of the cervix identified through screening.
Unfortunately, follow-up adherence with colposcopy for
abnormal Pap smears ranges from 27%-90% as reported in
the OCSP 2003-2008 report. When adherence to follow-up
colposcopy was reviewed at our centre, the average nonadherence rate was found to be approximately 20%. However,
actual daily adherence rates were unpredictable and similar to
the OCSP report.
In an effort to improve patient adherence to colpscopy, a
strategy, involving connecting with patients via written
notification of missed appointments and telephone followToday, after 5 years of usage and reorganization, the distress
up providing reinforcement on the importance of followscreening process has been extended and improved, it is carried
up, was undertaken based on the current evidence on
out by several health care professionals from the day center but
barriers to adherence, recommendations, and institutional
also on the in-patient unit of oncology and palliative care.
feasibility. The challenges and successes of engaging patients
through this initiative will be presented, along with future
From the exploration of the barriers and challenges related to
the implementation of such a process to the opinion of patients recommendations based on patient feedback.
and health professionals, this presentation will be a summary
of 5 years of implementation of the disctress screening,
assessment and follow-up.
P-24
P-23
Working Together to Improve Outcomes:
Strategies to Improve Appointment
Compliance with Colposcopy
Lisa Tinker, BScN, MHM, Jacklyn Ward , R N, Cat riona
Buick , MN, PhD(C). Princess Margaret Cancer Centre,
The Long Road Home Engaging Patients
in End of Life Care Decisions: A Key Role
for Oncology / Palliative Care Nurses
Facilitating Appropriate Place of Care
Sylvie Bruyere, BScN, CON(C), CHPCN(C), Wendy L.
Petrie, MScN, BScN, CON(C), CHPCN(C), Lynn E. Kachuik, RN,
BA, MS, CON(C), CHPCN(C), Edward Fitzgibbon. Palliative
Care, The Ottawa Hospital, Ottawa, Ontario, Canada.
Although most cancer patients prefer to receive end of life
care at home, many continue to die in acute care hospitals.
Although the incidence of cervical cancer in Ontario has
According to 2011-2012 CIHI (Canadian Institute for Health
decreased by approximately 2% per year since 1981 due to
Information) data, 45 % of Canadian cancer deaths occur
the early detection of precancerous lesions by the use of
in an acute care setting. Many could have died in the
the Papanicolau, or Pap smear, it is still ranked the fourth
setting of their choice if they had been engaged in earlier
most common cancer among women under the age of 50 in
discussions related to their wishes for end of life care. This
Ontario (Cancer Care Ontario, 2009, 2011). In 2011, Ontario
decision making is complex, requiring detailed discussions
saw approximately 500 women diagnosed and 140 die from a
disease that is almost entirely preventable. Persistent infection and planning with patients, families and the health care
with the Human Papillomavirus (HPV) causes the development team. The oncology / palliative care nurse’s role involves
of precancerous lesions which progress to invasive cancer. The advocating for patients’ wishes to die in the setting of their
progression is usually slow and precancerous lesions are easily choice, facilitating navigation of the health care system and
addressing barriers to care.
detectable through screening with the use of the Pap smear
(Everett et al., 2011; CCO, 2009, 2011).
128
This poster will present results of our retrospective chart review
of oncology patients (n = 283) who died in our acute care setting
in 2012 and were followed by our Supportive and Palliative
Care Consult Service. Information highlighted will include
barriers to palliative patients receiving end of life care in their
preferred settings, as well as potential interventions that can be
used by oncology/ palliative care nurses in facilitating system
navigation for this vulnerable group of patients.
P-25
The CALM Journey: Advanced Practice
Nurses Engage in Psychotherapy
Training for Patients Living with
Advanced Cancer
Kelly A. McGuigan, RN, BScN, MN, CON(C), CHPCN(C),
Patricia Murphy–Kane, RN, BA, BScN, MN, CHPCN(C), Maurene
A . McQuestion, RN, BA, BScN, MSc, CON (C). Nursing, Princess
Margaret Cancer Centre, Toronto, Ontario, Canada.
Individuals with advanced cancer have the challenge of
making the most of each day while facing the reality of their
death. In a large cancer centre, a group of social workers,
psychiatrists and psychologists have been trained to provide
a brief psychotherapy intervention to assist in meeting this
challenge. Managing cancer and living meaningfully (CALM)
is a brief, individual, psychotherapeutic intervention rooted
in several broad theoretical traditions, including relational
theory, attachment theory and existential psychotherapy.
A group of Advanced Practice Nurses (APNs) attended a
three day international training intensive CALM workshop in
May, 2013. A post-workshop meeting held with the Director
of Nursing resulted in an opportunity to develop skills in
delivering CALM in their Cancer Centre. In January of 2014
three APNs began the journey in psychotherapy training.
This presentation will review the training program, the benefits
and challenges in adapting this therapy in nursing practice and
the mutual lessons learned by the APNs and the CALM trained
members from the psychosocial oncology program.
Through this innovative therapy the APNs have engaged in an
exciting and enriching learning experience that has redefined
their relationship with individuals living with advanced cancer.
P-26
Addressing the Needs of Canadians
Living with Metastatic Breast Cancer
Diana Ermel, RN, BScN, MV/TEd, Past President, Canadian
Breast Cancer Network. Report co-authored by the Canadian
Breast Cancer Network and Rethink Breast Cancer.
It is estimated that this year 23,800 women in Canada will
be diagnosed with breast cancer, of whom approximately
10% will have an initial diagnosis of metastatic breast
cancer and approximately 30% of women diagnosed initially
with earlier stages of breast cancer will go on to develop
metastatic breast cancer. The five year relative survival rate
of women diagnosed with metastatic breast cancer is just 20
percent. Yet there remains a persistent lack of awareness and
understanding of the distinct challenges affecting metastatic
breast cancer survivors in Canada and around the world.
In June 2012, the Canadian Breast Cancer Network and
Rethink Breast Cancer released a new report, Metastatic
Breast Cancer in Canada: The lived experience of patients
and caregivers. The report highlights the patient journey by
examining the realities and lived experiences of metastatic
breast cancer survivors and their caregivers. The report
details the specific challenges associated with a metastatic
breast cancer diagnosis and emphasizes the impact on
survivors’ quality of life, focusing on both the physical and
psychosocial aspects of the disease.
Exploring the data in Metastatic Breast Cancer in Canada:
The lived experience of patients and caregivers, this poster
session will provide an opportunity for participants to gain
valuable insights into the challenges facing metastatic breast
cancer patients in Canada, particularly in regards to the
themes of accessibility of treatment and support resources,
access to new therapies and the financial burden associated
with treatment costs. The session will also describe and
discuss the potential opportunities for, challenges around
and successful strategies to address the needs and concerns
of metastatic breast cancer survivors.
129
Based on our previous research we identified that
transitioning from hospital to home or other care setting for
palliation is a complex process. It involves addressing many
barriers including: poor communication and documentation
of patients’ wishes, lack of clearly defined advanced
directives, overly aggressive treatment, complexity of
patient care needs and lack of available community–based
services. Well-organized, coordinated care in accordance
with patients’ wishes should prevent emergency room
visits, readmission to acute care hospitals, inappropriate
interventions and improve patient quality of life. However,
this will not occur without adequate patient and family
engagement earlier in the trajectory of illness.
P-27
Improving Nursing Compliance
with Documentation of Venous
Thromboembolism Education for Patients
and Families.
Linda Ramjohn, BScN, MSN, CON(C), Eleanor Miller, R
N, BScN, M A , A shley Andrade, R N, BScN, Amanda John , R N,
BScN, Victor Fosu , R N, BScN. Medical & Radiat ion Oncology,
Sunnybrook Health Sciences Cent re, Toronto, Ontario, Canada .
It is known that oncology patients are a high risk
patient population for the development of deep vein
thrombosis. Nurses play a key role in the engagement
of the patient and family in education regarding venous
thromboembolism prophylaxis. Nurses on a medical and
radiation oncology unit in a tertiary teaching hospital
provide venous thromboembolism prophylaxis teaching
to patients and families upon admission. Random chart
audits were conducted on the unit to monitor compliance
with documentation standards and the results revealed
that there is inconsistency in practice. Several focus groups
were conducted to explore the nursing team’s perspective.
It was identified that nurses needed further education
regarding the required organizational practice of venous
thromboembolism prophylaxis and its documentation.
Mandatory educational sessions were implemented and
evaluated. Post education, venous thromboembolism
prophylaxis documentation chart audits were conducted
monthly. The audits have illustrated a significant
improvement in the nurses’ documentation practices.
2:45 PM – 3:30 PM
Groupe 4 / Group 4
P-28
Applying Successful Innovative
Strategies to Deal with Severe Skin
Reactions from Chlorhexadine/Alcohol
Solutions
Julie Wilson, RN, BScN, CON(C), Car men Gosselin , R N,
CON(C). Nursing, Odet te Cancer Cent re, Sunnybrook Health
Sciences Cent re, Toronto, Ontario, Canada .
130
Peripherally inserted central catheter (PICC) maintenance
involves cleansing the site with an antiseptic solution, most
commonly chlorhexidine/alcohol preparations, for the
prevention of catheter related infections (Maiwald &Chan,
2012). In our centre, many patients experience severe
skin irritation with this practice. This skin reaction can
be extremely pronounced in patients receiving infusional
Fluorouracil, as well as patients of specific cultural or ethnic
backgrounds. Severe skin reactions result in poor skin
integrity, discomfort and itchiness for the patient. Without
intervention, these skin reactions compromise the patient’s
treatment experience. The patient may experience interruption
of treatment, due to the removal of the catheter and the
necessary reinsertion of a second CVAD. Another alternative
is cancellation of treatment, which has occurred at our centre,
possibly impacting outcome.
This poster will share specific strategies that have resulted in
the successful management of these severe skin reactions/
allergies, including the use of antihistamines, steroid puffers
and various dressings. The use of case studies will illustrate
the effectiveness of our strategies. Patient engagement in
the process of vascular access selection and maintenance
is important for early detection and intervention of skin
reactions. Teaching the patient about possible skin reaction
with associated symptoms will facilitate timely reporting.
In response to the issue, our interventions have enabled
patients to continue to use their vascular access device
while maintaining an extremely low rate of catheter related
complications. Use of these strategies have optimized our
clinical practice and have resulted in positive patient outcomes.
P-29
Utilizing Workload Measurement Data to
Support Nursing Time for Patient Teaching
and Emotional Support
Mary E. Glavassevich, BA, MN, Elaine Avila , BScN, Prasani
Jayaratne, BScN, Sarah Ionson, BScN, Irina Bobeica , BScN,
Anita Long, BSN, MSN/ED, CON(C), Brenda Leung, BSc,
Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada .
In our Surgical Oncology Unit, there is a perception that
nurses may not be spending enough time providing patient
with emotional support and teaching. This was confirmed
in a recent post discharge patient survey conducted by unit
staff. A need was identified for more patient education to
better prepare patients for their discharge.
Issues then to consider were how much time nurses
currently spent providing emotional support and teaching
and what did they understand those elements to be. The
workload measurement is a system used to quantify
nursing workload and resources required for patient care.
Nurses are responsible for completing their workload
daily through a computerized system but for the data to be
meaningful it must be accurate and valid. Therefore a team
of nurse leaders and staff nurses examined the workload
measurement data, specifically on extended emotional
support and teaching. Results showed that within the past
3 months, 86% of the patients received extended emotional
support and patient teaching. The average compliance
rate for data entry was 80%. The required target for
compliance is 100%. Reliability and validity of the workload
measurement tool was 81%. These results indicated a need
to improve the quality and validity of the data to use in
supporting nursing time spent on emotional support and
education.
Using a quality improvement process, nursing leaders and
staff nurses explored nursing understanding and definition
of emotional support and teaching, and developed strategies
to improve workload compliance, accuracy and engagement
of nurses with patient care.
P-30
A Standardized Approach to Ensuring
Safety and Improving Patient Experience
in the Systemic Suite
Nancy Zimny, BSN1, Joanne Svela , BSN2. 1systemic suite,
Durham Regional Cancer Center, Oshawa , Ontario, Canada ,
2Durham Regional Cancer enter, Oshawa , Ontario, Canada.
The chemotherapy suite does not have a primary model of
nursing and yet each nurse caring for the patient and family
on successive visits is fully committed to ensuring patient
safety, supporting the interprofessional plan of care, and to
improving the patient experience by continuing to identify,
communicate and resolve emerging unmet needs. But how
to effectively meet complex needs when the patient sees a
different nurse with each chemotherapy treatment?
After careful review of the CCO Patient Satisfaction Survey
scores and, noting that the area of emotional support was
one area that scored consistently lower, the chemotherapy
nurses met to identify ways they could maintain a focus
on safety yet optimize their role on the interprofessional
team by helping identify emerging unmet emotional
needs and play an active role in improving the patient
experience. The poster shows how the team developed a
structured approach to the 8 domains identified as critical
to improving emotional needs of the patient and family,
while never compromising the focus on patient safety. The
eight domains identified in the literature and included in
the approach were Empathy, Informative Communication,
Being Present and Available, Inspiration and Hope,
Personalization, Supportive Gestures, Humor and Ambient
Environment.
P-31
Through Patient Engagement: Practice
Changes Are Made to the Sarcoma
Treatment Plan
Laurie Ann Holmes, RN, BScN, CON(C), CHPCN(C).
Oncology, Ottawa Hospital , Ottawa , Ontario, Canada .
Sarcomas are rare tumors affecting bone and soft tissue.
Treatment for Sarcomas involve surgery, chemotherapy
and radiation depending on the stage. Most chemotherapy
regimes in the adult population include the drug
Ifosphamide. One of the major side effects of this
medication is hemorrhagic cystitis. In order to prevent/
diminish this side effect Mesna is given a multiple of
frequencies following the Ifosphamide. Mesna is only
available in IV formulation so patients are admitted to
hospital for their treatment. Most regimes involve 5 days
of chemotherapy and resue medication. Sarcomas tend to
affect young individuals in the prime of their lives, being in
hospital for 5-6 days of treatment has been seen as a major
inconvenience for these patients.
The question is how could we safely provide care for this
patient popluation in an out-patient setting? Some patients
opted to drink the IV formulation of Mesna in order to get out
of hospital, but since the taste of Mesna is extremely vile this
was not tolerated as an option for majority of our patients.
In this presentation I will discuss how patient’s desire for an
out-patient option pushed our team to develop a process to
ensure adminstration of the resue medication.
131
In today’s busy health care environment, the nursing
workforce is confronted with the challenge of meeting
competing demands to address the acuity and the
complexity of patient care (Shu Yin Hoi & et. al., 2010).
Considering that emotional support and teaching was
identified as important by patients, we had to justify time
spent on those activities.
P-32
An Engaging Journey
Rayelle Richard, BScN, Kathy Winters, R N, Laurie Ann
Holmes, R N, BScN, CON(C), CHPCN(C). The Ottawa Hospital ,
Ottawa , Ontario, Canada ..
A paradigm shift has occurred in the care of oncology patients.
Patients are no longer passive recipients, but are now active
participants of their care. Oncology nurses are working side by
side with patients and families to ensure they have a voice and
are able to engage in their care.
Engagement involves the full participation in one’s own
health care and treatment. Staff engagement is also crucial for
facilitating both formal and informal communication with the
patient and care team.
This case study presentation will explore a sarcoma patient’s
journey along the continuum of care from early diagnosis to
end of life. The journey included multiple hospital admissions,
surgery, chemotherapy and other treatments options. The
nurses strived to keep care patient centered, remaining within
determinded values and understanding of the disease.
We will describe the journey and focus on the ongoing open
dialogue between the patient and the oncology team. This
dialogue allowed for the patient to guide care towards his final
days maintaining autonomy with the best quality of life.
Conclusion: Le ou les medecin (s) traitant et l’ equipe
multidisciplinaire ont besoin de comprendre les facteurs de
risques associes a la culture, leur ethnicite, leurs croyances,
status-socio-economique et le mode de vie des femmes
Canadiennes Autochtone.
La sensibilite culturel doit etre primordial dans l’apport des
soins et a l’education aux femmes Autochtone du Canada.
Objective: The aim is to understand why the cervical cancer
incidence is 1.78 higher in Status Indians (ranking second
amongst cancer in women). To compare cervical cancer rates in
Aboriginal and Non-Aboriginal women. Examining risk factors:
culture, beliefs, socio-economic status and lifestyle choices.
Study methods: Literature search of over 40 scientific
articles pertaining on Canadian Aboriginal and Non-Aboriginal
women with cervical cancer.
Conclusion: The treating physician(s) and the
multidisciplinary team need to understand the risk factors
associated with: the culture, the belief system, socio-economic
status and the lifestyle choices of Canadian Aboriginal women.
Cultural sensitivity has to be a top priority in providing care
and education to this population.
P-34
P-33
séance d’afficahge
d’AFFICHAGE / poster presentations
Cancer Cervical et les Femmes
Canadiennes Autochtones / Cervical
Cancer and Canadian Aboriginal Women
Brenda Lagace, BN, Gynecology–Oncology, Ottawa Hospital,
Ottawa , Ontario, Canada .
Objectif: Comprendre pourquoi l’incidence du cancer
cervical est plus eleve de 1.78 chez les femmes avec un Statut
Autochtone (le 2ieme plus eleve chez les cancers feminins).
Comparer le taux du cancer crevical chez les femmes
Autochtones et Non-Autochtones.
Evaluation des facteurs de risques: culturel,
croyances, status socio-economique et mode de vie.
Methode d’evaluation: Revue de litterature de plus de
40 articles scientifiques contenant de l’information sur le cancer
cervical chez les Canadiennes Autochtones et Non-Autochtones.
132
Resultat: Les femmes Canadiennes Autochtones ont
beaucoup de facteurs de risques qui sont relies a la culture,
l’ethnicite, les croyances, le status-economique et le mode de vie.
A Patient’s Journey with Radiation
Induced Brain Necrosis
Laurie Ann Holmes, RN, BScN, CON(C)2, Maura Eleuterio,
RN1, Laura Giananntonio, BScN2. 1Radiation / Hematology,
The Ottawa Hospital, Ottawa, Ontario, Canada, 2Oncology, The
Ottawa Hospital, Ottawa, Ontario, Canada.
The diagnosis of a brain tumor is the start of the journey
that no one expects to take. Initial multiple feelings of fear,
anxiety, and loss of control complicate discussions and
outcome challenges. As healthcare providers this is a crucial
time to empower and engage patients and their falilies in
their healthcare decisions.
Standard treatment for brain tumors may include steriods,
surgery , radiation and chemotherapy. Although radiation
therapy is effective against many tumours of the brain and
spine, it also may damage normal tissue. One of the most
debilitating type of damage is brain necrosis.Radiation induced
brain necrosis occurs 6 months to 3 years post treatment.
Until a few years ago, treatment for brain necrosis
was restricted to steriods, however symptoms occured
from chronic use of steriods. Today management for
brain necrosis includes steriods, debulking surgery,
anticoagulation and hyberbariac oxygen therapy. While
research into treatment options for brain necrosis continues,
advances in radiation therapy may reduce the incidence
and severity of brain necrosis and other side effects by
minimizing radiation damage to health tissue.
In this presentation we will discuss the challenges
encountered by the patient, family and multidisciplinary
team dealing with radiation induced brain necrosis. What is
the right management for this challenging condition?
P-35
Taking a Lead in Oncology Nursing: The
Elimination of Non–Nursing Duties to
Facilitate Patient Teaching and Discharge
Planning
Anita Long, BScN, MSN/ED, CON(C), Mary
Glavassevich, RN, BA, MN2, Philiz Goh, BScN, CON(C)1,
Elaine Avila, BScN2. 1Breast Centre, Sunnybrook Health
Sciences Centre, Toronto, Ontario, Canada , 2Surgical
Oncology, Sunnybrook Health Sciences Centre, Toronto,
Ontario, Canada .
Patient teaching and discharge planning are essential
nursing responsibilities in an environment where patients
are discharged from the hospital earlier and as a result are
often sicker than they were in the past (McMurray et al,
2007). In addition, individual patient needs have become
more complex. Anecdotal evidence from nurses indicated
that they would spend more time engaging patients in
their care if they were not as busy with non-nursing
duties. Non-nursing duties were defined as work that
could be done by other members of the team and did not
require a professional nurse. A member of the nursing staff
surveyed the nurses on three oncology units regarding the
non-nursing duties. The duties were listed, collated and
compiled based upon who would be responsible for the
non-nursing duties. Themes were developed and presented
to management for their review and possible action. Using
the results, a group of oncology nursing leaders planned
to explore the impact for patients and nurses if the nurses
were relieved of the non-nursing duties. This presentation
will outline the process utilized in defining the non-nursing
duties, the appropriate allocation of non-nursing duties and
future plans to facilitate and enhance patients’ participation
in discharge planning and teaching.
LISTE DES
EXPOSANTS/
Exhibitor Listings
Abbott Nutrition
Abbott Nutrition is a leader in nutritional products to help
adults maintain an active, healthy lifestyle. We pioneered the
market for adult nutritionals more than 30 years ago with the
introduction of Ensure, a leading source of complete, balanced
nutrition. In addition to these well-known consumer brands,
we also offer enteral nutrition products as well as nutritional
products for patients with special dietary needs due to food
allergies or diseases that affect the body’s metabolism such as
cancer, respiratory conditions and gastrointestinal impairment.
We focus on combining the science of nutrition with stateof-the-art technology and design to offer nutritional products
that are easy to use and meet the changing nutritional needs of
people at each stage of life.
Advanced Innovations Inc. Bio Oil
Bio-Oil is the #1 physician & pharmacist recommended
product for scar therapy. It helps patients with surgery scars
and radiation burns. Bio-Oils unique blend of natural plant
oils & vitamins is non-greasy, rapidly absorbed, and suitable
for all skin types. Bio-Oil is effective against other skin
concerns like uneven skin tone, aging and dehydrated skin.
Alberta Health Services
Alberta Health Services (AHS) has over 104,000 employees,
including approximately 96,100 direct AHS employees and
almost 8,000 staff working in AHS wholly-owned subsidiaries.
We are the skilled and dedicated health professionals, support
staff, volunteers and physicians who promote wellness and
provide health care to approximately 3.9 million Albertans.
Programs and services are offered at over 450 facilities
throughout the province, including hospitals, clinics,
continuing care facilities, mental health facilities and
community health sites. Partnerships with educational
institutions foster unique research opportunities in medicine
and health sciences placing AHS at the forefront of innovation.
AHS is setting the national standard for quality health services
as Alberta’s largest employer. AHS strives to provide a patientfocused, quality health system that is accessible and sustainable
for all Albertans. Working at AHS enables a better quality of life,
not only for our staff, but their families too – there’s no shortage
of reasons to join our team!
Visit www.albertahealthservices.ca/careers to find out more
about our career opportunities.
133
Amgen
Becton Dickinson (BD) Canada
Becton Dickinson Canada is a leading medical technology
company that partners with customers and stakeholders
to address many of the world’s most pressing and evolving
health needs. Our innovative solutions are focused on
improving drug delivery, enhancing the diagnosis of
infectious diseases and cancers, supporting the management
of diabetes and advancing cellular research. We are nearly
30,000 associates in 50 countries who strive to fulfill
Amgen, a biotechnology pioneer, discovers, develops, and
our purpose of “Helping all people live healthy lives” by
delivers innovative human therapeutics. Our medicines help
advancing the quality, accessibility, safety and affordability
millions of patients in the fight against cancer, kidney disease, of healthcare around the world. For more information, please
rheumatoid arthritis, bone disease, and other serious illnesses. visit www.bd.com
With a deep and broad pipeline of potential new medicines,
Bristol-Myers Squibb (BMS)
we continue to advance science to serve patients. For more
information, visit www.amgen.ca.
Bristol-Myers Squibb Canada est une filiale indirecte détenue
en propriété exclusive de Bristol-Myers Squibb, une société
Astellas
biopharmaceutique d’envergure mondiale dont la mission
Astellas Pharma Canada, Inc. is a Canadian affiliate of Tokyo- est de découvrir, mettre au point et fournir des médicaments
novateurs ayant pour but d’aider les patients à combattre des
based Astellas Pharma Inc. Astellas is a pharmaceutical
company dedicated to improving the health of people around maladies graves. Pour plus d’information, visitez le
www.bmscanada.ca
the world through the provision of innovative and reliable
pharmaceutical products.
Bristol-Myers Squibb Canada is an indirect wholly-owned
subsidiary of Bristol-Myers Squibb Company, a global
The organization is committed to becoming a global category
biopharmaceutical company whose mission is to discover,
leader in focused areas by combining outstanding R&D and
develop and deliver innovative medicines that help patients
marketing capabilities. In Canada, Astellas has an intense
prevail over serious diseases. For more information, please
commercial focus on five therapeutic areas – urology,
visit www.bmscanada.ca
immunology, infectious disease, dermatology and oncology.
Visit: www.astellas.ca
Bayer
Boehringer Ingelheim is a research-driven pharmaceutical
group of companies committed to the development
Bayer is an inventor company with a long tradition of
of innovative, cost-effective medicines and finding
research. By applying science to the major global challenges,
medical breakthroughs for therapies which fulfill unmet
we deliver innovations that address unmet customer and
medical needs. Our drug discovery focuses on six major
market needs.
therapeutic areas: respiratory diseases, cardiometabolic
Our focus on innovation is the key to maintaining or gaining
diseases, oncology, neurological diseases, immunology and
a leading position in every market in which we operate. It is
inflammation, and infectious diseases. Boehringer Ingelheim
also the foundation for improving the lives of many millions
(Canada) Ltd. operations have been based in Burlington since
of people.
1978 with more than 550 employees across Canada. For more
information please visit our website:
By working sustainably and accepting our role as a socially
www.boehringer-ingelheim.ca
and ethically responsible corporate citizen – and by
committing to our Bayer values – we create benefits for the
Canadian Breast Cancer Network
communities in which we live.
Amgen, pionnière en biotechnologie, découvre, élabore et
distribue des traitements novateurs. Nos médicaments ont aidé
des millions de patients à combattre le cancer, les maladies
rénales, la polyarthrite rhumatoïde et d’autres maladies
graves. Nantis d’une solide pépinière de produits, nous faisons
avancer la science pour toujours mieux servir les patients. Pour
en apprendre davantage visitez le site www.amgen.ca
Science For A Better Life: this is the promise we all give to our
stakeholders.
134
The Canadian Breast Cancer Network (CBCN) exists to voice
the views and concerns of those affected by breast cancer
to assure equitable access to optimal breast cancer care for
all Canadians. CBCN is Canada’s leading survivor-directed,
national network of organizations and individuals concerned
about breast cancer. CBCN strives to voice the views and
concerns of breast cancer survivors through promotion of
information sharing, education and advocacy activities.
• National Network - Links and supports groups and individuals
to promote information exchange and collaboration
• Educate and Inform - Provides credible breast cancer related
information and education to those affected by breast cancer
• Advocacy - Promotes equitable access to support and care
throughout the breast cancer experience to ensure best quality of life
CNA is responsible for the overall management of the only
national areas of nursing practice competency certification
program. There are currently 20 areas of nursing practice and
more than 17,600 CNA-certified nurses in Canada. For more
information about the CNA Certification Program, visit the
CNA website at http://getcertified.cna-aiic.ca.
Carefusion
At C
areFusion (NYSE: CFN), we are united in our vision
CBCN also ensures that the issues affecting breast cancer survivors to improve the safety and lower the cost of healthcare for
and their families inform health care policy and guide research. generations to come. Our 15,000 worldwide employees are
passionate about healthcare and helping those that deliver it from the hospital pharmacy to the nursing floor, the operating
Cancer and Careers
room to the patient bedside.
Cancer and Careers empowers and educates people with
cancer to thrive in their workplace by providing expert advice, Our clinically proven product families include Pyxis® for
medication and supply dispensing, Alaris® for infusion,
interactive tools and educational events.
AVEA® ventilators, Jaeger® for respiratory diagnostic
instruments, AVAmax® and PleurX® for interventional
cano/acio
procedures, V. Mueller® and Snowden-Pencer® surgical
instruments, and ChloraPrep® skin antiseptic.
Fondée en 1985, l’Association canadienne des infirmières
en oncologie (ACIO/CANO) est un organisme d’envergure
To make global healthcare better, we partner with our
nationale qui appuie les efforts des infirmières du pays en
customers to help them improve medication management,
matière de promotion et développement de l’excellence dans
lower costs in procedural areas, reduce risk of infection,
les soins infirmiers en oncologie et ce, aussi bien sur le plan
advance the care of ventilated patients and turn the endless
de la pratique que sur celui de la formation, de la recherche
amount of data generated in healthcare into actionable
et du leadership. La mission de l’ACIO consiste à développer
information. Learn more at www.carefusion.com
l’excellence infirmière dans le domaine de la lutte contre le
Celgene
cancer pour le bénéfice de la population canadienne ; sa
vision est de devenir un leader international dans le domaine
Celgene Inc. is part of a global, integrated, biopharmaceutical
des soins infirmiers en cancérologie. Nous constituons une
association dirigée pas ses membres qui suit les orientations de company engaged in the discovery, development and
ces derniers lors de l’élaboration des activités et des initiatives. commercialization of innovative therapies designed to
improve the lives of patients dealing with hematological
disorders, cancer and immune-inflammatory related diseases.
The Canadian Association of Nurses in Oncology (CANO/
ACIO) is the national organization that supports Canadian
Cold Comfort Canada INC.
nurses to promote and develop excellence in oncology
nursing pratice, education, research and leadership. CANO/
ACIO’s mission is to lead nursing excellence in cancer control No longer do cancer patients receiving chemotherapy have to
for Canadians, with a vision of being an international nursing suffer the trauma of hair loss.
leader in cancer control. We are a member-run association
We are the exclusive importer and distributor of Paxman Scalp
that takes direction from its members in formulating activities Coolers in Canada. Paxman is the world standard in scalp cooling
and initiatives.
for the prevention of chemotherapy-related hair loss. Paxman
Scalp Cooling Systems have been used by hundreds of thousands
of patients in the UK, where it is offered as the standard of care to
CANADIAN NURSES ASSOCIATION (CNA)
the majority of patients undergoing chemotherapy. Scalp cooling
The Canadian Nurses Association (CNA) is the national
is widely used in the UK and Europe and has been proven to be
professional voice of registered nurses in Canada. A
safe and effective. Paxman Scalp Coolers are now available in
federation of 11 provincial and territorial nursing associations Canada for use in patients wishing to preserve their hair and selfand colleges representing 148,992 registered nurses, CNA
esteem during chemotherapy.
advances the practice and profession of nursing to improve
*Systems available for sale or lease to patients and institutions.
health outcomes and strengthen Canada’s publicly funded
not-for-profit health system.
135
Eisai Limited
GlaxoSmithKline (GSK)
Eisai Limited was established in Canada on April 1, 2010. Our
corporate mission involves giving first thought to patients
and their families and to increasing the benefits health
care provides, a concept called human health care (hhc).
Eisai strives to find and develop new compounds that help
to improve the lives of people. Global research focuses on
the therapeutic areas: neuroscience, oncology & vascular/
immunological reactions. Approved products in Canada:
Aloxi® (palonosetron HCl), which prevents chemotherapyinduced nausea & vomiting, Halaven® (eribulin mesylate),
a chemotherapy used for metastatic breast cancer, Gliadel®
Wafers, implantable chemotherapy for glioblastoma, and
Banzel®, which treats seizures associated.
GlaxoSmithKline (GSK) est un géant pharmaceutique voué
à la recherche dont la mission ambitieuse et Édifiante est
d’amÉliorer la qualitÉ de la vie en aidant les gens à être plus
actifs, à se sentir mieux et à vivre plus longtemps. De cette
mission dÉcoule l’objectif de GSK qui est de concevoir des
médicaments, des vaccins et des solutions de soins de santé
novateurs qui aident des millions de personnes. Pour en savoir
davantage, veuillez consulter le site www.gsk.ca.
Fondation sur La pointe des pieds
La Fondation Sur la pointe des pieds a pour but d’aider les
jeunes atteints par le cancer, à retrouver leur bien-être en
relevant le défi d’une expédition d’aventure thérapeutique
exceptionnelle. Encadrées par des experts du milieu médical
et du plein air, les expéditions ont aussi pour vocation de
changer l’image de la maladie tant auprès des participants
que du public.
The Mission of the On the Tip of the Toes Foundation is
to help young people living with cancer regain their wellbeing by facing the challenge of an exceptional therapeutic
adventure expedition. Supervised by medical and outdoor
experts, these expeditions also aim to change the image of
cancer for the participants and the general public alike.
Fresenius Kabi CANADA
Fresenius Kabi is a leading global health care company focused on
products for the therapy and care of critically and chronically ill
patients inside and outside the hospital. We develop, manufacture
and market pharmaceuticals and medical devices. Our product
portfolio comprises of a comprehensive range of I.V. generic
drugs, infusion therapies and clinical nutrition products as well
as the medical devices for administering these products. Within
transfusion technologies, Fresenius Kabi offers products for whole
blood collection and processing as well as for transfusion medicine
and cell therapies. Fresenius Kabi employs over 30,000 people
worldwide. Visit us at our booth to learn more about Freeflex and
Freeflex+, our new technologically advanced IV infusion bags.
136
GlaxoSmithKline (GSK) is a leading research-based
pharmaceutical company with a challenging and inspiring
mission: to improve the quality of human life by enabling
people to do more, feel better, and live longer. This mission
gives GSK the purpose to develop innovative medicines,
vaccines and healthcare solutions that help millions of people.
Discover more at www.gsk.ca.
ICU Medical INC.
ICU Medical helps you maximize clinician and patient safety
with easy-to-use, needlefree closed systems and closed
system transfer devices (CSTDs) for the safe administration
of hazardous drugs. These needle free solutions help you
minimize exposure to hazardous drugs and maintain drug
sterility while staying in compliance with recommended safe
handling guidelines. www.icumed.com/oncology
INNOVATIVE OncoSolutions Inc.
Innovative OncoSolutions Inc. is proud to be the exclusive
distributor of Equashield II ®, a second generation closed
system drug transfer device (CSTD), in Canada. Our mission
is to provide cost effective technologies and solutions for
use in cancer care providing institutions and/or sterile
compounding facilities. We strive to improve accessibility of
cancer drugs to patients in need. Our solutions enhance the
safety and health of patients and healthcare providers.
JANSSEN INC.
Look Good Feel Better and FacingCancer.ca
Nous mettons la science au service des patients
À titre de membre du groupe des enterprises pharmaceutiques
Janssen de Johnson & Johnson, Janssen Inc. s’emploie à
répondre aux besoins non satisfaits les plus importants de
notre temps. Poussés par notre passion de mettre la science au
service des patients, nous collaborons à de nouvelles solutions,
produits et services pour le bien des patients dans le monde
entier.
FACING CANCER WITH CONFIDENCE
Cancer and its treatment can take a toll on a woman’s
appearance. A free Look Good Feel Better Workshop can
help her look and feel more like herself. This two-hour
workshop is open to women facing any type of cancer and
any type of treatment.
Our purpose: Make a difference
As a member of the Janssen Pharmaceutical Companies of
Johnson & Johnson, Janssen Inc. is dedicated to addressing
and solving the most important unmet medical needs of our
time. Driven by our commitment to the passionate pursuit of
science for the benefit of patients, we work together to bring
innovative ideas, products and services to patients across
Canada and around the world.
Kidney Cancer Canada
Kidney Cancer Canada is a charitable patient-led support
organization established to improve the quality of life
for patients and their families living with kidney cancer.
Kidney Cancer Canada advocates for access to new
treatments, provides support and information to patients,
funds much-needed research, and works to increase
awareness of kidney cancer as a significant health issue.
Our Vision: To improve the lives of Canadians affected by
kidney cancer.
Our Mission: To improve the lives of Canadians affected
by kidney cancer by advocating for access to new
treatments, promoting research, and providing support,
information and education.
The Kidney Cancer Canada Nurses Network (KCCNN)
provides a national resource for nurses, nursing students
and other healthcare professionals working in the field of
renal cell carcinoma.
KCCNN Vision: To connect, educate, support and
facilitate collaboration between nurses practicing in
the field of kidney cancer across Canada, in an effort to
improve patient outcomes.
Workshop participants learn about:
• Cosmetic hygiene
• Skin care
• Cosmetics
• Sun care
• Nail care
• Hair alternatives
Beyond the practical benefits, she will receive warm support
and guidance from our expert volunteers and connect
with other women facing all types of cancer. She will also
take home a complimentary kit of cosmetics and skin care
products to help her face cancer with confidence.
To help your patients find a workshop near them, visit
lookgoodfeelbetter.ca or call 1.800.914.5665.
For even more information and support, visit our online
community at FacingCancer.ca.
LUNDBECK CANADA
Montreal-based Lundbeck Canada, proud sponsor of CANO/
ACIO 2014, is a subsidiary of H. Lundbeck A/S, a leading
international research-based pharmaceutical company. For
more than a decade, Lundbeck has been a respected leader
in developing and bringing central nervous system disorder
treatments to Canadians in a way that reflects our Danish
origins of respecting every individual and taking care of one
another. It is with this mindset that Lundbeck is bringing
new oncology treatments to Canada, wishing to give hope,
strength and humanity to Canadian cancer patients. Visit us
at lundbeck.ca
Lymphoma Canada
Lymphoma affects many people, from patients, family
and caregivers, to medical professionals and researchers.
Lymphoma Canada connects and empowers this community
through education, support and research. Together we
are promoting early detection, finding new and better
treatments, helping patients access those treatments,
learning lymphoma’s many causes and finding a cure. For
more information about this registered charity, please visit
lymphoma.ca or call 1-866-659-5556.
137
The Leukemia and Lymphoma Society of
Canada
The Leukemia & Lymphoma Society of Canada® (LLSC) is a
voluntary health agency dedicated to blood cancer. The LLSC
mission: Cure leukemia, lymphoma, Hodgkin’s disease and
myeloma, and improve the quality of life of patients and their
families. LLSC funds lifesaving blood cancer research across
Canada and provides free information and support services.
Founded in 1955, LLSC has offices across Canada. To learn
more, visit www.llscanada.org or contact 1-877-668-8326.
Merck
La société Merck d’aujourd’hui est un chef de file mondial
dans le domaine des soins de santé qui vise à aider le monde
à vivre mieux. Grâce à nos médicaments, vaccins, traitements
biologiques, produits de santé grand public et de santé
animale, nous collaborons avec nos clients et œuvrons à
procurer des solutions de santé novatrices dans plus de 140
pays. Pour de plus amples renseignements à propos de nos
activités au Canada, visitez le site www.merck.ca
Today’s Merck is a global healthcare leader working to help
the world be well.
Through our medicines, vaccines, biologic therapies, and
consumer and animal products, we work with customers
and operate in more than 140 countries to deliver innovative
health solutions. For more information about our operations
in Canada, visit www.merck.ca
Oncology Nursing Society
The Oncology Nursing Society (ONS) is a professional
organization of more than 35,000 registered nurses and
other healthcare providers dedicated to excellence in
patient care, education, research, and administration in
oncology nursing. The overall mission of ONS is to promote
excellence in oncology nursing and quality cancer care.
ONS is also a full-service publisher, with book titles in
symptom management, chemotherapy administration, and
survivorship, and will provide a bookstore for CANO/ACIO
members in the exhibit hall.
Pfizer Canada INC.
Pfizer Canada Inc. is the Canadian operation of Pfizer Inc.,
one of the world’s leading biopharmaceutical companies.
Our diversified health care portfolio includes some of the
world’s best known and most prescribed medicines and
vaccines. Every day, Pfizer Canada employees work to bring
therapies to patients that significantly improve their lives. The
company is a major contributor to health research in Canada.
We apply science and our global resources to improve the
health and well-being of Canadians at every stage of life. Our
commitment is reflected in everything Pfizer does, from our
disease awareness initiatives to our community partnerships,
to our belief that it takes more than medications to be truly
healthy. To learn more about Pfizer’s More than Medication
philosophy and programs, visit www.morethanmedication.
ca. To learn more about Pfizer Canada, visit pfizer.caor you
can follow us on Twitter (twitter.com/PfizerCA) or Facebook
(facebook.com/Pfizer.Canada).
Roche
From our approach to clinical trials for new drug therapies,
to industry partnerships and community involvement, Roche
Canada is a leader in providing pharmaceutical and diagnostic
solutions that make a profound difference in people’s lives.
Our innovative approach improves the effectiveness and
efficiency of the healthcare system in the diagnosis, treatment
and management of acute and long-term disease.
Roche Canada employs approximately 1,000 people across
the country, with its pharmaceuticals head office located in
Mississauga, Ontario and diagnostics division based in Laval,
Quebec. We serve a broad base of healthcare facilities and
practitioners across the country, working in partnership with
them to ensure that the diagnostics and therapies we deliver
meet the medical needs of today and of the future. For more
information, please visit www.rochecanada.com
Shoppers Drug Mart Specialty
health network
Shoppers Drug Mart Specialty Health Network (SDMSHN) is a
Canadian specialty healthcare company that delivers superior
service to our customers optimizing healthcare outcomes.
Our integrated national network of infusion/injection clinics,
specialty pharmacies and healthcare professionals place
patients at the centre of care, delivering the support they need
to start and stay on therapy. Operating from our main facility in
Mississauga and complying with all Health Canada regulations
SDMSHN provides:
• National infusion/injection clinics
• Integrated specialty pharmacy
138
• Patient assistance solutions
• Customized national wholesaling and
distribution strategies
• eSHN - Sales Solutions
Takeda
Better Health. Brighter Future.
For more than 230 years, Takeda has been serving society
with innovative medicines and helping patients reclaim
valuable moments of life from illness. Now, with new
healthcare solutions from prevention to care and cure, we
are determined to help even more people enjoy their lives
to the fullest. www.takedacanada.com
SPHINX MEDICAL INC.
Sphynx Médical est une entreprise qui se spécialise dans
l’importation et la commercialisation de produits médicaux
innovateurs. Nous distribuons, entre autres, deux produits
destinés à l’oncologie : l’équipement de refroidissement du
cuir chevelu DigniCap et le système de scellage de produits
toxiques Pactosafe.
Sphynx Medical is specialized in the importation and the
commercialization of innovative medical products. We
distribute, among others, two products for oncology: the
Dignicap scalp cooling system and the Pactosafe sealing
system for toxic products.
Trudell medical marketing limited
Trudell Medical Marketing Limited (TMML) is a leading
specialty sales and marketing company, supporting the
Canadian hospital market with its national reach and
clinically knowledgeable staff.
TMML is committed to selling, servicing and distributing
technologically advanced critical care and respiratory
product solutions and state of the art operating room
equipment to hospitals across Canada.
Our reputation is based on innovation, service and the
experience to provide our customers with specialized
healthcare solutions. We are dedicated to provide our
customers with specialized health care solutions. We are
dedicated to the continuous improvement of our products
and services and take comfort in knowing our products
make a difference to the delivery of superior patient care.
We all have
commitments
Ours are tO Canadians
fa C i n g s e r i O u s d i s e a s e s
at Bristol-Myers squibb Canada, we are committed to
helping Canadians prevail over serious diseases such as
cancer, diabetes, HiV/aids, heart disease, rheumatoid
arthritis, hepatitis B and psychiatric disorders.
We’re a long-established and experienced company
in research and development that has been helping
Canadians for more than 85 years, working to meet
today’s health challenges with the agility, innovation
and spirit of a young biotech company, discovering
and developing vital new treatments.
That’s why we call ourselves
The nexT-generaTion BioPharma leader.
We’re committed to delivering the new
medicines Canadians need, to research
and to the newest technology.
We’re meeting
our commitments
to Canadians.
Find out more about us
Visit www.bmscanada.ca
Publicité_BMS_AN_v1.indd 1
11-01-26
1391:31 PM
carte de Québec/quebec map
Hilton Québec
1100, boulevard René-Lévesque Est
Québec (Québec)
G1R 4P3 Canada
© 2014 Pfizer Canada Inc. Kirkland, Quebec H9J 2M5
FRAGMIN ® Pfizer Health AB, owner/Pfizer Canada Inc., Licensee
® Pfizer Inc, used under license
FRA_Booth_Poster_E.indd 1
14-08-15 11:44 AM
LES PERCÉES MÉDICALES VOIENT PEUT ÊTRE
LE JOUR DANS LE LABORATOIRE,
MAIS C’EST DANS LE CŒUR
QU’ELLES PRENNENT NAISSANCE.
Depuis plus de 150 ans, une passion unique en son genre anime
les gens de Merck. Nous avons pour objectif de mettre au
point des médicaments et des vaccins ainsi que des produits
grand public et des produits de santé animale novateurs qui
amélioreront la vie de millions de personnes. Oui, il y a encore
tant à faire, mais le travail est déjà bien amorcé, conformément à
notre engagement de longue date à l’égard de la recherche et du
développement. Et cet engagement n’a d’égal que notre résolution
à élargir l’accès aux soins de santé et à collaborer avec ceux qui
partagent notre passion pour la création d’un monde en meilleure
santé. Ensemble, nous relèverons ce défi. De tout notre cœur!
©2014 Merck Sharp & Dohme Corp., filiale de Merck & Co., Inc. Tous droits réservés.
L'AUTRE VISAGE
DU CANCER
THE OTHER FACE
OF CANCER
Grâce à ses ateliers, Belle et bien dans sa peau aide chaque année des milliers de femmes à
atténuer les effets que les traitements peuvent avoir sur leur apparence. Ces ateliers gratuits
de deux heures permettent à des femmes atteintes de cancer de reprendre le contrôle de leur
image, de partager leur histoire et de se sentir bien.
Visitez le kiosque de Belle et bien dans sa peau pour une mini-séance de maquillage gratuite
et un cadeau. Vous serez en mesure de comprendre la grande portée de gestes simples
remplis d'espoir.
Each year, Look Good Feel Better workshops help thousands of women manage the effects that
cancer and its treatment can have on their appearance. It’s an empowering free 2-hour cosmetic
and hair workshop for women with cancer that also provides a forum for them to share their stories
and feel good – from the inside out.
Visit the Look Good Feel Better booth for a free mini-makeover and gift,
and find out how sometimes the little things can make a big difference.
TM
N° D’ORGANISME DE BIENFAISANCE / REG CHARITY #13374 0316 RR0001
This is what Mary’s
looks like
Prendre soin n’a pas la même signification pour tout le monde.
Voilà pourquoi le Réseau de santé spécialisé de SDM offre des
services spécialisés dans les communautés partout au Canada
grâce à ses Centres de soins spécialisés intégrés.
Care doesn’t look the same for everyone. That’s why SDM
Specialty Health Network is bringing specialized services to
communities across Canada through our Integrated Specialty
Care Centres.
C’est pour cette raison que fournir l’accès à des soins plus
près du domicile est notre spécialité.
It’s why we make bringing care closer to home our specialty.
LES SOINS
SONT NOTRE
RAISON D’ÊTRE
© 2014 Shoppers Drug Mart Specialty Health Network
CARE
IS AT OUR CORE
1-855-454-3800
■
sdmshn.ca
50K
Start Strong with Nutrition
Stay Strong through Treatment
Early nutrition intervention can help: 1-6
• prevent lean body mass
and weight loss
• increase patient
quality of life (QOL)
• minimize treatment disruptions
• improve survival rates
Recommend Ensure Plus Calories as part of a nutrient-rich diet
2 bottles of Ensure Plus Calories provide:
• 710 calories
• 27 g protein
• 26 vitamins and minerals, including iron, zinc, and vitamin B12
1 National Cancer Institute: Nutrition Therapy. http://www.cancer.gov/cancertopics/pdq/supportivecare/nutrition/HealthProfessional/
page4, Last Modified: 02/26/2014. Accessed March 13, 2014. 2 National Cancer Institute: Tumor-induced Effects on Nutritional
Status. http://www.cancer.gov/cancertopics/pdq/supportivecare/nutrition/HealthProfessional/page2, Last Modified: 02/26/2014.
Accessed March 13, 2014. 3 Ravasco P et al. Head and Neck 2005;27:659-68. 4 Odelli C et al. Clinical Oncology 2005;17:639·45.
5 Ravasco P et al. J Clin Oncol 2005;23:1431-8. 6 Bosaeus I et al. J. Nutr. 2002;132:3465S–6S.
© Abbott Laboratories, Limited
ENS/921A08-August 2014 - 00491
00491 - ANI2014-08-18 - Ensure Oncology CANO Print Ad v4.indd 1
CANCER TAKES.
ET # 00491 - ANI2014-08-18
18
2014-08-21 2:18 PM
DESIGNER
APPROVALS
Client
FILE NAME
STEPHANE B. Ensure Oncology CANO Print Ad
Coordinator
TPUT
VENDOR NAME
CMS
th Vendor
N/A
N/A
PE
# OF COLOURS
4
Graphic Designer Colour Break
COLOUR BREAK BOX
Date
TYPE OF COMMODITY:
N/A
BAYER GIVES.
Date
Date
COLOURS
4-Colour Process (CMYK)
INVENTORY CODE
MATERIAL COLOUR
N/A
White
ONS
ADDITIONAL INFORMATION
5” x 5.5”
N/A
ATOR
CLIENT
hibault
Antoinette Dacoulis
PROOF VERSION
4
DELTA VALUE
PROCESS
L
A
B
PMS
L
Cyan
55
-37
-50
N/A
N/A
Magenta
48
74
-3
N/A
N/A
Yellow
89
-5
93
N/A
N/A
Black
16
0
0
N/A
N/A
NOTE: LAB colour values will ONLY be used by Vendors
to match Abbott colours on press sheet.
N/A: Not Applicable
Vendor must not change file
without prior approval from
Abbott Graphic Designer
Our hope is that through research,
we will be able to help those with cancer enjoy their lives to the fullest.
www.bayer.ca
® Bayer and Bayer Cross are registered trademarks of Bayer AG, used under licence by Bayer Inc.
One of a thousand reasons
to look for Astellas in oncology.
Astellas Pharma Canada is a proud sponsor of the
CANO/ACIO 2014 Conference.
© 2014 Astellas Pharma Canada, Inc. All rights reserved.
Spray Kit – Multiple uSe
20% Benzocaine Oral Anaesthetic
• Eliminatespainanddiscomfort
• Fastonset(20seconds)
• Shortduration(15minutes)
• Safe–availableoverthecounter
• Bestvalueamongtopicalanaesthetic
sprays
• GreatWildCherryflavour!
1/2
SECOND
SPRAY
is all it
takes!
Spray
ORDERING INFORMATION
Spray Kit – 2 oz. spray can and 200 disposable extension tubes
NDC 0283-0679-60
Spray – 2 oz. spray can and 1 disposable extension tube
NDC 0283-0679-02
Extension tubes – Box of 200 disposable extension tubes
Product number 0283-1185-20
extension tubes
QuicKly eaSe your
patientS’ oral pain
20% Benzocaine for fast, temporary relief of occasional minor
irritation and pain associated with sore mouth, gums and throat.
EFFECTIVE
Trusted by medical and dental
professionals for over 40 years
FAST-ACTING
Relief in 15 to 30 seconds
BUY 1 HURRICAINE TOPICAL
ANESTHETIC LIQUID AND GET 1 FREE!*
SAFE
Virtually no systemic absorption
Magic Mouth Rinse
VERSATILE
May be used alone as a rinse
or in one of the “Magic Mouth
Rinse” Recipes below
PLEASANT TASTING
Available in Original Wild Cherry
and Piña Colada flavours
QUICK TIP:
For patients experiencing mucositis or difficulty eating and drinking due
to oral pain, recommend HurriCaine® OTC “Magic Mouth Rinse.” This
mixture of over-the-counter ingredients provides fast, temporary relief
so your patients can maintain nutrition and fluid intake comfortably. For
patients experiencing oral thrush, try the Rx recipe for added relief.
HurriCaine OTC “Magic Mouth Rinse” Recipe
HurriCaine Rx “Magic Mouth Rinse” Recipe
• 15mL(1tablespoon)HurriCaineTopicalAnestheticLiquidOriginal Wild Cherry flavour
• 90mL(6tablespoons)liquidBenadryl®*
• 90mL(6tablespoons)Maalox®**
• 15mL(1tablespoon)HurriCaineTopicalAnestheticLiquidOriginal Wild Cherry flavour
• 30mL(2tablespoons)NystatinOralSuspensionUSP
• 90mL(6tablespoons)Maalox®**
Instructions:
• Mixingredientsthoroughly
• Swish,gargle,expectorateorswish/swallow1teaspoonofmixture
• Waitoneminutebeforeeating
Instructions:
• Mixingredientsthoroughly
• Swish,gargle,expectorateorswish/swallow1teaspoonofmixture
• Waitoneminutebeforeeating
For the temporary relief of oral pain associated
with stomatitis, mucositis and mouth ulcers
LLC
For the temporary relief of oral pain associated with oral thrush
*Specify your flavour of choice. Qualifying purchase must be on same order. To receive your free goods, please send a copy of your qualifying invoice dated
October 26 - November 2, 2014 to: Accellor Medical Inc., 490 Sheldon Drive, Unit 12, Cambridge, ON N1T 2C1, or fax to 1-866-703-5339. Questions?
Contact your Canadian Representative at 1-519-766-6343. www.beutlich.com. HurriCaine is a registered trademark of Beutlich Pharmaceuticals, LLC.
*Benadryl is a registered trademark of Pfizer Consumer Healthcare Inc. **Maalox is a registered trademark of Novartis Consumer Health Inc. CHA 698 0614
We take cancer personally
Patients are at the heart of everything we do
at Roche.
They motivate and inspire us to continue our
research with the goal of transforming the
lives of people with cancer around the globe.
We’ve come a long way, but there’s still a long
way to go.
© Copyright 2013, Hoffmann-La Roche Limited
Hoffmann-La Roche Limited
Mississauga, ON L5N 6L71
Le patient partenaire
Patient Engagement
26–29 Octobre 2014 | October 26–29 2014
Ville de Québec, Québec | Quebec City, Quebec
Hilton Québec
www.cano–acio.ca

final program pdf

Transcription

Documents pareils

SOIRÉE 1 – 27.04.2016

Researchers and Productivity Metrics: The Tail That Wags the Dog?

la dematerialisation

Blue Cross Optional Extended Health Care Plan (Part 2) Election

Registered Nurse (RN) 185 Despins

Care Au-Pair - Care Concept

Feuille: Care eurf Daniel Chany Veolia-Etude1-RAD-volumes

Assemblée publique du comité de lutte en santé

Appartement à louer Paris Porte de Versailles Cabinet CIME